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resumo 
 
 
O elevado número de gravidezes indesejadas a nível mundial (~41%) reflete a 
necessidade premente de novos métodos contracetivos. Para já, os 
contracetivos masculinos estão limitados ao preservativo, ao coito interrompido 
e à vasectomia dado que ainda não existem métodos farmacológicos 
disponíveis. Por outro lado, nos países desenvolvidos, 15% dos casais são 
inférteis e, em metade dos casos, as causas estão relacionadas com fatores 
masculinos, sendo a infertilidade idiopática o tipo mais comum de infertilidade 
masculina. Os principais objetivos deste trabalho consistiram em (1) identificar, 
caracterizar e modular alvos não-hormonais para a contraceção masculina; e 
(2) estabelecer um conjunto de biomarcadores para avaliar a fertilidade 
masculina. No que toca à identificação de alvos para a contraceção masculina, 
foi dada especial atenção a duas proteínas e aos seus interactors: a 
fosfoproteína fosfatase 1 (PPP1) e a proteína percursora amilóide (APP). 
Caracterizámos o interactoma da subunidade catalítica gama 2 da PPP1 
(PPP1CC2), uma isoforma específica do testículo e espermatozoide. 
Demonstrando, pela primeira vez, a interação entre a PPP1CC2 e a A-kinase 
anchor protein 4 (AKAP4), uma proteína expressa especificamente no testículo 
essencial para a motilidade do espermatozoide, e o potencial desse complexo 
como alvo contracetivo. A motilidade do espermatozoide foi, então, modulada 
eficazmente recorrendo a cell penetrating peptides (CPPs) como sistemas de 
transporte intracelular de sequências peptídicas direcionadas para padrões 
únicos de interações proteicas. Um outro interactor da PPP1CC2, a several 
ankyrin repeat protein variant 2 (SARP2), foi também caracterizado em 
testículo e espermatozoide. Descrevemos ainda, o interactoma da APP em 
testículo e espermatozoide humano sendo que a nossa abordagem permitiu a 
identificação de novos interactores e o reconhecimento de interactores-chave 
na fertilidade masculina, particularmente na interação espermatozoide-oócito, 
o que representa um potencial mecanismo alvo para a contraceção masculina. 
Identificámos diversas proteínas sinalizadoras cuja atividade se correlaciona 
com parâmetros seminais distintos, tendo o potencial para integrar uma 
plataforma de diagnóstico que poderá ter várias aplicações: explicar situações 
de infertilidade idiopática; explicar o insucesso de técnicas de procriação 
medicamente assistida (PMA) ou abortos de repetição; auxiliar a escolha da 
técnica de PMA mais apropriada; avaliar a eficácia de intervenções médicas; e 
clarificar os mecanismos responsáveis pela deterioração da qualidade dos 
espermatozoides associada com a idade. Para além do potencial para integrar 
um painel de biomarcadores, essas proteínas permitiram o reconhecimento de 
vias de sinalização responsáveis por regular funções específicas do 
espermatozoide que podem ser utilizadas com fins terapêuticos. 
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abstract 
 
The large number of unintended pregnancies worldwide (~41%) highlights the 
need for new contraceptive methods. Still, male contraceptive methods are 
limited to condoms, withdrawal or vasectomy as, currently, no pharmaceutical 
contraceptive agents exist for men. In contrast, in developed countries, 
infertility affects 15% of couples attempting to conceive and in half of these 
cases the cause is related to male reproductive issues. Moreover, idiopathic 
infertility remains the most common type of male infertility. 
The main goals of this work were to (1) identify, characterize and modulate 
non-hormonal targets for male contraception; and (2) establish a biomarker 
“fingerprint” to assess male fertility. Concerning the identification of targets for 
male contraception, particular attention was given to two distinct proteins and 
its interacting partners: phosphoprotein phosphatase 1 (PPP1) and amyloid 
precursor protein (APP). We characterized the interactome of PPP1 catalytic 
subunit gamma 2 (PPP1CC2), a testis-enriched/sperm-specific PPP1 isoform, 
in human testis/spermatozoa. We demonstrated for the first time the interaction 
between PPP1CC2 and A-kinase anchor protein 4 (AKAP4), a testis-specific 
protein essential for sperm motility, in human spermatozoa and the potential of 
the complex as a contraceptive target. Sperm motility was then successfully 
modulated by specific protein complex disruption using cell-penetrating 
peptides (CPPs) as a drug intracellular delivery system. Herein, we 
demonstrated for the first time the potential of CPPs to deliver peptide 
sequences that target unique protein-protein interactions in spermatozoa. 
Another PPP1CC2 interacting protein – several ankyrin repeat protein variant 2 
(SARP2) – was also characterized in testis and spermatozoa. Moreover, we 
provided the first report on APP interactome in human testis/spermatozoa and 
our approach allowed the identification of novel interactions and the recognition 
of key APP interacting proteins for male reproduction, particularly in sperm-
oocyte interaction, which represent a potential mechanism for male 
contraception modulation. 
We identified several signaling proteins that showed a high degree of 
differential activity in spermatozoa samples with distinct seminal parameters 
and have the potential to integrate a diagnostic array, which may have several 
applications: explain idiopathic infertility, failure in assisted reproductive 
techniques (ART) or repeated abortion; choice of the appropriate ART; assess 
the efficacy of medical interventions; and clarify the mechanisms responsible 
for age-dependent declines in spermatozoa quality. Besides the potential to 
integrate a biomarker "fingerprint" to assess sperm quality, those proteins 
allowed the recognition of the signaling pathways accountable for regulating 
specific spermatozoa functions that by future modulation could serve for 
therapeutic proposes. 
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1.!Male Reproductive System 
The male reproductive system consists of two testes, a system of genital ducts, the accessory glands 
and the penis. This system produces spermatozoa (spermatogenesis) and male sex hormones 
(steroidogenesis) and delivers the male gametes into the female reproductive tract. 
1.1.!Testis 
Testes are oval structures housed in separate compartments within the scrotum (Figure A.1 A). The 
testicular parenchyma is composed of highly convoluted seminiferous tubules (1 to 3 in each lobe) 
where the production of spermatozoa occurs, and by interstitial tissue that surrounds the tubules, 
containing the Leydig cells that secrete testosterone (Figure A.1 B). The seminiferous epithelium is 
composed of sustentacular Sertoli cells and a stratified layer of developing male germ cells 
(spermatogonia, spermatocytes, and spermatids; see section 2.3.2.1.) 1,2.  
 
Figure A.1 - Testis (A) Cross-section showing the location of the seminiferous tubules, the vas deferens and the 
epididymis. (B) Schematic cross-section of a testicular tubule, illustrating the germ cells at different stages of maturation 
embedded in somatic Sertoli cells (outlined). Leydig cells are present in the interstitium. Maturing sperm are shown in 
the lumen of the tubules. 
1.1.1.!Sertoli Cells – The supporting cells 
Sertoli cells provide the structural organization of the seminiferous tubules 3. These cells do not 
replicate after puberty and their number determines the testicular size, germ cell numbers and 
spermatozoa output 4,5. Sertoli cells are involved in (i) mechanical support and nutrition of germ 
cells, (ii) paracrine regulation of male germ cell proliferation and differentiation by secretion of 
regulatory proteins, including growth factors and hormones, (iii) phagocytosis, (iv) steroid 
hormone synthesis and metabolism, and (v) maintenance of the integrity of the seminiferous 
epithelium by establishing the blood-testis barrier 5. The adjacent Sertoli cells establish tight 
junctions forming the blood-testis barrier, dividing the seminiferous tubule into two compartments: 
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the basal containing the stem cells and the pre-meiotic cells (spermatogonia) and the adluminal 
including the meiotic (spermatocytes) and the post-meiotic (round and elongating spermatids) cells; 
thus protecting the differentiating germ cells from an immune response 6. 
1.1.2.!Leydig Cells – The interstitial cells 
Leydig cells lie within the intertubular region of the testis and are found adjacent to the blood 
vessels, reflecting their endocrine function. They are responsible for testosterone production, which 
is essential for spermatogenesis. In most species there are two generations of Leydig cells 7–9. A 
fetal generation under the stimulation of human Chorionic Gonadotropin (hCG) results in the 
production of testosterone during gestation in humans. These cells decrease in number and are lost 
from the intertubular space around twelve months of age 10. The adult generation of Leydig cells in 
humans results from Luteinizing Hormone (LH) stimulation which starts at puberty 11. 
1.2.!Genital ducts 
A system of genital ducts conveys the spermatozoa and the fluid that composes semen to the 
outside. The seminiferous tubules are connected by short straight tubules, the tubuli recti. From 
here, spermatozoa enter the ductuli efferentes that lead into the epididymis and then the vas 
deferens, where the seminal vesicle empties its secretions. The continuation of the duct, known as 
ejaculatory duct, enters the prostatic gland, which delivers its secretory product. Both ejaculatory 
duct (right and left) empty into the urethra, which conveys semen to the outside. 
1.2.1.!Epididymis 
The human epididymis is a long convoluted tubule that serves as a conduit for the transport of 
spermatozoa from the testis to the vas deferens and is the site where spermatozoa mature and 
acquire progressive motility (see section 2.4.1.) and fertility 12. Additionally, the epididymis has a 
role in: reabsorption of fluid from seminiferous tubules, elimination of defective male gametes, and 
sperm protection against oxidative damage 12,13. The epididymis can be divided into three major 
segments – caput (head), corpus (body) and cauda (tail) 14. 
The adult epididymis consists of a pseudostratified columnar epithelium of several cell types: 
principal (80%), basal, clear, narrow, apical and halo cells (Figure A.2). The principal cells are 
columnar with non-motile cilia and are responsible for most of the proteins secreted into the 
luminal fluid. Narrow and apical cells are found predominantly in the proximal and mid region of 
the caput, whereas the rest are present along the epididymis. Clear cells are also endocytic cells and 
together with the apical cells could be responsible for the endocytosis of proteins from the lumen. 
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The shorter, pyramid-shaped cells called basal cells lie under the principal cells and do not have 
access to the luminal compartment, nevertheless they may regulate the functions of the principal 
cells. Halo cells appear to be the primary immune cells of the epididymis. Principal cells form tight 
junctions to create an immunoprotective site within the epididymal lumen necessary for sperm 
maturation that is called blood-epididymis barrier 15. 
 
Figure A.2 - Schematic representation of a cross-section of the mammalian epididymis. Adapted from 14,16. 
 
The epididymal environment (extracellular milieu, also called epididymal fluid) is certainly the 
most sequentially modified and complex milieu of the body in which spermatozoa are bathed for 
the duration of the transit (in average from 3 to 11 days in humans) through this environment 17. 
The epididymal fluid consists of water, inorganic ions, small organic molecules, and organic 
macromolecules (proteins) 17,18. 
1.3.!Spermatozoa 
Germ cells divide and differentiate from spermatogonia to spermatozoa through a process that 
occurs in seminiferous tubules of the testis, designated spermatogenesis (see section 2.3.2.1.). In 
humans, the release of spermatozoa occurs in the early stages of puberty at approximately 13.5 
years of age, and spermatogenesis continues throughout life 19. 
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1.3.1.!Spermatozoa structure 
Sperm may be divided into two regions, the head and the flagellum (Figure A.3). Both are covered 
by the plasma membrane. The head comprises a nucleus, in which the DNA condensing core and 
linker histones have been partially replaced during spermiogenesis by protamines, positively 
charged DNA proteins that enable nuclear hypercondensation 20,21. In humans, sperm chromatin is 
tightly packaged by protamines, but up to 4% of the DNA remains packaged by histones 22. The 
histone-bound DNA sequences are less tightly compacted and are correlated with early embryo 
development 22. Infertile men have a higher sperm histone to protamine ratio when compared with 
fertile controls 23. The nucleus is covered by a reduced nuclear envelope, from which the nuclear 
pore complexes have been removed during spermiogenesis, except for the redundant nuclear 
envelopes (RNEs) found in some species at the base of the sperm nucleus 24. Sperm nucleus is 
protected by the perinuclear theca, forming a rigid shell composed of disulfide (SS) bond-stabilised 
structural proteins combined with various other proteins 25. The acrosome is a Golgi-derived 
structure that covers the anterior half to two thirds of the head 26. The inner and outer acrosomal 
membranes hold inside a dense acrosomal matrix containing the proteases that are believed to 
digest a fertilization slit in the zona pellucida 27. The equatorial segment is a folded-over complex 
of perinuclear theca, inner and outer acrosomal membranes, which carries receptors involved in the 
initial binding of the sperm to the oocyte plasma membrane. The postacrosomal sheath is believed 
to contain a complex of sperm borne, oocyte-activating factors (including phospholipase C ζ, 
PLCζ). 
The flagellum provides a motile force for the spermatozoon, which is based upon a 9 plus 2 
arrangement of microtubules within the flagellar axoneme 28. Inner and outer dynein arms project 
from each of the outer doublets, these arms being responsible for generating the motive force of the 
flagellum. Nine radial spokes, each deriving from one of the outer microtubular doublet pairs, 
extend inwards towards the central pair in a helical fashion 29. The flagellum can be divided in 
connecting piece, midpiece, principal piece and endpiece. From the remnant of the centriole at the 
connecting piece the axoneme extends throughout the length of all subdivisions of the sperm 
flagellum. The mid-piece presents nine outer dense fibers (ODFs) surrounding each of the nine 
outer axonemal microtubule doublets, and a mitochondrial sheath (MS) that encloses the ODFs and 
the axoneme. While the MS is restricted to the mid-piece, the ODFs extend into the principal piece 
of the flagellum. The end of the mid-piece and the beginning of the principal piece are marked by 
the annulus 30. At the start of the principal piece, the MS terminates and two of the ODFs are 
replaced by two longitudinal columns of fibrous sheet (FS). The most abundant protein present in 
the FS is A-kinase anchor protein 4 (AKAP4), a PKA-anchoring testis-specific protein 31. The FS 
columns run the length of the principal piece and are stabilized by circumferential ribs that 
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surround the ODFs. The FS is the only structure that is restricted to the principal piece. The end-
piece is the short terminal portion of the flagellum and has only the axoneme surrounded by the 
plasma membrane 30. While the axoneme is highly conserved in ciliated eukaryotic cells, the ODFs, 
MS and FS are accessory structures that are exclusive to mammalian spermatozoa 30. 
 
Figure A.3 - Schematic representation of the mammalian spermatozoa and the ultrastructure of the flagellum. (A) 
Mammalian spermatozoa flagellum is divided structurally into four areas: the connecting piece, mid-piece, principal 
piece and end-piece. The end of the mid-piece and start of the principal piece are demarcated by the annulus. (B) Cross-
section through the mid-piece showing the plasma membrane (PM) and mitochondrial sheath (MS) surrounding the nine 
outer dense fibres (ODFs). Within the ODFs are the components of the axoneme; the nine outer microtubule doublets of 
the axoneme (OMDA) with associated dynein arms (DA) and radial spokes (RS) and the central pair of microtubule 
doublets (CP). (C) Cross-section through the principal piece showing the PM surrounding seven ODFs. The ODFs 3 and 
8 have been replaced by the two longitudinal columns of the fibrous sheath (LC). The two columns are connected by 
transverse ribs (TR). The axonemal components are unchanged. (D) Cross-section through a representative segment of 
the end-piece showing the PM surrounding the axoneme. Adapted from 16 
1.3.2.!Epididymal maturation and storage 
In mammals, testicular spermatozoa are immotile and incapable of fertilizing the oocyte. During 
epididymal transit, spermatozoa are subjected to a sequentially changing environment where their 
function is modified as they undergo complex membrane remodeling and protein acquisition 14. 
Such properties acquired during maturation include progressive motility (see section 2.4.1.). The 
changes that occur in spermatozoa during the epididymal transit are related to protein exchanges 
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with the epididymal lumen or with modifications of the protein repertoire (e.g. post-translational 
modifications, PTMs). Epididymosomes are the key players in the protein exchange process 
between epididymal lumen and spermatozoa thereby protecting the proteins against the luminal 
proteases 17. Several epididymosomal proteins that are transferred to spermatozoa have functions 
related to immunological protection, sperm motility (see section 2.4.1.) or as decapacitation factors 
17,18.  
The cauda region in many mammals acts as a site for sperm storage until ejaculation. The human 
epididymis does not present such clearly defined sections in comparison to other species and lacks 
a pronounced cauda region decreasing the storage capacity 14. In humans, the sperm number after 
ejaculation can increase from 50 millions after 1 day to 300 millions after 10 days of abstinence. 
Beyond this time ejaculate sperm numbers remain constant as the epididymis is filled and sperm 
start to enter in the urine 17. 
1.4.!Ejaculation and seminal components 
Ejaculation results from a coordinated contraction of the smooth muscle surrounding the 
epididymis cauda and vas deferens 32. During ejaculation sperm cells are suspended in seminal 
plasma, which originates from the accessory sex glands (seminal vesicles, prostate, Cowper and 
Littre glands) 33. The seminal vesicles provide the majority of ejaculate volume rich in bicarbonate, 
prostaglandins, antioxidants, fructose, ascorbic acid, as well as, seminogelin I and II 34. 
Approximately 5% of the ejaculate results from secretions from the Cowper (bulbourethral) and 
Littre glands. The prostate provides secretions with zinc, citric acid, prostate specific antigen (PSA) 
and choline. PSA helps to liquefy the semen following ejaculation as it degrades Semenogelin (I 
and II) 34. The epithelial cells lining the prostate also secrete small membrane-bound vesicles called 
prostasomes. Prostasomes contain over 400 proteins 35 and are capable of undergoing hydrophobic 
fusion with sperm transferring their contents into the cell 36,37. The presence of prostasomes has 
been associated with beneficial effects on sperm motility 38,39. A small contribution is made from 
epididymal fluid containing carnitine inositol and potassium.   
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2.!Protein-Protein Interactions - no protein is an island 
2.1.!PPI determination, databases, networks and modulation 
Cells use different mechanisms, such as PTMs and protein-protein interactions (PPIs), to regulate 
its signal cascades 40. Phosphorylation is one of the most common PTMs and it functions by 
inducing conformational changes in a target protein or changing the accessibility between enzyme 
and interacting protein 41.  
PPIs are defined as physical contacts with molecular docking between proteins that occur in living 
organism and can be defined as permanent or transitory. The transient interactions would form 
signaling pathways while permanent interactions will form a stable protein complex. Stable protein 
assemblies include macromolecular protein complexes and cellular machines, such as ATP 
synthase (eight different proteins in mammals) or cytochrome oxidase (13 proteins in mammals). 
Another essential element for defining PPIs is the biological context. Not all possible interactions 
will occur in any cell at any time. Instead, interactions depend on cell type, cell cycle phase, 
development stage, environmental conditions, protein modifications (e.g., phosphorylation), 
presence of cofactors, and presence of other binding partners. PPIs can (i) change the kinetic 
properties of enzymes; (ii) act as a general mechanism to allow for substrate channeling; (iii) 
construct a new binding site for small effector molecules; (iv) inactivate or suppress a protein 
activity; (v) modify the specificity of a protein for its substrate through interaction with distinct 
binding partners; (vi) serve a regulatory role in either upstream or downstream level 42. 
Within the last years a large amount on PPI has been obtained both by in vitro (e.g. 
coimmunoprecipitation) and in vivo (e.g. Yeast two-hybrid, see section 2.2.) high-throughput and 
small technologies, as well as, in silico approaches (e.g. domain-pairs-based sequence approach) 43. 
The massive quantity of PPI data being generated on the last decades has led to the creation of 
biological databases in order to organize this data. A comparison of the main databases and 
repositories that include protein interactions is shown in Table A.1. 
Table A.1 - Main public PPI databases: (i) primary databases, which include PPIs from large- and small-scale (Lsc and 
Ssc) experimental data that are usually obtained from curation of research articles; (ii) meta-databases, which include 
PPIs derived from integration and unification of several primary repositories; and (iii) prediction databases, which 
include PPIs from experimental analyses together with predicted PPIs obtained from the analyses of heterogenous 
biological data. PPI databases containing only yeast and microbial data were excluded (adapted from 44). 
Primary DB Full name URL PPI sources Species Type of MI R 
BIND 
Biomolecular 
Interaction 
Network Database 
http://bond.unleashed
informatics.com/Acti
on Ssc & Lsc published studies 
(literature-
curated) 
All PPIs and others 45 
BioGRID 
Biological General 
Repository for 
Interaction Datasets 
http://thebiogrid.org All PPIs and others 46 
DIP Database of http://dip.doe- All Only PPIs 47 
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Interacting Proteins mbi.ucla.edu/dip/Mai
n.cgi 
HPRD Human Protein Reference Database http://www.hprd.org Human Only PPIs 
48 
IntAct 
IntAct Molecular 
Interaction 
Database 
http://www.ebi.ac.uk/
intact/ All PPIs and others 
42 
MINT 
Molecular 
INTeraction 
database 
http://mint.bio.uniro
ma2.it/mint All Only PPIs 
42 
MIPS-MPPI 
Mammalian 
Protein-Protein 
Interaction 
Database 
http://mips.helmholtz
-
muenchen.de/proj/ppi
/ 
Ssc published 
studies 
(literature-
curated) 
Mammalian Only PPIs 42 
Meta DB Full name URL PPI sources Species Type of MI R 
APID 
Agile Protein 
Interaction 
DataAnalyzer 
http://bioinfow.dep.u
sal.es/apid/ 
BIND, BioGRID, 
DIP, HPRD, 
IntAct, MINT 
All Only PPIs 42 
HIPPIE 
Human Integrated 
Protein-Protein 
Interaction 
rEference 
http://cbdm.mdc-
berlin.de/tools/hippie/ 
BioGRID, DIP, 
HPRD, IntAct, 
MINT, BIND, 
MIPS, manually 
selected studies  
Human Only PPIs 49 
PINA 
Protein Interaction 
Network Analysis 
platform 
http://csbi.ltdk. 
helsinki.fi/pina/ 
BioGRID, DIP, 
HPRD, IntAct, 
MINT, MPact 
All Only PPIs 42 
Prediction DB Full name URL PPI sources Species Type of MI R 
MiMI 
Michigan 
Molecular 
Interactions 
http://mimi.ncibi.org/
MimiWeb/ 
BIND, BioGRID, 
DIP, HPRD, 
IntAct, nonPPI 
data 
All PPIs and others 42 
PIPs Human PPI Prediction database 
http://www.compbio.
dundee. 
ac.uk/www-pips/ 
BIND, DIP, 
HPRD, OPHID, 
nonPPI data 
Human PPIs and others 42 
OPHID 
Online Predicted 
Human Interaction 
Database 
http://ophid. 
utoronto.ca/ 
BIND, BioGRID, 
HPRD, IntAct, 
MINT, MPact, 
nonPPI data 
Human PPIs and others 42 
STRING 
Known and 
Predicted Protein-
Protein Interactions 
http://string. 
embl.de/ 
BIND, BioGRID, 
DIP, HPRD, 
IntAct, MINT, 
nonPPI data 
All PPIs and others 42 
UniHI Unified Human Interactome 
http://www.mdc-
berlin.de/unihi/ 
BIND, BioGRID, 
DIP, HPRD, 
IntAct, MINT, 
nonPPI data 
Human PPIs and others 42 
DB, database; MI, molecular interaction; R, reference. 
 
PPI networks are defined as the networks of protein complexes formed by biochemical events 
and/or electrostatic forces and that serve a distinct biological function as a complex 50. Several 
bioinformatic tools have been developed to represent and explore such PPI networks, such as the 
Cytoscape, an open-source bioinformatics software platform for visualizing molecular interaction 
networks and biological pathways and for integrating these networks with annotations and other 
types of data 51. 
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In the past two decades PPI have emerged as promising drug targets, and the field is now evolving 
fast. Several approaches have been used to modulate PPIs 52, in particular those based on the use of 
small organic molecules, either derived from natural compounds or from organic synthesis (for 
review see 53–55). However, the large contact surfaces involved in PPIs, the fact that these protein–
protein interfaces are generally flat and often lack the grooves and pockets present on the surfaces 
of proteins that bind to small molecules represent considerable weaknesses to the use of this 
approach 54. Alternatively recombinant proteins/antibodies, and peptides, which can explore larger 
surfaces, may represent excellent PPI modulators. Peptides in particular present several advantages: 
(1) adaptability to large surfaces due to their flexibility; (2) easy modularity, which increases 
structural diversity allowing for higher selectivity and potency; (3) they accumulate only to a minor 
extent in tissues; and (4) biocompatibility, which means low toxicity in humans 56. However, 
peptides are hard to convert into oral drugs, as typically they are not metabolically stable 
undergoing rapid removal by hepatic and renal clearance, they do not cross physiological barriers 
easily and they have poor oral bioavailability as they present low stability against degradation by 
proteolytic enzymes of the digestive system and blood plasma. Fortunately peptides can be easily 
synthetized and modified to improve their stability, permeability and bioavailability.  
Cell-penetrating peptides (CPPs) are reliable vehicles for the intracellular delivery of therapeutic 
agents. CPPs are short peptide sequences (up to 30 amino acids in length) that can pass through the 
cellular membrane and deliver different types of cargo. The identification of intrinsically bioactive 
CPPs emphasizes the tremendous clinical potential of CPP technologies 57,58. The first described 
CPPs included penetratin and Tat peptides, cationic stretches of amino acids identified in the 
primary sequences of both insect- and virally-encoded transcription factors, respectively. These 
polycationic CPP motifs confer their native proteins the capacity to cross biological membranes to 
fulfill their role as transcriptional activators. Similar CPP sequences have been also identified in 
several human proteins 59. Recently Jones and colleagues demonstrated that CPPs are able of 
translocate into the sperm cell without affecting its viability and motility 60. In terms of clinical 
applications, CPP can potentially be used to deliver a wide range of therapeutic moieties, including 
small molecules, oligonucleotides and proteins. CPP internalization may be achieved by both direct 
plasma membrane translocation and energy-dependent endocytotic mechanisms.  
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2.2.!The power of the yeast two-hybrid system in the identification of novel drug targets: 
building and modulating PPP1 interactomes 
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2.2.1.!Abstract 
Since the description of the yeast two-hybrid (Y2H) method, it has become more and more evident 
that it is the most commonly used method to identify protein-protein interactions (PPIs). The 
improvements in the original Y2H methodology in parallel with the idea that PPIs are actually 
promising drug targets, offer an excellent opportunity to apply the principles of this molecular 
biology technique to the pharmaceutical field. Additionally, the theoretical developments in the 
networks field make PPI networks very useful frameworks that facilitate many discoveries in 
biomedicine. This review aims to highlight the relevance of the Y2H in the determination of PPIs, 
specifically Phosphoprotein Phosphatase 1 (PPP1) interactions, and its possible outcomes in 
pharmaceutical research. 
2.2.2.!Introduction 
The yeast two-hybrid system (Y2H) was first described by Fields and Song in 1989 61 and since its 
discovery it has been intensively used to search for novel protein-protein interactions (PPIs). In 
fact, the Y2H system rapidly turned into the most used method to study PPIs, being a major 
contributor to PPIs databases. In spite of the clear progress enabled by the introduction of the Y2H, 
the initial system presented several limitations. For instance, the Y2H does not reflect in vivo 
spatial or temporal context of the interactions and all the interactions are forced to occur in the 
yeast nucleus. Improvements on the original method not only overcame major limitations of the 
original Y2H system, but also expanded its applications: high-throughput Y2H can now be used to 
study complex protein interactomes, as well as other types of molecular interactions, such as 
protein-DNA and protein-RNA interactions. More recently, high-throughput Y2H has been applied 
in the screening of small molecule libraries to identify molecules capable of modulating a 
particular PPI or, conversely, to identify, from a group of interactions, the one that is targeted by a 
specific molecule. Progress on network medicine also contributed to the empowerment of the Y2H 
system. Interactome networks allow the attribution of spatial or temporal context, essential to 
identify regulatory networks of specific-cell types and recognize key protein complexes for a 
particular biological process. Here we will address the panoply of variations and applications of the 
Y2H system and its vast contribution to the discovery of PPIs and the study of interactomes. We 
will particularly focus our attention on the use of Y2H system in drug discovery. To emphasize the 
usefulness of the method, we will demonstrate how the Y2H contributed to the identification of 
phosphoprotein phosphatase 1 (PPP1) interactome and its potential application in the discovery of 
PPP1 complexes-modulating drugs.  
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2.2.3.!Yeast Two-Hybrid system: a useful system to the unraveling of molecular interactions  
The original Y2H method, established by Stanley Fields and Ok-Kyu Song in 1989 61, used the 
reconstitution of the GAL4 transcription factor of the Saccharomyces cerevisiae to assay for PPIs. 
The function of GAL4, like other eukaryotic transcription factors, requires the physical bound 
(though not covalent) between a DNA-binding domain (DBD) and an activation domain (AD). 
Based on this, Fields and Song fused one protein of interest, the “bait”, to the DBD of the GAL4 
and the other, the “prey”, was expressed as a fusion to the AD. As a consequence of the interaction 
between bait and prey proteins, the GAL4 transcription factor reassembled and induced the 
transcription of the lacZ reporter gene, resulting in a turning-blue phenotype in the presence of the 
substrate X-gal 61. The general scheme of the Y2H is depicted in Figure A.4. 
 
Figure A.4 - Schematic representation of the Y2H system. Two plasmids are constructed: the bait, which encodes the 
protein of interest (X) fused with the DNA-binding domain (DBD) of a transcription factor, and the prey, which encodes 
the potential interacting-protein (Y) fused with an activation domain (AD). The plasmids are co-transformed into an 
appropriate yeast strain where the hybrids—bait and prey—are expressed. Within the nucleus of the recipient cell, the 
DBD binds the upstream activating sequence (UAS). If the interaction of proteins X and Y occurs, the close proximity 
between DBD and AD leads to the activation of the transcription of the reporter gene. 
 
The Y2H system rapidly became a versatile method for the study of binary protein interactions, 
since it offers significant advantages when compared with other biochemical methods (Figure A.5). 
To further improve the method, a number of adaptations (e.g. different options for DBD, AD, and 
reporter gene revised in 62) were introduced in order to overcome the drawbacks of the original 
system (Figure A.5), and several variants were developed to extend the number of molecular 
interactions covered (Figure A.5). 
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Figure A.5 - Advantages and disadvantages of Y2H system. The disadvantages of the conventional Y2H system may lead 
to false-positive or false-negative results. However, several adaptations can be made to the traditional method in order to 
circumvent the majority of the problems. 
 
Additional information on the variants of the Y2H can be consulted in several review articles (e.g. 
62,63). The Y2H method has also been modified for large-scale screenings, using either the library 
screening or the matrix approaches. Most commonly, yeast cells expressing the bait protein are 
transformed with a library of cDNA molecules fused to AD (library screening approach). On the 
other hand, a given set of yeast cells expressing the bait protein can be screened against a specific 
set of yeast cells expressing the prey protein (matrix approach) (further details on 64). These mated 
improvements culminate in a wide range of applications for the Y2H and its variants, including the 
study of several types of molecular interactions (e.g. PPIs, RNA-protein, DNA-protein, and small 
molecule-protein interactions), as well as the study of PPIs in various subcellular compartments 
(e.g. nuclear, membrane, cytosol).  
The application of the Y2H system in drug discovery is a recent but very promising phenomenon, 
as further discussed below. Several variants of the method have been particularly adapted aiming 
pharmacological studies, including the reverse Y2H screening and the yeast three-hybrid. An in-
depth understanding of the vital contribution of the Y2H system for unravelling interactomes and 
driving drug discovery will be provided in the next section. 
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2.2.4.!Yeast Two-Hybrid system: 25 years of contribution  
Since the Y2H system development, 25 years ago 61, its contribution to identify new protein 
interactions is indisputable. In fact, the Y2H system evolved into one of the most popular tools in 
biology and the number of interactions identified by this method is in the order of the thousands. 
The high-throughput Y2H screening was the most significant improvement of this technique, since 
it allows the mapping of thousands of protein interactions in a short period of time. Several 
proteomes have been characterized by this method, ranging from complete organism to disease-
specific interactomes 91–93. The significant contribution made by the Y2H system to PPIs databases 
reflects the utmost importance of this technique. It is estimated that around 50% of the interactions 
described in Pubmed resulted from Y2H screenings 92. Moreover, from 1990 to 2007, the number 
of high confidence binary interactions identified using this method increased exponentially 94. A 
search in BIND, BioGrid, DIP, HPRD, IntAct and MINT databases (30/10/2014) also revealed that 
22% of Homo Sapiens PPIs were identified using Y2H methods. Nowadays, the Y2H system is 
probably the most commonly used technique for the detection of PPIs 95. 
2.2.4.1.!Unraveling organism interactomes 
Since the human genome was sequenced in 2001 96, revealing the complete proteome and 
interactome of the Homo sapiens has become the main goal to understand human physiology. 
However, Stumpf et al. estimated that the human interactome contains a range of 130 000 to 650 
000 binary interactions, and being, therefore, too complex to map 97. Over the last two decades, the 
interactome of several species far less complex than the human was identified due to the Y2H 95. 
For example, in 1994 Finley et al. tested 14 Drosophila melanogaster open reading frames (ORF) 
and identified 19 interactions 98. Today, complete or almost complete interactomes are described 
for several organisms. The first interactome to be described was the Saccharomyces cerevisiae, in 
2000 99,100, followed by the Drosophila melanogaster 101 and the Helicobacter pylori 102. More 
recently, Simonis et al. completed the Caenorhabditis elegans interactome 103. In 2005 Stelzl et al. 
and Rual et al. characterized part of the human interactome. While Rual et al. identified around 2 
800 interactions, 300 of which were new, Stelzl et al. identified 3186 interactions, mostly all of 
them new. Interestingly, the overlap between datasets is small—from the proteins identified, only 
16% were common to both datasets 50,104. From the common proteins, only 15% of the interactions 
were detected in both interactomes. Even though both interactomes were obtained by Y2H, the 
experimental procedures differed and this may explain the different results obtained from both 
scans 105. In addition to describing organism interactomes, the Y2H allowed the characterization of 
subcellular components or entire signaling pathways. For instance, in 2001, the metozoan 26S 
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proteosome was mapped, confirming several interactions reported previously, but also revealing 
novel interactions 106. Additionally, Colland et al. characterized the Transforming Growth Factor 
beta (TGFβ) signaling pathways. This work demonstrated that the use of the Y2H technique is not 
restricted to the determination of the interactome of a specific protein 107.  
2.2.4.2.!Unraveling pathophysiological mechanisms 
Bacterial and viral infections are a growing concern for the World Health Organization 108. 
However, our knowledge on the infection mechanisms is still patchy and identifying potential key 
interactions can help elucidating the mechanisms behind pathogen-human interaction 50. For that 
purpose, the interactome of several pathogens, such as Campylobacter jejuni, Human 
cytomegalovirus and the Human Immunodeficiency virus have been recently described 102,109–111. 
Furthermore, it is essential to identify and analyze interactions between host and pathogens to 
better characterize the pathophysiologic mechanisms of viruses and bacteria. In 2010, Dyer et al. 
mapped the protein interactions between human cells and three pathogens: Bacillus anthracis, 
Francisella tularensis and Yersinia pestis, which cause anthrax, lethal acute pneumonic disease and 
bubonic plague, respectively 112.  
2.2.4.3.!Protein interactomes 
As previously mentioned, the Y2H is the main technique used to identify PPIs. Numerous protein-
specific interactomes are described in the literature, most of which were characterized by the Y2H 
system 92. In the last year, at least six protein-specific interactomes were characterized using this 
system 113. The characterization of protein-specific interactomes allows researchers to infer on the 
physiological role of the targeted proteins. For example, Katsogiannou et al. characterized the 
Hsp27 interactome, revealing new potential roles for Hsp27 in DNA repair and alternative splicing 
114. The Y2H technique proved to be particularly critical in the comprehension of PPP1 molecular 
roles. Over the past two decades, it has become evident that the key to understand the regulation 
and versatility of this major serine/threonine protein phosphatase lies on the identification of its 
multiple targeting/regulatory subunits, known as PPP1-interacting proteins (PIPs). From this point 
on, we will discuss the role of the Y2H technique in the characterization of PPP1 interactomes. 
Furthermore, the potential of PPP1 complexes as new drug targets will also be addressed. 
2.2.5.!Yeast Two-Hybrid contribution to unravel the Phosphoprotein Phosphatase 1 
Interactome  
Phosphoprotein phosphatase 1 (PPP1) is estimated to catalyze about a third of all protein 
dephosphorylation reactions in eukaryotic cells 115. PPP1 catalytic subunit (PPP1C) is encoded by 
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three different genes giving rise to PPP1CA, PPP1CB and PPP1CC isoforms. After transcription, 
PPP1CC undergoes tissue-specific splicing, originating a ubiquitous isoform, PPP1CC1, and a 
testis-enriched and sperm-specific isoform, PPP1CC2 116. It has already been shown that PPP1 
isoforms are expressed in a wide variety of mammalian cells 117,118. PPP1CA is predominantly 
expressed in brain and was found to be ubiquitous in all tissues except in skeletal and heart 
muscles. PPP1CB has higher levels in liver and kidney and is also ubiquitous in all tissues except 
in skeletal muscle in which it is presented in low but detectable amounts. PPP1CC1 is present in 
higher levels in brain, small intestine and lung and was not detectable in heart and spleen. Finally, 
PPP1C2 is the isoform in higher amount in testis and spermatozoa 117,119. Although most studies 
had not directly addressed the significance of the distinct isoforms in vivo, data shows that they 
have distinct subcellular localizations 120,121. In the nucleus, PPP1CC1 accumulates in the nucleolus 
in association with RNA, whereas PPP1CA is primarily found in the nucleoplasm 121 and PPP1CB 
localizes to non-nucleolar whole chromatin 120. During mitosis, PPP1CA localizes to the 
centrosome, PPP1CC1 is associated with microtubules of the mitotic spindle and PPP1CB is 
strongly associated with chromosomes 120. This implies differences in their specificity to interact 
with specific targeting subunits and, therefore, to incorporate distinct signaling complexes 122. In 
brain, the different PPP1C isoforms were shown to be present in distinct regions and also revealed 
specific subcellular localization 116,123,124. All four isoforms are expressed in mammalian testis 
125,126. However, their cellular and subcellular distributions differ. PPP1CC2 is predominantly 
localized in post-meiotic cells, in the cytoplasm of secondary spermatocytes, round spermatids and 
elongated spermatids 125,126. Ppp1cc gene deletion in mouse testis causes loss of both isoforms 
(PPP1CC1 and PPP1CC2) and results in male infertility due to impaired spermatogenesis 127. 
Recently, Sinha et al. confirmed that the spermatogenic defects observed in the global Ppp1cc 
knockout mice were due to compromised functions of PPP1CC2 in meiotic and postmeiotic germ 
cells 126. The mammalian PPP1C isoforms exist within the cell associated with multiple regulatory 
proteins, the PIPs, which determine its enzymatic activity, substrate specificity and subcellular 
localization 128. The different cellular and subcellular localizations suggest that each PPP1C 
isoform interacts with a different set of substrates. Consequently, PPP1C isoforms are involved in 
distinct signal transduction pathways, in different cells and even in different cell regions. The key 
to understand PPP1 regulation in different cellular processes lies on the identification and 
characterization of its interacting partners 129. Additionally, the identification of the cellular 
compartment-specific interactome may help to understand PPP1 precise regulation 130. The 
majority of known PIPs contain a variant of a motif commonly referred to as the RVxF motif, 
which binds as an extended beta strand to a hydrophobic groove of PPP1 (away from the catalytic 
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site) 131–134. Beside the PPP1 docking motifs, PIPs do not show any obvious structural similarity 135. 
Classical biochemical approaches and Y2H screens have identified most PIPs 136. 
2.2.5.1.!PPP1 interactome in brain 
Esteves et al. took an in-depth survey to identify specific PPP1CA, PPP1CC1 and PPP1CC2 
interactors in human brain using a high-throughput Y2H approach 137,138. Sixty-six proteins were 
documented to bind PPP1CA, from which 39 had never been associated with this phosphatase. A 
search in PIP databases was also performed to complement the approach and a total of 246 
interactions were described 138. When using PPP1CC1, PPP1CC2 or PPP1CC2 C-terminus as baits, 
52, 141 and 4 PIPs were identified, respectively 137. From the proteins identified that bind to 
PPP1CC1, the most abundant clones corresponded to previously characterized PIPs, including the 
apoptosis-associated tyrosine kinase (AATK), the tumor suppressor p53-binding protein 2 
(TP53BP2) and Taperin (TPRN). Novel PPP1CC1 interactors, such as cysteine/serine rich nuclear 
protein 1 (CSRNP1), were also identified. Several novel PPP1CC2 interactors were also 
recognized, namely COPS5 and PINK 137. One of the novel PPP1 regulators isolated in three 
independent Y2H screens was the nuclear membrane protein lamina associated polypeptide 1B 
(LAP1B), which interacts with the DYT1 dystonia protein torsinA 139.  
2.2.6.!PPP1 Interactome in Testis 
Given the relevance of the testis/sperm-enriched variant PPP1CC2 in sperm motility and 
spermatogenesis, Fardilha et al. performed Y2H screens from a human testis cDNA library, using 
as baits different PPP1C isoforms (PPP1CC1, PPP1CC2 and PPP1CC2-specific C-terminus), to 
characterize the human testis PPP1 interactome 140. They reported the identification of 77 different 
proteins, some of them unique to a particular bait. Thirty-five proteins were found to exclusively 
bind PPP1CC2-specific C-terminus, meaning that they could reflect the PPP1CC2 isoform 
specificity 140. One of the novel interactors identified, TCTEX1D4, was recently characterized in 
human spermatozoa 141,142. As suggested by Dominguez and co-workers some PIPs interact with 
the flexible C-terminus of PPP1 to mediate isoform specificity 135. Y2H screenings conducted using 
a mouse testis expression library and PPP1CC2 as bait allowed the identification of isoform-
specific interactors such as endophilin B1t, a testis enriched isoform of the somatic endophilin B1a, 
and the spermatogenic zip protein (Spz1) 143,144. Both endophilin B1t and Spz1 do not interact with 
other PPP1C isoforms or with a truncated PPP1CC2 mutant lacking the unique C-terminus 143,144.  
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2.2.6.1.!Other PPP1 interactions identified using the Yeast Two-Hybrid system 
PPP1 has been implicated in the regulation of the cardiac function. Chen et al. conducted a search 
for proteins capable of interacting with PPP1CA in human heart using the Y2H methodology and 
identified a novel heart/testis-specific PIP named heart protein phosphatase 1-binding protein 
(Hepp1) 145. A 3T3-L1 adipocyte cDNA library was screened with PPP1CA as bait and a novel 
PIP, homologous with the myosin phosphatase targeting subunit (MYPT) family, was identified - 
MYPT3 146. The Y2H also allowed to recognize that Bcl-2 and Bad interact with PPP1CA 147 and 
that the binding of the pre-mRNA splicing factor SIPP1 to PPP1 involves the RVxF motif 148. The 
apoptosis-associated tyrosine kinase (AATYK) interaction with PPP1 and the relevance of a PPP1 
docking motif was demonstrated by Y2H 149. The dephosphorylation of one of the six subunits of 
the origin recognition complex (Orc2) by PPP1 promotes the binding of the complex to chromatin. 
Orc2 physical interaction with the distinct PPP1C isoforms (PPP1CA, PPP1CB and PPP1CC) was 
identified by Y2H 150. Additionally, the Y2H technique was used to prove that the interaction of 
Orc2 with PPP1C isoforms occurred through a variation of the RVxF motif (119-KSVSF-123), by 
generating Orc2 mutants that contained a deletion of the binding motif 150. Nucleolar protein with 
MIF4G domain 1 (NOM1), which was the first PIP identified as being involved in targeting PPP1 
to the nucleolus, was identified as an interactor in a Y2H screening. The Y2H technique was also 
used to characterize the Sds22-PPP1-I3 complex and to demonstrate that PPP1 is strictly controlled 
by both inhibitors, Sds22 and I3 151. Phostensin, a PPP1 F-actin cytoskeleton targeting subunit, was 
also identified as a PIP by Y2H, supporting the role of PPP1 in the modulation of actin 
rearrangements 152. PPIs are a recent but promising class of drug targets. As demonstrated above, 
PPP1-PIPs complexes are essential regulatory components in signaling cascades involved in a wide 
range of cellular function. An attractive approach to modulate PPP1 activity is to target specific 
interfaces between PPP1 and tissue/event-specific PIPs, disrupting their interaction. Thus, the Y2H 
system became essential not only to construct PPP1 interactome in different cell and tissue types, 
but also to screen for drugs that modulate PPP1/PIPs complexes. 
2.2.7.!Yeast Two-Hybrid in drug screening 
Drug discovery paradigm was forced to change in the post-genomic era—from protein-focused to 
pathway-centered. Instead of looking to the usual suspects (e.g. G protein coupled receptors and 
kinases), researchers and pharmaceutical industries invested in the huge amount of data retrieved 
from high-throughput proteome analyses, which include Y2H approaches (revised in 93). 
Constructing disease-specific PPI networks allows the identification of key proteins or protein 
complexes more prone to be druggable. For example, developing an Y2H screen in which the bait 
is a well-known disease-related protein drives the construction of specific disease-related networks, 
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thereby identifying promising PPIs. A drug screen approach based on the high-throughput Y2H can 
then be used to test drug libraries and identify compounds that modulate previously retrieved PPIs. 
For instance, p53 is mutated in approximately 50% of all human cancers. A search for p53 
interactors using the Y2H method allowed the identification of many partners and the building of 
the p53 interactome 153. One of the interactions identified, p53/MDM2, was further validated and a 
drug screen for the inhibition of the complex was performed allowing the identification of nutlins. 
These molecules induce p53 activation and apoptosis of cancer cells, since binding of MDM2 to 
p53 inhibits p53 activity 154. Another option is to use a wide proteome approach, in which several 
proteins associated with a certain disease are used as baits. Lim et al. identified the interactors of 
20 proteins that have been proved to be involved in the pathophysiology of Ataxia 155. PPI network 
analysis showed that the interactors form network modules suggesting that they function in a 
combined way. Finally, in a non-specific way, large scale PPIs can be obtained by performing Y2H 
methodology using thousands of baits to screen libraries 50,104. Bioinformatic analysis of the results 
allows the identification of disease-related interactions and the proposal of putative drug targets. 
Independently of the number of baits used or the particular goal behind the high-throughput Y2H 
performed, the result is always a collection of binary interactions. Consequently, it is possible to 
build protein networks and to identify promising protein complexes that can be subsequently 
subjected to a large-scale drug screen (also based in the Y2H). The drug targeting of protein 
complexes has much to grow and, accordingly, screening systems based on the Y2H methodology 
are still being improved. For instance, the mammalian Y2H is being used for high-throughput drug 
screening. Comparing to the yeast environment, mammalian cells are more permeable, support 
appropriate folding, as well as co-factors and post-translational modifications that are essential for 
proper PPIs and adequate drug action. The mammalian Y2H was used to identify small molecules 
that disrupt the p53/MDM2 complex. The compound library consisted of 3840 compounds and SL-
01, besides nutlin-3, was shown to activate p53 pathway and induce growth arrest in tumor cells 
156. There are many other examples that show the power of Y2H in the screening of drugs that 
target specific PPIs 92,93,157. Furthermore, it is expected that Y2H systems continue to be the 
reference method to identify PPIs and that, in the near future, they also turn into one of the most 
used methods to identify modulators of PPIs. 
2.2.7.1.!PPP1 complexes as therapeutic targets 
As previously stated, a great number of PPP1 interactors were identified using Y2H screenings. 
The diversity of the interactors is astonishing and the associated functions are diverse: from 
cytoskeleton organization and cell cycle control to apoptosis (revised in 129). Consequently, many 
disorders may arise from abnormalities in the PPP1 regulators or in the complexes themselves. This 
General Introduction Chapter 2 
University of Aveiro  31!
fact highlights the relevance of unravelling novel therapeutic drugs that target PPP1 holoenzymes 
and/or a specific regulator in certain pathophysiological conditions. Targeting PPP1 complexes has 
already been successfully accomplished using alternative methods. Salubrinal has been identified 
in a screen for small molecules that protect cells from endoplasmic reticulum (ER) stress. 
Salubrinal is a selective inhibitor of cellular complexes that dephosphorylates the eukaryotic 
eIF2alpha, thereby blocking eIF2alpha dephosphorylation, mediated by a Herpes simplex virus 
protein, and inhibiting viral replication 158. In fact, it does so by acting on the PPP1-GADD34 
complex, which was identified by the Y2H system and was found activated during ER stress. 
Trichostatin A (TSA) is used in the treatment of glioblastoma and prostate cancer cells through the 
inhibition of histone deacetylases (HDACs) by disrupting PPP1-HDAC6 complex 159 a complex 
also detected by the Y2H methodology. In both cases, the screen for small molecules was 
performed without taking into consideration the PPP1 complexes a priori. Nevertheless, those 
studies allowed to demonstrate the relevance of PPP1 complexes as druggable entities. The 
tendency, in the field of PPP1 research, is to perform high-throughput screens directed for drugs 
that modulate PPP1 complexes. A critical example of the importance of modulating PPP1 
complexes is the spermatozoon, a specialized cell incapable of genetic expression. Any functional 
alteration depends essentially on protein post-translational modifications (e.g., protein 
phosphorylation) or mechanisms based on the disruption or formation of protein complexes 
providing a key general mechanism for regulating vital sperm functions. As mentioned before, 
PPP1CC2 is a testis-enriched and sperm-specific PPP1C isoform, essential in sperm motility. 
PPP1CC2 activity is associated with immotile spermatozoa in the caput of epididymis. However, in 
the cauda of the epididymis, PPP1CC2 activity is lower and spermatozoa are motile 160.  
We proposed that PPP1CC2 is progressively inhibited along the epididymis and consequently the 
spermatozoa acquire motility 161. Two of the inhibitors possibly involved in this mechanism are 
PPP1R2P3 and SARP2, both sperm-enriched proteins that were first identified as PPP1 interactors 
by the Y2H methodology 140. Sperm-specific PPP1 complexes are challenging pharmacological 
targets for reversible male contraception. PPIs disruption can be achieved using synthetic peptides 
that mimic the interaction site or a peptide with higher affinity to the interaction site 162. 
Interestingly, most PPP1 inhibitors present a small motif (RVxF) that interacts with PPP1. A few in 
vitro studies used synthetic peptides (based in the RVxF motif) to disrupt the PPP1-inhibitor 
complex 163. However, the modulation of human spermatozoa physiology by synthetic peptides that 
disrupt PPP1-inhbitor complexes was never accomplished. A major issue in addressing sperm 
protein complexes is the bioavailability and translocation through the sperm membrane. A viable 
option is to use Cell Penetrating Peptides (CPPs) that are able to carry small peptides into specific 
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compartments of human spermatozoa, without affecting viability, mobility or morphology of cells 
60.  
In conclusion, a great amount of PPP1 complexes are actually known, mainly due to Y2H screens 
129,137,138,140, and may be tested as therapeutic targets in many pathological conditions. Following the 
boom of drugs that target G protein coupled receptors and kinases is now time to target protein 
phosphatases, in particular PPP1, through its regulators, and improve the therapeutic options. 
2.2.8.!Conclusion 
The recent revolution of the various omics, specifically proteomics, allowed the identification of a 
huge collection of PPIs that turned out to be attractive therapeutic targets. Furthermore, the 
development of systems biology endorsed a more accurate reflection of the protein complexes 
biological reality. The identification of drugs capable of modulating known protein complexes, 
using high-throughput methodologies, changed the paradigm of drug discovery which was 
previously based on phenotype alterations. Much of what is currently known concerning PPIs and 
protein complex modulating drugs is due to the Y2H method and its high-throughput variations. It 
is expected that now, more than ever, with the advances in technology, the Y2H will be improved 
and will be an essential tool for drug discovery. 
General Introduction Chapter 2 
University of Aveiro  33!
2.3.!Phosphoprotein Phosphatase 1 Complexes in Spermatogenesis 
 
Joana Vieira Silva, Maria João Freitas and Margarida Fardilha 
Laboratory of Signal Transduction, Department of Medical Sciences, Institute of Biomedicine – 
iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal. 
Corresponding author: Margarida Fardilha, Departamento de Ciências Médicas, Universidade de 
Aveiro, Campus Universitário de Santiago, Agra do Crasto – Edifício 30, 3810-193 Aveiro, 
Portugal. T: +351-918143947. E: mfardilha@ua.pt 
 
Silva JV, Freitas MJ, Fardilha M. Phosphoprotein phosphatase 1 complexes in spermatogenesis. 
Current Molecular Pharmacology. 2014; 7(2):136-46. 
  
Chapter 2 General Introduction 
34 University of Aveiro!
2.3.1.!Abstract 
The major post-translational modification in eukaryotes is protein phosphorylation, which mediates 
responses to signals in a myriad of cellular processes. Not surprisingly, many steps in 
spermatogenesis involve the concerted action of the protein (de)phosphorylation key players, 
kinases and phosphatases. Phosphoprotein phosphatase 1 catalytic subunit (PPP1C), an 
evolutionarily conserved Ser/Thr-protein phosphatase, catalyzes the majority of eukaryotic protein 
dephosphorylation reactions. Three genes, PPP1CA, PPP1CB and PPP1CC, encode four PPP1C 
isoforms, PPP1CA, PPP1CB, PPP1CC1, and PPP1CC2. After transcription, PPP1CC undergoes 
tissue-specific splicing, originating a ubiquitously expressed isoform, PPP1CC1 and a testis-
enriched and sperm-specific isoform, PPP1CC2 which is essential for completion of 
spermatogenesis. Highly similar PPP1C isoforms – PPP1CA and PPP1CB – are capable of 
compensating the loss of Ppp1cc in every tissue except in testis. PPP1C cellular functions depend 
on the complexes it forms with PPP1C Interacting Proteins (PIPs), which together with the 
different catalytic subunits, account for PPP1C specificity. This review will focus on the role of the 
major serine/threonine phosphatase – PPP1C and its holoenzymes in spermatogenesis. 
Furthermore, current challenges on the protein phosphatases field as targets to male contraception 
will be addressed.  
2.3.2.!Introduction 
2.3.2.1.!Spermatogenesis 
Spermatogenesis is a complex process by which a diploid spermatogonium develops into a highly 
specialized haploid male gamete, the spermatozoon that is capable of fertilizing an oocyte and 
produce an embryo 164. The spermatogenic process involves mitotic and meiotic divisions, as well 
as extensive cell morphological alterations. In humans, spermatogenesis takes approximately 74 
days 165. However, Misell et al. (2006) have shown through the use of ingested 2H2O that 
spermatogenesis can take much less time than previously suspected, 64±8 days (range 42-76) and 
that the duration is highly variable among individuals 166. This process can be divided in: (I) self-
renewal and differentiation of spermatogonia, (II) meiosis (III) spermiogenesis and (IV) 
spermiation. In the phase I spermatogonial stem cells self-renew and differentiate through mitosis 
producing different cell populations. In humans, four types of spermatogonias have been identified, 
A long, A dark, A pale and B 167–169. Type B spematogonia divide mitotically originating primary 
spermatocytes 167. Phase II, or spermatocytogenesis, is the meiotic phase in which primary 
spermatocytes undergo two meiotic cycles giving rise to haploid spermatids. During this process a 
new genome is built through chromosome pairing, crossover, and genetic exchange. Phase III, or 
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spermiogenesis, is the development and differentiation of the spermatid into a spermatozoon. 
During this process there is the formation and development of the acrosome and flagellum, 
condensation of the chromatin and major substitution of the histones by protamines, reshaping of 
the nucleus and removal of the cytoplasm so that the spermatid can be released to the tubule lumen 
during spermiation 167,170. 
Spermatogenesis is regulated through the hypothalamic-pituitary-gonadal axis. It is thus initiated 
by the release of gonadotropin-releasing hormone (GnRH) in the hypothalamus, which signals the 
pituitary to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to the blood 
stream that will eventually reach the testis. FSH acts on Sertoli cells and directly regulates sperm 
output by controlling the expansion of pre-meiotic germ cells, being mainly responsible for 
spermatogenesis. LH acts on Leydig cells inducing the release of androgens which maintain a male 
phenotype and stimulate sexual organs, being mainly responsible for steroidogenesis 171. Closing 
the loop, androgens also have a role as a feedback molecule on the hypothalamus.  
The hormonal regulation of spermatogenesis and other stimuli induce a series of alterations into 
appropriate receptors that are transduced into the interior of the cells by means of post-translational 
modifications, mainly (de)phosphorylations. Protein phosphorylation is a post-translational 
modification that allows the regulation of many cellular processes. It is accomplished by the 
concerted action of protein kinases and protein phosphatases that insert or remove, respectively, the 
γ-phosphate of ATP into the target amino acid, making protein phosphorylation a reversible 
process. In eukaryotic cells, most phosphorylation events occur in serine or threonine residues and, 
to a lesser extent in tyrosine residues 172. Several kinases and also (although much less) 
phosphatases have been identified as having a coordinating role on the molecular and cellular 
events that take place during spermatogenesis.  
The importance of protein kinases in spermatogenesis is reflected in infertility phenotypes 
observed when knocked out. Cyclins are crucial regulators of the cell cycle that are modulated by 
CDK (cyclin dependent kinases) and dephosphorylated by CDC25 (cell division cycle 25) family 
members, which are dual specificity phosphatases (phosphatases capable of dephosphorylating Ser, 
Thr and Tyr residues). Mice which lack cyclins A1 are sterile due to a failure of cyclin B-CDK1 
activation and subsequent meiotic arrest 173. Interestingly, fertility is not affected in mice lacking 
CDC25 174 suggesting a compensatory mechanism. CDK16, previously called an orphan kinase 
since its putative cyclin partner was unknown, is present in postmeiotic spermatids 175,176 and, 
analysis of the correspondent knockout mouse showed that CDK16 is essential for the completion 
of spermatogenesis 177. Other cell cycle related kinases have been linked to spermatogenesis: 
Aurora kinase C is highly expressed in testis 178,179 and Polo-like kinase 2 and 3 bind calcium and 
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integrin binding 1 (CIB1) 180. All these proteins are essential to male fertility and this data clearly 
indicates that cyclins/CDK complexes are crucial to the regulation of spermatogenesis and 
consequently to fertility. 
Many components of the MAPK pathway have been shown to be expressed during 
spermatogenesis. ERK1/2 are present in all stages of mouse spermatogenesis and in rat Sertoli cells 
181. ERK participates in the modulation of DNA condensation and in the nucleus/cytoplasm 
translocation of Sam68, an RNA-binding protein during meiosis 181. Furthermore, mice lacking JLP 
(JNK-associated leucine zipper protein), a scaffold protein for JNK and p38, were shown to be 
subfertile 182. 
FSH and LH induce Protein Kinase A (PKA) activation that is crucial for male germ cell 
development. The different PKA subunits (RIα, RIIα, Cα1 and Cα2) are differentially expressed 
during spermatogenic development 183. Mice lacking functional Cα1 and Cα2 have normal sperm 
counts 184, suggesting that the presence of active PKA in developing spermatogonia and spermatids 
is not essential for sperm production and differentiation. Nevertheless, the knockout mice for Cα2 
(the only Cα isoform present in sperm), could not fertilize the egg, since capacitation was impaired. 
Sperm motility parameters were also altered, suggesting that Cα2 is required for vigorous sperm 
motility, consistent with the hypothesis that phosphorylation of flagellar proteins mediated by PKA 
induces ATP-dependent motor activity 185. 
Although much has been described about the hormones and growth factors, as well as about many 
signaling cascades that control specific mechanisms of the spermatogenesis (mediated by the 
kinases), less is known about the contribution of protein phosphatases in spermatogenesis. In this 
chapter, we will address, specifically, PPP1C (Phosphoprotein Phosphatase 1) and its PIPs (PPP1C 
Interacting Proteins) on this process. 
2.3.2.2.!Phosphoprotein Phosphatase 1 (PPP1) 
Protein phosphatases are divided into four superfamilies, according to structural conservation and 
mechanism of action 186,187: the protein tyrosine phosphatase superfamily, which comprises the 
classical and non-classical receptor protein tyrosine phosphatases and the dual-specificity protein 
phosphatases, which dephosphorylate tyrosine but also serine and threonine residues; the haloacid 
dehalogenase superfamily of hydrolases which includes some protein serine/threonine/tyrosine 
phosphatases; the metal-dependent protein phosphatases superfamily; and the phosphoprotein 
phosphatases (PPP) superfamily which dephosphorylates serine and threonine residues. With such 
a broad family, PPPs are responsible for more than 90% of all the dephosphorylations that occur in 
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a cell. PPPs superfamily includes PPP1 to PPP7 and while all of the family members share high 
homology in the catalytic domains, they differ in their N- and C-terminal 188–194.  
Phosphoprotein phosphatase 1 catalytic subunit, PPP1C (also known as phosphorylase 
phosphatase) was first identified as the enzyme that converted phosphorylase a into phosphorylase 
b. Since its discovery, many roles have been attributed to PPP1C in the regulation of important 
cellular events. PPP1C has been involved in the regulation of the glycogen metabolism; cell cycle; 
and sperm motility 129. In mammals, PPP1C is coded by three genes (PPP1CA, PPP1CB and 
PPP1CC). The PPP1CC gene undergoes tissue-specific splicing, giving rise to a ubiquitously 
expressed isoform, PPP1CC1, and a testis-enriched and sperm-specific isoform, PPP1CC2. The 
difference between these isoforms resides strictly in the C-terminal 129. 
2.3.2.3.!PPP1 Complexes 
PPP1 isoforms share more than 90% aminoacid identity. Moreover, the catalytic subunit is 
identical in all isoforms and significantly similar to PPP2A and PPP2B. The few differences 
between PPP1C isoforms are localized to the N and C terminus. In contrast, there are 10 times less 
serine/threonine protein phosphatases than their counter parts protein kinases 195. The difference 
observed is explained by the diverse evolutionary strategy used by the two classes of enzymes. 
While kinases evolved through gene duplication, protein phosphatases and, specifically PPP1C, 
diversified by binding to different protein regulators and thus forming many holoenzymes. Indeed, 
PPP1 exists in the cell as an oligomeric complex in which the PPP1C subunit binds to one or two 
regulatory subunits known as PPP1 Interacting Proteins, PIPs, that modulate its cellular 
localization, substrate specificity and also activity 172,196,197. The different isoforms of the PPP1C 
also add to the diversity 161. All things considered, the lack of phosphatase genetic diversity is 
compensated with the high diversity of phosphatases’ complexes.  
To date more than 200 PIPs have been identified and they can be divided into PPP1C inhibitors, 
substrates, substrate-specifiers and targeting-subunits 196. The binding of PIPs to PPP1C is 
mediated by short amino acid motifs 128,133 and about 10 have already been described. Each PIP 
may contain only one or a combination of them. For example, the best known PPP1C binding 
motif, the RVxF, is present in about 90% of all known PIPs and is thought to be the anchor for 
subsequent interactions 198. Even more interesting, is the fact that some PIPs are PPP1 isoform 
specific. The fact that PPP1 isoforms differ at their N- and C terminal can explain this specificity. 
Indeed, MYPT1 can only interact with the PPP1CB C-terminus 135; Neurabin-1 (PPP1R9a) and 
Repo-man (CDCA2) bind preferentially to PPP1CC1. Also, Spz1 and Endophilin B1t can only 
interact with the testis-specific isoform PPP1CC2 143,144. 
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Most PIPs form a unique and stable complex with PPP1C by combining multiple binding motifs – 
this property led to the concept of the existence of a PPP1C-binding code 133,199. This code is 
universal, specific, degenerate, nonexclusive and dynamic 198. It is universal since the PPP1C 
binding motifs are conserved along evolution; specific since a PPP1C binding motif does not bind 
to any related Phosphatase; the amino acids in the binding motifs may have some flexibility which 
generates different binding affinities among different PIPs; non-exclusive since binding to a PIP 
does not exclude binding to a second PIP if the binding motif is different; finally, the code is 
dynamic since there is molar excess of PIPs in comparison to PPP1C, which allows for PPP1C-PIP 
interaction to be subjected to regulation, for instance by PIP’s phosphorylation 198.  
Thus, depending on the PIP that is bound to PPP1C, the complex formed is involved in a specific 
cellular task 129. For example, the Retinoblastoma protein (Rb) is dephosphorylated when 
associated with PPP1C, being converted into a E2F transcription factor inhibitor and thus inhibiting 
G1-S transition 200. The protein GADD34 targets PPP1C to the endoplasmic reticulum where they 
both regulate the initiation of protein translation in mammalian tissues by dephosphorylation of 
eIF-2α 201. PPP1R2 binds and inhibits PPP1CC2 but when PPP1R2 is phosphorylated by GSK3 the 
activity of PPP1CC2 is restored. We have recently proposed that a novel isoform of PPP1R2, 
PPP1R2P3, that cannot be phosphorylated by GSK3, is a PPP1CC2 irreversible inhibitor in caudal 
sperm 202. The recent unravelling of many properties of the binding pattern between PPP1C and its 
PIPs allowed the development of small molecules that can disrupt the non-covalent interactions 
that keep protein complexes together, with a high degree of selectivity 198. These small molecules 
can have an important role in research or, even more promising, a therapeutic potential to treat 
diseases where proteins in general or pools of proteins are hyper-phosphorylated 129,203. Indeed, it 
was shown that Guanabenz, an α2-adrenergic antagonist anti-hypertensive agent, inhibits the 
interaction of PPP1C and GADD34 by binding to GADD34. Therefore, Guanabenz has the 
potential to treat protein folding diseases since GAD34-PPP1C is involved in the modulation of 
endoplasmic reticulum-stress through eIF-2α dephosphorylation 204.  
2.3.3.!Role of PPP1C Isoforms in Spermatogenesis 
The fact that PPP1CC2 is enriched in testis and specific to spermatozoa suggested an essential role 
of this protein in spermatogenesis and spermatozoa physiology. Indeed, PPP1CC2 critical role in 
spermatogenesis was first observed in the Ppp1cc null male mice 127. Ppp1cc knockout is not lethal 
and female mice present a normal phenotype. Male mice, however, are infertile, despite the normal 
testosterone levels and sexual behavior. A closer look upon the testis revealed alterations in 
spermatogenesis, namely the breakdown of the transition between round and elongated 
spermatocytes and a great loss of germ cells, especially spermatids. There is also a generalized lack 
General Introduction Chapter 2 
University of Aveiro  39!
of spermatozoa that appears to stem from generalized apoptosis throughout the layers of the 
seminiferous epithelium instead of a localized apoptosis in the epithelium adjacent to the basement 
membrane 125,127. Sertoli cells are also affected in the Ppp1cc null mice: their nuclei is displaced 
from the basement membrane, suggesting a polarity loss 127,205. 
The most severe phenotype of Ppp1cc deletion is found in spermatids. Most round spermatids 
present severe abnormalities that hint a meiotic failure, such as large nuclei and multiple 
acrosomes, whereas the elongated spermatids display a multinucleated conjoined twin phenotype. 
The few condensing spermatids observed present histones instead of protamines for DNA packing 
in sperm head 127. This may result from abnormal chromatin packing and condensation in earlier 
germ cells 206. 
As a result of defective spermatogenesis, the epididymis of Ppp1cc null mice is virtually devoid of 
spermatozoa. Occasionally, germ cells can be observed, predominantly abnormal round spermatids 
and pachytene spermatocytes 125,127. Plus, the few spermatozoa observed show a wide range of 
head, mitochondrial sheath and midpiece defects, with the mitochondrial sheath being the most 
affected structure and being loosely arranged when it is not absent altogether. The head presents a 
round shape instead of the usual sickle shaped head, characteristic of mouse spermatozoa and a 
disorganized layer of outer denser fibers 125,127. Also the manchette, a transient organelle composed 
of numerous microtubules that assist in tail formation, does not involve the spermatid nucleus and 
there is a reduced quantity of β-tubulin in this organelle 207. The numerous defects in the Ppp1cc 
knockout seminiferous epithelium suggest a pleiotropic role PPP1CC2 in germ cell development 
morphogenesis and flagellar integrity 125,127.  
As always, the characterization of the phenotype of Ppp1cc null mice answered some questions, 
but it also uncovered others. Since Ppp1cc knockout eliminates both PPP1CC1 and PPP1CC2, the 
phenotype observed can result from the absence of one or both isoforms. To address this question, 
Soler et al expressed PPP1CC2 in Ppp1cc null mice and determined if fertility is restored. 
PPP1CC2 expression prevented generalized apoptosis and restored spermatozoa concentration to 
normal levels. However, some impairments of Ppp1cc null mice persist: mitochondrial sheath 
presents gaps in proximal and distal ends, epidydimal spermatozoa head fold back at the 
connecting piece with an angle at 180 degrees and all spermatozoa are immotile 207. In sum, 
transgenic expression of PPP1CC2 rescued spermatogenesis but not fertility. This could be the 
result of insufficient quantity of PPP1CC2; incorrect spatio-temporal PPP1CC2 expression; 
necessity of PPP1CC1 expression or a combination of all 207.  
In 2012, Sinha et al restored fertility in Ppp1cc null mice 208. This was possible by using either the 
Ppp1cc endogenous promoter or the testicular germ cell specific promoter (PKG2) to express 
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PPP1CC2 in sperm germ cells. The most relevant findings were that transgenic expression of 
PPP1CC2 rescued spermatogenesis but not fertility. If 50% was not reached, high percentages of 
morphological defective spermatozoa were observed. Curiously, PPP1CC2 appears to have a 
stoichiometric relationship with its interactors/substrates in testis, since decreasing levels of 
PPP1CC2 expression is associated with increasing morphologic abnormalities 208. On the other 
hand, mice with three genes for PPP1CC2 (overexpression of PPP1CC2) in testis were fertile and 
spermatozoa concentration, morphology and motility were indistinguishable from wild type. 
Interestingly, Ppp1cc2 mRNA levels were drastically increased while protein levels resembled 
wild type. This suggests a post-transcriptional regulating mechanism for PPP1CC2 levels.  
To better understand the role of PPP1 isoforms in spermatogenesis, the localization of each isoform 
was determined by Chakrabarti et al and Sinha et al. In testis, PPP1CC1 and PPP1CA are 
expressed in spermatogonia, pre-meiotic cells and testicular somatic cells (Sertoli and Leydig cells) 
126. PPP1CB is present through all stages of spermatogenesis in about the same levels, except in 
fully mature spermatozoa where it is absent 126. PPP1CC2 is localized in post-meiotic cells, 
predominantly in the cytoplasm of secondary spermatocytes, round spermatids and elongated 
spermatids. There is a week signal in spermatogonia, pachytene, peritubular cells and interstitial 
cells 125,126. Figure A.6 shows the cellular localization of PPP1 isoforms through spermatogenesis. 
PPP1 is without a doubt essential in spermatogenesis. PPP1CC2 is the only PPP1 isoform present 
in post-meiotic cells. In addition, PPP1CC2 has a unique 22 amino acid C-terminal and is a 
mammal specific protein suggesting a significant function in spermatogenesis and spermatozoa in 
these species 125,126.  
In vertebrates, PPP1 isoform ablation is usually compensated by other PPP1 isoforms 122. However, 
when Ppp1cc gene is disrupted in mammals, a deficient spermatogenesis is observed resulting in 
male sterility, despite an increased compensatory expression of PPP1CA and PPP1CB 125. This 
phenotype can result from the disruption key complexes, involving the mammalian testis-specific 
and sperm-enriched isoform PPP1CC2 and other testis-specific proteins. Besides, some of these 
proteins only interact with PPP1CC2, which seems to indicate that in mammals a new system is in 
place involving PPP1CC2 202. 
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Figure A.6 - PPP1C isoforms localization in mouse testis. PPP1CC1 and PPP1CA are expressed in spermatogonia, pre-
meiotic cells and testicular somatic cells (Sertoli and Leydig cells). PPP1CB is localized through the spermatogenesis 
except fully mature spermatozoa. PPP1CC2 is localized in post-meiotic cells, mainly in the cytoplasm of secondary 
spermatocytes, round spermatids and elongated spermatids. The expression level of each PPP1 isoform is not reflected in 
the image. 
 
2.3.4.!PPP1 complexes in spermatogenesis 
PIPs, structurally unrelated proteins that control PPP1 localization, activity and substrate 
specificity, show an exceptional diversity and specificity in testis 133. To this date, a large number 
of PIPs have been shown to interact with PPP1CC2 in testis and to be involved in spermatogenesis. 
These include, for instance Spz1, which interact specifically with the PPP1CC2 isoform and 
PPP1R42that has the ability to interact with multiple PPP1C isoforms. 
SPZ1 
The spermatogenic zip protein 1 (Spz1) is a member of the basic helix-loop-helix family of 
transcription factors, a family that has been associated with tissue-specific developmental 
processes, being highly expressed in testis and epididymis 209,210. Spz1 was identified by Yeast two-
hybrid as a specific binding partner of PPP1CC2 isoform in testis, demonstrated by the loss of 
interaction on deletion of the unique C-terminus of PPP1CC2 143. Despite the presence of a 
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degenerate RVxF motif, Spz1 does not interact with PPP1CA and PPP1CC1 isoforms 143. In testis, 
Spz1 localizes in the cytoplasm of condensing spermatids, which is consistent with the expression 
of PPP1CC2 in those cells 125,209. Spz1 localization is grossly abnormal in the testis of the Ppp1cc 
knockout mice, where elongating spermatids are mostly absent. Still, a lack of Spz1 expression is 
evident in those few tubules where clusters of elongating spermatids are present, which may 
indicate that the stability of the Spz1 in the cytoplasm is affected by loss of PPP1CC2 143. Spz1 was 
also shown to specifically inhibit PPP1CC2 isoform activity towards phosphorylase a. This fact 
does not exclude the possibility that Spz1 may increase PPP1CC2 activity toward other substrates 
143. 
Spz1 overexpression in testis leads to dysfunctional spermatogenesis with increased proliferation 
and apoptosis of germ cells 211. Moreover, Spz1 overexpression also results in considerable 
anomalies during late stages of spermatogenesis, since the developing spermatids that survive 
meiosis show gross morphological defects 211. Overexpression of Spz1 and loss of PPP1CC in the 
testis show similarities concerning increased apoptosis and morphological defects in elongating 
spermatids, suggesting a possible functional relationship between those two proteins. 
Endophilin B1t 
Endophilin B1t is a splice variant of endophilin B1 (SH3GLB1, SH3 domain GRB2-like 
endophilin B1) which lacks the last 10 amino acids from the C-terminus 144,212. Endophilin B1t 
interacts specifically with PPP1CC2 isoform and, in spite of the presence of a canonical RVxF 
motif near the N-terminus, does not interact with PPP1CA or with PPP1CC2 mutant lacking the 
unique C-terminus. In contrast, the somatic endophilin B1 does not interact with any PPP1 isoform 
144. Furthermore, endophilin B1t is able to inhibit PPP1CC2 activity toward phosphorylase a while 
having little effect on PPP1CA activity 144. Endophilin B1 isoforms present two kinds of protein 
distribution in seminiferous tubules: uniform/diffuse cytoplasmic staining (in spermatocytes in 
some tubules and in elongating spermatids in other tubules) and punctate staining at cell 
membranes (condensing spermatids). In Ppp1cc mutant testis the punctate staining disappears 
almost completely and only the diffuse pattern is retained 144. Endophilin involvement in the 
endocytic pathway, its relationship with PPP1CC2 and the phenotype in the Ppp1cc mutant may 
indicate a role in germ cell release from the seminiferous epithelium 144. 
DDOST 
The dolichyl-diphosphooligosaccharide−protein glycosyltransferase 48 kDa subunit (DDOST) was 
identified as a PPP1CC2 interacting protein by tandem affinity purification in transgenic mouse 
embryonic stem cells 213. Though DDOST ability to bind to other PPP1 isoforms has not yet been 
tested, it contains a classical PPP1 binding RVxF motif. This PIP catalyzes the transfer of high-
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mannose oligosaccharides to nascent polypeptide chains across the membrane of the endoplasmic 
reticulum (ER) and it plays a non-catalytic role in the assembly of the oligosaccharyltransferase 
(OST) complex 214,215. DDOST localizes in a range of spermatogenic cell types and shows a 
prominent punctate localization to the nuclear envelope that is especially prevalent in 
spermatocytes. This is consistent with the localization of DDOST in the rough ER (RER) and with 
the fact that the spermatocyte nuclei are known to be covered by a layer of RER 213,216. Even in late 
elongating spermatids and mature spermatozoa, a smaller but significant amount of DDOST 
remains present around the nucleus. These facts support a potential role in 
spermatogenesis/spermiogenesis. DDOST localization in testis is unaffected by the loss of 
PPP1CC2, suggesting that it may function as a substrate target, directing PPP1CC2 to the nuclear 
envelope 213. Moreover, DDOST and other members of the OST complex have been identified in 
the membrane of human and mouse spermatozoa, which may indicate a putative role in sperm-
oocyte interaction 217. 
TSKS/ TSSK1 
The testis-specific serine/threonine-protein kinase 1 (TSSK1) is essential for spermatogenesis and 
interacts with PPP1CC2 in testis 218–220. TSSK1 is only expressed in post-meiotic spermatids 221, 
being essential for spermiogenesis as demonstrated by the dysregulation caused by targeted 
deletion of the two genes Tssk1 and Tssk2 220. This knockout phenotype is distinct in terms of 
severity from the Ppp1cc phenotype which is consistent with a requirement for Ppp1cc earlier than 
Tssk1/2 in spermatogenesis. However, the peak of PPP1CC2 levels in the testis overlaps with that 
of TSSK1/2 and both knockouts present some similarities such as defects in the organization of the 
mitochondrial sheaths and reduction in the number and motility of spermatozoa 127,220, suggesting a 
functional link between PPP1CC2 and TSSK1 late in spermatogenesis. Recently, it was 
demonstrated that the interaction between PPP1CC2 and TSSK1 in testis is mediated by testis-
specific serine/threonine kinase substrate (TSKS) 219. TSKS, a TSSK1/2 substrate, also displays a 
post-meiotic expression pattern and is localized to the centrioles of human spermatozoa 222. TSKS 
was firstly associated with PPP1 by bioinformatics and then the interaction with PPP1CA was 
validated in vitro 134. Additionally, the interaction between PPP1CC2 and TSKS is mediated 
through an RVxF docking motif, that once phosphorylated in testis prevents the interaction with 
PPP1CC2 219. TSSK1 and TSKS have been suggested to play a role in the formation and function 
of chromatoid body derived structures in elongating spermatids 220 and has been suggested that they 
function upstream of PPP1CC2 219. The happloinsufficiency of TSSK1 and TSKS and their binding 
to PPP1CC2 reinforces the theory of stoichiometric requirement of the later in post-meiotic germ 
cells. 
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PPP1R42 
Protein phosphatase 1 regulatory subunit 42 (PPP1R42), otherwise known as leucine-rich repeat 
protein (TLLR), was validated as PPP1CC2 interacting protein in mouse testis 223,224. PPP1R42 
binding to PPP1C is not solely dependent on the RVxF motif and it binds preferentially to 
PPP1CC2 when compared with PPP1CA 224. PPP1R42 is associated with the spermatid 
cytoskeleton, being located at the manchette in early elongating spermatids and being later 
transported to the centrosome at the base of the flagellum, suggesting a possible role in the 
formation of the sperm tail. PPP1R42 interacts with proteins involved in protein stability, such as 
motor kinesin 1B (KIF1B) and β-tubulin 224. Along with previous studies showing that PPP1CC2 is 
required for sperm maturation and that it is localized in developing spermatids, these facts support 
the theory that PPP1R42 links signaling molecules, including PPP1CC2, to the spermatid 
cytoskeleton in order to regulate important substrates involved in spermatid transformation 224. 
Recently, it was demonstrated that PPP1R42 is localized to the basal body/centrosome of ciliated 
ARPE-19 cells, similar to its localization in elongating spermatids 225. Also, PPP1R42 is a positive 
regulator of PPP1, a phosphatase known to regulate centrosome separation, which is illustrated by 
the reduction of PPP1 activity by inhibition of PPP1R42 expression, leading, in turn, to activation 
of NEK2, which is responsible for phosphorylation of centrosomal linker proteins, culminating in 
centrosome separation 225. 
PPP1R11/ PPP1R7 
PPP1R7 (phosphoprotein phosphatase 1 regulatory subunit 7, Sds22) was originally identified in 
yeast as a positive regulator of PPP1, required for mitotic metaphase/anaphase transition 226–228. 
Furthermore, PPP1R7 is a PPP1C inhibitor as suggested by the demonstration of an inhibitory 
effect elicited by a synthetic polypeptide corresponding to the Sds22 sixth leucine-rich repeat 
(LRR) in cultured mammalian cells 229 and the lack of catalytic activity of the PPP1R7-PPP1CC2 
complex in spermatozoa 230. Likewise, PPP1R11 (phosphoprotein phosphatase 1 regulatory subunit 
11, inhibitor 3, I3) is a potent heat-stable PP1 inhibitor and was identified in yeast two-hybrid 
studies designed to identify PIPs in human brain 231. PPP1R11, PPP1R7 and PPP1CA were shown 
to form a trimeric complex in which PPP1CA is catalytically inactive 151,232. Moreover, PPP1R11 is 
cleaved by caspase-3 and participates in the apoptotic response 233. Recently, the formation of a 
complex between PPP1CC2, PPP1R11, PPP1R7, and actin in testis was demonstrated, in which 
PPP1CC2 appears to be catalytically inactive 234. Furthermore, there is a reciprocal relationship 
between the levels of PPP1CC2 and PPP1R11. In the Ppp1cc knockout mice, PPP1R11 appears to 
be ubiquitinated and the protein levels are significantly reduced, which is overcome when 
transgenic PPP1CC2 is expressed. Cheng et al suggested that complex formation between 
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PPP1CC2 and PPP1R11 in testis might prevent proteolysis of the last and consequently, germ cell 
apoptosis. 
14-3-3 
14-3-3 (also known as YWHA) proteins comprise a family of highly conserved small acidic 
proteins, expressed in all eukaryotic cells and involved in the regulation of multiple cell signaling 
cascades 235,236. Different 14-3-3 isoforms display a certain degree of tissue specificity 237. It is well 
established that 14-3-3 is expressed in testis; however, the isoform specific expression of the seven 
14-3-3 isoforms in different testicular cell types has not yet been fully characterized 238,239. 14-3-3 
family members and its binding partners are regulators of protein-protein interactions during 
spermatogenesis 240,241, with PPP1CC2 as one of its predominant interactors in testis 241. Puri and 
colleagues proposed that 14-3-3, PGK-2 and PPP1CC2 might exist as a trimeric complex 242 and 
more recently they showed in vivo that PPP1CC2 and PGK-2 are present as a complex in testis and 
that PPP1CC2 bound to 14-3-3 is catalytically active 241. Taking these evidences together with the 
fact that PGK-2 is hyperphosphorylated in Ppp1cc knockout mice testis, they suggested PGK-2 is a 
PPP1CC2 substrate and 14-3-3 serves as a scaffolding protein 241. 14-3-3 zeta (YWHAZ) was also 
shown to interact with phosphorylated PPP1CC2 in spermatozoa from diverse species 243. 
Phosphorylated PPP1CC2 and 14-3-3 both localize to the postacrosomal region of the head and 
principal piece of spermatozoa. 
Other PIP potentially involved in spermatogenesis 
We identified twelve PPP1CC interactors associated with mouse mutations causing male infertility 
due to impaired spermatogenesis (Table A.2). We retrieved PPP1CC interactors from the HIPPIE 
database 244. HIPPIE is regularly updated by incorporating interaction data from major expert-
curated experimental protein-protein interaction databases (such as BioGRID, HPRD, IntAct and 
MINT) using the web service PSICQUIC. The interaction search revealed 204 PPP1CC interactors. 
Then, proteins associated with defects in male fertility were obtained from the Jackson 
Laboratories mouse knockout database 245. Tissue-specification was taken into consideration and 
the dataset was compared with published proteomes (testis, epididymis and spermatozoa) and 
tissue-expression databases (C-it database 246; TiGER 247; Very Gene database 248, HPA (Human 
Protein Atlas) 249; and BioGPS 250). Future studies on those interactors can increase the knowledge 
on PPP1CC2 function in spermatogenesis (Table A.2) and uncover new key players in the 
multifactorial regulation of this process. 
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Table A.2 - PPP1CC interacting proteins associated with mouse mutations causing male infertility due to impaired 
spermatogenesis. Protein overlaps with proteomic datasets included human testis, epididymis and spermatozoa 
proteomes. In gray are the proteins identified as highly specific to or strongly expressed in testis in at least one tissue-
expression database. 
PPP1CC 
interactor Infertile KO mice – Phenotype Overlap with proteomic datasets Ref. 
AKT1 abnormal spermatogenesis oligozoospermia  
251 
BRCA1 
arrest of male meiosis 
abnormal spermatid morphology 
abnormal male germ cell apoptosis 
 252,253 
CCND1 abnormal spermatogenesis  254 
CDK1 
abnormal male meiosis 
abnormal spermatocyte morphology 
abnormal spermatid morphology 
abnormal male germ cell apoptosis 
 255 
CDK2 
abnormal spermatogenesis 
abnormal spermiogenesis 
abnormal spermatocyte morphology 
abnormal spermatid morphology 
azoospermia 
abnormal male germ cell apoptosis 
 256,257 
CTSL abnormal spermatogenesis  258 
ESR1 
abnormal spermatogenesis 
oligozoospermia 
asthenozoospermia 
teratozoospermia 
detached sperm flagellum 
 259–261 
HSPA2 arrest of spermatogenesis Non-sperm located sperm-milieu epididymal and testicular protein 
262 
HSPA4 
arrest of male meiosis 
abnormal spermatocyte morphology 
abnormal spermatid morphology 
oligozoospermia 
asthenozoospermia 
abnormal male germ cell apoptosis 
Sperm located testicular and 
epididymal protein also detected in the 
epididymal fluid (sperm-milieu) 
263 
LMNA arrest of male meiosis azoospermia 
Sperm located epididymal protein also 
detected in the epididymal fluid 
(sperm-milieu) 
264 
PCNA arrest of spermatogenesis  265 
VDR 
abnormal spermatogenesis 
oligozoospermia 
asthenozoospermia 
 266 
2.3.5.!Conclusion 
Modern and non-invasive contraceptive methods for men are still not available. The currently 
available contraceptive options for men (condoms, vasectomy and withdrawal) are not ideal. 
Protein-protein interactions are a recent but promising class of drug targets. PPP1CC2-PIPs 
complexes are essential regulatory components in signaling cascades involved in spermatogenesis. 
An attractive approach to modulate PPP1 activity is to target specific interfaces between PPP1 and 
tissue/event-specific PIPs, disrupting their interaction 129,140. One of these interfaces, which occur in 
PIPs, is the RVxF-motif, which binds to a site on PPP1 that is remote from the active site. 
Synthetic peptides that contain variants of the RVxF motif were reported to disrupt a subset of 
PIP–PPP1 complexes in vitro 163,267. Additionally, PPP1CC2 has a unique 22 amino-acid C-
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terminus that is thought to be important in the binding with its specific interactors, such as 
endophilin B1t and SPZ1 143,144 that target the enzyme to a function essential for spermatogenesis. 
Currently two drugs (salubrinal and trichostatin A) are known to modulate PPP1 complexes 268. 
Blocking PPP1CC2-PIP interactions in post-meiotic germ cells will prevent a correct sperm 
morphogenesis, which may represent a good contraceptive target (Figure A.7). For instance, 
TSSK1 and TSKS, testis-specific proteins, are post-meiotic in their expression patterns 219, which 
make them potential targets of reversible contraceptive intervention by preserving spermatogonia 
and spermatocytes. 
 
Figure A.7 - Schematic representation of the disruption of PPP1 complexes in post-meiotic germ cells. PPP1CC2 is 
essential for a correct spermatozoa morphogenesis. An attractive approach to modulate PPP1 is to target specific 
interfaces between PPP1 and tissue-specific PIPs, using peptides based on PPP1 interacting sequences. PIP, PPP1 
Interacting Protein; CPP, Cell Penetrating Peptide sequence. 
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2.4.!Phosphoprotein phosphatase 1 complexes in sperm motility 
2.4.1.!Sperm motility 
Paoli and colleagues defined sperm motility as a propagation of transverse waves along the 
flagellum in a proximal-distal direction. This produces an impulse that pushes the spermatozoon 
through the female genital tract 269. To be motile, human spermatozoa requires (i) a morphological 
complete flagellum (see section 1.3.1.), (ii) energy to power flagellar movement and (iii) well-
orchestrated signaling pathways.  
The regulation of the flagellar bending appears to reside in the control of the ATPase activity of 
axonemal dynein arms. Although the mechanism is not yet fully understood, sperm motility 
appears to be modulated by alterations on pH, ATP availability, calcium concentration and 
phosphorylation 30. Most of the times the root cause of asthenozoospermia is not known and poor 
sperm motility remains predominantly a clinical sign of infertility, rather than a true diagnosis of 
the cause of infertility; however research on the mechanisms involved in regulating sperm motility 
is still sparse 270. 
2.4.1.1.!Activated and hyperactivated motility 
The motility pattern differs between ejaculated spermatozoa and spermatozoa that are recovered 
from the site of fertilization 271,272. The two forms of motility (activated and hyperactivated) are 
characterized by differences in the amplitude of flagellar beat and trajectory pattern. Activated 
motility generates symmetrical, low amplitude flagellar beats resulting in relatively straight and 
progressive trajectory in moderately non-viscous media such as seminal plasma 30,271. Activated 
motility is acquired in the epididymis and is involved in the initial stages of sperm transport 
through the female reproductive tract 273. During transit through the female tract, motility switches 
to a hyperactivated state, which coincides with the onset of capacitation. This is characterized by 
asymmetrical, high amplitude flagellar beats, which facilitates sperm progression in the oviduct, 
dissociation with the oviductal epithelium, through mucoid oviductal secretions and provides the 
motile thrust needed for zona pellucida penetration 274.  
2.4.1.2.!Energy: Oxidative phosphorylation versus glycolysis 
One of the key requirements for spermatozoa motility is energy to fuel the movement. ATP is the 
fuel used for axonemal dynein ATPases within the flagellum 275. Also, protein modifications, such 
as, phosphorylation depend on ATP. So, it is not surprising that sperm require exceptionally more 
ATP than other cells 276. It has been shown that the ATP production and availability in human 
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spermatozoa, is a cooperation between oxidative phosphorylation in mitochondria and glycolysis in 
the flagellum 276,277.  
2.4.2.!Role of PPP1 in sperm motility acquisition in the epididymis 
During sperm maturation in the epididymis a series of biochemical and morphogenic changes occur 
resulting in progressive motility 160. Those include alterations in pH, intracellular concentration of 
Ca2+ and cyclic adenosine mono-phosphate (cAMP) leading to shifts in the proteins 
phosphorylation status are also essential 278. PPP1CC2 is the only PPP1 isoform highly enriched in 
sperm present along the entire flagellum including the mid-piece 161. A number of previous studies 
have shown that PPP1CC2 plays a key role in sperm motility. The inhibition of PPP1CC2 activity 
in caudal sperm is tightly linked to the onset of progressive motility, and to a significant increase in 
vigorous movement in already progressively motile sperm 160,279. The PPP1 inhibitors, okadaic acid 
and calyculin A both initiate and stimulate motility of epididymal spermatozoa 160,279. Additionally, 
these phosphatase inhibitors also promote hyperactivated sperm motility and acrosome reaction 
280,281. A decline in PPP1CC2 activity occurs during epididymal sperm maturation not due to a 
decline in amounts of the enzyme but due to lowering of its catalytic activity. PPP1CC2 is also 
involved in sperm tail morphogenesis 125. The Ppp1cc-null mice had malformed sperm tails, 
missing mitochondrial sheaths and disorganized outer dense fibers on the sperm 127. Recent studies 
observed that PPP1CC2 alone in the absence of PPP1CC1 in testis restored sperm morphogenesis 
and sperm function 208. 
2.4.2.1.!PPP1CC2 complexes in sperm motility 
PPP1CC2 activity during sperm maturation has been suggested to be mainly regulated by its 
inhibitors – PPP1R2 (inhibitor 2, I2), PPP1R7 (sds22) and PPP1R11 (inhibitor 3, I3) – YWHA (14-
3-3) and AKAPs (Figure A.8). However, the role of these and other complexes in sperm motility 
still needs to be elucidated.  
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Figure A.8 - Schematic representation of the PPP1CC2 based regulation of sperm motility acquisition. AKAPs anchoring 
appear to modulate PPP1CC2 and PKA activities regulating phosphorylation events. In caput epididymis, PPP2CA is 
phosphorylated and consequently active, which in turn dephosphorylated GSK3 at Ser residues, rendering it active. 
GSK3 phosphorylates PPP1R2 (I2) at Thr73 which inhibits the interaction between PPP1R2 and PPP1CC2 resulting in 
active PPP1CC2. Sds22 (PPP1R7) is unable to inhibit PPP1CC2 since it is bound to p17. Active PPP1 results in protein 
dephosphorylation and consequently immotile spermatozoa. In cauda epididymis, PME1 activity decreases which 
increases PPP2CA methylation, resulting in inhibition of PPP2CA. Consequently, GSK3 serine phosphorylation 
increases leading to GSK3 inhibition. Also, Wnt binds to LRP6 receptor which promotes GSK3 inhibition. Calcium 
influx activates sAC, which produces cAMP activating Rap guanine nucleotide exchange factor (RAPGEFs), which 
activates PKB (AKT1) that phosphorylates GSK3 at serine residues inactivating it. GSK3 is inhibited, which leads to 
decrease Thr73 PPP1R2 phosphorylation. Consequently, PPP1R2 binds PPP1. Also, PPP1 is bound to PPPP1R2P3 (I2-
L) that cannot be phosphorylated by GSK3. Also, a multimeric complex has been identified composed by PPP1CC2, 
sds22 (PPP1R7), actin and I3 (PPP1R11), where PPP1CC2 was inactive. Thus, PPP1 activity is inhibited and ser/thr 
phosphorylation of key residues increases leading to motile spermatozoa. PPP1CC22 activity may also be regulated by 
phosphorylation in a C-terminal threonine residue by a CDK, most likely CDK2. Phosphorylated GSK3 and 
phosphorylated PPP1CC2 are bound to YWHA (14-3-3) in caudal sperm. P, phosphorylated; M, methylated. 
 
PPP1R2 
PPP1R2 (I2) is capable of inhibiting the catalytic subunit of PPP1 leading to the production of a 
stable PPP1-PPP1R2 complex. GSK3 phosphorylates PPP1R2 in the PPP1-PPP1R2 complex, 
relieving the inhibition and producing active PPP1. Immotile bovine caput epididymal sperm 
contains 2-fold higher levels of protein phosphatase activity, identified as being PPP1CC2, and 6-
fold higher GSK3 activity than do mature motile caudal sperm 160,161,279. Thus, a model was 
proposed in which in the first segments of the epididymis (caput) the sperm is immotile due to the 
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activation of the PPP1R2/PPP1CC2 complex by GSK3, while in the last segment of the epididymis 
(cauda), PPP1R2P3 (PPP1R2 pseudogene 3) takes place and substitutes PPP1R2 as an irreversible 
inhibitor of PPP1CC2 triggering sperm motility 140. Korrodi-Gregório et al demonstrated that 
PPP1R2P3 protein binds directly to PPP1CC and that this inhibitor cannot be phosphorylated by 
GSK3 since the key phosphosites are substituted to non-phosphorylated residues, T73P and S87R 
202. It is possible that PPP1R2P3 is somehow bound another protein that may keep it from binding 
to PPP1CC2 in immotile caput sperm, in a manner similar to what is suggest to occur with PPP1R7 
(sds22) in caput sperm. 
PPP1R11/ PPP1R7 
PPP1R11/I3 is a potent heat-stable PPP1 inhibitor 231 and is a human homologue of the mouse t-
complex expressed protein 5 (Tctex5), being genetically linked to the male infertility phenotypes of 
impaired sperm tail development and poor sperm motility 282. In epididymal mouse spermatozoa 
Tctex5 is present in the head and principal piece of the tail 283. These are also the locations where 
PPP1CC2 is expressed 284. A yeast sds22 homologue, PPP1R7, was identified in sperm 285, and 
inhibits the PPP1 catalytic subunit in rat liver nuclei 229. Consistently, a PPP1R7 homologue was 
also identified in rat testis in association with PPP1CC2 286. PPP1R7 was also identified in motile 
caudal spermatozoa as a regulator of PPP1CC2 catalytic activity 230. In male germ cells PPP1CC2, 
PPP1R11, PPP1R7 and actin form a multimeric complex in which PPP1CC2 is inactive 234. The 
stability of the complex depended on functional PPP1 interaction sites in PPP1R7 and PPP1R11, 
indicating that PPP1 mediates the interaction between these two proteins, forming a catalytically 
inactive complex in the germ cell 151. The function of this complex in sperm motility, if any, still 
needs to be elucidated. 
CDK2, GSK3 and 14-3-3 
PPP1CC2, as well as other PPP1 isoforms, have at the C-terminus a consensus TPPR amino acid 
sequence containing a threonine residue (T311) that can be phosphorylated by cyclin-dependent 
kinases (CDKs) 287–289. The proportion of phosphorylated PPP1CC2 in caudal sperm is higher than 
in caput epididymal sperm and is localized to the head equatorial region, implicated in sperm-egg 
binding, and in the principal piece of the tail 278. In spermatozoa, phosphorylated PPP1CC22 is the 
only catalytically active form of the enzyme in caudal spermatozoa. Huang et al. revealed that that 
CDK2 is present in spermatozoa 278. Interestingly, CDK2 knockout mice are viable but are sterile 
257. CDK2 regulation of PPP1CC2 may be achieved through binding of PPP1CC2 to the bridging 
molecule 14-3-3 (YWHA). 14-3-3 binds phosphorylated PPP1CC2 in spermatozoa 243. 
Additionally, GSK3 was found to bind 14-3-3 241,242. Sperm 14-3-3 is present in the post-acrosomal 
region of the head and the principal piece, similar to PPP1CC2 243. As already stated, an increase in 
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GSK3 phosphorylation occur in parallel with motility stimulation in sperm 290. Besides being 
infertile due to impaired sperm motility, the Gsk3a knockout mice revealed that PPP1CC2 activity 
was elevated in sperm 291. Since, phosphorylation at the threonine residue is known to reduce PPP1 
activity, Bhattacharjee and colleagues suggested that GSK3A might be responsible for PPP1CC2 
phosphorylation in spermatozoa. Additionally, GSK3A may also be involved in regulating PPP1 
inhibitors 291. 
AKAPs 
Compartmentalization of the cyclic AMP (cAMP)-dependent protein kinase (PKA) is mediated 
through association of its regulatory subunits with A-kinase anchoring proteins (AKAPs). To date, 
over 40 AKAPs have been identified, and in testis/sperm there are three AKAPs that have been 
related to PPP1CC2 (AKAP220, AKPA3 and AKAP4) 161. Given that many AKAPs have been 
shown to be present in germ cells and localized to compartments related to motility where 
PPP1CC2 is also present they might be putatively involved in motility acquisition. 
AKAP220/AKAP11 binds PKA and PPP1, being a competitive inhibitor of PPP1 292. AKAP220 is 
present in human male germ cells and mature sperm and like RIIα, is located in the midpiece and is 
probably associated with cytoskeletal structures 293. The midpiece associated AKAP220 could 
serve to anchor PKA and/or PPP1CC2, directly regulating the contractile machinery in the sperm 
axoneme. Furthermore, it has been shown that disruption of RII interaction with AKAPs, by 
membrane-permeable peptides, causes the arrest of sperm motility 294. AKAP4/AKAP82 
expression was only detected in testis and it was determined that transcription is initiated at 20-22 
days after birth and the mRNA is present in spermatids but not in pachytene spermatocytes 295,296. 
Targeted disruption of the Akap4 gene causes absence of sperm motility together with a complete 
lack of fibrous sheath on the principal piece of mature mice sperm, causing male mice to be 
infertile 31. Additionally, Akap4 gene knockout mice exhibit a significant change in the activity and 
phosphorylation of PPP1CC2 284. AKAP3 is a testis-specific protein found only in the fibrous 
sheath and localized to the circumferential ribs of human sperm 297. 
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2.5.!Amyloid precursor protein (APP) complexes in male fertility 
Amyloid precursor protein (APP), a type I transmembrane glycoprotein consisting of a large 
extracellular domain, a single transmembrane domain, and a short cytoplasmic tail, is expressed 
ubiquitously and given its receptor-like and adhesive characteristics, may play important roles 
outside the nervous system Figure A.9. In fact, Fardilha et al have previously showed that APP is 
present in spermatozoa 298. The APP superfamily includes APP and APP-like proteins (APLP) 1 
and 2 that are codified in chromosome 21, chromosome 11 and chromosome 19, respectively. 
Alternative splicing of exons 7, 8 and 15 of the APP mRNA produces eight isoforms, ranging in 
size from 677-770 amino acids. Alternative splicing produces four APLP1 and two APLP2 protein 
isoforms. Although some isoforms may be cell type specific, APP and APLP2 are ubiquitously 
expressed. In contrast, APLP1 is expressed selectively in the nervous system 299. The APP is 
synthesized on membrane-bound polysomes and matures as it is transported through the secretory 
pathway, becoming N- and O-glycosylated and tyrosyl-sulfated while it moves through the trans-
Golgi network. Immature APP (being N-glycosylated only) may be cleaved in the endoplasmic 
reticulum (ER) or the cis-Golgi, but mature APP is rapidly degraded as it is transported to or from 
the cell surface via either a biosynthetic or endocytic pathway 300. APP proteolytic processing 
originates alpha secreted APP (sAPP), a C-terminal domain (APP Intracellular Domain, AICD) and 
a non-toxic small peptide (p3). Alternative proteolytic routes originate beta sAPP, AICD and Abeta 
fragments 299. The transmembrane structure of APP is consistent with a role as a receptor or a 
mediator of extracellular interactions. It has been suggested that APP may have CAM (Cell 
Adhesion Molecule)- and SAM (Substrate Adhesion Molecule)-like activities. Indeed, APP 
possesses several domains that promote binding to specific substrates, such as heparin and 
collagen, which implicate cell-surface APP in both cell-cell and cell-substrate adhesion 301. 
Additionally, some studies indicate that full length APP can act as a cell surface G-protein coupled 
receptor (GPCR) and shows that APP binds heterotrimeric G proteins (Gαo) 302,303. Recently, Deyts 
and colleagues discovered an interaction between APP intracellular domain and the heterotrimeric 
G-protein subunit Gαs 304. 
Various lines of evidence implicate APP and APLP2 in fertility. APP was shown to be expressed in 
rat testis and localized in the acrosome region and growing tail of spermatids in the seminiferous 
tubules 305. Knock-out mice, homozygotes to either APP(-/-) or APLP2 (-/-) were fertile, but mice 
with the deletion of both APP(-/-) and APLP2(-/-) were infertile (9 of 10 females and all males) 306. 
Fardilha et al previously characterized the subcellular distribution of the APP superfamily 
members 298. The presence of APP superfamily members along the entire length of the tail may be 
related to signaling events involved in sperm motility, whereas their presence in the head and 
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particularly in the equatorial region suggests their involvement in sperm-oocyte interaction 298. 
Those results were consistent with the previous localization of APLP2 in mammalian sperm, but 
also prove the presence of APP itself in human sperm. APP and APLPs distribution only partially 
overlap, suggesting that besides a common role they might also have distinct functions in 
spermatozoa 298. A human sperm transmembrane protein initially termed YWK-II (later shown to 
be an APLP2 homologue) was shown to be involved in fertilization 307,308. The YWK-II gene was 
shown to be expressed in germ cells at various stages of differentiation and in the plasma 
membrane enveloping the acrosome of mature spermatozoa 308. YWK-II/APLP2 antibodies 
agglutinate human and rat spermatozoa, and block the penetration of hamster eggs. Additionally 
the treatment of mice of both genders with YWK-II/APLP2 antibodies or a synthetic peptide 
results in reduction of zygote formation 309. APLP2/YWK-II also exhibits properties of a receptor 
and its extracellular domain was shown to interact with Müllerian-inhibiting substance 310. 
Müllerian-inhibiting substance increases the viability and longevity of human spermatozoa through 
binding the YWK-II component on the sperm membrane 310. Huang and colleagues showed that 
YWK-II component binds to a GTP-binding protein (Gαo) and was phosphorylated by PKC and 
cdc2 kinase in the cytoplasmic domain. Thus, APLP2/YWK-II functions as a novel Gαo-protein-
coupled receptor for Müllerian inhibiting substance in cell survival 307.  
 
Figure A.9 - Overall structure and conservation of APP-family proteins. (A) Domain architecture, functional segments 
and conservation of APP-family proteins. APP and its mammalian homologues APLP1 and APLP2 share on overall a 
similar domain architecture including the E1-domain, the acidic region (AcD), the E2-domain (also called central APP 
domain, CAPPD), the juxtamembrane region (JMR), the transmembrane region (TM) and an intracellular domain [APP 
intracellular domain (AICD); APP-like intracellular domain (ALID1/ALID2)]. The Aβ-peptide and the extension domain 
(ED) are only present in APP, the KPI/OX2-insertion only in APP and APLP2 and the E1-domain is less conserved in 
APLP1 as indicated by its light green color. Additional functional units are indicated by brackets [heparin binding 
domain (HBD); copper binding domain (CuBD); zinc binding domain (ZnBD); collagen binding domain (CBD); growth 
factor like domain (GFLD)]. Phosphorylation and glycosylation sites are shown as P and empty circles, respectively. (B) 
The two folded domains E1 and E2 of APP as well as the transmembrane segment connecting the JMR with the AICD 
are shown as surface representation based on their respective crystal or NMR structures. The KPI-domain, only present in 
the longer splicing forms in between the AcD and the E2-domain, is likewise shown as surface representation and the 
surface-associated helix at the very C-terminus of APP is shown as idealized α-helix 311                                                    . 
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Aims 
The present work aimed primarily to identify, characterize and modulate non-hormonal targets for 
male contraception, selectively expressed in testis and sperm, in order to specifically inhibit/disrupt 
a process essential to reproduction, such as, post-meiotic events in spermatogenesis, sperm 
maturation in the epididymis or sperm function (Aim 1).  
Moreover, many questions regarding the etiology of male infertility remain unanswered with 
idiopathic infertility as the most common type of male infertility. Thus, we intended to determine 
the association between semen parameters and age, and the expression and activity of signaling 
proteins in order to establish a biomarker "fingerprint" to assess male fertility based on molecular 
parameters (Aim 2). 
 
To that end the following aims were proposed: 
1.! Aim 1. Identification, characterization and modulation of protein complexes in human 
testis and spermatozoa as potential targets for pharmacological intervention in male 
fertility 
1.1.! Construction and analysis of a testis/sperm-enriched interaction network: unraveling the 
PPP1CC2 interactome (Chapter 3.1.) – Submitted to Biology of Reproduction 
1.2.! Modulation of PPP1CC2/AKAP4 and PPP1CC2-specific interactions in spermatozoa 
using cell-penetrating peptides as a drug intracellular delivery system (Chapter 3.2.) – In 
the process to file a patent application 
1.3.! Characterization of SARP2, a PPP1 interacting protein, in testis and spermatozoa 
(Chapter 3.3.) – Published in Reproduction, Fertility and Development 
1.4.! Construction of APP interaction network in human testis: sentinel proteins for male 
reproduction (Chapter 3.4.) – Published in BMC Bioinformatics 
 
2.! Aim 2. Identification of signaling proteins as targets for diagnostic intervention in male 
fertility 
2.1.! Profiling signaling proteins in human spermatozoa: biomarker identification for sperm 
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3.1.1.!Abstract 
Phosphoprotein phosphatase 1 catalytic subunit gamma 2 (PPP1CC2), a PPP1CC tissue-specific 
alternative splice restricted to testicular germ cells and spermatozoa, is essential for 
spermatogenesis and spermatozoa motility. The key to understand PPP1CC2 regulation lies on the 
characterization of its interacting partners. This study aimed to integrate tissue-specific protein 
expression and protein-protein interaction data in order to identify key PPP1CC2 complexes for 
male reproductive functions and potential targets for male contraception. We construct a 
testis/sperm-enriched protein interaction network using the breath-first searching algorithm and 
analyzed the topological properties and biological context of the network. A total of 1,778 proteins 
and 32,187 interactions between them were identified in the testis/sperm-enriched network. The 
network analysis revealed the members of functional modules that interact more tightly with each 
other. In the network, PPP1CC was located in the fourth maximum core part (k=41) and had 106 
direct interactors. Sixteen PPP1CC interactors were involved in spermatogenesis-related categories. 
Also, PPP1CC had 50 direct interactors, highly interconnected and many of them part of the 
network maximum core (k=44), associated with motility-related annotations, including several 
previously uncharacterized interactors, such as, LMNA, JAK2 and RIPK3. One of the most 
intriguing interactors was A-kinase anchor protein 4 (AKAP4), a testis-specific protein related to 
infertility phenotypes and involved in all major motility-related annotations. We demonstrated for 
the first time the interaction between PPP1CC2 and AKAP4 in human spermatozoa and the 
potential of the complex as contraceptive target. 
3.1.2.!Introduction 
Some proteins are known to be expressed in a tissue-specific manner and therefore, the signal 
transduction cascades in which they are involved are diverse, reflecting the specific biological roles 
of each individual tissue 1. Expression of the phosphoprotein phosphatase 1 catalytic subunit 
gamma 2 (PPP1CC2), a PPP1 isoform, is restricted to testicular germ cells and spermatozoa. PPP1, 
an evolutionarily conserved phospho Ser/Thr-protein phosphatase, catalyzes the majority of 
eukaryotic protein dephosphorylation reactions in a highly regulated and selective manner 2. Three 
genes, PPP1CA, PPP1CB and PPP1CC, encode four PPP1 isoforms, PPP1CA, PPP1CB, 
PPP1CC1, and PPP1CC2, which show a high degree of sequence similarity (~90%) 3. The 
PPP1CC transcript undergoes tissue-specific splicing, giving rise to an ubiquitously expressed 
isoform, PPP1CC1 and a testis-enriched and sperm-specific isoform, PPP1CC2 4. PPP1CC2 has an 
unique 22 amino acid C-terminus, which is highly identical in mammals and plays a role in binding 
to specific regulatory subunits 5. Targeted disruption of the mouse Ppp1cc gene results in male 
infertility due to aberrant spermiogenesis 6. However, this deficiency causes no obvious 
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abnormality in other tissues. Additionally, the production of normal spermatozoa can take place in 
the complete absence of PPP1CC1 7. Inhibition of PPP1 in spermatozoa by treatment with 
inhibitors results in initiation and stimulation of motility 8,9. These results indicate that PPP1CC2 
functions in the regulation of mammalian spermatogenesis and sperm motility 10,11. Over the past 
two decades it has become apparent that PPP1’s functional versatility is achieved by its ability to 
interact with multiple targeting and regulatory subunits known as PPP1 interacting proteins or PIPs 
2,10–12. PIPs generally fall into one of four categories: substrates, inhibitors, subcellular targeting 
subunits or substrate specifying subunits. PIPs show an exceptional diversity in brain and testis 13 
and tissue-restricted expression of PIPs accounts for the specificity of PPP1 activity 3,13. Another 
aspect of the regulation of the PPP1 activity lies in the selectivity of some PIPs. Most PIPs appear 
to interact with all PPP1 isoforms however, an increasing number seems to preferentially interact 
with a specific PPP1 isoform 3 and this may be caused by differences at the C-termini of the PPP1 
isoforms. For instance, Repo-man and Neurabin-1 preferentially bind to PPP1CC1 14,15. Some PIPs 
are fully isoform specific; e.g., SPZ1 and a testis-specific Endophilin B1 isoform (SH3GLB1), 
which only interacts with PPP1CC2 16,17. MYPT1 (PPP1R12A) on the other hand selectively 
interacts with a specific region of the PPP1CB C-terminus 18. It is noteworthy that the study of 
PPP1 isoform-specific functions has some major hindrances: first, most studies do not specify the 
isoform used and second there is a lack of isoform-specific antibodies and inhibitors. Also, when 
reconstructing the PPP1 interactome, the time-point at which the proteins are expressed, the tissue, 
cell type and intracellular compartment where the proteins are localized, and the methods used to 
validate the interaction all need to be taken into account. Furthermore, the initial job of identifying 
PPP1 interactors is a main challenge as the interactions between PPP1 isoforms and their 
interactors are typically transitory and weak 19. 
In this study, we aimed to use a tissue-specific network-based approach 20 to characterize the 
human testis and spermatozoa interactome in order to identify new, yet poorly explored candidates 
involved in PPP1CC2 regulation of male fertility. 
3.1.3.!Material and Methods 
Identification of PPP1CC interacting proteins 
The HIPPIE database 21 was used for retrieving human protein-protein interaction (PPI) data 
(released May 09, 2014 and downloaded March 23, 2015). This database is regularly updated by 
incorporating interaction data from major expert-curated experimental PPI databases (such as 
Bell09, BioGRID, HPRD, IntAct and MINT). In addition, PPP1CC2 interacting proteins from 
other sources were included. First, the PubMed database was searched for proteins with published 
literature showing the preferential binding to PPP1CC2 and/or tissue, cellular, subcellular 
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localization that matches PPP1CC2. Second, the PubMed database was also used to search for 
PPP1CC2 substrates 22,23. Finally, Yeast Two-Hybrid (Y2H) data from our laboratory 5 was also 
considered and proteins that only interacted with PPP1CC2 C-terminus were included. 
Identification of proteins highly enriched or specifically expressed in testis  
From the C-it database 24, testis-specific proteins were searched with the keywords, 'testis-enriched' 
for 'Human'. The limitation factors for the literature information were 5 for PubMed and 3 for 
MeSH terms. The proteins with a SymAtals z-score higher than |1.96| were selected.  In the 
UniGene database 25 the tissue-specific proteins were searched using 'testis restricted' in 'Homo 
sapiens' as keywords. The TiGER 26 and the Very Gene 27 databases were also searched for 'Testis' 
in 'Tissue View' category. In HPA (Human Protein Atlas) 1 the protein list was obtained within the 
“Tissue enriched” category. In the BioGPS portal the keywords, 'testis, spermatogonia, spermatid, 
spermatozoa' in 'Human' were used. Using the plugin 'Gene expression/activity chart', proteins 
highly expressed in testis-related categories were selected. If the expression level was less than the 
mean value or the data were not shown, the corresponding proteins were removed from the list. In 
addition, proteins that had high correlation levels of expression (≥0.9) with testis-specific proteins 
were investigated.  
Development of testis-enriched/specific PPI network and network properties analysis 
In order to construct a testis/sperm-enriched PPI network, the testis-enriched/specific proteins and 
their direct interactions were collected from the HIPPIE database, the literature search, and the 
Y2H experimental data from our laboratory. Their direct interacting partners were selected 
regardless of their tissue specificity. Then, the inner connections between those proteins were 
captured. The isolated interactions from the major cluster of the network were kept. However, the 
amount of isolated clusters was negligibly small to analyze the network’s properties and the 
biological functionality of the whole network. To figure out the functional relations among the 
testis-enriched/specific proteins, specifically PPP1CC’s role in male fertility, the topological 
properties of the network, such as connectivity, betweenness centrality, clustering coefficient, 
modularity, and k-core of the network were analyzed. For searching the notable biological 
functions of PPP1CC, subnetworks related to spermatogenesis and sperm motility were extracted 
from the main testis/sperm-enriched PPI network. First, the proteins associated with 
spermatogenesis and sperm motility annotations and their first connected neighbors were selected. 
Also, the inner connections between them were kept. For each group, we checked how PPP1CC 
and its directly interacting partners correlate to the specific biological functions. 
Bioinformatic analyses: gene ontology, pathways and involvement in diseases 
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The data were analyzed using the Database for Annotation, Visualization and Integrated Discovery 
(DAVID) v6.7 28. The UniProt identifiers of all proteins were entered into the DAVID functional 
annotation program. The overall set of human protein-coding genes was used as background in 
DAVID. The AmiGO Term Enrichment tool was used to annotate the proteins in broader gene 
ontology terms whenever necessary. Protein identities associated with defects in male fertility were 
obtained from the Jackson Laboratories mouse knockout database 29. The OMIM 25 and the UniProt 
databases were also queried with the term ‘male infertility’ and the associated genes or proteins 
were downloaded. The full-length codifying sequence of AKAP4 was retrieved from NCBI with 
the purpose of performing a PPP1 binding motif search using ScanProsite 30. 
Ethical approval 
This study was approved by the Ethics and Internal Review Board of the Hospital Infante D. Pedro 
E.P.E. (Aveiro, Portugal) and was conducted in accordance with the ethical standards of the 
Helsinki Declaration. All donors signed informed consent allowing the samples to be used for 
scientific purposes. 
Sperm extracts 
Ejaculated semen samples were obtained from healthy donors by masturbation into a sterile 
container. Basic semen analysis was performed by qualified technicians according to World Health 
Organization (WHO) guidelines 31. After semen liquefaction, sperm cells were washed three times 
in phosphate buffered saline (PBS) by centrifugation (600 g for 5 min at 4°C). For 
immunocytochemistry assays, washed sperm cells were placed onto a glass coverslip and dried at 
room temperature. For Western blot and immunoprecipitation assays, sperm cells were lysed in 1X 
RIPA buffer (0.5M Tris-HCl, pH 7.4, 1.5M NaCl, 2.5% deoxycholic acid, 10% NP-40, 10mM 
EDTA) (Millipore Iberica S.A.U., Madrid, Spain) supplemented with protease (10 mM 
benzamidine, 1.5 µM aprotinin, 5 µM pepstatin A, 2 µM leupeptin, 1 mM PMSF) and phosphatase 
(1 mM sodium fluoride, 2.5 mM sodium pyrophosphate, 50 mM beta-glycerophosphate, 1 mM 
sodium orthovanadate) inhibitors, and centrifuged at 16000 g for 20 min at 4ºC. The supernatant 
was used for the subsequent steps (sperm soluble extract). The pellet (sperm insoluble extract) was 
ressuspended in 1% SDS (sperm insoluble extract). 
Antibodies 
The anti-PPP1CC2 antibody was raised in rabbit against the specific PPP1CC2 C-terminal peptide 
(VGSGLNPSIQKASNYRNNTVLY) and has been described previously 32. Mouse anti-AKAP4 
(ab56551) used for the immunofluorescence studies was obtained from Abcam (Cambridge, UK). 
Rabbit anti-AKAP4 (ab123415) used for the Western blot and immunoprecipitation studies was 
obtained from Abcam (Cambridge, UK). The infrared IRDye labelled anti-rabbit secondary 
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antibody for the Western blot analyses was obtained from LI-COR Biosciences (Lincoln, NE, 
USA) and the fluorescently labeled secondary antibodies (Texas Red-X goat anti-rabbit IgG and 
Alexa Fluor 488 goat anti-mouse IgG) for the immunocytochemistry studies were obtained from 
Life Technologies (Carlsbad, CA)). 
Immunoprecipitation 
RIPA supernatant sperm extracts were pre-cleared using Dynabeads Protein G (Life Technologies 
S.A., Madrid, Spain). A direct immunoprecipitation approach was performed using 1 µg of 
homemade rabbit anti-PPP1CC2 or rabbit anti-AKAP4 (ab123415, Abcam, Cambridge, UK), pre-
incubated with Dynabeads Protein G during 1 h at 4ºC with rotation. After incubation, pre-cleared 
sperm extracts were applied to the antibody-Dynabeads complex and incubated overnight with 
rotation at 4ºC. After washing three times with PBS in 3% BSA for 10 min with rotation at 4ºC, the 
beads were re-suspended in 1% SDS. 
Western blotting 
Extracts were resolved by 12% SDS–polyacrylamide gel electrophoresis (PAGE). Proteins were 
subsequently electrotransferred onto nitrocellulose membranes. Nonspecific protein-binding sites 
on the membrane were blocked with 5% nonfat dry milk in Tris-buffered saline (TBS: 25 mM Tris-
HCl, pH 7.4, 150 mM NaCl). The blots were then washed twice for 15 min each with TBST (TBS 
containing 0.1% Tween 20) and then incubated with primary antibodies for 2h at room 
temperature. After the wash, the blots were incubated with the appropriate secondary antibody for 1 
h at room temperature. Blots were washed with TBST three times 15 min each. Blots were 
immunodetected using the Odyssey Infrared Imaging System (LI-COR Biosciences, US). 
Membrane overlay 
Immunoprecipitation extracts loaded onto SDS-PAGE gel and subsequently transferred to a 
nitrocellulose membrane were then overlaid with purified PPP1CC2 protein, prepared as described 
previously 33. After washing to remove excess protein, bound PPP1CC2 was detected by incubating 
the membrane with a homemade rabbit anti-PPP1CC2 antibody, raised against a isoform-specific 
C-terminal peptide 8.  Immunoreactive bands were revealed by incubation with an Infrared IRDye-
labeled anti-rabbit specific followed by Odyssey Infrared Imaging System (LI-COR Biosciences, 
US) detection. 
Mass spectrometry 
After immunoprecipitation, SDS in the samples was removed using HIPPR detergent removal spin 
columns (Pierce). Next, the samples were boiled for 5 min and put on ice for another 5 min. The 
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proteins were then digested overnight by trypsin (Promega) at 37°C. The peptide mixtures were 
acidified with formic acid to stop the digestion. 
LC-MS/MS analysis was performed using an Ultimate 3000 HPLC system (Dionex) in-line 
connected to an LTQ Orbitrap XL mass spectrometer (ThermoScientific). The peptides were first 
trapped on a pre-column (in-house, 100 µm internal diameter (I.D.) x 20 mm, 5 µm beads C18 
Reprosil-HD, Dr. Maisch) after which they were loaded onto an analytical column (in-house, 75 
µm I.D. x 150 mm, 3 µm beads C18 Reprosil-HD, Dr. Maisch). The peptides were separated using 
a linear gradient over 30 min from 2% solvent A (0.05% formic acid, 2% acetonitrile) to 55% 
solvent B (0.05% formic acid, 80% acetonitrile) at a flow rate of 300 nl/min. The mass 
spectrometer was operated in data-dependent acquisition mode during which the six most intense 
ions were selected for fragmentation with a dynamic exclusion of 60 s. Mascot Distiller (version 
2.3.2, Matrix Science) was used to generate Mascot Generic Files (MGFs) as previously described 
34. The Mascot search algorithm (version 2.3, Matrix Science) was used to search these peak lists 
against the human subsection of the Swiss-Prot database (version 2013_06, 20,257 entries). 
Trypsin/P was set as the protease used, allowing for one missed cleavage. Mass tolerances were set 
to 10 ppm and 0.5 Da for the precursor and fragment ions respectively. Protein N-terminal 
acetylation, methionine oxidation and N-pyroglutamate were set as variable modifications. Only 
peptide spectrum matches that ranked first and scored above the identity threshold set at the 99% 
confidence level were withheld. The raw data files have been submitted to the ProteomeXchange 
database (PXD002888). 
Immunocytochemistry of human spermatozoa 
Washed spermatozoa were placed onto a glass coverslip and dried at room temperature in a six well 
plate containing one coverslip per well. To each well, 4% paraformaldehyde in PBS was added and 
wells were incubated for 10 min. Subsequently, spermatozoa were washed twice. For 
permeabilization, methanol at -20 C was added for 2 min and specimens were then washed twice 
before being blocked for 30 min with 3% BSA in PBS and then incubated with primary antibodies 
[homemade rabbit anti-PPP1CC2 (previously described in 35), and mouse anti-AKAP4 (ab56551, 
Abcam, Cambridge, UK)] for 1 h at room temperature. After three washes, the fluorescently 
labeled secondary antibodies [Texas Red-X goat anti-rabbit IgG (Life Technologies, Carlsbad, CA) 
and Alexa Fluor 488 goat anti-mouse IgG (Life Technologies, Carlsbad, CA)] were added and the 
coverslips were incubated for 30 min at room temperature. Finally, samples were washed and the 
coverslips mounted on microscope glass slides with one drop of antifading reagent containing 
DAPI for nucleic acid staining (Vectashield; Vector Laboratories). Negative controls were 
processed in parallel by adding PBS instead of the first antibodies. Fluorescence images were 
Chapter 3 Results 
84 University of Aveiro!
obtained using an Imager.Z1 (Zeiss), Axio-Cam HRm camera (Zeiss) and AxioVision software 
(Zeiss).  
3.1.4.!Results 
Identification of highly enriched or specific testis proteins 
We identified a total of 1,919 unique proteins highly specific or strongly expressed in testis. Of all 
proteins, 610 proteins (31.8% of the total 1,919 highly testis-specific proteins) were identified in at 
least two databases and were further considered as strongly expressed in testis (Supplementary 
Table D.1). The criteria used in the tissue-expression databases were set for maximum stringency 
to identify tissue-specific proteins with a high confidence level. The GO term enrichment analysis 
of the testis-enriched proteins revealed that the most significant biological process categories were 
all reproduction-related, such as sexual reproduction (p=3.71E-156), spermatogenesis (p=5.36E-
147) and fertilization (p=4.33E-44) (Supplementary Table D.2), which support our approach. 
Concerning the cellular component, the top 3 significant categories were sperm part (p=6.02E-54), 
motile cilium (p=1.47E-43) and acrosomal vesicle (p=1.65E-39) (Supplementary Table D.2). 
Identification of PPP1CC interacting proteins 
In this study, PPP1CC2 (testis-enriched and sperm-specific isoform) and PPP1CC (whenever the 
tissue-specific alternative splicing product was not specified) were considered. We identified 313 
PPP1CC/PPP1CC2 interactors from different sources (Supplementary Table D.3). From the PPI 
databases 252 PPP1CC interactors were identified. Thirty-two proteins were identified as 
PPP1CC2 interactors using a literature search (Table B.1).  From those, SPZ1, ACE, TSSK1B, 
AKAP4, HSPA2 and FADS2 were associated with infertility phenotypes in gene knockout mice. A 
total of 37 proteins were identified as candidate PPP1CC2 substrates in testis (Table B.1). From 
those, 5 had been previously associated with infertility phenotypes in gene knockout mice 
(HMGA1, HSPA4, SYCP2, YBX2 and HSPA2). In the Y2H screens, 36 proteins (corresponding to 
45% of all PPP1CC isoforms identified) were obtained exclusively from the Y2H screen in which 
the PPP1CC2 C-terminus was used as bait, meaning that they might represent specific binders of 
the PPP1CC2 isoform (Table B.1). Of the 313 direct PPP1CC interactors identified from several 
sources (PPI databases, literature search, substrates and Y2H), 10 interactors were identified as 
highly specific to or strongly expressed in the testis in at least two database (AKAP4, PGK2, 
TSKS, TSSK1B, YBX2, SPZ1, NEK2, C9orf50, GLB1L and PPP1R2P9).  
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Table B.1 – PPP1CC2 regulatory subunits/substrates identified by literature searching and Y2H screen. The PIPs shown 
were chosen taking into consideration if PPP1CC isoforms were distinguished and if there was substantial work that 
showed preferential binding to PPP1CC2 giving the cellular and sub-cellular context. *indicate an infertility phenotype in 
knockout mice; + represent proteins with testis-specific alternative splicing isoforms. 
Candidate PPP1CC2 
substrates identified in testis 
by MacLeod et al. 2014 and 
Henderson et al. 2010 (gray) 
PPP1CC2 interactors 
identified in a Y2H using 
PPP1CC2’s C-terminus as bait 
and a human testis library 
(Fardilha et al. 2010) 
Specific regulatory subunits of PPP1CC2 
isoform identified by a literature searching 
Uniprot ID Gene Name Uniprot ID Gene name Uniprot ID Gene name Reference 
Q9UKV3 ACIN1 O14727 APAF1 Q7Z4L9 PPP1R42 57,58 
Q9NYF8 BCLAF1 Q9UBL3 ASH2L Q9Y371 SH3GLB1 + 17 
Q7Z7K6 CENPV Q86VG3 C11orf74 P39656 DDOST 59 
P55884 EIF3B Q5SZB4 C9orf50 Q15435 PPP1R7 60,61 
Q6UN15 FIP1L1 Q6PJW8 CNST O60927 PPP1R11 61 
P17096 HMGA1 * Q92905 COPS5 Q9UJT2 TSKS 41 
P34932 HSPA4 * P07711 CTSL P63104 YWHAZ + 62 
Q6PKG0 LARP1 Q7L576 CYFP1 Q9BXG8 SPZ1 * 16 
Q4G0J3 LARP7 Q9NYF0 DACT1 Q5JR98 TCTEX1D4 63 
O95819 MAP4K4 Q9NR20 DYRK4 P41236 PPP1R2 64 
Q15154 PCM1 Q9H0I2 ENKD1 Q6NXS1 PPP1R2P3 64 
Q13442 PDAP1 Q6UWU2 GLB1L O14990 PPP1R2P9 65 
O75475 PSIP1 O43708 GSTZ1 Q96I34 PPP1R16A 66 
P15151 PVR O60674 JAK2 O00299 CLIC1 67 
Q86X27 RALGPS2 Q6B0I6 KDM4D Q9Y696 CLIC4 67 
Q9UKM9 RALY Q9NPI7 KRCC1 Q9NZA1 CLIC5 67 
P49792 RANBP2 O95819 MAP4K4 P17252 PRKCA 68 
Q9H7N4 SCAF1 O60551 NMT2 Q12972 PPP1R8 + 45 
O75533 SF3B1 Q9UHY1 NRBP1 P51955 NEK2 + 45 
Q86XK3 SFR1 Q7Z5V6 PPP1R32 Q8N9B4 ANKRD42 + 35,69 
Q8IYB3 SRRM1 Q8TAP8 PPP1R35 P12821 ACE * + 62 
Q9UQ35 SRRM2 Q12972 PPP1R8 P07205 PGK2 62 
Q9BX26 SYCP2 * Q96S59 RANBP9 P11021 HSPA5 62 
O60343 TBC1D4 Q6ZMZ0 RNF19B Q9BXA7 TSSK1B * 41 
Q9Y2W1 THRAP3 P23921 RRM1 Q9UKA4 AKAP11 11 
Q07157 TJP1 Q9NRG7 SDR39U1 Q5JQC9 AKAP4 * 70 
Q9UKE5 TNIK O43556 SGCE O75969 HSPA2 * 22 
Q14669 TRIP12 Q9H0A9 SPATC1L P54652 UQCRC2 41 
Q9Y2T7 YBX2 * Q5JR98 TCTEX1D4 P22695 FADS2 * 41 
P09488 GSTM1 Q5VZQ5 TEX36 O95864 SCCPDH 41 
P63261 ACTG1 Q9BXJ8 TMEM120A Q8NBX0 ATP5C1 41 
P60709 ACTB Q9HBL0 TNS1 P36542   
P55795 HNRNPH2 Q92547 TOPB1    
Q9NY65 TUBA8 T Q13595 TRA2A    
P54652 HSPA2 * Q3B726 TWISTNB    
P11021 HSPA5 Q8IW00 VSTM4    
P07437 TUBB      
 
PPI networks 
Among 610 testis-enriched/specific proteins only 316 proteins have interactions in the PPI 
databases. The remaining 294 testis-enriched/specific proteins have no PPI information; therefore, 
they were excluded for generating the testis-enriched network. With 316 testis-enriched/specific 
proteins, we capture their directly interacting neighbors (1,462 non-testis-enriched proteins 
included) and their inner connections between the proteins. The total number of proteins in the 
testis/spermatozoa-specific PPI network is N=1,778 and the total number of interactions between 
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them is L=32,187. The averaged connectivity, number of neighbors of a node in the network, is 
<q>=36.2 with the power-law connectivity distribution, P(q) ~ q-γ, where γ is the degree exponent 
44. We find that the average shortest path length between two nodes is l =2.63 and the longest 
distance between two nodes is 6. Thus, the testis-enriched/specific network has a sparse structure 
with hubs and small-world properties. The mean clustering coefficient is C=0.19. The clustering 
coefficient characterizes how nearest neighboring nodes of a node are connected to each other. If 
all of them are tightly connected to each other, then they form a clique and the clustering 
coefficient is 1. For a sparse random uncorrelated network of finite size N, this coefficient is close 
to zero 44. Note that the value C=0.19 is about ten times larger than the clustering coefficient 
expected for a sparse random uncorrelated network (in the latter case C = <q>/N ~ 0.02). 
Therefore, the testis-enriched network has a complex motifs structure, which may play a functional 
role, and contains numerous hubs, i.e. highly connected proteins. According to the degree-degree 
correlation analysis, which aims to reveal correlations between connectivities of nearest neighbors, 
the Pearson coefficient of the network is small and negative, r=-0.04 (note that r=0 in uncorrelated 
networks 44.) This result shows that the degree correlations in the testis/spermatozoa-specific PPI 
network are very weak and disassortative. The disassortativity means that weakly connected nodes 
prefer to have strongly connected neighbors, on average. The topological properties of the testis-
enriched/specific network are shown in Supplementary Table D.4. 
The k-core is the network subgraph in which all nodes have degree at least k 36,37. The k-core is 
obtained by recursively removing nodes with connectivity lower than k. Among the 316 testis-
strongly expressed proteins in the network, only 19% of them remain after 10-core decomposition 
(Supplementary Table D.4 B). In the maximum k-core subgraph in which each node has at least 
k=44 connectivity, only RPL10L and HSPA1L remained in the core part (Supplementary Table D.4 
B). The most significant cellular compartment annotations among the proteins in the highest k-core 
were intracellular non-membrane-bounded organelle (60.4%; p=3.5E-38) and cytosol (56.2% of the 
proteins; p=6.0E-60), more specifically the cytosolic ribosome (29.7%, p=3.2E-88). Also, 37.5% 
shared the same biological process (translation, p=7.2E-67). Among the proteins strongly 
expressed in testis, PBK, TUBA3C, and PIAS2 are located in high k-cores with k=42, 36, and 36, 
respectively (Supplementary Table D.4 B). PPP1CC is located in the fourth maximum core part 
(k=41). PPP1CC in this network has 106 nearest neighbors (Figure B.1). Among those, 27.4% (29 
proteins) are involved in cell cycle (p=4.50E-13) and 22.6% (24 proteins) in regulation of 
programmed cell death (p=9.50E-09). Nineteen PPP1CC interactors from the network were 
associated with male infertility phenotypes knockout mice (LMNA, ESR1, TP53, PGK2, CDK4, 
CDK2, AKT1, HSPA4, BRCA1, CDKN2A, TRIM28, LBR, AKAP4, RIF1, SIAH1, AURKB, 
RANBP9, YBX2 and IKBKG, Supplementary Table D.5). 
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Figure B.1 – PPP1CC interactors in the testis/sperm-enriched network. Node sizes represent relative degree of the nodes 
and other interactions of the nodes are not expressed for simplicity's sake. Square nodes represent testis-enriched/specific 
proteins; Darker node color represents infertility related proteins; Node color according the modularity: module 1, light-
cyan; module 2, violet; module 3, pink; module 4, orange; module 5, yellow; module 6, light-green; module 7, 
aquamarine. 
 
We identified community structures in the network without taking into account overlapping by use 
of a modularity matrix following the method in reference 38 (Supplementary Table D.4 B). Seven 
modules were identified in the network, which have 19.3% (module 1), 5% (module 2), 12.7% 
(module 3), 13.3% (module 4), 25.3% (module 5), 7.7% (module 6) and 35.7% (module 7) of 
testis-enriched/specific proteins. PPP1CC was located in module 5 in this network and our analysis 
showed that module 5 included the highest percentage of proteins with a similar functional role. In 
Supplementary Table D.6 lists listed the top 10 most statistically significant categories for both 
biological process and cellular component in each module. Modules 2 and 5 included a higher 
percentage of proteins with a similar functional role. Module 5 included 320 proteins of which 
52.8% are involved in regulation of transcription (p = 1.3E-54) and 38.4% are localized at the 
nuclear lumen (p = 2.1E-57). From the KEGG analyses, the most significant pathway associated 
with module 5 is cell cycle (8.5%, p = 6.9E-19). Among the 272 proteins in module 2, 28.8% were 
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involved in translation, more specifically in translational elongation (p = 1.7E-98). KEGG analysis 
corroborated these results and indicated that 22.7% proteins in module 2 were associated with 
ribosomes (p=4.6E-83). Module 1 included 223 proteins of which 22.0% were involved in protein 
kinase cascade (p=2.4E-32). Pathway analysis revealed that the most significant pathway was the 
JAK-STAT signaling (22.0%; p=4.6E-38). The most prominent biological process detected in 
module 6 (80 proteins) was RNA processing (20%, p=1.0E-10), more specifically RNA splicing 
(18.8%; p=2.4E-10).  
Fifty-nine genes associated with the term “male infertility” were extracted from OMIM database 
and 18 (AR, CFTR, ACR, FSHR, CATSPER1, PIWIL1, FKBP6, PRND, FKBP4, CLCN2, TEX11, 
ZBTB16, PRM1, SEPT12, PICK1, SPAG6, AURKC and DAZL) overlapped with proteins from 
the network. Proteins associated with “male infertility” were also searched in UniProtKB and 45 
records were obtained from which 32 (AR, CFTR, ACR, FSHR, CATSPER1, PIWIL1, FKBP6, 
PRND, FKBP4, CLCN2, TEX11, ZBTB16, PRM1, SEPT12, PICK1, SPAG6, AURKC, DAZL, 
DAZ1, DAZ4, DZIP3, PUM2, SYCP3, CREM, DDX4, DNAI1, HSFY1, INSL3, NEK2, RXFP2, 
TAF7L and TSSK2) were part of the testis/sperm-enriched network. 
PPP1CC in spermatogenesis and motility 
We selected the proteins annotated with GO terms related to spermatogenesis (Supplementary 
Table D.7 A) and associated with abnormal spermatogenesis phenotypes. Then, extracted PPP1CC 
interactors annotated in those categories from the testis/sperm-enriched network (Figure B.2). In 
this subnetwork, we had 16 direct connections to PPP1CC. 
 
Figure B.2 – PPP1CC-based sub-network for spermatogenesis extracted from the testis/sperm-enriched network. 
PPP1CC and its interactors associated with spermatogenesis-related annotations were extracted from the network. Square 
nodes represent testis-enriched proteins; Node colors represent spermatogenesis-related annotations. Node size according 
to the degree in the network. 
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A PPP1CC-based subnetwork for sperm motility was also constructed. The PPP1CC interactors 
associated with motility annotations (Supplementary Table D.7 B) were extracted from the 
testis/sperm-enriched network (Figure B.3). In this subnetwork, PPP1CC had 50 direct 
connections. 
 
Figure B.3 – PPP1CC-based sub-network for sperm motility extracted from the testis/sperm-enriched network. PPP1CC 
and its interactors associated with motility-related annotations were extracted from the network. Square nodes represent 
testis-enriched proteins; Node colors represent motility-related annotations. Node size according to the degree in the 
network. 
 
PPP1CC2 and AKAP4 interaction in human spermatozoa 
To demonstrate the interaction of PPP1CC2 and AKAP4 in human spermatozoa we performed a 
co-immunoprecipitation using an isoform-specific anti-PPP1CC2 antibody from three independent 
normozoospermic human ejaculated sperm samples followed by mass spectrometry analysis 
(Figure B.4 A). Using the Orbitrap XL mass spectrometer 6 peptides were identified that matched 
PPP1CC (Table B.2). Mass spectrometry data of the same immunoprecipitates showed that AKAP4 
was also present. Fourteen peptides were identified that matched AKAP4 (Table B.2). 
Additionally, several previously well-characterized PPP1 interacting proteins, such as 14-3-3 
(YWHAQ), were also identified. This is the first report of AKAP4 recovery from multiple 
PPP1CC2 immunoprecipitates of human sperm extracts. Endogenous PPP1CC2 was also shown to 
coimmunoprecipitate with endogenous AKAP4 in normozoospermic human spermatozoa by 
Western blot (Figure B.4 B right panel). However, the signal was weak. This was expected since 
AKAP4 is present in the insoluble fraction of the spermatozoa and is very resistant to extraction 
(Figure B.4 B left panel). Additionally, we also showed that the amount of AKAP4 in 
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asthenozoospermic samples (AZ) was reduced compared with normozoospermic samples (NZ) 
(Figure B.4 B, left panel). To further confirm the interaction between PPP1CC2 and AKAP4, 
endogenous immunoprecipitated AKAP4 from human spermatozoa was also found to directly 
interact with PPP1CC2 by blot overlay (Figure B.4 C). In addition, and particularly relevant to 
PIPs, the canonical PPP1 binding motif RVxF was detected by bioinformatics analysis, comprising 
a region within amino acids 40-44 of human AKAP4 protein, 40FCIVK44. We also examined the 
localization of those proteins in human spermatozoa. Double immunolabeling experiments 
demonstrated co-localization of PPP1CC2 and AKAP4 in the human sperm flagellum (Figure B.4 
C). A co-localization in the flagellum was detected in 97% of the cells (100 cells in each 
independent experiment were scored), which supports the role of these proteins in motility. 
Table B.2 – Peptides identified by Orbitrap XL mass spectrometry for AKAP4 and PPP1CC, after immunoprecipitation 
of human spermatozoa samples with rabbit anti-PPP1CC2 antibody. 
Sequence Modified sequence Start End Score Id threshold 
AKAP4 (Accession Q5JQC9) 
VGDTEGEYHR NH2-VGDTEGEYHR-COOH 140 149 75 31 44 31 
NTNNNQSPSAPPAKPPSTQR NH2-NTNNNQSPSAPPAKPPSTQR-COOH 184 203 
65 34 
86 34 
LSSLVIQMAHK NH2-LSSLVIQM<Mox>AHK-COOH 224 234 40 34 
NLHNITGVLMTDSDFVSAVK 
NH2-
NLHNITGVLM<Mox>TDSDFVSAVK-
COOH 
389 408 54 34 
QNATDIMEAMLK NH2-QNATDIM<Mox>EAM<Mox>LK-COOH 417 428 53 33 
RLVSALIGEEK NH2-RLVSALIGEEK-COOH 429 439 54 32 LVSALIGEEK NH2-LVSALIGEEK-COOH 430 76 34 
SQSLSYASLK NH2-SQSLSYASLK-COOH 443 452 49 34 
NQSLEFSTMK NH2-NQSLEFSTM<Mox>K-COOH 462 471 64 32 
VGEHILK NH2-VGEHILK-COOH 496 502 42 31 
LIQYHLTQQTK NH2-LIQYHLTQQTK-COOH 551 561 77 33 
MDMSNIVLMLIQK 
NH2-
M<Mox>DM<Mox>SNIVLM<Mox>LIQ
K-COOH 
624 636 75 34 
YSNDGAALAELEEQAASANKP
NFR 
NH2-
YSNDGAALAELEEQAASANKPNFR-
COOH 
714 737 59 32 
ERQPDEAVGK NH2-ERQPDEAVGK-COOH 831 840 64 34 
PPP1CC (Accession P36873) 
ADLDKLNIDSIIQR Ace-ADLDKLNIDSIIQR-COOH 2 15 100 33 
NVQLQENEIR NH2-NVQLQENEIR-COOH 27 36 71 35 
EIFLSQPILLELEAPLK NH2-EIFLSQPILLELEAPLK-COOH 44 60 116 25 
IKYPENFFLLR NH2-IKYPENFFLLR-COOH 112 122 34 31 YPENFFLLR NH2-YPENFFLLR-COOH 114 55 34 
AHQVVEDGYEFFAK NH2-AHQVVEDGYEFFAK-COOH 247 260 68 33 
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Figure B.4 – PPP1CC2 and AKAP4 interact in human spermatozoa. (A) Co-immunoprecipitation, using an isoform-
specific anti-PPP1CC2 antibody from ejaculated normozoospermic (NZ) sperm samples, followed by mass spectrometry 
analysis identified 14 peptides that matched AKAP4 (see Table 2). (B) Left panel - Western blot analysis of AKAP4 
expression in both soluble and insoluble fractions of ejaculated asthenozoospermic (AZ) and NZ sperm samples; Sperm 
preparations corresponding to 5x106 cells were loaded in the lanes. Right panel – Soluble sperm extract was co-
immunoprecipitated with anti-PPP1CC2 antibody and immunoblotted with anti-AKAP4 antibody. Sperm soluble extract 
preparation corresponding to 10x106 cells was also loaded. (C) Human sperm soluble extract was immunoprecipitated 
with anti-AKAP4 antibody or no primary antibody (No Ab) in control and extracts were run on SDS-PAGE gels. Prior to 
immunoblot with anti-PPP1CC2 antibody the membrane was overlaid with recombinant PPP1CC2. Image is 
representative from three independent experiments. Sperm soluble extract preparation corresponding to 5x106 cells was 
also loaded.  (D) Co-localization of PPP1CC2 and AKAP4 in human spermatozoa was demonstrated by dual 
fluorescence staining (PPP1CC2 with Texas Red staining and AKAP4 with FITC staining). Double labeling of human 
spermatozoa revealed co-localization of PPP1CC2 and AKAP4 over the flagellum. Nucleus was stained with DAPI. 
Negative controls with the secondary antibodies alone were performed and presented no reactivity (data not shown). 
Images are representative from three independent experiments. Co-IP, co-immunoprecipitation; IP, immunoprecipitation; 
IB, immunoblot; HC, heavy chain; NZ, normozoospermic; AZ, asthenozoospermic. Note that anti-AKAP4 antibody has a 
reported unspecific band at approximately 72 KDa (*). 
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3.1.5.!Discussion 
In this study, we characterized the interactome of PPP1CC2 in human testis and spermatozoa using 
a tissue-specific network-based approach.  This methodology led to the identification of functional 
relationships between proteins associated with male reproductive functions and new candidates, 
currently poorly explored, such as AKAP4, that might be involved in PPP1CC2-based regulation of 
male fertility. 
Tissue-specific gene expression results in the presence or absence of certain protein complexes 
leading to functional implications. Of the 313 direct PPP1CC/PPP1CC2 interactors identified from 
several sources (PPI databases, literature search, substrates and Y2H), 10 were identified as highly 
specific to or strongly expressed in the testis in at least two databases (AKAP4, PGK2, TSKS, 
TSSK1B, YBX2, SPZ1, NEK2, C9orf50, GLB1L and PPP1R2P9). A PubMed search revealed that 
7 of those PPP1CC interactors had been previously studied in the context of male fertility, 
strengthening our approach. AKAP4, a testis-specific protein transcribed only in the postmeiotic 
phase of spermatogenesis, is the major fibrous sheath protein of the principle piece of sperm 
flagellum involved in motility regulation 39. PGK2 is a glycolytic enzyme that is not required for 
the completion of spermatogenesis, but is essential for sperm motility 40. TSKS mediates the 
interaction between PPP1CC2 and TSSK1B and has been proposed to play a critical role in the 
completion of spermatogenesis 41. YBX2 was proposed as a PPP1CC2 substrate in testis 23 and its 
depletion leads to spermatogenic arrest due to incomplete nuclear condensation in spermatids 42. 
SPZ1 was identified as a specific binding partner of PPP1CC2 isoform in testis 16. NEK2 has been 
shown to be involved in chromosome condensation during the first meiotic division 43–45. 
Functional relationships can be neglected when considering only tissue-specific proteins 46. We 
addressed this challenge by integrating tissue-specific proteins with their interacting proteins to 
construct a testis/sperm-enriched network. By generating such a network, we can effectively 
represent the diversity of tissue-specific protein functions. However, this study presents limitations 
since the knowledge of protein tissue distribution is still quite limited and the databases do not take 
into consideration tissue-specific alternative splicing products from a single gene, which is 
particularly relevant in the testis 47. From the PPI data, including the HIPPIE database, Y2H data 
and literature search results, we selected the 616 testis-enriched proteins direct interactions and 
then captured inner connections between these proteins. A total of 1,778 proteins and 32,187 
interactions between them were identified in the testis/sperm-enriched network. In the testis/sperm-
enriched network PPP1CC had 106 nearest neighbors (Figure B.1). 
Since k-cores represent the densest parts of networks, they play an important role in the structure 
and dynamics of complex network systems. It can provide insights into the members of functional 
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modules interacting more tightly with each other, since most interacting proteins in protein 
complexes share similar functions 48. Most testis-specific proteins are located at the periphery of 
the network. In the maximum k-core subgraph in which each node has at least k=44 connectivity, 
only RPL10L and HSPA1L remained in the core part (Supplementary Table D.4 B). HSPA1L is a 
testis-specific heat shock protein chaperone present in the human sperm surface, suggested to be 
involved in binding to the zona-pellucida 49. RPL10L, previously reported to be expressed 
exclusively in the testis 50, is a ribosomal protein involved in spermatogenesis. 
Community is another important feature of network structure. Nodes in a community are more 
highly inter-connected to each other than to nodes out of the community and are usually involved 
in the same function, for instance, the communities in PPI networks are identified as functional 
modules 51. We identified community structures in the network without taking into account 
overlapping by use of a modularity matrix following the method in reference 38 (Supplementary 
Table D.4 B). Seven modules were identified in the testis/sperm-enriched network. PPP1 
interactors in each module are represented in Figure B.1. Changes that occur during 
spermatogenesis require transcription, translation and post-translational modifications of numerous 
ubiquitous and germ cell-specific products, and those processes appear to be regulated by the 
highly interconnected proteins in modules 5, 2 and 1, respectively. Additionally, alternative 
splicing regulation has been particularly relevant in testis and module 6 reflects the relevance of 
this process in the testis/sperm-enriched network 47.  
Two decades ago, scientists started paying attention not only to the role of PPP1CC2 in 
spermatogenesis, but also to a prominent role of PPP1CC2 in the regulation of sperm motility 
5,6,9,11. We explored the biological functionalities of proteins in the PPI network based on GO term 
search and phenotype analysis and constructed PPP1CC-centric spermatogenesis and sperm 
motility subnetworks (Figure B.2 and Figure B.3). In the PPP1CC-centric spermatogenesis 
subnetwork, we had 16 direct connections to PPP1CC (Figure B.2). From those, only SPZ1, TSKS, 
TSSK1B, YBX2 and YWHAZ were already described in the literature as potentially involved in 
spermatogenesis (for review see 10). Future studies on the other spermatogenesis-associated 
interactors presented in Figure B.2 can increase the knowledge on PPP1CC2 function in 
spermatogenesis and uncover new key players in the multifactorial regulation of this process. For 
instance the subnetwork showed that, TSSK1B, YBX2, HSPA4, TRIM28, RANBP9 and CDK2 
were specifically involved in spermiogenesis (Figure B.2). Interestingly, targeted disruption of 
mouse Ppp1cc gene results in male infertility due to aberrant spermiogenesis. 
In the PPP1CC-centric motility subnetwork, PPP1CC had 50 direct connections. As shown in 
Figure B.3, motility-related PPP1CC interactors were highly interconnected and many of them 
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were in the core part (k=44) of the testis/sperm-enriched network (Supplementary Table D.4 C). 
The large number of PPP1CC interactors involved in motility-associated categories emphasizes the 
role of this protein in regulating this function. We identified several previously uncharacterized 
interactors, such as, LMNA, JAK2, RIPK3, PGK2, CSNK2B, CDK1 and RAF1, as players in this 
process (Figure B.3). One of the most intriguing interactors resulting from the analysis of the 
PPP1CC-centric motility subnetwork was AKAP4: (1) testis/sperm-specific protein, (2) involved in 
all major motility-related annotations and (3) related to a motility-related infertility phenotype. The 
Akap4 knockout mice revealed that AKAP4 is not involved in spermatogenesis, but sperm failed to 
show progressive motility 39. Miki and colleagues concluded that effective sperm motility is lost in 
the absence of AKAP4 because signal transduction enzymes fail to become associated with the 
fibrous sheath. In fact, The Akap4 gene knockout mice present a significant increase in the activity 
and decrease in phosphorylation of PPP1CC2 in spermatozoa 52. Here we show for the first time, 
the interaction between AKAP4 and PPP1CC2 in human spermatozoa and their co-localization in 
the sperm flagellum (Figure B.4). We speculate that AKAP4 may recruit PPP1CC2 to the fibrous 
sheath regulating the catalytic activity of PPP1CC22 by modulating its ability to interact with other 
proteins. Additionally, AKAP4 was previously shown to suffer changes in its phosphorylation 
status during the spermatozoa epididymal maturation 53 which may be, in turn, regulated by 
PPP1CC2. AKAP220/AKAP11 was previously described as a direct interactor and a competitive 
inhibitor PPP1 54. 
Blocking motility-related PPP1CC2-PIP interactions, such as PPP1CC2/AKAP4, during the 
epididymal transit will potentially generate active PPP1 that efficiently dephosphorylates a subset 
of substrates, preventing motility acquisition, which represents good contraceptive targets. An 
attractive approach to modulate PPP1 activity is to target specific interfaces between PPP1 and 
tissue/event-specific PIPs, disrupting their interaction. One of these interfaces, which occur in 
AKAP4, is the RVxF-motif, which binds to a domain on PPP1 that is remote from the active site. 
Synthetic peptides that contain variants of the RVxF motif were reported to disrupt a subset of PIP–
PPP1 complexes in vitro 55,56. 
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3.2.1.!Abstract 
The large number of unintended pregnancies worldwide highlights the need for new contraceptive 
methods. Still, modern and non-invasive contraceptives for men are not available. The mechanism 
of spermatozoa motility acquisition is a perfect target for a new male contraceptive since it affects 
only the post-testicular sperm maturation. Phosphoprotein phosphatase 1 catalytic subunit gamma 2 
(PPP1CC2), a PPP1 isoform restricted to testicular germ cells and spermatozoa, is essential for 
sperm motility acquisition. In an effort to understand PPP1CC2 regulation in male germ cells, we 
have devoted efforts to characterize its interacting partners (PPP1 Interacting Proteins, PIPs). 
Protein-protein interactions (PPIs) are a promising class of drug targets. Cell penetrating peptides 
(CPPs) represent a widely recognized intracellular delivery system to target PPIs. In the present 
study, we designed peptide sequences capable of selectively disrupting PPP1-PIPs complexes as a 
strategy to modulate sperm motility. These endogenous sequences were covalently coupled to inert 
CPPs as sychnologically-organized bioportide constructs in order to affect intracellular delivery 
and potentially modulate PPP1 function. Herein, we demonstrate for the first time the potential of 
CPPs to deliver peptide sequences that target unique PPIs in spermatozoa. Specifically, a 
bioportide that mimics the unique 22 amino acid C-terminus of PPP1CC2, potentially 
compromising isoform-specific interactions, inhibited sperm motility. Additionally, a peptide 
sequence that mimics the interaction interface between PPP1CC2 and a sperm-specific PPI - 
AKAP4 - was also successfully delivered to sperm cells with an impact upon sperm motility. 
3.2.2.!Introduction 
Despite currently available contraceptives, the world's population has risen to an alarming level, 
and overpopulation continues to be a significant contributor to environmental degradation and 
human suffering worldwide. It is estimated that half of all conceptions are unintended 1,2. The 
contraceptive shortfall results in over 20% of pregnancies ending in abortion 3,4. Furthermore, 
undesired pregnancies result in children who suffer from poverty and negligence. These statistics 
illustrates the urgent need to develop new male contraceptive methods to overcome uncontrolled 
fertility. Condom and vasectomy have been the main methods of male contraception and he 
development of new male contraceptives has focused upon hormonal modulation 5,6. However the 
severe side effects have been an obstacle to this technology 7. The mechanism of sperm motility is 
a perfect target for a new male contraceptive, since it allows normal hormone and spermatozoa 
production and affects only the post-testicular sperm maturation. The spermatozoon is a specialized 
cell virtually incapable of genetic expression. Any functional alteration (e.g. motility aquisition) in 
these cells depends on processes such as protein post-translational modifications (e.g. 
phosphorylation), or mechanisms based on the disruption/formation of protein complexes. 
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Phosphoprotein phosphatase 1 (PPP1) is a major serine/threonine phosphatase in eukaryotic cells 
8,9. PPP1CC2 is a testis-enriched and sperm specific-isoform, distributed along the entire flagellum 
10,11,12. The observation that PPP1C had a two-fold higher activity in immotile bovine caput 
epididymal sperm compared to mature motile caudal sperm is consistent with it being directly 
involved in sperm motility 10,11. Moreover, inhibition of PPP1CC2 activity by okadaic acid or 
calyculin A induced and stimulated motility in caput and caudal sperm, respectively 10,11.  
Regulation of PPP1 catalytic activity is mediated via binding to specific regulatory subunits, the 
PPP1 interacting proteins (PIPs) 13–18. We previously characterized testis/sperm-enriched/specific 
PIPs by integrating tissue-specific protein-expression, PPI data and constructing a testis/sperm-
specific network. We analyzed several topological properties of the network and specified the 
biological and physiological properties that allowed the identification of sperm-specific PPP1CC2 
complexes potentially involved in sperm motility. Previously uncharacterized PIPs, such as A 
kinase anchor protein 4 (AKAP4, also called fibrous sheath component 1 or AKAP 82) were 
identified. AKAP4 is the major fibrous sheath protein of the principle piece of sperm flagellum. 
Absent or weak AKAP4-labelling seems to be associated with absent or weak sperm motility 19. 
Additionally, AKAP4 and AKAP3 gene deletions were found in men with dysplasia of the fibrous 
sheath, which causes severe asthenozoospermia (reduced motility) or total immotility 20–22. The 
male mice lacking AKAP4 were infertile, the motility of their sperm was poor, the principal piece 
of the flagellum was reduced in diameter, the fibrous sheath was incompletely developed, and other 
proteins usually found in the principal piece region of the flagellum were either absent or reduced 
in amount 23.  The Akap4 gene knockout mice also presented a significant change in the activity 
and phosphorylation status of PPP1CC2 24. Besides reporting AKAP4 as a PPP1CC2 interactor in 
spermatozoa (see section 3.1.), we also described the presence of a canonical PPP1 binding motif 
RVxF in AKAP4. The interfaces between PPP1 and PIPs represent an excellent target for 
pharmacological intervention. Regarding PPP1, only a few in vitro studies used synthetic peptides 
(based on the RVxF motif) to disrupt the PPP1-PIP complex 25 and currently only two drugs 
(salubrinal e trichostatin A) modulate PPP1 complexes (for review see 8). However, modulation of 
human spermatozoa physiology by synthetic peptides or small molecules that disrupt PPP1 
complexes was never accomplished. The therapeutic targeting of PPIs with selective inhibitors is a 
widely recognized strategy 26. However, the cellular bilayered lipid membrane is an obstacle for the 
development of therapeutic agents against intracellular targets. Cell penetrating peptides (CPPs) 
represent a very promising intracellular delivery system to target PPIs 27. CPPs can efficiently 
traverse the lipid membrane and deliver a wide range of therapeutic moieties, including small 
drugs, more bulky proteins and oligonucleotides 28. It was recently demonstrated that CPPs are able 
of translocate into the sperm cell without affecting its viability and motility 27.  
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The main goal of this study was to design and synthesize peptides capable of selectively disrupting 
PPP1-PIPs complexes. These endogenous sequences and structural analogues were coupled to inert 
CPPs in order to affect significant intracellular delivery and so modulate PPP1 function.  
3.2.3.!Methods 
Microwave-assisted solid phase peptide synthesis 
Peptide sequences derived from (a) the 22 amino acid C-terminus of the human PPP1CC2 
(303KPNATRPVTPPRVASGLNPSIQKASNYRNNTVLY336) [PPP1CC2-CT], (b) the region 
including the PPP1 binding motif (40KVICF44) of the human AKAP4 
(33GQQDQDRKVICFVDVSTLNV52) [AKAP4-BM] and (c) a mutated homologue 
(33GQQDQDRAAAAAVDVSTLNV52) [AKAP4-BM M] were synthesized using microwave-
assisted solid-phase peptide synthesis. These endogenous sequences were coupled to a CPP – 
penetratin (RQIKIWFQNRRMKWKK) (Table B.3). 
Microwave-assisted solid phase peptide synthesis was performed using a Discover SPS Microwave 
Peptide Synthsizer (CEM Microwave Technology Ltd, Buckingham, UK) with fibre optic 
temperature control. Peptides were synthesized (0.1 mmol scale) using Rink amide MBHA resins 
pre-loaded with the first amino acid (AnaSpec, Inc., Cambridge Bioscience Ltd, Cambridge, UK) 
and employed an N-α-Fmoc protection strategy with HCTU activation. Deprotection with 7 ml of 
20 % piperidine was performed for 3 min at 50 W/75 °C A majority of AA coupling reactions were 
accomplished with a 4-fold molar excess of Fmoc-protected AA with HCTU and 
diisopropylethylamine (DIPEA), molar ratio of 1:1:2 (AA/HCTU/DIPEA), in 4 ml for 10 min at 25 
W/75 °C. Arg coupling was performed in two stages: 30 min 0 W/25 °C followed by 5 min at 17 
W/75 °C. To reduce racemization of Cys and His, coupling conditions were 5 min at 0 W/25 °C 
followed by 6 min at 17 W/50 °C with the hindered base collidine (TMP) at a molar ratio of 1:1:2 
(AA/HCTU/TMP; 29). Aspartimide formation was reduced by the substitution of piperidine for 5 % 
piperazine and 0.1 M 1-hydroxybenztriazole hydrate (HOBt) in the deprotection solution. 
Fluorescent peptides, to be used in cell imaging and quantitative uptake analyses, were synthesized 
by amino-terminal acylation with 6-carboxy-tetramethylrhodamine (TAMRA) (Novabiochem, 
Beeston, UK) as previously described 30. Peptides were purified by semi-preparative scale high-
performance liquid chromatography, and the predicted masses of all peptides were confirmed by 
matrix-assisted laser desorption ionization (MALDI) time of flight mass spectrometry. Sequences, 
abbreviations and masses of all peptides used in this study are shown in Table B.3. 
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Table B.3 – Peptide sequences, abbreviations and molecular masses. To enable both quantitative and qualitative uptake 
analysis, peptides were extended with TAMRA. Peptide masses (M+ H+) were confirmed by MALDI time of flight mass 
spectrometry. Underlined, penetratin (CPP); Bold, PPP1 binding motif (pattern: [RK]-X(0,1)-[VI]-{P}-[FW]). 1The last 
amino acid of PPP1CC2 C-terminus (glutamic acid) was excluded due to its negative charge. 
Peptide 
designation Abbreviation Peptide sequence Mass (g/mol) 
PPP1CC2 C-
terminal 1 PPP1CC2-CT 
NH2- 
RQIKIWFQNRRMKWKKKPNATRPVTPPRVASGLNPSI
QKASNYRNNTVLY-H 
5953,0124 
AKAP4 binding 
motif AKAP4-BM 
H-
KKWKMRRNQFWIKIQRVNLTSVAVFCIVKRDQDQQG
-NH2 
4448,3148 
AKAP4 binding 
motif mutant AKAP4-BM M 
H-
KKWKMRRNQFWIKIQRVNLTSVAVAAAAARDQDQQ
G-NH2 
4212,9217 
 
Semen samples 
This study was approved by the Ethics and Internal Review Board of the Hospital Infante D. Pedro 
E.P.E. (Aveiro, Portugal) and was conducted in accordance with the ethical standards of the 
Helsinki Declaration. Human semen samples were obtained from a randomized group of donors, by 
masturbation to a sterile container. All donors signed informed consent allowing the samples to be 
used for scientific purposes. Basic semen analysis was performed according to World Health 
Organization (WHO) guidelines. Fresh semen from Holstein Frisian bulls was obtained from 
LusoGenes, LDA (Aveiro, Portugal). Semen was collected by artificial vagina and assessed by a 
certified veterinarian. Human and bovine spermatozoa were isolated and washed from seminal 
plasma by centrifugation (800 g for 5 min, 3 times) using ALLGrade Wash medium (LifeGlobal, 
Brussels, Belgium). Spermatozoa pellets were resuspended in medium to a final concentration of 
20x106 cells/0.5 mL and incubated at 37 °C with 5 % CO2 until the appropriated treatments were 
added. 
Microscopy evaluation of the intracellular accumulation of the peptides 
Isolated bovine and human spermatozoa (40x106 cells) were resuspended and incubated with 10 
µM TAMRA-labeled peptides for 1 h at 37 °C in a humidified atmosphere of 5 % CO2. Cells were 
then washed three times (800 g for 5 min) in ALLGrade Wash medium (LigeGlobal, Brussels, 
Belgium). To confirm if the fluorescently labeled peptides were not merely surface associated, we 
divided the sperm cell population in two and used a trypsin incubation to remove any surface 
associated peptides. In summary, half of the cells were set aside (20x106 cells) and fixed in 4 % 
paraformaldehyde (PFA) for 20 min. The other half was incubated with 1 % (wt/vol) trypsin at 37 
°C, collected by centrifugation at 3000 g, washed in ALLGrade Wash medium (LigeGlobal, 
Brussels, Belgium) and resuspended in 4 % PFA 20 min. Fixed cells from each preparation were 
spread into coverslips and allowed to air dry. After mounting, slides were assessed by fluorescence 
microscopy (Imager.Z1, Axio-Cam HRm camera and AxioVision software, Zeiss, Jena, Germany). 
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Quantitative analyses of the peptides translocation 
Translocation efficacy of CPP-mediated intracellular delivery of the peptides sequences was 
determined by quantitative uptake analysis of fluorescently labeled moieties and based upon the 
method previously described by Holm et al. 31. Isolated bovine and human spermatozoa were 
incubated with 10 µM TAMRA-labeled peptides for 1 h at 37 °C in a humidified atmosphere of 5 
% CO2. Cells were then washed four times with PBS, detached with 1 % (w/v) trypsin at 37 °C, 
collected by centrifugation at 3000 g and lysed in 300 µl 0.1 M NaOH for 2 h on ice. 250 µl of each 
sample cell lysate were transferred to a black 96-well plate, and analyzed using an Infinite® 200 
PRO (Tecan, Switzerland) (λAbs 544 nm/λEm 590 nm). 
Cell viability assays 
Bovine spermatozoa viability was evaluated using the trypan blue viability test according to 
manufacturer’s guidelines. Human spermatozoa viability was measured using the CellTiter 96® 
AQueous Non-Radioactive Cell Proliferation Assay (Promega, Madison, USA) according to 
manufacturer's guidelines. The reduction of tetrazolium compounds has previously been used as a 
reliable and rigorous assessment of spermatozoa viability 32.  
Motility assays 
Media were prepared and peptides (PPP1CC2-CT, PPP1CC2-CT TAMRA, AKAP4 and AKAP4 
M) were added to individual volumes. Bovine and human sperm cells were added to the media to 
give a total volume of 500 µl. Approximately, 20x106 sperm cells per treatment/well were used. 
Control samples included sperm cells in media. The influence on sperm motility parameters was 
assessed using the Sperm Class Analyzer CASA System (Microptic S L, Barcelona, Spain) with 
SCA® v5.4 software. Samples and controls (2 µl) were loaded into individual chambers of Leja 
Standrat Count 8 chamber slide 20 µm depth (Leja Products B. V., The Netherlands) which were 
pre-heated at 37 °C. This temperature was maintained while at least 1000 sperm cells/per 
measurement were evaluated. Each peptide was tested on samples from 3 individual donors and all 
the conditions were performed in triplicate. 
3.2.4.!Results 
Therefore, CPPs were used to deliver PPI disruptor peptide sequences into sperm cells aiming at 
affecting their motility. A peptide sequence that mimics the unique 22 amino acid C-terminus of 
PPP1CC2 (PPP1CC2-CT) and is conserved in both bovine and human was used to compromise the 
isoform-specific interactions between PPP1CC2 and its interactors. The AKAP4-BM peptide 
mimics the PPP1 binding motif RVxF in AKAP4 (40KVICF44), which is also conserved in both 
species, and was used to disrupt PPP1CC2-AKAP4 complexes. A peptide with a mutation in the 
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PPP1 binding motif of AKAP4 (AKAP4-BM M) was used as a control of the AKAP4-BM. A 
negative control (samples without any treatment) was used in all the experiments. 
Peptides translocate into bovine and human spermatozoa 
Fluorescent microscopy clearly revealed the intracellular accumulation of the peptides within 
bovine and human spermatozoa (Figure B.5). Quantitative uptake analyses also demonstrated a 
range of translocation efficacies amongst those peptides tested (Figure B.5, Supplementary Table 
D.8). To confirm that the fluorescently labeled peptides were not merely surface associated, 
peptide-treated spermatozoa were firstly incubated with high concentrations of exogenous trypsin 
that rapidly degrades polycationic peptides as previously described 33. The microscopy analyses 
showed that the PPP1CC2-CT and AKAP4 BM peptides internalized very efficiently in both 
human and bovine spermatozoa, while the AKAP4 BM M peptide internalized less efficiently 
giving rise to a reduced florescent signal (Figure B.5). Quantitative comparison of the uptake 
efficacies (Figure B.5) was in accordance with the microscopic observations. The PPP1CC2-CT 
and AKAP4 BM peptides revealed higher cellular uptake, when compared to the AKAP4 BM M 
peptide, probably reflecting specific binding of PPP1CC2-CT and AKAP4 BM peptides after 
membrane translocation . The uptake of the peptides differed between species, with human 
spermatozoa revealing higher uptake of all the peptides when compared with bovine cells. 
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Figure B.5 – Intracellular accumulation of the TAMRA-labeled peptides. Upper panel and lower panel (left): To establish 
that the detected fluorescence was not attributed to surface-associated peptide, isolated sperm cells were incubated for 1h 
with 10 µM TAMRA-labeled peptide and subsequently treated with 1% (w/v) trypsin. Negative controls without the 
TAMRA-labeled peptides were performed and presented no reactivity (data not shown). Images are representative from 
three independent experiments. Lower panel (right): Quantitative analysis of peptide translocation into bovine and human 
spermatozoa. Bovine and human spermatozoa were incubated with TAMRA-labeled bioportides (10 µM) for 1 h at 37°C. 
Data are expressed as fluorescence (minus negative control). Three independent experiments were performed in 
quadruplicate. Error bars 95% CI. 
 
Impact of the protein-protein interaction disruptor peptides on sperm motility 
Bovine and human spermatozoa were exposed to different extracellular peptide concentrations (10 
and 20 µM) and motility parameters were assessed at 1 and 2 h. For reference, negative controls 
were performed in the absence of peptides (Supplementary Table D.9 - D.15). 
The percentage of viable spermatozoa was not significantly changed after treatment with peptides, 
except by the 2h incubation with the AKAP4-BM peptide where a slight decrease was observed 
(Figure B.7, Supplementary Table D-12).  
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PPP1CC2-CT peptide 
Exposure of bovine spermatozoa to 10 µM PPP1CC2-CT induced a decrease in both fast (mean 
decrease at 1h of 55,9 ± 19,4%; at 2h 53,9 ± 19,9%; compared with negative control) and slow 
(mean decrease at 1h of 49,9 ± 41%; at 2h 17,4 ± 57%; compared with negative control) 
progressive motility. Incubation of bovine spermatozoa with 20 µM PPP1CC2-CT induced similar 
effects: decrease in both fast (mean decrease at 1h of 64,2 ± 8,3%; at 2h 44,6 ± 9,7%; compared 
with negative control) and slow (mean decrease at 1h of 31,4 ± 35%; compared with negative 
control) progressive motility. In contrast, immotile spermatozoa increased with both 10 µM (mean 
increase at 1h of 72,5 ± 33,6%; at 2h 128,3 ± 85,3%; compared with negative control) and 20 µM 
PPP1CC2-CT (mean increase at 1h of 86,2 ± 72,3%; at 2h 79,1 ± 37,0%; compared with negative 
control). No significant alterations were observed in non-progressive motility (Figure B.6, 
Supplementary Table D-11). 
Both PPP1CC2-CT and TAMRA-PPP1CC2-CT induced a similar effect on sperm motility 
parameters (Figure B.6; Supplementary Table D-11), revealing that the fluorescent labelling did not 
affect significantly peptides action. 
There were no significant differences between the concentrations tested (10 and 20 µM) for any 
motility parameter, suggesting that there was no concentration-dependent effect of the PPP1CC2-
CT peptides for the concentrations tested. 
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Figure B.6 – Impact of the PPP1CC2-CT peptides (PPP1CC2-CT and TAMRA-PPP1CC2-CT) treatment in bovine 
spermatozoa motility and viability parameters: (A) fast progressive motility; (B) slow progressive motility; (C) non-
progressive motility; (D) immotile spermatozoa; and (E) viability. Graph bars represent the mean values of three 
independent experiments performed in triplicate. Error bars 95% CI. Statistically significant findings are indicated with a 
(*). * P<0.05; ** P<0.01. 
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Figure B.6 – (continuation) Impact of the PPP1CC2-CT peptides (PPP1CC2-CT and TAMRA-PPP1CC2-CT) treatment 
in bovine spermatozoa motility and viability parameters: (A) fast progressive motility; (B) slow progressive motility; (C) 
non-progressive motility; (D) immotile spermatozoa; and (E) viability. Graph bars represent the mean values of three 
independent experiments performed in triplicate. Error bars 95% CI. Statistically significant findings are indicated with a 
(*). * P<0.05; ** P<0.01. 
 
Exposure of human spermatozoa to 10 µM PPP1CC2-CT did not induced any significant 
alterations in the motility parameters (data not shown). Exposure 20 µM PPP1CC2-CT induced a 
decrease in fast progressive motility at 2h (mean decrease of 34,5 ± 12,3%; compared with 
negative control) (Supplementary Table D-14). 
AKAP4-BM peptide 
Exposure of bovine spermatozoa to 10 µM AKAP4-BM induced a decrease in both fast (mean 
decrease at 1h of 41,9 ± 20,0%; at 2h 43,9 ± 15,3%; compared with AKAP4-BM M; mean decrease 
at 1h of 49,8 ± 22,5%; at 2h 50,5 ± 9,7%; compared with negative control) and slow (mean 
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decrease at 2h 21,6 ± 64,4%; compared with AKAP4-BM M; mean decrease at 2h 42,4 ± 20,4%; 
compared with negative control) progressive motility. Incubation with 20 µM AKAP4-BM induced 
a decrease in both fast (mean decrease at 1h of 95,0 ± 6,5%; at 2h 98,4 ± 2,6%; compared with 
AKAP4-BM M; mean decrease at 1h of 95,7 ± 5,4%; at 2h 98,6 ± 2,9%; compared with negative 
control) and slow (mean decrease at 1h of 95,7 ± 4,7%; at 2h 94,1 ± 4,9%; compared with AKAP4-
BM M; mean decrease at 1h of 95,3 ± 4,8%; at 2h 94,2 ± 4,8%; compared with negative control) 
progressive motility. In addition, exposure to 20 µM AKAP4-BM peptide led to a significant 
decrease in non-progressive motility (mean decrease at 1h of 63,1 ± 8,3%; at 2h 63,0 ± 7,5%; 
compared with AKAP4-BM M; mean decrease at 1h of 50,0 ± 10,9%; at 2h 59,4 ± 13,2%; 
compared with negative control). In contrast, immotile spermatozoa increased with both 10 µM 
(mean decrease at 1h of 49,9 ± 33,2%; at 2h 73,5 ± 43,3%; compared with AKAP4-BM M; mean 
decrease at 1h of 90,0 ± 51,4%; at 2h 91,8 ± 25,4%; compared with negative control) and 20 µM 
AKAP4-BM (mean decrease at 1h of 155,7 ± 46,1%; at 2h 123,2 ± 38,1%; compared with AKAP4-
BM M; mean decrease at 1h of 91,8 ± 25,4%; at 2h 183,7 ± 88,4%; compared with negative 
control) (Figure B.7, Supplementary Table D-12). Application of the mutated AKAP4-BM did not 
lead to significant differences in motility parameters in bovine spermatozoa (compared with 
negative control), with two exceptions (fast progressive motility at 1h with 20 µM incubation and 
the percentage of immotile spermatozoa with 10 µM incubation at 1h) (Figure B.7, Supplementary 
Table D-12). 
Upon exposure to the AKAP4-BM peptide, at both 1h and 2h, the progressive (fast and slow) and 
the non-progressive motility were higher at a lower peptide concentration (10 µM) compared with 
the higher concentration (20 µM), while the percentage of immotile spermatozoa was higher with 
20 µM peptide incubation, suggesting a concentration-dependent effect for the concentrations 
tested.  
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Figure B.7 – Impact of the AKAP4-BM peptides (AKAP4-BM and AKAP4-BM M) treatment in bovine spermatozoa 
motility and viability parameters: (A) fast progressive motility; (B) slow progressive motility; (C) non-progressive 
motility; (D) immotile spermatozoa; and (E) viability. Graph bars represent the mean values of three independent 
experiments performed in triplicate. Error bars 95% CI. Statistically significant findings are indicated with a (*). * 
P<0.05; ** P<0.01. 
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Figure B.7 – (continuation) Impact of the AKAP4-BM peptides (AKAP4-BM and AKAP4-BM M) treatment in bovine 
spermatozoa motility and viability parameters: (A) fast progressive motility; (B) slow progressive motility; (C) non-
progressive motility; (D) immotile spermatozoa; and (E) viability. Graph bars represent the mean values of three 
independent experiments performed in triplicate. Error bars 95% CI. Statistically significant findings are indicated with a 
(*). * P<0.05; ** P<0.01. 
 
Exposure of human spermatozoa to 20 µM AKAP4-BM induced significant alterations in the 
motility parameters (Figure B.8, Supplementary Table D-15). A decrease in both fast (mean 
decrease at 1h of 87,0 ± 4,3%; at 2h 82,7 ± 20,7%; compared with AKAP4-BM M; mean decrease 
at 1h of 49,8 ± 22,5%; at 2h 50,5 ± 9,7%; compared with negative control) and slow (mean 
decrease at 1h 85,1 ± 5,2%; at 2h 82,3 ± 11,5%; compared with AKAP4-BM M; mean decrease at 
1h 87,6 ± 5,2%; at 2h 85,7 ± 8,7%; compared with negative control) progressive motility was 
observed. In addition, a significant decrease in non-progressive motility (mean decrease at 1h of 
43,4 ± 24,8%; at 2h 50,6 ± 21,0%; compared with AKAP4-BM M; mean decrease at 1h 31,0 ± 
26,9%; at 2h 58,6 ± 16,1%; compared with negative control) was also observed. In contrast, 
immotile spermatozoa increased (mean decrease at 1h of 47,3 ± 19,2%; at 2h 41,9 ± 14,7%; 
compared with AKAP4-BM M; mean decrease at 1h of 63,0 ± 27,8%; at 2h 74,5 ± 28,3%; 
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compared with negative control). Application of the mutated AKAP4-BM did not lead to 
significant differences in motility parameters in human spermatozoa (compared with negative 
control), with one exception (fast progressive motility at 2h with 20 µM incubation). 
 
 
Figure B.8 – Impact of the AKAP4-BM peptides (AKAP4-BM and AKAP4-BM M) treatment in human spermatozoa 
motility parameters: (A) fast progressive motility; (B) slow progressive motility; (C) non-progressive motility; and (D) 
immotile spermatozoa; Graph bars represent the mean values of three independent experiments performed in triplicate. 
Error bars 95% CI. Statistically significant findings are indicated with a (*). * P<0.05; ** P<0.01. 
3.2.5.!Discussion 
One strategy to improve intracellular drug delivery is to employ CPPs to overcome the 
permeability barrier represented by a lipid bilayer. These cationic and/or amphipathic peptides are a 
class of transport vectors, usually less than 30 amino acids in length, which possess the ability to 
rapidly translocate into mammalian cells. CPPs have the ability to carry along various cargo 
molecules, including oligonucleotides, peptides, proteins, plasmids, liposomes, and nanoparticles, 
which do not readily diffuse into the cytoplasm. The cargo may be reversibly or irreversibly linked 
to the CPP 34,35. Jones et al have shown previously that CPPs enter mammalian spermatozoa 
rapidly, with a half-time between 1 and 3 min, dependent on the CPP 27. The 16-amino acid long 
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peptide penetratin was used in this study to deliver PPI disruptor peptide sequences in sperm cells. 
Penetratin was chosen for its very efficient translocation into spermatozoa flagellum 27. The 
intracellular accumulation of fluorescence-labeled peptides was verified and quantified and it was 
established that the detected fluorescence was not attributed to surface-associated CPP (Figure 
B.5). Further studies using a range of peptide concentrations should be performed in order to adjust 
the external concentrations of different peptides to achieve approximately the same uptake. 
Exposure of bovine and human spermatozoa to the PPI disruptor peptide sequences induced 
significant alterations in motility parameters without altering the cell viability. Here we showed 
that a peptide that mimics the unique 22 amino acid C-terminus of PPP1CC2 coupled with a CPP 
was able to penetrate the sperm cell and led to a statistically significant effect on sperm motility 
(Figure B.6). In bovine spermatozoa, upon treatment with the PPP1CC2-CT peptide, the percentage 
of progressive motile spermatozoa decreased significantly. In turn, the percentage of immotile 
spermatozoa increased significantly. The percentage of non-progressive spermatozoa was not 
affected significantly after peptide treatment (Figure B.6). In human spermatozoa, exposure to 
PPP1CC2-CT peptide induced a decrease in fast progressive motility. We hypothesize that the 
PPP1CC2-CT peptide, which mimics the unique 22 amino acid C-terminus of PPP1CC2, competes 
with isoform-specific interactions potentially involved in the targeting/inhibition of this 
phosphatase, affecting its action and, consequently, spermatozoa motility. Endophilin B1t, a testis 
enriched isoform of the somatic endophilin B1a, and the spermatogenic zip protein (Spz1) 
represent two PPP1CC2 isoform-specific interactors previously identified 36,37. Both endophilin B1t 
and Spz1 do not interact with other PPP1C isoforms or with a truncated PPP1CC2 mutant lacking 
the unique C-terminus. Endophilin B1t and Spz1 were previously shown to specifically inhibit 
PPP1CC2 isoform activity towards phosphorylase a 36,37. As stated previously, PPP1 inhibition is 
essential for sperm motility. Further studies comparing the PPP1CC2 interactome in spermatozoa 
with and without incubation with the competition peptide will allow the identification of other 
isoform-specific interactors. 
In this study we also demonstrated that a peptide that mimics the interaction interface between 
PPP1CC2 and AKAP4 (AKAP4-BM peptide) based on the RVxF motif was also successfully 
delivered to sperm cells and led to a statistically significant effect on sperm motility (Figure B.7 
and Figure B.8). Upon treatment of bovine spermatozoa with the AKAP4-BM peptide, the 
percentage of progressive and non-progressive motile spermatozoa decreased significantly. In turn, 
the percentage of immotile spermatozoa increased significantly. Exposure of human spermatozoa 
to the AKAP4-BM peptide also induced a significant decrease in both progressive and non-
progressive motility and an increase in immotile spermatozoa. Exposure to the mutated AKAP4-
BM did not lead to significant differences in motility parameters in both bovine and human 
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spermatozoa (compared with negative control), with one exception in human sperm cells (fast 
progressive motility at 2h with 20 µM incubation). 
Several findings suggest that the AKAP/PRKA/PPP1 complex is essential for regulation of sperm 
motility. In somatic cells, members of the AKAP family scaffold both kinases and phosphatases to 
a single place within the cell. In testis/sperm there are three AKAPs that have been directly related 
to PPP1CC2 (AKPA220, AKAP3 and AKAP4) and many more show a similar localization. 
AKAP220 binds PRKA and PPP1, being a competitive inhibitor of PPP1 38, 39. Brown et al. 
reported that AKAP4 anchors AKAP3 and two novel spermatogenetic cells-specific proteins, 
Fibrous sheath interacting proteins 1 and 2 (FSIP1 and FSIP2) (Figure B.9) 40, 41. 
Compartmentalization of proteins to the flagellum via AKAPs is believed to ensure that the 
appropriate proteins find themselves in the right place at the right time to facilitate normal flagellar 
function. In support of this, mice containing a targeted mutation of the AKAP4 gene had a 
reduction in or a total loss of several proteins (in addition to PRKA) from the flagellum 23.  We 
have previously reported for the first time that AKAP4 interacts with PPP1CC2 in ejaculated 
spermatozoa (see chapter 3.1.). If AKAP4 is a scaffold for localizing and grouping functionally 
important proteins in addition to PRKA, its interaction with PPP1CC2 suggests a key role for 
AKAP4 in organizing the phosphorylation/dephosphorylation pathways that are required for the 
regulation of spermatozoa motility (Figure B.9). Huang and colleagues reported a significant 
decrease in PPP1CC2 phosphorylation and increase in its activity in spermatozoa lacking AKAP4. 
This suggests that AKAP4 is required to regulate the phosphorylation level, and consequently the 
activity, of PPP1CC2 in spermatozoa. Since PPP1CC2 inhibition is required for sperm motility, 
and AKAP4 is necessary for PPP1CC2 activity inhibition, it is reasonable to assume that the loss of 
PPP1CC2-AKAP4 interaction due to the competitive peptide is associated with immotile 
spermatozoa. Further studies are needed to determine the alterations on PPP1 activity and 
phosphorylation status upon exposure to the competition AKAP4 BM peptide. Additionally, 
competition assays will be used to conclusively determine that the effect of the AKAP4-BM 
peptide is due to AKAP4-PPP1CC2 interaction interference. 
Given that AKAP4 undergoes several phosphorylation changes during the epididymal transit 42, it 
is plausible that PPP1CC2 may potentially be involved in regulating AKAP4 phosphorylation state. 
During the early stages of epididymal transit, AKAP4 is phosphorylated on the binding site for the 
regulatory subunits (PRKA1/RI and PRKA2/RII) of PRKA and, PRKA2A (RIIα) itself is also 
phosphorylated exclusively in caput/corpus-derived bovine spermatozoa. Baker and colleagues 
hypothesize that the two “negative” charges may have a repulsive role preventing the interaction 
from occurring contributing to maintaining the spermatozoa in a quiescent state in the early stages 
of the epididymal journey (Figure B.9) 42. In fact, disruption of the anchoring of the RII subunit of 
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PRKA to AKAPs, by membrane-permeable peptides, resulted in an arrest of bovine sperm motility 
43, 44. 
 
Figure B.9 – Putative roles of AKAP4 complexes in spermatozoa motility acquisition. In caput epididymis, PPP1CC2 is 
free and active resulting in the dephosphorylation of residues in key sperm proteins and therefore leading to immotile 
spermatozoa. In cauda epididymis, PPP1CC2 is bound to inhibitors (e.g. PPP1R2, PPP1R2P3, PPP1R7 and PPP1R11) 
and phosphorylated in a C-terminal threonine residue by a CDK. Thus, phosphorylation (by ser/thr protein kinases, such 
as, PRKACA) increases, leading to motile spermatozoa. The absence of AKAP4 leads to a significant decrease in 
PPP1CC2 phosphorylation and increase in its activity. Further studies are needed to establish if AKAP4/PPP1CC2 
interaction occurs in the early stages of the epididymal transit or if AKAP4 recruits PPP1CC2 during the epididymal 
transit in order to allow PPP1CC2 phosphorylation and inhibition and, consequently, sperm motility acquisition. AKAP4 
interactome also includes the regulatory subunits of PRKACA (also known as PKA) - PRKAR1A (also known as RIα) 
and PRKAR2A (also known as RIIα), PRKAR2B (RIIβ), AKAP3, SUMO2, FSIP1 and FSIP2. PIPs, PPP1 interacting 
proteins. 
 
Further studies to test additional concentrations and incubation times in human spermatozoa are 
needed in order to clarify the impact of the peptides in spermatozoa. Additional studies are also 
needed to confirm the alterations on PPP1 activity by using phosphatase assays and of global 
protein serine/threonine phosphorylation status upon exposure to the PPI disruption peptides. The 
assessment of phosphatase activity and global phosphorylation levels will help to understand the 
changes produced by the peptides at the cellular level and that have a profound impact on motility. 
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3.3.1.!Abstract 
Phosphoprotein phosphatase 1 (PPP1) catalytic subunit gamma 2 (PPP1CC2), a PPP1 isoform, is 
largely restricted to testicular germ cells and spermatozoa. The key to understanding PPP1 
regulation in male germ cells lies in the identification and characterization of its interacting 
partners. This study was undertaken to determine the expression patterns of the several ankyrin 
repeat protein variant 2 (SARP2), a PPP1-interacting protein, in testis and spermatozoa. SARP2 
was found to be highly expressed in testis and spermatozoa, and its interaction with human 
spermatozoa endogenous PPP1CC2 was confirmed by immunoprecipitation. Expression analysis 
by RT-qPCR revealed that SARP2 and PPP1CC2 mRNA levels were significantly higher in the 
spermatocyte fraction. However, microscopy revealed that SARP2 protein was only present in the 
nucleus of elongating and mature spermatids and in spermatozoa. In spermatozoa, SARP2 was 
prominently expressed in the connecting piece and flagellum, as well as, to a lesser extent, in the 
acrosome. A yeast two-hybrid approach was used to detect SARP2-interacting proteins and a 
relevant interaction with a novel sperm associated antigen 9 (SPAG9) variant, a testis and 
spermatozoa-specific c-Jun N-terminal kinase-binding protein, was validated in human 
spermatozoa. Given the expression pattern of SARP2 and its association with PPP1CC2 and 
SPAG9, it may play a role in spermiogenesis and sperm function, namely in sperm motility and the 
acrosome reaction. 
3.3.2.!Introduction 
Spermatozoa are devoid of any major transcriptional and translational activity; thus, post-
translational modifications and mechanisms based on disruption or formation of protein complexes 
are central in regulating sperm function 1–4. Phosphoprotein phosphatase 1 (PPP1), a major Ser/Thr 
protein phosphatase, catalyses most of the eukaryotic protein dephosphorylation events in a highly 
regulated and selective manner 5–7. The predominant PPP1 catalytic subunit in both testicular germ 
cells and spermatozoa is PPP1 catalytic subunit gamma 2 (PPP1CC2), one of the four highly 
conserved PPP1 isoforms (along with PPP1CA, PPP1CB and PPP1CC1; 2,8,9). The PPP1CC1 and 
PPP1CC2 isoforms are alternatively spliced products from the single PPP1CC gene. These 
polypeptides differ at their C-termini, in which PPP1CC2 has a unique 22-amino acid extension. 
Targeted disruption of the mouse Ppp1cc gene results in male infertility due to aberrant 
spermiogenesis 10,11. However, this deficiency causes no obvious abnormality in other tissues, 
probably due to compensatory expression of PPP1CA and PPP1CB. Recent data show that mice 
fertility is restored upon expression of transgenic PPP1CC2 alone and that sufficient levels of 
expression are required to achieve this outcome 12,13. In addition, inhibition of PPP1CC2 in 
spermatozoa using PPP1 inhibitors results in the initiation and stimulation of motility 3,14,15. These 
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results indicate that PPP1CC2 has a crucial role in the regulation of mammalian spermatogenesis 
and sperm motility. 
Over the past two decades, it has become apparent that PPP1 versatility is achieved by its ability to 
interact with multiple targeting and regulatory subunits known as PPP1-interacting proteins (PIPs) 
5,16,17. PIPs are ubiquitously expressed and show exceptional diversity in brain, testis and white 
blood cells 2,7,8,17. Several PIPs have been characterized in somatic cells and considerable progress 
has been made in defining how they regulate PPP1 18. However, understanding of PPP1 regulation, 
specifically the testis and sperm-enriched isoform (PPP1CC2), in male germ cells is limited 8. The 
key to understanding the roles of PPP1 is identifying and characterizing its regulatory subunits. 
Several ankyrin repeat protein variant 2 (SARP2) was first identified in a yeast two-hybrid (YTH) 
screen using PPP1CC1 as bait 8. SARP2 (National Center for Biotechnology Information (NCBI) 
EF041819.1) is an alternatively spliced transcript variant of the ANKRD42 gene 19. In addition to a 
consensus RVxF PPP1 binding motif (354KVHF357), SARP2 possess another PPP1- docking 
motif that consists of eight ankyrin repeats (AnkCap) 19. The RVxF motif lies partially within the 
first ankyrin repeat, in contrast with other proteins; for example, in myosin phosphatase target 
subunit 1 (MYPT1) the PPP1-binding motif precedes the ankyrin repeats. In addition, SARP was 
shown to inhibit PPP1 catalytic activity when phosphorylase was used as a substrate 19. 
In the present study we characterized the expression patterns of the SARP2 isoform in testis and 
spermatozoa and established how it is related to PPP1CC2. In addition, we identified a new sperm-
associated antigen 9 (SPAG9) variant that interacts with SARP2 in the testis and spermatozoa. 
3.3.3.!Materials and Methods 
Unless stated otherwise, all reagents were purchased from Sigma-Aldrich Química (Sintra, 
Portugal). 
Human testicular biopsies 
Testicular biopsies for immunofluorescence microscopy were obtained from three individual 
patients presenting at the Department of Andrology, University Hospital Hamburg-Eppendorf. 
Informed consent was obtained and the study was conducted in accordance with the Helsinki 
Declaration. Tissues were taken for diagnostic purposes and their histology was extrapolated from 
examinations of parallel biopsies from the same testis as part of the routine diagnostic work-up. 
Only samples presenting normal spermatogenesis on histological analysis were used. Testicular 
biopsies for western blot analysis and immunoelectron microscopy were collected in vivo, after 
Ethics Committee approval was obtained, from a brain-dead 35-year-old man at the Centro 
Hospitalar de Coimbra (Coimbra, Portugal) during a procedure to collect organs for transplantation. 
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Different regions of both testes were collected and the biopsies were diagnosed as ‘normal’ based 
on histopathological analysis. Testicular biopsies for research purposes are covered by the 
legislation of the Portuguese Constitution (decreto-lei no. 274/99; 22 July 1999). Human testis 
extracts for western blot analysis were prepared by homogenization using 1% sodium dodecyl 
sulfate (SDS).  
Human sperm samples  
Ejaculated sperm samples were obtained from eight donors by masturbation into an appropriate 
sterile container. All donors signed informed consent allowing the samples to be used for scientific 
purposes, and all human samples were used in accordance with the appropriate Ethics and Internal 
Review Board guidelines. A copy of the written consent is available for review. Basic semen 
analysis (concentration, motility and morphology) was performed by experienced technicians 
according to the World Health Organization guidelines (World Health Organization 2013) and only 
normal sperm samples were used. For all procedures, spermatozoa were washed three times in 1x 
phosphate-buffered saline (PBS). For immunoprecipitation, spermatozoa were lysed in 1x 
radioimmunoprecipitation buffer (RIPA) buffer (Millipore Iberica, Madrid, Spain) supplemented 
with protease inhibitors (10 mM benzamidine, 1.5 mM aprotinin, 5 mM pepstatin A, 2 mM 
leupeptin, 1mM phenylmethylsulphonyl fluoride) and phosphatase inhibitors (1mMsodium 
fluoride, 2.5 mM sodium pyrophosphate, 50mM b-glycerophosphate, 1mM sodium orthovanadate), 
sonicated three times for 10 s and centrifuged at 16 000g for 20 min at 4°C. The supernatant was 
collected and used in the subsequent steps. For western blot analysis, extracts were resuspended 
in1% SDS. For immunocytochemistry, washed spermatozoa were placed directly on coverslips. For 
the colocalisation studies with an acrosome marker, spermatozoa were subjected to a swim-up 
procedure, as described previously 20. 
Animals 
C57/Bl6 mice were used for the isolation of testicular germ cells and BALB/c mice were used for 
immunohistochemistry studies. Housing of mice was approved by the responsible government 
commission and all animals were kept under standard conditions at the animal facility of the 
University Hospital Hamburg-Eppendorf under a 12-h light–dark. Male mice, 6–10 weeks of age, 
were used. 
Antibodies 
The anti-PPP1CC2 antibody was raised in rabbit against the specific PPP1CC2 C-terminal peptide 
(VGSGLNPSIQKASNYRNNTVLY) and has been described previously 15. Anti-SARP2 antibody 
was raised in rabbits against the specific SARP2 C-terminal peptide (DSASCESNKEKRRVK) and 
was affinity purified (Figure B.10 a). Anti-SPAG9 antibody was obtained from Sigma-Aldrich, the 
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infrared IRDye labelled anti-rabbit secondary antibody was obtained from LI-COR Biosciences 
(Lincoln, NE, USA) and the secondary antibodies for the immunofluorescence studies were 
obtained from Molecular Probes, (Eugene, OR, USA). 
Expression analysis in isolated testicular germ cells 
Cell populations were isolated from mouse testis using an established protocol based on unit 
gravity sedimentation that isolates germ cell populations from a heterogeneous suspension of 
mouse testis 21. The three fractions were microscopically evaluated as spermatocytes (Spc), round 
spermatids (rSpd) and elongated spermatids (eSpd), based on their predominance. Total RNA from 
isolated cells was prepared using the RNeasy Plus Universal Midi Kit (Qiagen, Hilden, Germany). 
The RNA concentration was determined spectrophotometrically (NanoDrop 1000 
Spectrophotometer; Thermo Scientific, Bremen, Germany). For synthesis of cDNA, a reverse 
transcription reaction was performed using 1 µg RNA and a Transcriptor First Strand cDNA 
Synthesis Kit (Roche, Mannheim, Germany). Expression levels of distinct mRNAs were 
determined by RT-qPCR using the LightCycler 480 SYBR Green I Master (Roche) and the 
following cycle conditions: initial denaturation at 95°C for 15 min, followed by 45 cycles of 
denaturation (94°C, 15 s), annealing (58°C, 30 s) and polymerization (72°C, 30 s). Thereafter, a 
melting curve was generated over the range 55–95°C with 30 s/1°C rampage. Polymerase chain 
reaction (PCR) analysis was performed on 96-well plates using the Light Cycler 480 Real-Time 
PCR System (Roche). The combination of Gapdh and Hprt was identified as the optimal reference 
genes for the testis and all expression levels were calculated as relative values using the mean 
expression of both reference genes. All samples were run in triplicate and mean values were used 
to calculate expression levels of the different genes. Relative gene expression was quantified using 
the 2-ΔΔCT method 22. The cDNA obtained from the cell suspension of whole testis was used as 
control sample for RT-qPCR reactions. Genes already established as markers for each step of 
spermatogenesis were analysed to ensure minimal contamination from other spermatogenic cells. 
The primers used are listed in Supplementary Table D-16 and D.17, and were made to span exon–
exon junctions (intron splice sites) in order to avoid genomic DNA amplification. 
Immunoprecipitation 
RIPA supernatant sperm extracts were precleared using Dynabeads Protein G (Life Technologies, 
Madrid, Spain). Using a direct immunoprecipitation approach, 1 µg rabbit anti-PPP1CC2 or anti-
SPAG9 was pre-incubated with Dynabeads Protein G for 1 h at 4°C with rotation. After incubation, 
sperm precleared extracts were applied to the antibody–dynabeads complex and incubated 
overnight with rotation at 4°C. After washing three times with 1xPBS for 10 min with rotation at 
4°C, the beads were resuspended in the appropriate buffer. For gel loading, beads were 
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resuspended in 1% SDS and boiled for 5min. For overlay assays, beads were resuspended in 0.1M 
glycine-HCl (pH 2.5). 
Western blotting 
Extracts were mass normalised using the bicinchoninic acid (BCA) assay (Fisher Scientific, 
Loures, Portugal). Extracts were resolved by 10% SDS–polyacrylamide gel electrophoresis 
(PAGE). Proteins were subsequently electrotransferred onto nitrocellulose membranes and 
immunodetected with appropriate antibodies using the Odyssey Infrared Imaging System (LI-COR 
Biosciences). 
Immunofluorescence of human testis 
For fluorescence microscopy of cryosections, human testis biopsies and testes of BALB/c mice 
were fixed with 4% paraformaldehyde and 0.1M HEPES, pH 7.4, and subsequently immersed in 
30% sucrose solution for approximately 4 h. Tissues were frozen in isopentane at -30°C and stored 
at -80°C until further analysis. Cryosections (10–14 mm) were cut on a Microm HM500 O 
cryostate (Microm, Walldorf, Germany). Non-specific binding sites were blocked with 3% bovine 
serum albumin (BSA) and incubated with primary antibodies (rabbit anti-PPP1CC2, 1:500; and 
rabbit anti-SARP2, 1:100) for 2 h at room temperature and then incubated with a fluorochrome 
conjugated rabbit secondary antibody (Alexa Fluor 594 Goat Anti-Rabbit IgG) for 1 h. Negative 
controls were processed in parallel by adding Tris-buffered saline Tween-20 (TBST) instead of the 
primary antibodies. Nuclei were stained with 40, 60-diamidino-2-phenylindole (DAPI; 1:200; 
Vectashield; Vector Laboratories, Burlingame, CA, USA) for 5 min at room temperature and 
washed twice with TBST for 5 min. Finally, samples were inspected under a fluorescence 
microscope (Axio Vision Rel 4.8 series; Zeiss, Jena, Germany). 
Immunoelectron microscopy of human testis 
After collection, human testicular biopsies were immediately immersed in fixative (4% 
depolymerised paraformaldehyde, 0.05% glutaraldehyde in 0.1M cacodylate buffer, pH 7.4, and 
2% sucrose). Fixed samples were embedded into LRWhite resin (Sigma-Aldrich, Seelze, Germany) 
after dehydration in a graded series of ethanol (medium grade). LR White-filled gelatin capsules 
were polymerised at 50°C for 3 days. After preparation of semithin sections (1 mm) and 
observation under a light microscope, blocks were trimmed for areas with defined stages of 
seminiferous tubules. Ultrathin sections (80nm) were cut on a Leica microtome (VT1000S), 
collected on 100-mesh nickel grids and thereafter coated on the back with a 1% formvar film 
(support film). The sections were incubated with glycine solution (0.05M glycine in TBST, pH 7.4) 
for 15min to disable free aldehyde groups. Subsequently, sections were incubated in blocking 
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solution (1% BSA in TBST, pH 7.4) for 30 min at room temperature. Sections were incubated 
overnight at room temperature with anti-SARP2 antibody in a wet chamber. The sections were then 
washed and incubated for 90min at room temperature with a protein A–gold solution (1:50; 12 nm 
colloidal gold particles). Negative controls were processed in parallel by addition of TBST instead 
of the primary antibodies. The grids were rinsed on droplets of washing solution (0.1% BSA in 
TBST, pH 7.4) three times for 10 min and subsequently contrasted with uranyl acetate for 2 min 
and lead citrate for 45 s. Sections were examined using a LEO 906 electron microscope (LEO, 
Oberkochen, Germany). 
Immunocytochemistry of human spermatozoa 
An aliquot (25 µL) of washed spermatozoa was placed onto a glass coverslip precoated with 100 
µg/mL 1 poly-L-ornithine and dried room temperature in a six-well plate containing one coverslip 
per well. To each well, 4% paraformaldehyde in 1xPBS was added and left to stand for 10min. 
Subsequently, spermatozoa were washed twice with 1xPBS for 10 min. For permeabilisation, a 1:1 
methanol:acetone solution was added for 2min and specimens were then washed twice with 1xPBS 
for 10 min before being blocked for 1 h with 3% BSA in 1xPBS and then incubated with primary 
antibodies (rabbit anti-PPP1CC2, 1:1000; and rabbit anti-SARP2, 1:250) for 2 h at room 
temperature. After three washes with PBS, the fluorescent-labelled secondary antibody (goat anti-
rabbit Texas-Red; 1:300; Molecular Probes) was added and the coverslips were incubated for 2 h at 
room temperature. Finally, samples were washed three times with 1xPBS and the coverslips 
mounted on microscope glass slides with one drop of antifading reagent containing DAPI for 
nucleic acid staining (Vectashield; Vector Laboratories). Fluorescence assessment of the acrosomal 
state was determined with fluorescein isothiocyanate-labelled Pisum sativum agglutinin (PSA-
FITC), as described previously 23. Briefly, 1106 motile spermatozoa were incubated in capacitating 
medium (37°C, 5% CO2) for 2 h. To induce the acrosome reaction, capacitated spermatozoa were 
incubated with progesterone (3 mM), for 30 min. Then, the sperm samples were applied to the 
coverslip and left to dry. Fixation and permeabilisation was performed with 95% ethanol for 30 
min. The fixed sperm smear was placed in PSA-FITC for 1 h. The following procedure was the 
same as described in the ‘Immunocytochemistry of human spermatozoa’ section. Images were 
acquired using an epifluorescence microscope (IX81; Olympus Portugal – Opto-Digital 
Tecnologias, Lisboa, Portugal) and digital camera equipped with appropriate software (Olympus 
Portugal – Opto-Digital Tecnologias, Lisboa, Portugal). 
YTH screening of the human testis library 
The cDNA of the C-terminus of SARP2 (EDSASCESNKEKRRVKKKVSS) was subcloned into 
SalI/SmaI-digested pAS2–1, which adds a galactosidase (GAL4)-binding domain (GAL4BD) 
Results Chapter 3 
University of Aveiro 127!
peptide to the N-terminal part of the protein. The product, pAS-SARP2 C-terminal (bait), was 
inserted in Saccharomyces cerevisiae Y187 strain to confirm the expression of GAL4BD-SARP2 
C-terminal recombinant protein and to test for self-activation of reporter genes, which was negative 
(data not shown). The yeast AH109 strain was transformed with a human testis cDNA library, 
inserted into a pACT2 vector (prey), which adds a GAL4 activation domain (GAL4AD) peptide to 
the N-terminal part of the proteins. For library screening, transformed Y187 and AH109 yeast 
strains were mated and half the mating mixture was plated onto high-stringency medium 
(quadruple dropout medium: supplemented dropout (s.d.)/–Ade/–His/–Leu/–Trp) and the other half 
onto low-stringency medium (triple dropout medium: s.d./–His/–Leu/–Trp) and plates were then 
incubated at 30°C until colonies appeared (maximum 2 weeks). Colonies obtained on the low-
stringency plates were replica plated onto high-stringency medium. Finally, all high-stringency 
growing colonies were plated onto selective medium containing X-a-Galactosidase (X-a-Gal) and 
incubated at 30°C until blue colonies appeared (maximum 2 weeks) to check for MDS1/EVI1-like 
gene 1 (MEL-1) expression (indicated by the appearance of a blue colour). All YTH reagents were 
purchased from Clontech (Enzifarma, Portugal). 
Recovery of plasmids from yeast and sequence analysis 
Yeast plasmid was recovered by the boiling method and used to transform Escherichia coli XL1-
Blue strain. The plasmid DNAs were extracted from three isolated colonies of each transformation 
and digested to identify bait and prey plasmids. Recovered prey plasmids were analysed by DNA 
sequencing, using an automated DNA sequencer (Applied Biosystems, Carlsbad, CA, USA). A 
GAL4-AD primer (TACCACTACAATGGATG) was used to amplify the library cDNAs. The 
DNA sequences obtained were compared against the GenBank database, using the BLAST 
algorithm to identify the corresponding proteins. 
Membrane overlay 
A single Rosetta (DE3; Novagen, Madison, WI, USA) colony transformed with recombinant His-
tagged SARP2 (amino acids 331–847) was selected and grown overnight in 3 mL Luria–Bertani 
and ampicillin medium at 37°C. Aliquots (0.5 mL) were transferred to 50 mL Luria–Bertani and 
ampicillin until A600 reached 0.6. Expression was induced with 1mMisopropyl β-D-
thiogalactoside at 37°C for 3 h with shaking. Cells were recovered by centrifugation (12 000g, 1 
min, 4°C), resuspended in 0.5 mL of 1% SDS and increasing protein quantities of the bacterial 
extracts were loaded onto 12% gels for SDS-PAGE and subsequently transferred to nitrocellulose 
membranes that were then overlaid with SPAG9 immunoprecipitate. After washing with PBS to 
remove excess protein, bound SPAG9 was detected by incubating the membrane with a rabbit anti-
SPAG9 antibody. Immunoreactive bands were revealed by incubation with an infrared goat anti-
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rabbit IgG labeled with IRDye followed by detection using the Odyssey Infrared Imaging System 
(LI-COR Biosciences). 
3.3.4.!Results 
SARP2 tissue expression and interaction with PPP1CC2 in human spermatozoa 
A tissue screen with an isoform-specific antibody (Figure B.10 a) recognising the C-terminus of 
SARP2 was performed on several tissues (Figure B.10 b). SARP2 was found to be highly 
expressed in human spermatozoa. SARP2 was also expressed in human and mouse testis, but at 
lower levels than in human spermatozoa. The predicted molecular mass for SARP2 was 94.3 kDa 
(849 amino acids). Previously, it was shown that an antibody recognizing both isoforms (SARP1 
and SARP2) revealed a different immunoreactive profile 19. This could mean that the expression 
levels observed previously in liver, heart, lung, intestine and cortex were primarily SARP1 19. 
Given that SARP2 is highly expressed in human spermatozoa, RIPA-soluble extracts and insoluble 
fractions of human sperm lysates were resolved by SDS-PAGE and immunoblotted (Figure B.10 
c). The results showed that SARP2 was present in both fractions, but was more abundant in the 
insoluble fraction. To prove the interaction between SARP2 and PPP1CC2 in sperm cells, 
endogenous PPP1CC2 immunoprecipitated from human spermatozoa was found to 
coimmunoprecipitate with endogenous SARP2 isoform (Figure B.10 d). 
 
Figure B.10 - Several ankyrin repeat protein variant 2 (SARP2) is enriched in the testis and spermatozoa and binds to 
phosphoprotein phosphatase 1 (PPP1) catalytic subunit gamma 2 (PPP1CC2) in human spermatozoa. (a) Schematic 
representation of SARP2 (National Center for Biotechnology Information (NCBI) EF041819.1), an alternatively spliced 
transcript variant of the ANKRD42 gene (NCBI GeneID: 338699). SARP2 possesses a PPP1-binding motif, eight 
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ankyrin repeats, a putative EF hand and a putative leucine zipper domain. Homology analysis of the C-termini of SARP 
isoforms was performed using a CLUSTALW2 (EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, 
Cambridgeshire, UK) multiple sequence alignment. The black box in the C-terminal indicates the peptide used to 
generate SARP2 antisera in rabbit. (b) The SARP2 protein expression profile was analysed in extracts of human testis 
and spermatozoa and other mouse tissues (50 mg) by western blot using SARP2 isoform-specific antibody. The 
molecular mass of SARP2 (90 kDa) on sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDSPAGE) is 
consistent with it possessing the same N-terminal sequence as SARP3 (NCBI: DQ508934). (c) The presence of SARP2 
in the RIPA supernatant (soluble fraction) and pellet (insoluble fraction) of sperm lysates was analysed using anti-SARP2 
antibody: 50 mg of both fractions were subjected to SDS-PAGE. (d) PPP1CC2 was immunoprecipitated (IP) from human 
sperm extract using anti-PPP1CC2 antibody and SARP2 was detected with the corresponding antibody. As a control, 50 
mg human testis extract was also loaded. HT, human testis; HS, human spermatozoa; IB, immunoblot; MT, mouse testis; 
ML, mouse liver; MH, mouse heart; MLu, mouse lung; MI, mouse intestine; MC, mouse cortex; MCe, mouse 
cerebellum; MHi, mouse hippocampus; aa, amino acid. 
 
Expression profiling of SARP2 and PPP1C isoforms in isolated cell fractions of mouse testis 
Because of the localisation of SARP2 and PPP1CC2 in mammalian testis, we investigated the 
mRNA expression of different SARP and PPP1C isoforms during spermatogenesis by RT pPCR 
using whole testis sample as control. Analyses of the DCT values show that the PPP1CC2 isoform 
is by far the most abundant isoform in all fractions with 5-, 15-, 40- and 200-fold higher expression 
than SARP2 and the PPP1CB, PPP1CC1 and PPP1CA isoforms, respectively. We obtained the 
highest relative gene expression values for all genes at the spermatocyte stage with exception of 
Ppp1ca gene, in which the expression levels were higher at the round spermatids fraction (1.6-
fold). Expression of Ppp1c mRNA was detected in all testicular fractions. Higher relative Ppp1cb 
and Ppp1cc expression was observed in spermatocytes (2.4- and 1.9-fold, respectively; Figure 
B.11). In terms of the PPP1CC isoforms, the relative mRNA expression of PPP1CC2 was greater 
than that of PPP1CC1 (1.6-and 1.1-fold, respectively). The relative expression of PPP1CC1 was 
not altered during spermatogenesis. Furthermore, although Ppp1cb was strongly expressed in the 
spermatocyte fraction (2.4- fold), reduced levels were seen in spermatid fractions. Thus, of all the 
genes analysed, Ppp1cb was the one that underwent the greatest decline in the late stages of 
spermatogenesis (Figure B.11). Regarding the Ankrd42 gene, the primer that recognises all SARP 
isoforms exhibited a similar profile compared with the primer specific for the SARP2 isoform. This 
reinforces our protein expression data, which showed SARP2 as the only isoform present. In 
addition, the relative expression of SARP2 decreased 0.3-fold in elongated spermatids, similar to 
what was obtained for the sperm-specific PPP1CC2 isoform (Figure B.11). 
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Figure B.11 - Relative gene expression of several ankyrin repeat protein (SARP) and phosphoprotein phosphatase 1 
(PPP1) catalytic subunit (PPP1C) isoforms. Relative expression values for the isolated cell fractions were calculated by 
the ΔΔCT method. *Altered mRNA expression (1.5-fold) compared with control (testis). **Altered mRNA expression 
(twofold) compared with control (testis). All altered expression values highlighted are significant (p<0.01). P-values were 
calculated based on Student’s t-test of the replicate 2(-ΔΔCT) values for each gene in the control group and treatment groups. 
Spc, spermatocyte; rSpd, round spermatid; elSpd, elongated spermatid. 
 
Localisation of SARP2 in the testis 
Immunofluorescence studies showed that during the course of spermatid differentiation, SARP2 
immunoreactivity was first observed in the nucleus of late elongating spermatids (Figure B.12). 
This localisation of SARP2 was consistent in human and mouse testis. Round spermatids and less 
mature germ cells showed no specific staining (Figure B.12). Direct evidence of localisation was 
provided at the ultrastructural level by electron microscopy (Figure B.12 d–f). Electron 
microscopic studies on human testis also confirmed the association of SARP2 with the nucleus of 
haploid germ cells, more specifically in elongated and mature spermatids. Round spermatids and 
more immature germ cells showed no staining (Figure B.12 d–f). 
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Figure B.12 - Several ankyrin repeat protein variant 2 (SARP2) localisation in the testis. (a–c) Immunofluorescence of 
SARP2 in mouse testis. Strong immunostaining was observed in elongated spermatids. Identical fluorescence staining 
patterns were observed in human testis (data not shown). 40, 60-Diamidino-2-phenylindole (DAPI; blue) was used to 
stain nuclei. Representative images are shown from three independent experiments. (d–f) Electron micrographs of 
immunoreactivity for SARP2 in human testis. In elongated spermatids (Espd) SARP2 shows significant staining in the 
nucleus, whereas round spermatids (Rspd) shows no labelling. (e) Higher magnification view of the region indicated by 
the box in (d). Arrows indicate gold particles indicating positive staining. Representative images are shown from two 
independent experiments. Scale bar = 500 nm. 
 
Localisation of SARP2 in human spermatozoa 
Given the presence of SARP2 in late-stage germ cells, we further analysed the subcellular 
localisation of this protein in mature human ejaculated spermatozoa. Four human sperm samples 
were evaluated and a total of 1600 cells was assessed. As seen in Figure B.13 c, SARP2 
immunoreactivity was predominantly detected in the connecting piece (54.69%) and in the entire 
length of the flagellum (100%). In addition, in approximately 33.75% of spermatozoa, staining also 
appeared in the acrosome (Figure B.13 f). To confirm acrosomal localisation, spermatozoa were 
capacitated and the acrosome reaction was induced. PSA-FITC was used as an acrosome marker, 
which means that the acrosome reaction was assessed by disappearance of the labelling. Before the 
acrosome reaction, the colocalisation pattern between PSA-FITC and SARP2 supported acrosomal 
localisation of the protein (Figure B.13 e–h). After the acrosome reaction, both SARP2 and PSA 
staining disappeared, further confirming SARP2 as an intra-acrosomal protein (Figure B.13 i–l). 
The staining was specific because there was no fluorescence observed in the negative controls, 
when the primary antibodies were omitted (data not shown). 
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Figure B.13 - Subcellular localisation of several ankyrin repeat protein variant 2 (SARP2) in human spermatozoa. (a–d) 
Human ejaculated spermatozoa stained with anti-SARP2 antibody and detected using a Texas Red secondary antibody. 
Representative images are shown from four independent experiments. (e–l) Subcellular localisation of SARP2 in human 
capacitated spermatozoa stained with: (f, j) anti-SARP2 antibody and detected using a Texas Red secondary antibody 
before (f) and after (j) the acrosome reaction; (e, i) fluorescein isothiocyanate-labelled Pisum sativum agglutinin 
(PSAFITC) before (e) and after (i) the acrosome reaction. Arrowheads indicate colocalisation of SARP2 and PSA. 
Asterisks represent the acrosomal localisation of SARP2 before the acrosome reaction. Arrows indicate staining of 
SARP2 in the flagellum. Representative images are shown from two independent experiments. Nuclei were stained with 
40,60-diamidino-2-phenylindole (DAPI; blue). 
 
SPAG9, a SARP2-interacting protein 
To identify proteins capable of interacting with SARP2, an YTH screen was performed with the 
SARP2 C-terminal as bait. From the 1.1 × 106 clones screened, 513 positives were obtained. The 
results suggest that SARP2 interacts with several proteins implicated in processes crucial to 
reproduction, such as cell differentiation, cell motility and cell adhesion. One of the positive clones 
(clone 71) identified from the human testis library contained a cDNA found to encode the c-Jun-N-
terminal kinase (JNK)-interacting protein 4 (also known SPAG9). Sequencing of the clone 
determined that it corresponds to a new variant of SPAG9, now termed SPAG9 variant 5 and 
submitted to the NCBI (KJ624756; Figure B.14). Alternative splicing of the SPAG9 gene results in 
multiple transcript variants. In the GenBank database there are four SPAG9 variants 
(NM_001130528.2, NM_001130527.2, NM_003971.5 and NM_001251971.1). SPAG9 variant 5 
seems to be complete and differs from the rest of the database variants due to the extension of exon 
6, which originates a stop codon, giving rise to a shorter isoform (Figure B.14 a). This new isoform 
encodes a 275-amino acid protein that is missing the coiled coil domains, the leucine zipper motif 
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and the transmembrane domain described for SPAG9, but possesses the conserved JNK-binding 
domain (JBD; Figure B.14 b) 24. Binding of SPAG9 to SARP2 was demonstrated by blot overlay. 
His6-SARP2 (331–847) expression was induced in bacteria. After SDS-PAGE resolution, samples 
were transferred onto a nitrocellulose membrane that was incubated successively with recombinant 
SPAG9 immunoprecipitate, rabbit anti-SPAG9 antibody, anti-rabbit infrared secondary antibodies 
and developed using the Odyssey infrared-imaging system. Immunoreactive bands of the expected 
molecular weights were observed, corresponding to the expressed SARP2. Increased quantities of 
His6-SARP2 resulted in a proportionate increase SPAG9 binding, thus demonstrating its specific 
interaction with SARP2 (Figure B.14 c). The existence of SARP2–SPAG9 complexes in vivo was 
shown by co-immunoprecipitation of the latter from human spermatozoa (Figure B.14 d). In 
addition, and particularly relevant to PIPs, the canonical PPP1 binding motif RVxF was detected in 
SPAG9 by bioinformatics analysis, 102KFIEF106. Usually, the flanked N- and C-terminus regions 
of the RVxF motif have four or five basic (KR) and acidic (DE) amino acids, respectively. In this 
case, the flanked C-terminal region of the RVxF motif is enriched in acidic residues (four of seven 
residues). 
 
Figure B.14 - Interaction between several ankyrin repeat protein variant 2 (SARP2) and sperm-associated antigen 9 
(SPAG9). (a) Schematic illustration of SPAG9 variant 5 encoded by clone 71 and SPAG9 variant 1, previously described 
in the databases (NCBI, National Center for Biotechnology Information, U.S. National Library of Medicine, USA). 
SPAG9 transcript variant 1 (NM_001130528.2, NP_001124000.1) represents the longest transcript (8273 bp). The new 
SPAG9 variant 5 differs in its C-terminus from the other SPAG9 variants described in GenBank (light grey). The end of 
each exon is indicated. SPAG9 variant 5 coding DNA sequence (CDS) comprises nucleotides (nt) 181–1006, which 
encode 275 amino acids. (b) Schematic comparison of the protein domain structures of SPAG9 variant 1 and the new 
SPAG9 variant 5. (c) SARP2 was expressed in bacteria and the membranes overlaid with SPAG9 immunoprecipitate 
(performed under non-denaturing conditions). Binding was detected with SPAG9 antibody. Lanes 1–3, 4, 2 and 1 mL 
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bacterial lysate expressing SARP2, respectively; lane 4, 4 mL soluble bacterial lysate expressing pET vector alone. 
Molecular weights of the proteins are given in kDa. (d) SPAG9 was immunoprecipitated from human sperm extract using 
SPAG9 antibody and SARP2 was detected with an isoform-specific antibody. aa, amino acids; PBM, phosphoprotein 
phosphatase 1 binding motif; JBD, c-Jun N-terminal kinase-binding domain; LZ, leucine zipper motif; Coil, extended 
coiled-coildomain; T, transmembrane domain; IB, immunoblotting; IP,immunoprecipitation;E, exon. 
3.3.5.!Discussion 
The SARP2 interaction was originally identified in an YTH screen of a human testis cDNA library 
using the PPP1CC isoform as bait 19. In the present study we show that SARP2 is highly expressed 
and interacts with PPP1CC2 in human spermatozoa (Figure B.10 b, d). The present study revealed 
that SARP2 exhibits tissue, cell type and spermatogenic stage enrichment. We showed that SARP2 
is more abundant in testis and spermatozoa (Figure B.10 b) and that within the testis SARP2 
protein localizes in post-meiotic haploid spermatids, specifically in mid-late stages of elongating 
spermatids (Figure B.12). The absence of the SARP2 protein in spermatogonia and spermatocytes 
suggests that SARP2 is translated post-meiotically in humans and mice. Using RT-PCR, we found 
that both PPP1CC2 and SARP2 are highly transcribed in spermatocytes and round spermatids and 
that expression falls markedly in elongated spermatids, in which protein abundance is high (Figure 
B.11 and Figure B.12). The changes that occur during spermiogenesis require the transcription, 
translation and post-translational modification of numerous constitutive and germ cell-specific gene 
products during the early steps of spermiogenesis 25,26. The comparison between RNA and protein 
expression in the testis is not as simple as in other tissues. Increasing evidence shows that mRNAs 
are transcribed in early stage germ cells, when the genome is more accessible, and stored to be 
translated in later stages of spermatogenesis, when the haploid genome repacking makes 
transcription virtually absent 27. Therefore, the presence of SARP2 protein in late germ cells 
(elongating spermatids) does not imply that its mRNA will be increased in these cells. Moreover, it 
has already been shown that the human spermatozoon is enriched in nucleosomes, histone 3 Lys27 
trimethylated (H3K27 me3), H3K4 me2 and H3K4 me3 in regulatory regions of genes with 
specific functions. Whereas H3K27 me3 tags sperm developmental regulators, H3K4 me2 tags 
genes relevant to spermatogenesis. The ANKRD42 promoter is enriched in H3K4 me2 and not 
H3K27 me3, suggesting a role for this gene in spermatogenesis. High enrichment of SARP2 in the 
nucleus of elongating spermatids (Figure B.12) is consistent with the putative nuclear localisation 
signal at the N-terminus. In addition to SARP2 expression, the interaction with PPP1CC2 
strengthens the idea that it may participate in spermatid development. Furthermore, the peak in 
PPP1CC2 protein levels in the testis overlaps that of SARP2 28 in the spermatogenic phase, when 
PPP1CC2 is essential 10. In spermatozoa, SARP2 is predominantly localised in the flagellum 
(Figure B.13), which is similar to PPP1CC2 9. The fact that both primary antibodies (anti-
PPP1CC2 and anti-SARP2) were raised in rabbits did not allow visualisation of both proteins in the 
Results Chapter 3 
University of Aveiro 135!
same preparation. Localisation studies also showed that, to a lesser extent, SARP2 is located in the 
acrosome (Figure B.13). Nevertheless, the most consistent localisation pattern for SARP2 is the 
sperm tail, which, together with the interaction with PPP1CC2, may suggest involvement of 
SARP2 in sperm motility. In further support of this, SARP2 was predominantly expressed in the 
sperm insoluble fraction, which is consistent with SARP2 being tightly attached to the axoneme 
with a possible role in sperm motility. Moreover, SARP2 possesses an EF hand-type Ca2+-binding 
motif and it is well established that Ca2+ is pivotal in controlling sperm function 29. However, we 
tested binding to Ca2+ using 45Ca-binding assay and Ruthenium red staining and no positive binding 
was obtained (data not shown). Additional studies are required to determine the biological 
significance of the interaction between SARP2 and PPP1CC2 in testis and spermatozoa. The 
known actions of SARP2 include the capacity to bind DNA and the ability to inhibit PPP1 catalytic 
activity 19. Given that a high level of PPP1C2 catalytic activity suppresses sperm motility 15, further 
studies are needed to identify the role of this complex in the acquisition of sperm motility. In 
addition, because a bioinformatics search revealed that SARP2 can be phosphorylated at multiple 
residues, one can also deduce that SARP2 can be a substrate for PPP1. 
To identify proteins capable of interacting with SARP2, an YTH screen was performed with 
SARP2 C-terminal as bait. One of the 513 positive clones identified from a human testis cDNA 
library was found to encode a novel SPAG9 variant, a JIP associated with the mitogen-activated 
protein kinase signalling cascade (Figure B.14). The newly identified SPAG9 variant has lost the 
extended coiled-coil domains and transmembrane domain, which were previously shown to be 
essential for dimerisation and proper localisation 24. The JBD of SPAG9, which is also present in 
the novel SPAG9 variant, was shown to be involved in JNK interaction (Figure B.14). SPAG9 
interacts with higher binding affinity with JNK2 and JNK3 than JNK1 24. SPAG9 has been 
described as a testis-specific protein, transcribed postmeiotically in human and non-human 
primates 30, that is not only restricted to the acrosome, but also undergoes relocation to the 
equatorial region in a stage-specific manner during acrosome reaction 24. In the present study we 
showed that SARP2 is also located in the acrosome. Studies have shown that anti-SPAG9 
antibodies inhibit the binding of human spermatozoa to intact human oocytes, as well as to matched 
hemizona, indicating that SPAG9 may have a role in sperm–egg interactions 24,31. Recent studies 
revealed the location of SPAG9 protein in the flagella of human spermatozoa 32, which is similar to 
the localisation of SARP2 in the present study and previously described for PPP1CC2 9. Because 
SARP2, SPAG9 and PPP1CC2 colocalise in human spermatozoa, it is reasonable to deduce that the 
three proteins can be associated and can function as a tri-complex. In addition to the consensus 
RVxF PPP1 binding motif, SARP2 possesses another PPP1- docking motif, which consists of eight 
ankyrin repeats (Ank-Cap). The AnkCap motif is involved in substrate selection 33, meaning that 
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SARP2 can act to prevent or promote the dephosphorylation of substrates by occupying or 
providing docking sites for substrates (Figure B.15). A bioinformatics search revealed that SPAG9 
could be phosphorylated at multiple residues. So, future studies should investigate whether SPAG9 
is a PPP1CC2 binding partner and whether it is a substrate for PPP1. In addition, the potential 
interaction between the testis and spermatozoa-specific proteins SPAG9 and PPP1CC2 may be 
indirect and mediated by a common interactor, such as SARP2 34. 
In the present study, we have shown conclusively that the SARP2 isoform is highly enriched in 
testis and spermatozoa. The localisation of SARP2 in late germ cells and in spermatozoa, and its 
interaction with PPP1CC2 and SPAG9, lays the basis for future studies in spermiogenesis, 
acrosome reaction and sperm motility. We speculate that the actions of SARP2 can directly affect 
the catalytic activity of PPP1CC2, or rather regulate PPP1CC2 by modulating its ability to interact 
with other proteins, namely SPAG9 and JNK, which, in turn, may be involved in the regulation of 
PPP1CC2 function (Figure B.15). 
 
 
Figure B.15 - Schematic representation of potential relationships between several ankyrin repeat protein variant 2 
(SARP2), phosphoprotein phosphatase 1 (PPP1) catalytic subunit gamma 2 (PPP1CC2) and sperm-associated antigen 9 
(SPAG9). SPAG9 protein is a c-Jun N-terminal kinase (JNK)-interacting protein (JIP) exclusively expressed in the testis. 
The JNK modules are regulated by several different scaffold proteins (JIPs), which target the JNK to different subcellular 
localisations and play roles in kinase activation and/or substrate selection. Effects that are consistent with the model or 
may be predicted on the basis of studies on other cell types or denote speculation and indicated in red. MAPK, mitogen-
activated protein kinase. 
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3.4.!Construction of APP interaction network in human testis: sentinel proteins for male 
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3.4.1.!Abstract  
Amyloid precursor protein (APP) is widely recognized for playing a central role in Alzheimer's 
disease pathogenesis. Although APP is expressed in several tissues outside the human central 
nervous system, the functions of APP and its family members in other tissues are still poorly 
understood. APP is involved in several biological functions, which might be potentially important 
for male fertility, such as cell adhesion, cell motility, signaling, and apoptosis. Furthermore, APP 
superfamily members are known to be associated with fertility. Knowledge on the protein networks 
of APP in human testis and spermatozoa will shed light on the function of APP in the male 
reproductive system. We performed a Yeast Two-Hybrid screen and a database search to study the 
interaction network of APP in human testis and sperm. To gain insights into the role of APP 
superfamily members in fertility, the study was extended to APP-like protein 2 (APLP2). We 
analyzed several topological properties of the APP interaction network and the biological and 
physiological properties of the proteins in the APP interaction network were also specified by gene 
ontologyand pathways analyses. We classified significant features related to the human male 
reproduction for the APP interacting proteins and identified modules of proteins with similar 
functional roles, which may show cooperative behavior for male fertility. The present work 
provides the first report on the APP interactome in human testis. Our approach allowed the 
identification of novel interactions and recognition of key APP interacting proteins for male 
reproduction, particularly in sperm-oocyte interaction. 
3.4.2.!Introduction 
Amyloid precursor protein (APP) is known as a pathological hallmark of Alzheimer's disease 
(AD). Nevertheless, APP, a type I transmembrane glycoprotein consisting of a large extracellular 
domain, a single transmembrane domain, and a short cytoplasmic tail, is expressed ubiquitously 
and given its receptor-like and adhesive characteristics may play important roles outside the 
nervous system. In fact, we have previously showed that APP is present in spermatozoa 1. The APP 
superfamily includes APP and APP-like proteins (APLP) 1 and 2. Alternative splicing of the APP 
mRNA produces eight isoforms, ranging in size from 677-770 amino acids 2. Alternative splicing 
produces four APLP1 and two APLP2 protein isoforms. Although some isoforms may be cell type 
specific, APP and APLP2 are ubiquitously expressed. In contrast, APLP1 is expressed selectively 
in the nervous system 3. Only APP, but not APLP1 and 2, contains a sequence encoding the beta-
amyloid domain. The transmembranar structure of APP is consistent with a role of APP as a 
receptor or a mediator of extracellular interactions. It has been suggested that APP may have CAM 
(Cell Adhesion Molecule) and SAM (Substrate Adhesion Molecule) like activities 4.  
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Various lines of evidence implicate APP and APLP2 in fertility. APP was shown to be expressed in 
rat testis and localized in the acrosome region and growing tail of spermatids in the seminiferous 
tubules 5. Knock-out mice, homozygotes to either APP(-/-) or APLP2(-/-) were fertile, but mice 
with the deletion of both APP(-/-) and APLP2(-/-) were infertile (9 of 10 females and all males) 6. 
We previously characterized the subcellular distribution of the APP superfamily members in 
spermatozoa using a variety of antibodies that either recognizes APP-specific epitopes or the 
epitopes shared with other APP family members 1. The presence of APP superfamily members 
along the entire length of the tail may be related to signaling events involved in sperm motility, 
whereas their presence in the head and particularly in the equatorial region suggests their 
involvement in sperm-oocyte interaction 1. These results not only were consistent with the previous 
localization of APLP2 in mammalian sperm, but also prove the presence of APP itself in human 
sperm.  APP and APLPs distribution only partially overlap suggesting that, besides a common role, 
they might also have distinct functions in spermatozoa. A human sperm transmembrane protein 
initially termed YWK-II (later shown to be an APLP2 homologue) was shown to be involved in 
fertilization 7,8. The YWK-II gene was shown to be expressed in germ cells at various stages of 
differentiation and in the plasma membrane enveloping the acrosome of mature spermatozoa 7.  
The discovery of tissue-specific interacting proteins can lead to the identification of pathways for 
the APP family members associated with testis and sperm functions. Hence, we performed a Yeast 
Two-Hybrid (YTH) screen of a human testis cDNA library using APP as bait. A comprehensive 
bioinformatic analysis was also performed using the APP interacting proteins identified in the YTH 
in addition to the proteins selected from public protein-protein interactions (PPI) databases (DB) 
and published APP interactome data 9 associated with testis/sperm. APLP2 interacting partners 
were also included. Additionally, protein interaction maps were constructed allowing the 
visualization of PPI data as a connectivity graph and the data was subjected to a statistical analysis 
based on the complex network theory. The advantage of this approach is that it allows the study not 
only of the local properties of proteins in the network, but also their global structural characteristics 
in the entire network of PPI. We reveal that proteins with similar biological functions are tightly 
connected to each other and form dense groups (modules or k-cores) in the networks. Also, the 
function, cellular distribution and pathways were analyzed and significant features were classified. 
3.4.3.!Methods 
Human testis library screening by Yeast Two-Hybrid 
The APP cDNA was directionally subcloned into EcoRI/BamHI digested pAS2-1 (GAL4 binding 
domain expression vector) to produce pAS-APP. This expression vector was first used to confirm 
the expression of the resulting fusion proteins (GAL4-APP) in yeast strain AH109. For library 
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screening, the yeast strain AH109 transformed with pAS-APP, was mated with yeast strain Y187 
expressing the human testis cDNA library in the pACT-2 vector (Gal4 activation domain 
expression vector). Half the mating mixture was plated onto high stringency medium (quadruple 
dropout medium (QDO): SD/-Ade/-His/-Leu/-Trp) and the other half onto low stringency medium 
(triple dropout medium (TDO): SD/-His/- Leu/-Trp), and the plates were incubated at 30ºC. 
Colonies obtained in the low stringency plates were replica plated onto high stringency medium. 
Finally, all high stringency surviving colonies were plated onto selective medium containing X-α-
Gal and incubated at 30ºC to check for MEL-1 expression (indicated by the appearance of a blue 
colour) 10. All the YTH reagents were purchased from Enzifarma, Clontech, Portugal. All other 
nonspecified reagents were purchased from Sigma-Aldrich, Portugal. This study did not require 
ethics approval since the material used was purchased for Enzifarma, Clontech, Portugal (human 
testis cDNA library which contained cDNAs already inserted in pACT-2 vector. 
Recovery of plasmids from yeast and sequence analysis 
Yeast plasmid DNA was recovered and used to transform E. coli XL1-Blue. Plasmid DNA was 
obtained from each resulting bacterial colony and digested with the restriction enzyme HindIII 
(NEB, Ipswich, USA) to identify the corresponding library plasmids. DNA sequence analysis was 
performed using an Automated DNA Sequencer (Applied Biosystems, Carlsbad, USA) using the 
GAL4-AD primer - TACCACTACAATGGATG (Enzifarma, Clontech, Portugal). The DNA 
sequences obtained were compared to the GenBank DB, using the BLAST algorithm, to identify 
the corresponding encoded proteins. 
Data mining of APP and APLP2 interacting proteins from public DB and published 
interactome 
Several data sources were used to human protein-protein interaction data retrieval. First, we 
collected all interaction data of human proteins from: APID 11, BioGRID 12, DIP 13, HPRD 14, 
InnateDB 15, Intact 16, MINT 17, Reactome 18, TopFind, and STRING 19. The interaction search was 
restricted to Homo sapiens (Human, 9606) protein pairs. Then, only the interactions defined as 
“association (MI:0941)” under the interaction type categories (http://www.ebi.ac.uk/ontology-
lookup/browse.do?ontName=MI) and “experimental interaction detection (MI:0045)” from 
STRING were extracted. Next, we unified protein names based on the Uniprot ID and gene 
symbols in order to prevent abundant interactions caused by the different notations for the same 
gene between DBs. We removed proteins which have unreviewed, no gene symbols or Uniprot 
IDs, and removed (obsolete) genes from the Uniprot database up to the date of our data-mining and 
their interactors from our PPI list. We also included the interacting proteins from the published 
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APP interactome 9 and the YTH experiment (37 proteins).  Finally, 248,714 interactions between 
15,189 proteins were obtained in total. 
Identification of testis/sperm specific proteins in public DBs and publish human proteomes 
From the large PPI data obtained in the previous data-mining, we narrowed down the candidate 
proteins into the testis/sperm enriched proteins. We first used three distinct data sources to select 
the proteins associated with the testis: UniProt 20, UniGene 21 and the Human Protein Reference 
Database (HPRD) 14. From UniGene expressed sequence tags (ESTs) from Homo sapiens were 
used as source of gene expression data. Among our previous interaction data set, we chose all 
proteins associated with the keywords ‘‘testis’’ and/or “sperm” in the description of tissue-
specificity. Then, we kept the interactions, if both proteins in a pair of interaction were associated 
to testis/sperm. We got totally 155,457 interactions among 12,884 proteins in this procedure.  
Second, tissue-expression DBs (C-It, TiGER, UniGene, BioGPS, VeryGene and HPA) were used 
in order to identify the interactors characterized as highly specific or strongly expressed in 
testis/sperm. The C-it DB was queried with the keywords, 'testis-enriched' for 'Human'. The 
limitation factors for the literature information were 5 for PubMed and 3 for MeSH terms. Proteins 
with a SymAtals z-score higher than |1.96| were chosen.  The TiGER and the Very Gene database 
were also searched for 'Testis' in 'Tissue View' category. In HPA (Human Protein Atlas), proteins 
listed within the fields of high or medium HPA evidence and annotated protein expression based on 
IHC staining patterns in normal male reproductive tissues were selected. Also, the BioGPS was 
used to find testis/sperm restricted proteins with the keywords, 'testis, sperm, epididymis, 
spermatid, spermatogonia, spermatozoa, spermatocyte' in 'Human'. Using the plugin 'Gene 
expression/activity chart', the proteins with highly/strongly expressed in testis were selected. If the 
expression level was less than mean value or the data were not shown, those proteins were removed 
from the list. Also the proteins with high correlation level of expression (≥0.9) with testis-specific 
proteins, such as ACRV1, AKAP4, BRDT, PGK2, TSGA10, and TSPY8 were selected. From this 
search, 1,949 testis/sperm enriched proteins were obtained.  
Development of protein-protein network and network properties analysis 
From testis/sperm enriched proteins, APP/APLP2 interactors were selected. Functional 
relationships can be neglected when considering only tissue-enriched/specific proteins. This 
challenge was addressed by integrating tissue-enriched/specific APP/APLP2 interactors with its 
interacting proteins regardless whether they were enriched or not. Using the breath-first searching 
(BFS) algorithm, direct connectors with APP and the interactions between those proteins were 
kept. The same procedure was applied to APLP2. Since APLP2 is the nearest neighbor of APP, we 
combined two sub-networks and analyzed several network properties. We extended this local 
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network to the second order neighbors of APP in order to see the wide relations around APP and 
APLP2. All YTH data were included in this process. Finally, 1,803 interactions between 457 
proteins were obtained for the local APP/APLP2 network and 17,188 interactions between 2,733 
proteins for the extended APP/APLP2 network. 
Bioinformatic analyses: gene ontology, pathways and involvement in diseases 
The interactome was analyzed using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) v6.7 22. The UniProt 20 identifiers (UniProt_ID) for the proteins were entered 
into the DAVID functional annotation program. Overall, the proteins were analyzed for gene 
ontologies and pathways using the Homo sapiens genome-wide genes with at least one annotation 
in the analyzing categories as background. Proteins associated with defects in male fertility, or a 
functional or morphological defect in the epididymis, testis, or sperm were obtained from the 
Jackson Laboratories mouse knockout database (http://www.informatics.jax.org/). To obtain a list 
of the genes that have a male infertility phenotype, we also queried the OMIM 23, Phenopedia 24 
and the Uniprot database 20 with the term “male infertility”, and then downloaded the associated 
genes. 
3.4.4.!Results 
In this study, we characterized the testis/spermatozoa interactome of APP using a network-based 
approach (Figure B.16). 
 
Figure B.16 - Experimental methodology. 
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Identification of APP interacting proteins in human testis by Yeast Two-Hybrid screening  
Nowadays the YTH methodology is a very robust technique to identify PPI 10,25,26. The method that 
we use has been highly improved and overcomes the initial problems of the YTH, e.g. the 
appearance of false positive or false negative interactions 27, since, for instance, we use four 
reporter genes with different strength promoters 10,25,26.  
In order to identify APP interacting proteins expressed in human testis, an YTH screen of a human 
testis cDNA library was carried out using full-length human APP. The screen yielded 147 positive 
clones from a total of 3x108 clones screened. After partial or complete sequence analysis 
(depending on the length of the positive clone’s cDNAs), in silico searches of the GenBank DB 
allowed their identification and classification into three separate groups. Table B.4 corresponds to 
library inserts encoding known proteins identified as putative APP interactors. The second and 
third groups correspond to clones putatively encoding novel APP interacting proteins with 
homology to genomic sequences and lists positives where the GenBank sequence similarity did not 
correspond to an annotated gene and false positive hits, respectively. Table B.4 lists only 1 positive 
encoding a previously identified APP interacting protein (RANBP9) (Figure B.17). 77 clones 
encoded 36 known proteins that were not previously associated with APP (Figure B.17). Only the 
clones in Table B.4 were included in the network and further functional analyses.  
 
Figure B.17 - Diagram for the number of proteins interacting with APP from each dataset. The numbers indicate 
testis/sperm-annotated proteins interacting with APP from the different data sources; the numbers within parentheses 
represent the proteins enriched in testis and sperm. Self-connection for APP was neglected. 
 
Table B.4 - Human testis cDNA library inserts encoding known proteins identified as putative APP interactors. 
 GenBank acession Uniprot ID Gene symbol Protein name Chr No. of clones 
1 NM_022735 Q9H3P7 ACBD3 Golgi esidente protein GCP60 1 1 
2 NM_007247 Q9UMZ2 SYNRG Synergin gamma 17 2 
3 NM_007348 P18850 ATF6 Cyclic AMP-dependent transcription factor ATF-6 alpha 1 5 
4 NM_018844 Q9UHQ4 BCAP29 B-cell receptor-associated protein 29 7 1 
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 GenBank acession Uniprot ID Gene symbol Protein name Chr No. of clones 
5 BC002461 Q12982 BNIP2 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 15 1 
6 NM_020531 Q9HDC9 APMAP Adipocyte plasma membrane-associated protein 20 2 
7 NM_001745 P49069 CAMLG Calcium signal-modulating cyclophilin ligand 5 4 
8 NM_019052 Q8TD31 CCHCR1 Coiled-coil alpha-helical rod protein 1 6 1 
9 NM_004356 P60033 CD81 CD81 antigen 11 5 
10 NM_002414 P14209 CD99 CD99 antigen X/Y 7 
11 NM_000747 P11230 CHRNB1 Acetylcholine receptor subunit beta 17 2 
12 NM_030782 Q96KA5 CLPTM1L Cleft lip and palate transmembrane protein 1-like protein 5 1 
13 NM_006837 Q92905 COPS5 COP9 signalosome complex subunit 5 8 3 
14 NM_006368 O43889 CREB3 Cyclic AMP-responsive element-binding protein 3 9 1 
15 NM_021227.3 Q9NRP0 OSTC Oligosaccharyltransferase complex subunit OSTC 4 3 
16 NM_004413 P16444 DPEP1 Dipeptidase 1 16 5 
17 NM_024293 Q8NC44 FAM134A Protein FAM134A 2 1 
18 NM_020937 Q8IYD8 FANCM Fanconi anemia group M protein 14 2 
19 NM_000146 P02792 FTL Ferritin light chain 19 1 
20 NM_002510 Q14956 GPNMB Transmembrane glycoprotein NMB 7 1 
21 NM_002213 P18084 ITGB5 Integrin beta-5 3 1 
22 NM_018559 Q8IXQ4 KIAA1704 Uncharacterized protein KIAA1704 13 2 
23 NM_024874 Q8IZA0 KIAA0319L KIAA0319-like, transcript variant 1  1 
24 NM_014400 O95274 LYPD3 Ly6/PLAUR domain-containing protein 3 19 1 
25 NM_005493 Q96S59 RANBP9 Ran-binding protein 9 6 4 
26 NM_002951 P04844 RPN2 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 20 1 
27 NM_005086 Q14714 SSPN Sarcospan 12 3 
28 NM_004206 Q9BRL7 SEC22C Vesicle-trafficking protein SEC22c 3 9 
29 NM_003164 Q13190 STX5 Syntaxin-5 11 1 
30 NM_003487 Q92804 TAF15 TATA-binding protein-associated factor 2N 17 1 
31 NM_016495 Q9P0N9 TBC1D7 TBC1 domain family member 7 6 1 
32 NM_182559 Q86WS5 TMPRSS12 Transmembrane protease serine 12 12 1 
33 NM_003270 O43657 TSPAN6 Tetraspanin-6 X 3 
34 NP_001001790 Q8N4H5 TOMM5 Mitochondrial import receptor subunit TOM5 homolog 9 1 
35 NM_001242313.1 P0C7N4 TMEM191B Transmembrane protein 191B  1 36 NM_001207052.1 A6NGB0 TMEM191C Transmembrane protein 191C  
37 NR_003377 A8MUH7 PDZK1P1 Putative PDZ domain-containing protein 1P 1 1 
 
Analysis of the YTH screen revealed that the most abundant interaction was detected with SEC22C 
(9 out of the 147 positive clones). This protein is involved in vesicle transport between the ER and 
the Golgi complex.  
The 37 proteins identified as APP interactors were classified into broad functional categories 
according to Gene Ontology annotation using the DAVID bioinformatics resource (Supplementary 
Table D.18). Regarding the biological process, the categories with the largest number of proteins 
were related to intracellular transport (20.6%) and protein localization (20.6%). From the proteins 
involved in transport, 5 were linked with vesicle-mediated transport (SYNRG, BCAP29, SEC22C, 
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FTL and STX5). Also, 5 proteins (CD99, LYPD3, GPNMB, ITGB5 and SSPN) were associated 
with cell adhesion. CD81, CREB3 and FANCM were annotated as being involved in reproduction. 
The majority of APP interactors identified in the YTH (67.6%) are intrinsic to membrane and 7 are 
specifically at the plasma membrane (Supplementary Table D.18). Analysis of human proteomes 
(testis, epididymis, and spermatozoa) allowed the classification of DPEP1 and TMPRSS12 as 
testicular proteins; ITGB5 and COPS5 as sperm-located testicular proteins also detected in 
epididymal fluid; and FTL as a non-sperm located epididymal fluid protein (Supplementary Table 
D.19). CD81, CD99, COPS5 and FAM134 were identified as testis/sperm-enriched in tissue-
expression DBs 28–31. Also, TMPRSS12 was reported in the Unigene as a testicular/spermatozoa 
restricted protein. To determine which proteins are known to be important for normal male 
reproductive function, the dataset was screened against the Jackson Laboratory mutant mouse DB 
23 and Phenopedia 24. From the APP interactors identified in the YTH screen, 3 were connected 
with reproductive phenotypes in gene knockout models (RANBP9, CREB3 and FANCM). From 
the comparison with the disease genes listed in Phenopedia no results were obtained. 
Identification of literature curated interactions 
In order to identify the potentially relevant interactors of APP and APLP2 to male fertility, human 
PPI were collected from currently available public DBs, including APID 11, BioGRID 12, DIP 13, 
HPRD 14, InnateDB 15, Intact 16, MINT 17, Reactome 18, TopFind, and STRING 19. Only the 
interactions between both proteins associated with the terms “testis” and “sperm” in Unigene 21, 
HPRD 14 and Uniprot 20 were selected. Then, the interactors characterized as highly specific to or 
strongly expressed in testis/sperm were identified from tissue-expression DBs (C-It 28, TiGER 29, 
UniGene 21, BioGPS 32, VeryGene 30 and HPA 31). (See Methods and Supplementary Table D.20). 
Besides the DBs, the tissue expression data was also retrieved from the published proteomes of 
reproductive tissues 33–36. This analysis allowed the classification of the APP direct interactors into 
distinct but overlapped localizations. First, we focused on local interactions of APP/APLP2, that is, 
the first direct interactors of APP/APLP2 and interactions between them. We identified 455 
proteins connected to APP (Methods) including the partners identified by YTH (Figure B.18 a). All 
the proteins in the YTH data were newly found as interactors of APP except RANBP9, which was 
previously published as an APP interactor 9. The absence of protein overlapping may be due to the 
fact that the YTH was performed using a library from human testis and the previous APP 
interactors were mainly identified in neuronal tissues. Indeed, published data indicate that 4% of 
the mammalian genome (more than 2,300 genes) encodes genes specifically expressed in the male 
germ line during or after the completion of spermatogenesis. Regarding APLP2, we identified 6 
proteins (including APP) as its interactors from the DBs which were highly specific to or strongly 
expressed in testis. In total, 1,803 interactions were identified between 457 proteins including APP 
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and APLP2. Only one protein (BRCA1) among the nearest neighbors of APLP2 was not directly 
connected to APP which may reflect an isoform-specific role for APLP2. 
Second, we extended the local interaction network of APP/APLP2 into the second nearest 
neighborhoods since the local network of APP could limit an overview of the pathways in which 
this protein may be involved in testis and spermatozoa. In this network, we had 2,733 proteins 
and17,188 interactions between them (Methods). 
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Figure B.18 - APP protein-protein interaction networks. (a) Local APP/APLP2 network. Proteins with light orange (M1) 
and dark orange (M4) are mostly involved in G-protein coupled receptor protein signaling pathway (Biological Process; 
BP) and located at the plasma membrane (Cellular Component; CC). Proteins with light green (M2) and dark green (M3) 
are mostly involved in regulation of apoptosis (BP) and located at the cell surface (CC). (b) Subnetwork of APP 
interactors involved in cell adhesion (BP) extracted from the extended APP/APLP2 protein-protein interaction network. 
(c) Subnetwork of APP interactors involved in vesicle-mediated transport (BP) extracted from the extended network. Red 
colored nodes represent the proteins from the YTH screen.  Blue colored nodes indicate interactors extracted from the 
DBs. Node size represents relative degree of the nodes and the other interactions of nodes are neglected for the sake of 
simplicity. Dashed lines represent the interactions revealed by the YTH screening in human testis and solid lines are 
interactions from DBs. (d) Subnetwork of APP interactors involved in G-protein-coupled singnal pathways. 
 
Topological analysis of APP/APLP2 PPI network 
The overall structural properties for the local and extended APP/APLP2 network showed mostly 
linear relationship between degree [the number of nearest neighbors (connectivity) of a certain 
node] and betweenness centrality [fraction of shortest paths between all other nodes that pass 
through a certain node (Supporting Text)]. In our APP/APLP2 local network, proteins with high 
connectivity also revealed high centrality which can be a significant indication of the relevant 
proteins in a biological network.  
Local APP/APLP2 interaction network 
In the testis/sperm related APP/APLP2 network (Figure B.18 a), most proteins were densely 
connected to each other. Average degree of this network was <q> = 3.95 and global clustering 
coefficient was C = 0.51. The clustering coefficient reflects how neighbors of a node are connected 
to each other (Supporting Text). It is known that proteins with high connectivity (hubs) in PPI 
networks potentially have functional importance in biological systems and are likely to be critical 
proteins 37. The key proteins for disease are known to have low clustering coefficients in addition to 
high connectivities 38. In order to characterize the APP network topology, the clustering 
coefficients of each protein were calculated. Betweenness centrality and closeness centrality of 
each protein in the APP/APLP2 network were also measured to find the relevant proteins involved 
in pathways (Supporting Text). In biological networks, e.g. signaling pathways and genetic 
interactions, the dysfunction of the proteins with high centrality may be crucial for the other 
biological functions due to missing of signal transference. In yeast, the proteins with high 
betweenness centrality, but small number of degrees were found to be important links between well 
connected modules 39. Proteins with high centrality rank in our network were represented in 
Supplementary Table D.21. The top rated interactors included a calcium/phospholipid-binding 
protein which promotes membrane fusion and is involved in exocytosis (ANXA1, annexin A1). 
PIK3CG (phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform), 
PLCB3 (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3), LPAR2 
(lysophosphatidic acid receptor 2), RLN3 (relaxin-3 receptor 2) and ADORA3 (protein ADORA, 
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isoform 3) also composed the top rated proteins and were all related with the G-protein coupled 
receptor signaling pathway. 
The proteins identified as APP/APLP2 interactors were classified into functional categories 
according to Gene Ontology annotation using the DAVID program 22.  Regarding the biological 
process, the results revealed that the categories with the largest number of proteins were related to 
cell surface receptor linked signal transduction (43.0%; p value = 7.0E-60) and G-protein coupled 
receptor protein signaling pathway (33.3%; p value = 7.5E-58). 50.8% of the proteins were located 
at the plasma membrane (p value = 2.4E-26) and 23.2% in the extracellular region (p value = 1.7E-
6). 13.0% were associated with vesicles (p value = 1.8E-11). These vesicle related proteins may 
participate in specialized vesicle activity in the testis, such as acrosome formation. Additionally, 
13.9% are annotated as part of a cell projection (e.g. a flagellum) (p value = 1.0E-12).  
Metabolic pathways were analyzed using the KEGG PATHWAY 40, which indicated that the top 4 
significant categories were: Neuroactive ligand-receptor interaction (16.3%; p value = 2.5E-34); 
Chemokine signaling pathway (10.4%; p value = 1.3E-18); Calcium signaling pathway (8.6%; p 
value = 1.8E-13); and Progesterone-mediated oocyte maturation (5.5%; p value = 2.2E-11). 
In order to find the core and peripheral part of the local APP/APLP2 network, k-core analysis was 
performed. k-core is a subgraph of a graph in which all vertices have at least k-degree (Supporting 
Text). The core of this network has a connectivity, k = 11, between them. 75.0% of the proteins 
within this core shared the same biological process GO category (G-protein coupled receptor 
protein signaling pathway; p value = 6.6E-15) and 50.0% share the same subcellular localization 
(plasma membrane; p value = 6.9E-4).  
Four modules were identified by community detection analysis (Supporting Text). The nodes in a 
community are more tightly connected to each other than to nodes out of the community and may 
perform a common function. Our analysis shows that, in the local APP/APLP2 network, 206 
proteins are included in module 1 (light orange in Figure B.18 a). Among them, 19.7 % were 
involved in the regulation of apoptosis (p value = 1.5E-12) and the most significant represented 
cellular localization was the cell surface (16.3%, p value = 2.3E-17. The most prominent biological 
process detected in module 2 (which comprised 84 proteins in total, dark green in Figure B.18 a) 
was G-protein coupled receptor protein signaling pathway (76.2 %; p value = 6.6E-52) and 71.4 % 
of the proteins in module 2 shared the same localization (plasma membrane; p value = 5.6E-15). 
Module 3 included 85 proteins (light green in the Figure B.18 a), which were mainly involved in 
G-protein coupled receptor protein signaling pathway (94.0%; p value = 5.0E-80) and localized at 
the plasma membrane (76.2%, p value = 2.5E-18). Similarly to module 1, the most significant 
category in module 4 (which comprised 82 proteins in total, dark orange in Figure B.18 a) was 
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regulation of apoptosis (39.0%, p value = 4.8E-19). Modules 2 and 3 also share a common 
biological function and cellular component. In the local APP/APLP2 network, the core part of the 
network, that is, the proteins with the highest k-core (k=11) which includes APP, shared the same 
biological function (G-protein coupled receptor protein signaling pathway). The core part was 
included mostly in module 2, which was also associated with the same function. Therefore, this 
result showed that APP might be involved in G-protein coupled receptor protein signaling pathway 
in human testis/sperm. In addition, APP has high possibility that it is associated with regulation of 
apoptosis according to the results that the most interaction partners surrounding APP share the 
same function within modular structure. 
Extended APP/APLP2 network 
The local APP network only allows us to study relationships between APP and its nearest 
neighboring proteins. In order to study relationships with other proteins, we extended the network 
to the second nearest neighbors of APP. Topological properties of the extended networks are 
analyzed in Supplementary Table D.22. From k-core analysis, a densely connected group with high 
k (= 17)-core was found (186 proteins). The proteins in the core were involved in cell cycle 
(41.1%; p value = 6.4E-46). Also, the majority of proteins were found in the cytosol (49.2%; p 
value = 1.0E-41) and the nucleoplasm (40.0%, p value = 2.0E-38). 
Based on the community structure analysis, APP is located in module 2. The most significant 
biological processes associated with this module were proteolysis (19.3%; p value = 6.6E-9) and 
cell adhesion (15.9%; p value = 1.3E-9). Additionally, the majority of proteins were located at the 
plasma membrane (42.0%; p value = 1.3E-6) and at the extracellular region (32.4%; p value = 
5.4E-12). Table B.5 represents the gene ontology analysis for the modules of the extended network 
in which at least 40% of proteins shared a biological function.  
Table B.5 - Enriched GO categories for each module of the extended network. Only modules with at least 40.0% of the 
proteins sharing a biological function are represented. M, modularity. 
M Most significant Biological Process Most significant Cellular Component GO term p value % GO term p value % 
4 
cell cycle 2.7E-82 60.2 cytosol 4.3E-41 48.8 
regulation of ubiquitin-
protein ligase activity during 
mitotic cell cycle 
1.3E-130 41.0 proteasome complex 1.9E-67 25.3 
5 DNA metabolic process 1.2E-88 45.0 nuclear lumen 2.1E-56 48.6 nucleoplasm 8.7E-66 44.1 
7 microtubule-based process 3.8E-40 40.0 microtubule cytoskeleton 6.1E-68 70.8 centrosome 3.8E-70 58.4 
10 cell cycle 6.6E-20 47.2 
chromosomal part 1.2E-19 39.6 
chromosome, centromeric 
region 7.9E-26 35.8 
11 G-protein coupled receptor protein signaling pathway 9.5E-141 63.1 plasma membrane 4.3E-45 65.1 
12 modification-dependent protein catabolic process 1.7E-16 40.4 endoplasmic reticulum 4.2E-9 32.7 
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Specific topological features of proteins from YTH 
Based on the extended network structure analyses, COPS5 has a large number of connections 
(q=152) and also a relatively high betweenness centrality (b=0.046) among our 37 YTH proteins, 
contrasting with a low clustering coefficient (C=0.014). COPS5 is sperm-located testicular protein 
41. CD81 (q=27, b=0.005, C=0.029), CD99 (q=13, b=0.001, C=0.064) and IGTB5 (q=10, 
b=0.0003, C=0.089) also revealed prominent topological properties (Supplementary Table D.22). 
Topological role of APP and APLP2 in the network 
Previous data has shown that the absence of both APP and APLP2 lead to the abnormal 
developments of sexual organs, the reduction of synaptic vesicles, and even postnatal lethality in 
mice 6. On the other hand, the absence of either APP or APLP2 does not affect viability and 
fertility. Based on these, one can imagine that these two proteins should co-exist for the 
mammalian life maintenance. Here, we focus on the role of APP and APLP2 for the human male 
fertility. Based on experimental results of gene knock-outs in mice 6, one can assume that APP and 
APLP2 are simultaneously involved in important pathways. Some proteins or protein complexes 
cannot accomplish biological functions in the absence of APP/APLP2, because this blocks the 
functional routes between the proteins. In order to find a conformity of the functional property 
within a structural property, we checked the local triangle structure between APP, APLP2, and the 
common interactors (CDK1, DAB2, JUN, and PIK3CA). Among the interactors of APLP2, only 
BRCA1 is not connected to APP. These common interactors of APP and APLP2 form a small 
modular structure. Therefore, one can guess the proteins in this module possibly share a biological 
function in testis.  
3.4.5.!Discussion 
Biomolecular networks are now frameworks that facilitate many discoveries in molecular biology. 
The theoretical advances in network science in parallel with high throughput efforts to map 
biological networks, offer an excellent opportunity to apply the principles of theoretical physics to 
the molecular biomedicine field.  
The APP network in testis/sperm was built first using an YTH screen and then expanded by 
incorporating literature curated interactions. Since protein profiles of the different tissues are 
critical to understand the unique characteristics of the various human cell types, in this study, we 
took into account the tissue expression of the interactors in the network. From the YTH screen, we 
reported the identification of 36 novel APP interacting proteins in human testis/sperm. Only 1 
positive encoded a previously identified APP interacting protein (RANBP9). This may be 
explained by the fact of testis being a very peculiar organ which possesses specific patterns of 
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transcription and expresses novel protein isoforms 37. APLP2 interacting partners were also 
included in this study.  
To determine which PPI in our APP/APLP2 network were biologically more relevant for male 
reproduction, we performed network structure analyses and bioinformatic analyses. Based on the 
community/modularity analysis of the PPI network along with gene ontology analysis, we 
confirmed that proteins involved in similar functions are group together and form modules. The 
biological process GO category more significantly represented in the APP/APLP2 local network in 
human testis/sperm was cell surface receptor linked signal transduction with 43.0% of the proteins 
annotated in this class. These proteins may indicate how the male germ cells interact with the 
outside world. Among those proteins, 33.3% carry the GO functional tag for G-protein coupled 
receptor protein signaling pathway. Some studies indicate that full length APP can function as a 
cell surface GPCR and show that APP binds heterotrimeric G proteins (Gαo) 42,43. Recently, Deyts 
and colleagues discovered an interaction between APP intracellular domain and the heterotrimeric 
G-protein subunit Gαs 44. G protein-coupled receptors signalling pathways have been proposed to 
control several processes essential for sperm function and fertilization, namely in sperm 
capacitation and acrosome reaction 45–48. APLP2/YWK-II also exhibits properties of a receptor and 
its extracellular domain was shown to interact with Müllerian-inhibiting substance 47. Müllerian-
inhibiting substance increases the viability and longevity of human spermatozoa through binding 
the APLP2/YWK-II component on the sperm membrane 48. Huang and colleagues showed that 
APLP2/YWK-II component binds to a GTP-binding protein (Gαo).  
The most abundant interaction detected in the YTH was with SEC22C. This protein is involved in 
vesicle transport between the ER and the Golgi complex 49. Vesicular membrane trafficking is an 
essential process during acrosome biogenesis 50. Also, SEC22C may control the APP traffic 
through the secretory pathway. Besides SEC22C, other four YTH clones (BCAP29, FTL, STX5, 
and SYNRG) are involved in vesicle-mediated transport (Figure B.18 c). This GO term includes 
the regulation of the acrosomal vesicle exocytosis, an essential process for fertilization, which 
begins with the fusion of the outer acrosomal membrane with the sperm plasma membrane and 
ends with the exocytosis of the acrosomal contents into the oocyte. 
The cellular component category most enriched in the GO term analysis of the APP/APLP local 
network was the plasma membrane. Fertilization is achieved through gamete interactions, 
specifically cell adhesion and then membrane fusion of the gamete plasma membranes. The 
occurrence of 50.8% of proteins in the plasma membrane may suggest their involvement in sperm-
egg interaction. Additionally, 10.2% of APP interactors are involved in cell adhesion (Figure B.18 
b). Of these, CD99, GPNMB, ITGB5, LYPD3, and SSPN were identified in the YTH screen 
Chapter 3 Results 
156 University of Aveiro!
performed using a testis library. The APP yeast mating efficiency in the YTH was much higher 
than usual (50%, when compared to a normal 5%), which may be related to APP cell adhesion 
properties. This strengthens previous results suggesting APP to be involved in cell-to-cell contact, a 
very important process in gamete fusion. Recent approaches to identify candidate proteins involved 
in sperm-egg interaction have been characterizing the sperm proteome and analyzing specific 
subpopulations of interest, for instance, glycoslylated proteins and integrins. Additionally, proteins 
with motifs or belonging to families of interest like transmembrane domains and the tetrasparin 
family should also be considered.  Interestingly, some of the YTH positive clones are included in 
those categories.  APP interacts with ITGB5, identified in the YTH screen, and ITGB1 51, both 
belonging to the integrin beta chain family. Integrins on eggs became of interest with the discovery 
of an integrin ligand-like domain in ADAM2, a sperm antigen essential for sperm-egg 
interaction.TSPAN6 and CD81 belong to the tetraspanin family. The discovery that the knockout 
of CD9, a member of the tetraspanin family, in mouse leads to healthy, but subfertile females due 
to defective sperm-egg interaction revolutionized the fertility field. CD81 is 45% identical to CD9 
and Cd81 knockout mouse also presents defects in female fertility. Cd9-/-/Cd81-/- female mice are 
completely infertile. We found that, in local network, APP, TSPAN6, ITGB1, ITGB5, GPNMB, 
LYPD3, SSPN, CD81 and CD99 were in the same module (module 1). However, in extended 
network, APP, TSPAN6, GPNMB, LYPD3, SSPN, and ITGB5 were in module 2, whereas ITGB1, 
CD81, CD9 and CD99 were well connected in module 9 in which 20.3% of the proteins share the 
biological function – cell adhesion (Figure B.18 b). We also identified tissue-specific APP 
interacting proteins which can lead to the identification of pathways for the APP family members 
associated with testis and sperm functions. TMPRSS12, a transmembrane serine protease, was 
identified in the YTH screen and was reported in the Unigene as testicular/spermatozoa restricted. 
TMPRSS12 belongs to the same module from network community as APP. Since this protein is 
connected to APP only, it cannot have any route to the main network without APP. Sperm-surface 
proteases were already shown to be required for fertilization 52. There is also evidence for the 
participation of serine proteolytic activities during spermatogenesis and sperm maturation 53. 
However, most of the specific proteases that are involved in these processes are unknown. The 
exact localization of TMPRSS12 at sperm membrane has to be determined.  
The present work provided the first report on APP interactome in human testis. We identified 
several novel APP interactions in human testis and incorporated YTH data and PPI databases to 
construct the PPI network of APP in human testis and spermatozoa. The protein interaction 
network allowed the recognition of proteins complexes and modules crucial for several biological 
functions, such as cell adhesion. 
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4.1.1.!Abstract 
Objective: To determine the correlation between semen basic parameters and the expression and 
activity of signaling proteins. Design: In vitro studies with human spermatozoa. Settings: 
Academic research institute in collaboration with a hospital. Patients: Thirty-seven men provided 
semen samples for routine analysis. Interventions: None. Main outcome measures: Basic semen 
parameters tracked included sperm DNA fragmentation (SDF), the expression levels of 75 protein 
kinases and the phosphorylation/cleavage patterns of 18 signaling proteins in human spermatozoa. 
Results: The results indicated that the phosphorylated levels of several proteins [Bad, GSK-3β, 
HSP27, JNK/SAPK, mTOR, p38 MAPK and p53], as well as, cleavage of PARP (at D214), and 
Caspase-3 (at D175)] were significantly correlated with motility parameters. Additionally, the 
percentage of morphologically normal spermatozoa demonstrated a significant positive correlation 
with the phosphorylated levels of p70 S6 kinase and, in turn, head defects and the teratozoospermia 
index (TZI) showed a significant negative correlation with the phosphorylated levels of Stat3. 
There was a significant positive correlation between SDF and the TZI, as well as, the presence of 
head defects. In contrast, SDF negatively correlated with the percentage of morphologically normal 
spermatozoa and the phosphorylation of Akt and p70 S6 kinase. Subjects with varicocele 
demonstrated a significant negative correlation between head morphological defects and the 
phosphorylated levels of Akt, GSK3β, p38 MAPK and Stat1. Additionally, 34 protein kinases were 
identified as expressed in their total protein levels in normozoospermic samples. Conclusions: This 
study contributed towards establishing a biomarker "fingerprint" to assess sperm quality based on 
molecular parameters. 
4.1.2.!Introduction 
Infertility is a major public health issue, especially in industrialized countries where birth rates are 
declining drastically below replacement levels 1. The male factor is involved in approximately 50% 
of infertility cases. Male infertility may be caused by numerous factors including genetic 
abnormalities, acute and chronic diseases, treatments for certain conditions, lifestyle factors and 
exposure to environmental, occupational, and infectious agents. A common risk factor for male 
infertility is varicocele, which is found in about 15% of all adult males, up to 35% of men who 
present for infertility evaluation, and in as many as 81% of men with secondary infertility 2. Still, 
many questions regarding the etiology of male infertility remain unanswered with idiopathic 
infertility as the most common type of male infertility 3,4. 
The physiology and molecular biology of the spermatozoa has been neglected in the last decade 
due to the use of assisted reproduction technologies (ART) that bypassed the need for a “normal” 
ejaculated sperm sample. However, despite several ART improvements over the last few years, 
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there is still the need to increase live birth rates 5, and it is preferable to rise sperm quality and 
avoid ART. Identification of the male infertility factors and biomarkers will improve fertility 
management and even allow for conception through intercourse.  
Many signaling pathways have been thoroughly investigated in somatic cells. However, limited 
information is available on their characterization in male germ cells. In the past few years, some 
studies have indicated that hormones, cytokines and growth factors regulate processes such as 
spermatogenesis and sperm motility and their levels differ in the genital tract secretions of fertile 
and infertile men 6–11. In addition, several findings clearly demonstrate that the cellular actions of 
signaling pathways in spermatozoa occur through mechanisms that are distinct to those described 
for somatic cells 12. 
Several signaling pathways that were described in somatic cells have also been documented in 
spermatozoa: apoptotic 13, mitogen-activated protein kinase (MAPK) 14, cAMP/PKA 15, JAK/STAT 
16, among others. Despite these efforts, not much information is available on the biological 
significance of specific signaling pathways in human spermatozoa or their possible roles in male 
infertility. Additionally, the association between the activated states of these pathways and 
spermatozoa quality has not been established. 
4.1.3.!Methods 
Sperm samples collection, basic semen analysis and DNA fragmentation assessment 
This study was approved by the Ethics and Internal Review Board of the Hospital Infante D. Pedro 
E.P.E. (Aveiro, Portugal) and was conducted in accordance with the ethical standards of the 
Helsinki Declaration. All donors signed informed consent allowing the samples to be used for 
scientific purposes. A total of 37 semen samples were obtained from a randomized group of 
donors, by masturbation to a sterile container. Basic semen analysis was performed by qualified 
technicians according to World Health Organization (WHO) guidelines 17. Briefly, after complete 
liquefaction of the semen samples at 37˚C, during approximately 30 minutes, a macroscopic 
examination was performed. The microscopic examination included the analysis of motility, 
concentration and morphology of the spermatozoa. DNA fragmentation was measured using a 
Sperm Chromatin Dispersion (SCD) test (Halosperm® kit, Halotech®, Madrid, spain) according to 
the manufacturer’s instructions. All microscopy analysis were performed using the Zeiss ® Primo 
Star microscope (Zeiss ®, Jena, Germany).  
Antibody array 
Antibody-based arrays were carried out using the PathScan® Intracellular Signaling Array Kit 
(#7744, Cell Signaling Technology, Danvers, MA, USA) to determine the expression patterns of 18 
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well-characterized signaling molecules when phosphorylated or cleaved, in 32 semen samples 
obtained from a randomized group of donors. After semen liquefaction, sperm cells were washed 
three times in 1x phosphate buffered saline (PBS) by centrifugation (600xg for 5 minutes at 4°C) 
and lysed according to the manufacturer’s instructions. Protein concentration was measured using 
bicinchoninic acid (BCA) assay (Pierce Biotechnology, USA) and final absorbance was measured 
at 562 nm in a microplate reader (TECAN, Genius, Männedorf, Switzerland). Each cell extract was 
diluted to 250 µg/ml and applied to its own multiplexed array according to the manufacturer’s 
instructions. Fluorescence readouts from the arrays were captured digitally using LI-COR® 
Biosciences Odyssey® imaging system (LI-COR® Biosciences, Nebraska, USA). Pixel intensity 
was quantified using Odyssey software. The intensity from the negative control within each array 
was subtracted from all signals, and all data from each array were normalized to the internal 
positive control within each array. 
Protein kinase screening 
The total protein levels of 75 protein kinases were analyzed in normozoospermic samples by the 
commercial Kinetworks™ Protein Kinase Screen 1.2 (KPKS-1.2; Kinexus Bioinformatics 
Corporation, Vancouver, Canada) as described online at www.kinexus.ca. This involved 
immunoblotting of sperm lysate samples following resolution by SDS-polyacrylamide gel 
electrophoresis with a panel of 72 pan-specific protein kinase antibodies as described in Pelech et 
al. 18. A pool of five normozoospermic samples (NZ) with high motility (45%–55% progressive 
motility) was analyzed. Samples were centrifuged at 16,000xg. Afterwards, the sperm pellet was 
homogenized in lysis buffer (20 mM Tris-HCl, pH 7.0, 20 mM beta-glycerophosphate, 150 mM 
NaCl, 3 mM EDTA, 3 mM EGTA, 1 mM Na3VO4, 0.5% Nonidet P-40, 1 mM dithiothreitol, 1 mM 
phenylmethane sulphonylfluoride (PMSF), 2 µg/mL leupeptin, 4 µg/mL aprotinin, and 1 µg/mL 
pepstatin A) according to Kinexus instructions. Total protein extracts were resolved on 10% SDS-
PAGE gels and transferred to nitrocellulose membranes (300 µg of total lysate protein per 
membrane). Following the use of a 20-lane multiblotter (BioRad, Hercules, CA, USA), the 
membrane was incubated with mixes of up to three antibodies per lane (roughly 12 µg of total 
lysate protein per lane). Each protein kinase was further classified with respect to its molecular 
weight. Relative amounts of each protein band were quantified as counts per minute (CPM). The 
data were normalized following the correction for protein content. 
Statistical analysis 
Statistical analysis was conducted using the IBM SPSS Statistics Software 22. First, a descriptive 
analysis to each quantitative parameter analyzed was performed. Lastly, we calculated the Pearson 
correlation coefficient, r, or the Spearman’s rho correlation coefficient, rs, (a nonparametric 
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correlation method) to determine the relationship between two variables. We performed a test of 
normality (Shapiro-Wilk test) and we analyzed the box-plots to decide between a parametric or 
non-parametric method. The significance level was set at 0.05. 
Bioinformatic analyses 
The HIPPIE database was used for retrieving human protein-protein interaction (PPI) data 
(downloaded on April 17, 2015). This database is regularly updated by incorporating interaction 
data from major expert-curated experimental PPI databases (such as BioGRID, HPRD, IntAct and 
MINT). For the identification of testis enriched/specific proteins, proteins were searched against six 
tissue-expression databases: C-it 19, UniGene 20, TiGER 21, Very Gene 22, Human Protein Atlas 
(HPA) 23 and BioGPS 24. The criteria used in the databases were set for maximum stringency to 
identify the tissue-specific proteins with a high confidence level. Only proteins that appeared in at 
least two databases were included as testis-enriched/specific. The protein network was build using 
Cytoscape V3.2.0 software 25. Gene Ontology annotations and pathways were analyzed using the 
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 26. The UniProt 
identifiers of all proteins were used as input for the DAVID functional annotation program. The 
overall set of human protein-coding genes was used as background. Enrichment p-values indicated, 
correspond to the Bonferroni corrected retrieved by DAVID. Protein identities associated with 
defects in male fertility or a functional/morphological defect in the male reproductive system were 
obtained from the Jackson Laboratories mouse knockout database 
(http://www.informatics.jax.org/). 
4.1.4.!Results 
Correlation between semen quality and signaling proteins phosphorylation and cleavage 
A total of 32 semen samples, obtained from a randomized group of donors, were included in this 
study (Supplementary Table D.23). From those, 18.8% were diagnosed with varicocele. The 
dataset size was considered reasonable since based on the central limit theorem it was possible to 
approximate the distribution of variables to a normal distribution. 
Basic semen parameters were analyzed according to the WHO’s guidelines (Supplementary Table 
D.23). The spermatozoa DNA fragmentation was measured using a Sperm Chromatin Dispersion 
(SCD) test and the levels of signaling molecules (in distinct activation states) were determined with 
the PathScan Intracellular Signaling Array, which includes antibodies for phosphorylated or 
cleaved signaling proteins (Supplementary Table D.23). Initially, a descriptive analysis of the 
results was performed (Supplementary Table D.24). Next, to evaluate the relation between the 
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results obtained from the seminal parameters analysis and the PathScan array, Spearman’s and 
Pearson correlation tests were performed (Table B.6). 
The results indicated that the levels of several phosphoproteins (i.e., Bad (pS112), GSK-3β (pS9), 
HSP27 (pS78), JNK/SAPK (pT183/pY185), mTOR (pS2448), p38 MAPK (pT180/pY182) and p53 
(pS15), as well as, the cleavages of PARP (at D214) and Caspase-3 (at D175) were negatively 
correlated with the percentage of motile spermatozoa. Bad (pS112) and JNK/SAPK 
(pT183+pY185) levels were also negatively correlated with progressive motility. In turn, 
phosphorylation of Bad (pS112), JNK/SAPK (pT183+pY185) and p53 (pS15) showed a positive 
correlation with the percentage of immotile sperm cells. Concerning sperm morphology, the 
percentage of normal spermatozoa positively correlated with the phosphorylation of p70 S6 kinase 
(pT389). In contrast, head defects and the TZI showed a negative correlation with the levels of 
phospho-Stat3 (pY705). The results indicated that DNA fragmentation in spermatozoa was 
positively correlated with the presence of head defects, the TZI and the volume, and negatively 
correlated with the percentage of morphologically normal spermatozoa. DNA fragmentation also 
presented a negative correlation with the levels of phosphorylated Akt (pT308) and p70 S6 kinase 
(pT389). In the subjects diagnosed with varicocele, a strong negative correlation between the 
percentage of head abnormalities and the levels of phosphorylated Akt (pT308+pS473), GSK3β 
(pS9), p38 MAPK (pT180+pY182) and Stat1 (pY701) was observed. 
Protein kinases in normozoospermic sperm samples 
The antibody-based KPKS-1.2 (KinetworksTM Protein Kinase Screen 1.2) was employed to 
investigate the presence of a large number of protein kinases in pooled human sperm samples (NZ, 
Supplementary Table D.25). The affinities of individual antibodies used to screen the different 
kinases varied; therefore, this screening approach does not provide an absolute comparison of total 
levels between different proteins but indicates the relative amounts of a target protein in two 
different samples. The KPKS screen allows the detection of 75 protein kinases (Supplementary 
Table D.26). From those, 34 protein kinases were detected in the sperm pool (NZ, Table B.7). 
Pathways analyses indicated that the top 3 overrepresented categories were: MAPK signaling 
pathway (44.4%, 16 proteins, p=6.1E-12); Neurotrophin signaling pathway (38.9%, 14 proteins, 
p=8.1E-14); and Progesterone-mediated oocyte maturation (30.6%, 11 proteins, p=3.7E-11). To 
determine which proteins were known to be important for normal male reproductive function our 
dataset was screened against the Jackson Laboratory mutant mouse DB. The analysis revealed 3 
protein kinases (CDK2, RSK2 and CK2a) that are required for normal male reproductive function 
(Table B.7). The remainder of the targeted protein kinases screened were undetectable, either due 
to their absence in the sperm samples tested or because their levels were below the detection limit.  
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Table B.6 - Associations between the results obtained from the basic seminal analyses, sperm DNA fragmentation and the PathScan Intracellular Signaling Array. *- correlation is significant 
at the 0.05 level (2-tailed); **- correlation is significant at the 0.01 level (2-tailed); TZI, teratozoospermia index; SDF, sperm DNA fragmentation; NA, not applicable; rs, Spearman´s rho 
correlation coefficient; r, Pearson correlation coefficient. 1 Experimental data (total protein) was compared with the human sperm proteome lists published to date 70,71,74–80,83; 2 Whenever 
proteins were not described in human the species is indicated; 3 Whenever the localization of the phosphorylated/cleaved status was not described, the total protein was considered (+). 4 
Experimental data was compared to the gene knockout mice phenotypes. 
Uniprot 
ID 
Abbreviation Recommended 
protein name 
Previously id  
human sperm 
proteome1 
Previously 
described in 
spermatozoa2 
Localization in 
spermatozoa3 
Function in 
spermatozoa 
Infertility 
phenotype4 
Phosphorylati
on/ cleavage, 
residue, status 
Clinical 
correlation 
Correlation 
Coefficient/ 
Sig. (2-tailed) Formerly Presently 
P23443 p70 S6 kinase RPS6KB1 
Ribosomal 
protein S6 
kinase beta-1 
70 Yes, mouse 54 Cytoplasm+ 54 Unknown  Phospho T389 Activation 
Normal 
morphology 
rs= 0.384* 
p= 0.030 
SDF rs= -0.371* p= 0.037 
P40763 Stat3 STAT3 
Signal 
transducer and 
activator of 
transcription 3 
70,71 Yes (47) 
Head plasma 
membrane and 
flagellum 
cytoskeleton+ 60 
Regulation of 
mitochondrial 
activity 
Capacitation? 
Transcription in 
the fertilized 
oocyte? 
Male infertility; Phospho Y705 Activation 
Head defects rs= -0.458** p= 0.008 
TZI rs= -0.460** p= 0.008 
P31749 Akt AKT1 
RAC-alpha 
serine/threonine-
protein kinase 
70 Yes 72 
Caudal part of 
the post 
acrosomal region 
and midpiece 
48,49 
Sperm vitality 
and motility 
Abnormal testis 
morphology; 
Seminiferous 
tubule 
degeneration; 
Abnormal 
spermatogenesis
; 
Phospho T308 
Activation 
SDF rs= -0.377* p= 0.033 
Head defects 
(varicocele) 
r= -0.877* 
p= 0.022 
Phospho S473 
Activation 
Head defects 
(varicocele) 
r = -0.829* 
p= 0.042 
P42224 Stat1 STAT1 
Signal 
transducer and 
activator of 
transcription 1-
alpha/beta 
70,71 Yes 16 
Head apical 
region+ 16; 
Neck region of 
the flagellum+ 63 
Transcription in 
the fertilized 
oocyte? 
 Phospho Y701 Activation 
Head defects 
(varicocele) 
r= -0.890* 
p= 0.017 
P42345 mTOR MTOR 
Serine/threonine
-protein kinase 
mTOR 
70,73 No Unknown Unknown  
Phospho 
S2448 
Activation 
Motility rs= -0.370* p= 0.048 
P04792 HSP27 HSPB1 Heat shock protein beta-1 
70,74–80 No Unknown Unknown  Phospho S78 Activation Motility 
rs= -0.389* 
p= 0.037 
Q16539 
Q15759 
P53778 
p38 MAPK14/11/12/13 
Mitogen-
activated protein 
kinase 
70 
(MAPK14/13) Yes 
34 Upper midpiece
+ 
34 
Negatively 
regulates motility  
Phospho 
T180/Y182 
Activation 
Motility rs= -0.388* p= 0.038 
Head defects r= -0.814* 
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Uniprot 
ID 
Abbreviation Recommended 
protein name 
Previously id  
human sperm 
proteome1 
Previously 
described in 
spermatozoa2 
Localization in 
spermatozoa3 
Function in 
spermatozoa 
Infertility 
phenotype4 
Phosphorylati
on/ cleavage, 
residue, status 
Clinical 
correlation 
Correlation 
Coefficient/ 
Sig. (2-tailed) Formerly Presently 
O15264 14/11/12/13 (varicocele) p= 0.049 
P45983 
P45984 
P53779 
SAPK/ JNK MAPK8/9/10 
Mitogen-
activated protein 
kinase 8/9/10 
70 (MAPK9) No Unknown Unknown  
Phopho 
T183/Y185 
Activation 
Motility rs= -0.446* p= 0.015 
Progressive 
motility 
rs= -0.443** 
p= 0.016 
Immotile rs= 0.399* p= 0.032 
P42574 Caspase-3 CASP3 Caspase-3 70 Yes 46 
Post acrosomal 
region 13 
Midpiece 46 
Apoptosis  
Cleavage 
D175 
Activation 
Motility rs= -0.392* p= 0.035 
P49841 GSK-3β GSK3B 
Glycogen 
synthase kinase-
3 beta 
70,80 Yes, bull 38 Posterior head and flagellum+ 39 Motility  
Phospho S9 
Inhibition 
Motility rs= -0.383* p= 0.040 
Head defects 
(varicocele) 
r= -0.918** 
p= 0.010 
P04637 p53 TP53 Cellular tumor antigen p53  Yes 
81 Unknown Apoptosis 
Small testis; 
Abnormal 
spermatogenesis
; 
Phospho S15 
Activation 
Motility rs= -0.451* p= 0.014 
Immotile rs= 0.424* p= 0.022 
Q92934 Bad BAD 
Bcl2-associated 
agonist of cell 
death 
70 Yes 82 Midpiece+ 82 Apoptosis 
Abnormal 
reproductive 
system 
morphology and 
seminiferous 
tubule 
morphology; 
Phospho S112 
Inhibition 
Motility rs= -0.561** p= 0.002 
Progressive 
motility 
rs= -0.554** 
p= 0.002 
Immotile rs= 0.512** p= 0.005 
P09874 PARP PARP1 
Poly [ADP-
ribose] 
polymerase 
70,71,79 Yes 45 Unknown DNA damage repair system  
Cleavage 
D214 
Inhibition 
Motility rs= -0.388* p= 0.038 
NA Sperm DNA Fragmentation NA NA NA NA NA  NA 
Volume rs= 0.391* p= 0.027 
Normal 
morphology 
rs= -0.535** 
p= 0.002 
Head defects rs= 0.447** p= 0.01 
TZI rs= 0.506** p= 0.003 
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Table B.7 - Protein kinases detected in the Kinetworks KPKS-1.2 Protein Kinase Screen. Protein kinases identified in the pool of 5 normozoospermic human sperm samples (NZ) and their 
respective detections as Counts per Minute (CPM). PTYK, protein-threonine/tyrosine kinases; PYK, protein-pyruvate kinase; PTK, protein-tyrosine kinase; AR, acrosome Reaction. 
Uniprot 
Abbreviation 
Protein Name Type 
NZ Previously identified in 
human sperm 
proteome1 
Previously 
described in 
spermatozoa2 
Localization in 
spermatozoa3 Infertility phenotype
4 
Formerly Presently CPM 
P15056 RafB BRAF RafB proto-oncogene-encoded protein-serine kinase PSTK 593 
70 No   
Q9ULU4 PKCb1 ZMYND8 Protein-serine kinase C beta 1 PSTK 92 71,79 Yes 84 Principal piece 84  
Q16539 p38a MAPK MAPK14 Mitogen-activated protein-serine kinase p38 alpha PSTK 1968 
70 Yes, chicken 85 Head 85  
P27361 Erk1 MAPK3 Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) PSTK 688 
70 Yes 86 
Post acrosomal (before 
AR) and equatorial 
region (after AR) 86; 
Midpiece 34 3 
 
P28482 Erk2 MAPK1 Extracellular regulated protein-serine kinase 2 (p42 MAP kinase) PSTK 404 
70 Yes 86 
Post acrosomal (before 
AR), equatorial region 
(after AR) 86; 
Midpiece 34 3 
 
P17252 PKCa PRKCA Protein-serine kinase C alpha PSTK 775 No Yes 84 Equatorial region 84  
P24941 CDK2 CDK2 Cyclin-dependent protein-serine kinase 2 PSTK 378 No Yes, bull 
69 Unknown 
Abnormal spermatogenesis, 
spermiogenesis, male 
reproductive system 
morphology and 
fertility/fecundity; 
Small testis and seminiferous 
tubules; 
Azoospermia; 
Q05655 PKCd PRKCD Protein-serine kinase C delta PSTK 161 70 No   
P24723 PKCl PRKCH Protein-serine kinase C lambda/iota PSTK 173 
70 No   
P45983 
P45984 
P53779 
JNK MAPK8/9/10 
Jun N-terminus protein-serine 
kinases (stress-activated protein 
kinase (SAPK)) 1/2/3 
PSTK 176 70 (MAPK9) No   
Q05513 PKCz PRKCZ Protein-serine kinase C zeta PSTK 276 70 Yes, mouse 87 Acrossomal 87  
P36507 MEK2 MAP2K2 MAPK/ERK protein-serine kinase 2 PTYK 452 
70,80 Yes 88 Flagellum 88  
O75914 PAK3 PAK3 p21-activated serine kinase 3 (beta) PSTK 2290 No No   
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Uniprot 
Abbreviation 
Protein Name Type 
NZ Previously identified in 
human sperm 
proteome1 
Previously 
described in 
spermatozoa2 
Localization in 
spermatozoa3 Infertility phenotype
4 
Formerly Presently CPM 
P49840 GSK3α  GSK3A Glycogen synthase-serine kinase 3 alpha PSTK 105 
70,79 Yes, bull 89 Posterior head and flagellum 39  
P49841 GSK3β  GSK3B Glycogen synthase-serine kinase 3 beta PSTK 34 
70,80 Yes, bull 89 Posterior head and flagellum 39  
Q15418 RSK1 RPS6KA1 Ribosomal S6 protein-serine kinase 1 PSTK 130 
70 No   
P41279 COT MAP3K8 Osaka thyroid oncogene protein-serine kinase (Tpl2) PSTK 405 
79 No   
P51812 RSK2 RPS6KA3 Ribosomal S6 protein-serine kinase 2 PSTK 62 
70 No  Infertility 
P19784 CK2a CSNK2A2 Casein protein-serine kinase 2 alpha/ alpha prime PSTK 1725 
70,74,78–80 Yes 90 Unknown 
Abnormal spermatid 
morphology, male germ cell 
apoptosis, sperm nucleus 
morphology and sperm motility; 
Globozoospermia; 
Oligozoospermia; 
Teratozoospermia; 
Detached acrosome; 
Kinked sperm flagellum; 
Male infertility; 
O15111 IKKa CHUK Inhibitor of NF-kappa-B protein-serine kinase alpha (CHUK) PSTK 629 
70,71 No   
Q8IVT5 Ksr1 KSR1 Protein-serine kinase suppressor of Ras 1 PSTK 402 No No   
P51813 BMX (Etk) BMX Bone marrow X protein-tyrosine kinase PSTK 45 No Yes, bull 
91 Unknown  
P41240 Csk CSK C-terminus of Src tyrosine kinase PYK 158 70 Yes 92 Unknown  
P53355 DAPK1 DAPK1 Death associated protein kinase 1 PSTK 241 No No   
P43405 Syk SYK Spleen protein-tyrosine kinase PYK 403 70 Yes, boar 93 Unknown  
Q13043 MST1 STK4 Mammalian STE20-like protein-serine kinase 1 PYK 121 
70 No   
P48730 CK1d CSNK1D Casein protein-serine kinase 1 delta PSTK 348 No No   
P49674 CK1e CSNK1E Casein protein-serine kinase 1 epsilon PSTK 2663 
70 No   
Q12851 GCK MAP4K2 Germinal centre protein-serine PSTK 178 No No   
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Uniprot 
Abbreviation 
Protein Name Type 
NZ Previously identified in 
human sperm 
proteome1 
Previously 
described in 
spermatozoa2 
Localization in 
spermatozoa3 Infertility phenotype
4 
Formerly Presently CPM 
kinase 
Q8IU85 CaMK1d CAMK1D Calcium/calmodulin-dependent protein-serine kinase 1 delta PSTK 334 
70 No   
P04049 Raf1 RAF1 Raf1 proto-oncogene-encoded protein-serine kinase PSTK 1047 
70,83 No   
P25098 GRK2 ADRBK1 G protein-coupled receptor-serine kinase 2 PSTK 319 
70 No   
O43293 ZIPK DAPK3 ZIP kinase (death associated protein-serine kinase 3 (DAPK3)) PSTK 582 No No   
P23458 JAK1 JAK1 Janus protein-tyrosine kinase 1 PTK 3323 70,73,78 Yes 60 
Neck 60; 
Equatorial region and 
midpiece 63 
 
1 Experimental data was compared with the human spermatozoa proteome lists published till date 70,71,74–80,83; 2 Whenever proteins were not described in humans the species is indicated; 3 
Subcellular localization is stated for the specific kinase isoform, except for Erk1 and Erk2; 4 Experimental data was compared to the gene knockout mice phenotype 
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Network analyses 
A PPI network was constructed based on the proteins identified in the PathScan Intracellular 
Signaling Array (green and pink nodes in Figure B.19), the KPKS-1.2 (orange and pink nodes in 
Figure B.19) and the interactions between these proteins. Additionally, testis-enriched/specific 
interactors of those proteins were added (blue nodes and edges in Figure B.19). Only proteins 
identified in at least 2 tissue-expression databases were included. The total number of proteins in 
the PPI network is N=75 and the total number of interaction between them is L=205. In Figure 
B.19, node size is proportional to the number of interactions of each node (degree). 
Proteins identified in the PathScan Intracellular Signaling Array and KPKS-1.2 were highly 
interconnected. HSPA1L, PIAS2 and PBK were, among the testis-enriched/specific proteins, the 
ones with higher degree of connectivity in the PPI network (Figure B.19). Testis-enriched/specific 
interactors were analyzed for gene ontology. Gene ontology analysis annotated 10 testis-
enriched/specific proteins with biological process terms associated with reproduction (p= 1.011e-
05). Several testis-enriched/specific proteins had no functional annotation and thus deserve further 
investigation. 
 
Figure B.19 - Network of the signaling proteins identified in the PathScan Intracellular Signaling Array as correlated with 
seminal parameters (green and pink nodes) and in the KPKS-1.2 (orange and pink nodes). Blue nodes and edges 
represent direct testis-enriched/specific interactors/interactions of those signaling proteins. Node sizes represent relative 
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degree of the nodes. Testis-enriched/specific interactors annotated for reproduction-associated gene ontology categories: 
PRKACG, spermatogenesis (BP) and ciliary base (CC); CABYR, sperm fibrous sheath (CC), sperm principal piece (CC) 
and sperm end piece (CC); HSPA1L, binding of sperm to zona pellucida (BP) and zona pellucida receptor complex (CC); 
RPL10L, spermatogenesis (BP); PIWIL1, spermatogenesis (BP) and spermatid development (BP); HIST1H2BA, 
spermatogenesis, exchange of chromosomal proteins (BP); DPY19L2, spermatid development (BP); TDRD12, 
spermatogenesis (BP) and fertilization (BP); TNP1, spermatogenesis (BP), spermatid development (BP), spermatid 
nucleus differentiation (BP), sperm motility (BP), fertilization, exchange of chromosomal proteins (BP) and male germ 
cell nucleus (CC); ADCY10, spermatogenesis (BP). BP, biological process; CC, cellular component. 
4.1.5.!Discussion 
Sperm cells are incapable of genetic expression and thus highly dependent upon post-translational 
modifications and signal cascades to execute their function. For instance, it is well established that 
protein phosphorylation is essential for sperm motility 27,28. In this study we attempted to unravel 
the signaling pathways involved in regulating human sperm function and to correlate them with 
clinical data. To gain a global understanding into spermatozoa signaling pathways, we examined 
eighteen well-characterized signaling proteins for their phosphorylation or cleavage status. Data 
was then correlated with basic semen parameters and spermatozoa DNA integrity. Additionally, we 
established a profile for the differential expression of a large number of protein kinases in human 
spermatozoa. 
Motility is acquired during the spermatozoa journey through the epididymis and depends on several 
signaling pathways, such as cAMP/PKA, MAPK and PPP1-related signaling 29,30. The correlation 
between sperm (im)motility and proteins involved in specific signaling pathways can pinpoint the 
problems in abnormal spermatozoa and reveal the importance of a specific protein for assessment 
of spermatozoa motility.  
In this study a negative correlation between the levels of activated mTOR (i.e. phosphorylated at 
S2448) and motile spermatozoa was identified. mTOR is a protein-serine/threonine kinase, which 
increases translation, cell growth and proliferation in response of growth factors. In terms of tissue 
specificity, mTOR is expressed in numerous tissues, but has not been previously detected in 
spermatozoa. PI3K signaling pathway controls mTOR activity, by regulating the TSC1/2 complex, 
an indirect mTOR inhibitor. Chiang et al. showed that the p70S6 kinase can be responsible for 
mTOR activation by phosphorylation in S2448 31. Still, in human spermatozoa, the function of 
mTOR signaling is not yet clear. 
HSP27 promotes the interaction of several proteins involved on structural integrity, membrane 
stability, cell cycle progression, apoptosis and thermo balance resistance 32. HSP27 is known to be 
present in human testis, but was not identified in human spermatozoa 33. This study is the first to 
report HSP27 in human spermatozoa and to show that the activation of HSP27 (S78) correlates 
negatively with motility. The well-characterized signaling pathway that activates HSP27 at S78 
involves the p38 MAP kinase. p38 is a member of the MAPK family, and it is activated by 
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T180/Y182 phosphorylation by MKK3 and MKK6. It is a crucial participant in growth, 
differentiation, stress and apoptosis. In human spermatozoa, p38 is located in the tail and factors 
that activate p38 are still unknown 34,35. Almog et al. showed that in human spermatozoa, upon 
phosphorylation and consequent activation, p38 inhibits forward and hyperactivated motility 34. 
Our study also identified a negative association between p38 phosphorylation and spermatozoa 
motility. Moreover, the fact that we negatively correlated p38 and HSP27 (a p38 indirect substrate 
via MK2) activation with motility in human spermatozoa hints the importance of this pathway in 
controlling motility and reinforces the fidelity of our screen. Besides motility, we established a 
negative correlation between p38 phosphorylation and head abnormalities in patients with 
varicocele. Almog et al. also reported a correlation between p38 activation and human sperm 
morphology 34. These results indicated that p38 has a crucial influence on spermatozoa physiology, 
from motility to morphology. JNK (c-Jun N-terminal kinases), another MAPK kinase, is activated 
by phosphorylation at T183/Y185 upon stress stimulus resulting in alterations in cell proliferation, 
apoptosis and migration 36,37. In spermatozoa, the presence of JNK is still uncertain, so the fact that 
we identified and correlated it with motility (progressive and immotile) is another novel finding. 
Glycogen synthase kinase 3 (GSK3) is a protein-serine/threonine kinase that exists in two highly 
related isoforms: GSK3α and GSK3β. The first report of GSK3β in spermatozoa established that 
after serine phosphorylation at S9, the phosphotransferase activity of this enzyme is lost. Moreover, 
a positive correlation was established between bull spermatozoa recovered from epididymis and 
GSK3β (S9) phosphorylation 38. Interestingly, in human we found a negative correlation between 
phosphor-GSK3β (S9) and motility in ejaculated spermatozoa. Additionally, we identified a 
negative correlation of phosphor-GSK3β with spermatozoa head defects (in subjects with 
varicocele). To our knowledge, there is no described correlation between GSK3β and head defects 
in the literature. However, the fact that GSK3β is located on the posterior head region 39 can hint an 
association between head integrity and GSK3 activity. 
We reported the association between several apoptosis-related signaling proteins and spermatozoa 
motility. Bad is a well-described pro-apoptotic protein. In human spermatozoa, it promotes 
apoptosis after significant stress 40. Bad exerts its death- promoting effect by hetero-dimerizing 
with Bcl-2 in mitochondria. Upon phosphorylation, at several serine residues, Bad dissociates from 
Bcl-2 and is sequestered by the 14-3-3 protein. Consequently, Bcl-2 is activated and promotes cell 
survival 41. Harada et al. identified PKA as the kinase involved in Bad phosphorylation at S112 42. 
Here, we report that Bad S112 phosphorylation is negatively correlated with progressive motility 
and positively correlated with immotile spermatozoa. It appears that Bad phosphorylation 
decreases spermatozoa motility, and it does not influence spermatozoa viability as expected. 
Additionally, we established a negative correlation between p53 activity and motility. In 
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spermatozoa, p53 is coupled with MDM2 in physiological conditions. Upon DNA damage, p53 
undergoes phosphorylation at S15 (primary target) 43. This promotes p53 uncoupling from MDM2 
leading to p53 activation and consequently cell death promotion. In spermatozoa, p38 appears to be 
the main kinase responsible for p53 phosphorylation at S15 43. Since p38 phosphorylation also 
correlates negatively with motility (both in this study and in the literature) 34,35, we suggest that a 
single signaling pathway controlled by sequential phosphorylation could be involved in 
spermatozoa motility. Poly (ADP-ribose) polymerase (PARP) primary function is to signal DNA 
breaks to base excision repair and nucleotide repair pathways 44. In human spermatozoa, it is the 
first line of defense against DNA breaks mostly caused by ROS. Moreover, PARP activation leads 
to p53 inhibition, which results in cell survival. Here, we observed a negative correlation between 
inactive PARP (cleaved, D214) and spermatozoa motility 44,45. The enzyme responsible for PARP 
inactivation is caspase-3, a key player on apoptosis 44. Caspase-3 activation, by cleavage at D175, 
is considered the no return point for apoptosis. In human spermatozoa, the presence and activation 
of capase-3 has been proven and extensively studied. Moreover, Weng et al. and Almeida et al. 
correlated caspase-3 activity with abnormal sperm concentration, morphology, and motility 46,47. In 
our study, we correlated negatively caspase-3 activation (cleavage) with spermatozoa motility, 
which is in accordance with the literature. This reinforces the fidelity of our screen. 
Akt plays a critical role in controlling survival and apoptosis in human sperm cells 48. Recently it 
was suggested that phosphorylated Akt maintains the membrane integrity of ejaculated stallion 
spermatozoa, presumably by inhibiting caspases 3 and 7, which preserves sperm vitality 49. Here, 
we report for the first time a negative correlation between phosphorylated Akt (pT308) levels and 
the percentage SDF, which supports a role of Akt in sperm survival. Additionally, in subjects 
diagnosed with varicocele, the levels of activated Akt (pT308/pT473) were negatively correlated 
with the percentage of head abnormalities. 
p70 S6 kinase is a mitogen activated protein-serine/threonine protein kinase required for cell 
growth and G1 cell cycle progression 50. Although it was originally described as being exclusively 
involved in cell growth and translational control 50, more recent published data described p70 S6 
kinase as a multifunctional protein proposed to regulate spermatogenesis 51,52 by, for instance, 
regulating the actin dynamics in testis 53. In mouse testis, p70 S6 kinase localizes in the 
spermatocytes’ nucleus and in the cytoplasm of sperm cells, which indicated a translocation during 
spermatogenesis 54. Here, we described that in human spermatozoa the levels of active p70 S6 
kinase (pT389) were positively correlated with the percentage of normal spermatozoa and 
negatively correlated with the percentage of SDF. Phosphorylation of the T389 residue is critical 
for kinase function and correlates with its activity in vivo 50,55.  
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The relationship between SDF, sperm morphology and fertilization/pregnancy rates has been 
widely investigated, but the results are often inconsistent 56–58. Here, we show that sperm 
morphology, specifically head abnormalities, and the TZI are related to elevated degree of DNA 
fragmentation. In contrast, the percentage of normal spermatozoa negatively correlates with the 
percentage of SDF. Sperm head abnormalities may, in part, be due to irregular sperm chromatin 
integrity. In turn, we showed that head abnormalities and the TZI are negatively correlated with the 
levels of activated phospho-Stat3 (pY705). Lachance and Leclerc have reported that Stat3 is 
present in human spermatozoa, and it is detected in the fraction containing mostly sperm head 
plasma membranes and in the flagellum cytoskeleton 59,60. We reported a negative correlation 
between head morphological defects and the phosphorylation of Stat3 (pY705). The TZI also 
correlates negatively with phosphor-Stat3 (pY705) levels. Phosphorylation of Y705 is essential for 
Stat3 activation and has been reported in sperm 61. Recent findings demonstrated that Stat3 
function is not restricted to transcription factor activity, but is also involved in other functions 
through PPI 62. Lachance and colleagues reported that Stat3-mediated signaling as significant for 
spermatozoa function 12. 
Stat1 was previously shown to be present in human sperm in the apical region of the sperm head 16 
and in the neck region of the sperm flagellum 60. Stat1 is activated by phosphorylation at Y701 in 
response to the cytokines IFNα and IFNγ in human spermatozoa 16. Capacitation-associated 
tyrosine phosphorylation of Stat1 was also demonstrated 59 and the JAK1-2/Stat1 pathway was 
shown to be activated by progesterone in human sperm 63. However, the exact biological processes 
controlled by this pathway in sperm are still unknown. Here, we described that phosphorylated 
Stat1 (pY701) levels negatively correlate with the percentage of head abnormalities in subjects 
with varicocele. Previous reports have suggested a role for Stat1 in the first rounds of transcription 
in the fertilized oocyte 16,59. It is already established that sperm delivers not only the male genome 
to the oocyte, but also crucial molecules for fertilization and embryo development 64–68. D’Cruz and 
colleagues hypothesize that sperm-derived phosphorylated Stat proteins could contribute to the 
pool of transcription factors during sperm–oocyte fusion as well as transmit signal to the oocyte 
nucleus 16. Here, we suggest that defects in Stat1- and Stat3-mediated signaling may compromise 
fertility. 
Phosphorylation is a key mechanism for sperm motility acquisition, capacitation and acrosome 
reaction 27,38,39,69. However, the players involved in the regulation of these processes are still far 
from being all identified. The KPKS-1.2 screen allowed the detection of 34 protein kinases (Table 
B.7), which include 29 PSTK, 1 PTYK, 3 PYK, and 1 PTK. From those, 8 protein kinases (CDK2, 
PAK3, KSR1, BMX, DAPK1, CSNK1D, MAP4K2 and ZIPK) were identified for the first time in 
human spermatozoa (Table B.7).  
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Finally, a PPI network was constructed based on the interactions between the signaling molecules 
examined in this study and their testis-enriched/specific interactors (Figure B.19). The key to 
understand how the proteins analyzed in this study are regulated in male germ cells lies in the 
identification and characterization of its interacting partners. Each protein interacts with a specific 
set of interactors according to the temporal and spatial (subcellular, cellular or tissue) context. This 
is particularly relevant in testis and spermatozoa since they present the largest number of 
enriched/specific genes leading to functional specifications 23. For instance, TP53 interacts with 3 
testis-enriched/specific proteins involved in spermatogenesis (PIWIL1, RPL10L and TDRD12) and 
1 protein localized in the zona-pellucida receptor complex and involved in the binding to the zona-
pellucida (HSPA1L). The recognition that GSK3β interacts with 2 testis-enriched/specific proteins 
localized in the sperm flagellum, specifically in the ciliary base (PRKACG) and sperm fibrous 
sheath (CABYR), may help to elucidate the role of this protein in sperm motility. TNP1, DPY19L2 
and PIWIL1 are testis-enriched/specific proteins involved in spermatid development. They interact 
with PRKCA, AKT1 and TP53, respectively, suggesting a potential involvement of these proteins 
in the late stages of spermatogenesis. This PPI network approach may help to shed light on the 
function of the signaling proteins examined in the male reproductive system. 
Seminal quality is a reflex of the signaling pathways occurring in the sperm cell. At the same time, 
spermatozoa integrity is crucial to the proper functioning of signaling cascades. We have identified 
several proteins that showed a high degree of differential activity and have the potential to integrate 
a quantitative array, which may have several applications: explain idiopathic infertility, failure in 
ART or repeated abortion; choice of the appropriate ART; assess the efficacy of medical 
interventions or treat infectious diseases and assess the efficacy of antioxidant therapies and 
lifestyle alterations 
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4.2.1.!Abstract 
Objective: To determine the correlation between male age and the activity of signaling proteins in 
human spermatozoa. Design: In vitro studies with human spermatozoa. Settings: Academic 
research institute in collaboration with a local hospital. Patients: Sixty-three men provided semen 
samples for routine analysis. Interventions: None Main Outcome Measures: 
Phosphorylation/cleavage patterns of 18 signaling proteins in human spermatozoa.  Results: The 
volunteers for this study were Caucasian males, with ages ranging from 18 to 47 years (mean 
age±SD of 26±7). The results indicated that the phosphorylated levels of several proteins [p53 
(S15), PRAS40 (T246), Bad (S112), p38 (T180/Y182), mTOR (S2448), HSP27 (S78), GSK-3b 
(S9) and Akt (S473)], as well as, cleavage of Caspase-3 (at D175) showed a significant positive 
correlation with age. HSP27 (S78), Bad (S112), PRAS40 (T246), p53 (S15) and p38 (T180/Y182) 
expression was consistently and significantly higher as early as 25 years of age. Conclusions: This 
study contributed towards understanding the molecular mechanisms underlying the age-based 
impact in semen quality. Furthermore, age thresholds for changes in certain spermatozoa signaling 
parameters were established.  
4.2.2.!Introduction 
Infertility is a growing concern in modern society, especially in industrialized countries where birth 
rates are declining drastically below replacement levels. Consequences are dramatic: there will be 
fewer women of childbearing age, fewer family members to care for elders, pensions will increase 
public spending and the workforce will be older and less adaptable decreasing productivity 1. 
Infertility affects ~15% of couples attempting to conceive and in half of the cases the cause is at 
least partly related to male reproductive issues 1. Moreover, idiopathic infertility remains the most 
common type of male infertility 2,3. 
The trend in parenthood at an older age is increasingly more pronounced, with the age of first child 
averaging 30 years in several countries. In addition to intentionally delayed childbearing due to 
professional activities, increased rates of obesity, sedentary lifestyle, alcohol and nicotine 
consumption found in reproductive-aged men and women further perpetuate the problem. The idea 
that "men can have children at any age" is untrue. While it is well documented that women have a 
decline in fecundity with age 4, the studies available regarding the effects of age on male fertility 
have a wider disparity of results. Most studies are mainly focused on basic semen parameters and 
DNA integrity (revised in 5), many have reported lower semen volume, sperm concentration, sperm 
motility and proportions of sperm of normal morphology in older men; and some have, however, 
found semen quality to be independent from age or, even reported improvements in semen traits 
(revised in 5,6). Additionally, most studies are limited to a specific study population and are 
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influenced by the female partner age 6,7. Recently, Johnson and colleagues conducted a systematic 
review and meta-analysis to quantify the effect of male age on basic semen parameters and DNA 
fragmentation. Age-associated declines in semen volume, percentage motility, progressive motility, 
normal morphology and unfragmented cells were statistically significant and results appeared to be 
robust against confounding factors 5. Stone et al reported that these parameters start to decline at 34 
years of age 8. Other age thresholds have also been established for several basic semen parameters 
9–11. Numerous studies have described adverse associations between male age and reproductive 
outcomes. Advanced paternal age has been associated with lower pregnancy rates, higher risk of 
pregnancy loss, as well as with a broad range of developmental, morphologic and neurologic 
disorders of the newborn, including schizophrenia, autism, X-linked recessive and autosomal 
dominant disorders, trisomy and some cancers (revised in 5,6,12–14). While the molecular 
mechanisms are still not understood, aging is associated with an increase in oxidative stress and a 
decline in sperm quality has been correlated with the excessive generation of reactive oxygen 
species (ROS) 5. 
Since the molecular mechanisms responsible for age-dependent decline in spermatozoa quality are 
not fully understood, in this study we evaluated the impact of aging on the human spermatozoa 
signaling pathways. Additionally, we determined whether age thresholds for the molecular 
parameters examined existed.  
4.2.3.!Methods 
Sperm samples collection and basic semen analysis 
This study was approved by the Ethics and Internal Review Board of the Hospital Infante D. Pedro 
E.P.E. (Aveiro, Portugal) and was conducted in accordance with the ethical standards of the 
Helsinki Declaration. All donors signed informed consent allowing the samples to be used for 
scientific purposes. A total of 63 semen samples were obtained from a randomized group of 
donors, by masturbation to a sterile container. Basic semen analysis was performed by qualified 
technicians according to World Health Organization (WHO) guidelines 15. Briefly, after complete 
liquefaction of the semen sample a macroscopic examination was performed. The microscopic 
examination included the analysis of spermatozoa motility, concentration and morphology. All 
microscopy analyses were performed using the Zeiss ® Primo Star microscope (Zeiss ®, Jena, 
Germany).  
Antibody array 
Antibody-based arrays were carried out using the PathScan® Intracellular Signaling Array Kit 
(#7744, Cell Signaling Technology, Danvers, MA, USA) to determine the expression patterns of 18 
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well-characterized signaling molecules when phosphorylated or cleaved, in 63 semen samples 
obtained from a randomized group of donors. After semen liquefaction, sperm cells were washed 
three times in 1x phosphate buffered saline (PBS) by centrifugation (600xg for 5 minutes at 4°C) 
and lysed according to the manufacturer’s instructions. Protein concentration was measured using 
bicinchoninic acid (BCA) assay (Pierce Biotechnology, USA) and final absorbance was measured 
at 562 nm in a microplate reader (TECAN, Genius, Männedorf, Switzerland). Each cell extract was 
diluted to 250 µg/ml and applied to its own multiplexed array according to the manufacturer’s 
instructions. Fluorescence readouts from the arrays were captured digitally using LI-COR® 
Biosciences Odyssey® imaging system (LI-COR® Biosciences, Nebraska, USA). Pixel intensity 
was quantified using Odyssey software. The intensity from the negative control within each array 
was subtracted from all signals, and all data from each array were normalized to the internal 
positive control within each array. 
Statistical analysis 
Statistical analysis was conducted using the IBM SPSS Statistics Software 22. First, a descriptive 
analysis to each quantitative parameter analyzed was performed. Lastly, we calculated the Pearson 
correlation coefficient, r, or the Spearman’s rho correlation coefficient, rs, (a nonparametric 
correlation method) to determine the relationship between two variables. We performed a test of 
normality (Shapiro-Wilk test) and we analyzed the box-plots to decide between a parametric or 
non-parametric method. The dataset size was considered reasonable since based on the central limit 
theorem it was possible to approximate the distribution of variables to a normal distribution. The 
age brackets were set to create three consecutive subgroups and we performed the Kruskal Wallis 
test (grouping variable: age bracket). When differences were statistically significant between 
groups, they were compared by post hoc analysis. The significance level was set at 0.05. 
4.2.4.!Results 
Correlation between age and signaling proteins in distinct states of activation 
A total of 63 semen samples, obtained from a randomized group of donors, were included in this 
study (Supplementary Table D.27). The volunteers ages ranged from 18 to 47 years (mean age±SD 
of 26±7). Basic semen parameters were analyzed according to the WHO’s guidelines 
(Supplementary Table D.27). The levels of signaling molecules were determined with the PathScan 
Intracellular Signaling Array, which includes antibodies for phosphorylated or cleaved signaling 
proteins (Supplementary Table D.27). Initially, a descriptive analysis of the results was performed 
(Supplementary Table D.28). Next, to evaluate the association between age and the levels of 
signaling molecules, Spearman’s and Pearson correlation tests were performed (Table B.8). The 
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results indicated that the levels of several phosphoproteins positively correlates with age: p53 
(S15), PRAS40 (T246), Bad (S112), p38 (T180/Y182), mTOR (S2448), HSP27 (S78), GSK-3b 
(S9) and Akt (S473). The cleavage, and consequently activation, of Caspase-3 (at D175) was also 
positively correlated with age (Table B.8).  
Table B.8 – Associations between age and the phosphorylation/cleavage patterns of signaling proteins in human 
spermatozoa. 
Uniprot 
ID 
Abbreviation Recommended protein 
name 
Phosphorylation/ 
cleavage, residue, status 
Correlation 
Coefficient/ 
Sig. (2-tailed) Formerly Presently 
P04637 p53 TP53 Cellular tumor antigen p53 
Phospho S15 
Activation 
rs= 0.511** 
p= 0.000 
Q96B36 PRAS40 AKT1S1 Proline-rich AKT1 substrate 1 
Phospho T246 
Inhibition 
rs= 0.460** 
p= 0.000 
Q16539 
Q15759 
P53778 
O15264 
p38 MAPK MAPK14/11/12/13 Mitogen-activated protein kinase 14/11/12/13 
Phospho T180/Y182 
Activation 
rs= 0.427* 
p= 0.000 
Q92934 Bad BAD Bcl2-associated agonist of cell death 
Phospho S112 
Inhibition 
rs= 0.404** 
p= 0.001 
P42574 Caspase-3 CASP3 Caspase-3 Cleavage D175 Activation 
rs= 0.404** 
p= 0.001 
P42345 mTOR MTOR Serine/threonine-protein kinase mTOR Phospho S2448 Activation 
rs= 0.370** 
p= 0.003 
P04792 HSP27 HSPB1 Heat shock protein beta-1 Phospho S78 Activation 
rs= 0,346** 
p= 0.006 
P49841 GSK-3β GSK3B Glycogen synthase kinase-3 beta 
Phospho S9 
Inhibition 
rs= 0,307* 
p= 0.015 
P31749 Akt AKT1 
RAC-alpha 
serine/threonine-protein 
kinase 
Phospho S473 
Activation 
rs= 0.298* 
p= 0.018 
*- correlation is significant at the 0.05 level (2-tailed); **- correlation is significant at the 0.01 level (2-tailed); rs, 
Spearman´s rho correlation coefficient 
 
In order to determine whether age thresholds for the molecular parameters exist, three consecutive 
age subgroups were created and the Kruskal Wallis test was performed. Asterisked values in Table 
B.9 indicate the age brackets in which average values for the measured parameters consistently and 
significantly increased. It was established that HSP27 (S78), Bad (S112), PRAS40 (T246), p53 
(S15) and p38 (T180/Y182) expression consistently and significantly increased after 25 years 
(Figure B.20). 
Table B.9 – Summary of statistical measures and Kruskal Wallis Test p-value. 
 
Age Bracket 
p-value of 
Chi-Square a 
<25 [25,33] >33 
Frequency 35 16 12 
Percentage 55,6% 25,4% 19,0% 
Formerly Presently Mean ± SD Mean ± SD Mean ± SD 
Erk1/2 MAPK3/1 0,12 ± 0,06 0,14 ± 0,07 0,13 ± 0,10 NS 
Stat1 STAT1 0,11 ± 0,07 0,14 ± 0,09 0,14 ± 0,12 NS 
Stat3 STAT3 0,10 ± 0,04 0,12 ± 0,06 0,12 ± 0,13 NS 
Akt AKT1 0,09 ± 0,03 0,10 ± 0,04 0,10 ± 0,08 NS 
Akt AKT1 0,06 ± 0,04 0,11 ± 0,07 0,11 ± 0,08 NS 
AMPKa PRKAA 0,14 ± 0,08 0,20 ± 0,11 0,19 ± 0,15 NS 
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Age Bracket 
p-value of 
Chi-Square a 
<25 [25,33] >33 
Frequency 35 16 12 
Percentage 55,6% 25,4% 19,0% 
Formerly Presently Mean ± SD Mean ± SD Mean ± SD 
S6 ribosomal protein RPS6 0,07 ± 0,04 0,12 ± 0,07 0,11 ± 0,08 NS 
mTOR MTOR 0,11 ± 0,06 0,23 ± 0,17 0,22 ± 0,16 NS 
HSP27 HSPB1 0,09 ± 0,06 0,20 ± 0,17 * 0,19 ± 0,13 * 0.005 
Bad BAD 0,08 ± 0,03 0,14 ± 0,08 * 0,15 ± 0,09 * 0.002 
p70 S6 Kinase RPS6KB1 0,03 ± 0,02 0,05 ± 0,02 0,04 ± 0,03 NS 
PRAS40 AKT1S1 0,06 ± 0,05 0,14 ± 0,11 * 0,14 ± 0,10 * 0.000 
p53 TP53 0,03 ± 0,02 0,06 ± 0,04 * 0,07 ± 0,05 * 0.000 
p38 MAPK MAPK14 0,08 ± 0,05 0,18 ± 0,13 * 0,18 ± 0,13 * 0.001 
SAPK/JNK MAPK8/9/10 0,10 ± 0,04 0,18 ± 0,15 0,18 ± 0,13 NS 
PARP PARP 0,09 ± 0,04 0,14 ± 0,08 0,12 ± 0,08 NS 
Caspase-3 CASP3 0,07 ± 0,04 0,13 ± 0,08 0,12 ± 0,08 NS 
GSK-3β (S9) GSK3B 0,14 ± 0,10 0,27 ± 0,18 0,25 ± 0,23 NS 
a. Grouping variable: Age Bracket; * The average value is significantly higher than in the age bracket <25 
 
 
Figure B.20 – Signaling proteins consistently and significantly increased after the age bracket <25. See Table 2 for p 
values. 
4.2.5.!Discussion 
Several studies have investigated age-based impact in semen parameters, such as, semen volume, 
sperm concentration, morphology, motility and DNA fragmentation, but the impact of paternal age 
on human spermatozoa signaling pathways remains unknown. Using a total of 63 semen samples, 
obtained from a random group of donors, we conducted a study to determine the association of 
male age and the activity patterns of 18 signaling proteins in human spermatozoa. The correlation 
between age and proteins involved in specific signaling pathways that were previously correlated 
with spermatozoa quality can pinpoint the age-depended alterations in sperm function. 
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A schematic representation of the pathways in which each of the signaling molecules examined in 
this study are involved is presented in Figure B.21. When known, the outcome in human 
spermatozoa of the signaling pathways in which the proteins are involved, is presented. 
 
Figure B.21 – Pathways in which the signaling proteins identified as correlated with paternal age are involved (orange). 
Whenever the pathway output was previously described in spermatozoa it is indicated in blue boxes. Light blue boxes 
represent correlations between the signaling proteins and the semen parameters previously described in 16. 
 
p38 MAPK, p53 and HSP27 activities, which correlates negatively with human spermatozoa 
motility 17,18,16, revealed positive associations with age. In spermatozoa, p38 MAPK appears to be 
the main kinase responsible for p53 phosphorylation (S15) 19, that subsequently leads to apoptosis 
19. Besides motility, a correlation between p38 MAPK activation and human sperm morphology 
was also previously established 17,16. The p38 MAPK signaling pathway is also involved in the 
activation of HSP27 by phosphorylation at S78. We reported recently, for the first time, the 
presence of HSP27 and its activation in human spermatozoa. This signaling pathway appears to be 
involved in regulating spermatozoa apoptosis 19, motility 17,18,16 and age-dependent alterations. 
Moreover, we have also shown that the activation of the PI3K/AKT1/mTOR pathway in human 
spermatozoa was associated with increased age. We previously reported the presence of mTOR in 
human spermatozoa for the first time and established a negative correlation between its activity and 
sperm motility. 
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Glycogen synthase kinase 3 (GSK3) activity has been extensively correlated with spermatozoa 
motility. GSK3 phosphorylation at S9 inhibits its catalytic activity. GSK3 is 6 times more active in 
caput than in caudal spermatozoa and its activity is correlated negatively with spermatozoa motility 
(bovine and mouse and macaque models) 20–22. Recently, we reported an opposing correlation in 
human ejaculated spermatozoa 16. Here we established a positive association between the levels of 
GSK-3β (S9) and male age. 
In human spermatozoa Bad promotes apoptosis after significant stress in human spermatozoa 23. 
Phospho-Bad (S99) is predominantly located in the human spermatozoa midpiece; however, when 
PI3K is inhibited phospho-BAD (S99) cross-reactivity is lost 24.  Upon serine phosphorylation Bad 
apoptotic activity is inhibited, due to dissociation from Bcl-2, and is sequestered by the 14-3-3 
protein, rendering Bcl-2 active 25. It was previously described that Bad is phosphorylated at S112 
by p90RSK 26 and PKA 27. Here we showed a positive correlation between Bad S112 
phosphorylation, which was previously described as associated with decreased spermatozoa 
motility 16, with increased male age. Caspase-3 activation, by cleavage at D175, has been correlated 
with abnormal sperm concentration, morphology, and motility 28,29,16. Caspase-3 is responsible for 
PARP inactivation, which is the first line of defense against DNA damage in human spermatozoa 
30. Here we demonstrated that higher amounts of activated caspase-3 are associated with increased 
age. 
Recently, Stone and colleagues reported that semen parameters do not change before 34 years old 8. 
Our analysis revealed that consistent significant increase in HSP27 (S78), Bad (S112), PRAS40 
(T246), p53 (S15) and p38 (T180/Y182) appeared as soon as 25 years (Figure B.20 and Table B.9). 
This threshold occurs prior than the ones established for basic semen parameters, which may 
indicate that alterations at the molecular level occur earlier. Rising levels of ROS in semen were 
reported in men older than 40 years and ROS have been suggested as the causative factor for 
incremental sperm defects with aging 31. Our analysis revealed alterations at the molecular level 
occurring before this age threshold, which may indicate other possible mechanisms for age-
dependent patterns of sperm quality decline. The reduced number of individuals with more than 33 
years (19% of the study population) did not allow to draw consistent conclusions for the other 
signaling proteins correlated with age. Further studies, to increase the number of volunteers older 
than 33 years, are needed in order to determine the exact age thresholds for each molecular 
parameter. In the future, the variables correlated with age will also be analyzed by change-point 
regression analysis, which will allow the definition of discrete age thresholds. 
We have identified several signaling proteins that presented high correlation with aging (Table B.8, 
Figure B.20 and Figure B.21). The identification of the male molecular factors associated with the 
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age-dependent decline in seminal parameters and, consequently, in the reproductive outcomes, will 
improve fertility management.  
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Concluding remarks 
The main objective of this thesis was to identify and characterize spermatozoa proteins as targets 
for pharmacological and diagnostic intervention in male fertility. 
To fulfill this goal, we identified, characterized and modulated key protein-complexes uniquely or 
selectively expressed in testis and spermatozoa in order to specifically modulate a process essential 
to reproduction, such as, post-meiotic events in spermatogenesis, sperm maturation in the 
epididymis or sperm function (Chapters 3.1., 3.2., 3.3. and 3.4., Figure C.1). Particular attention 
was given to two distinct proteins and its interacting partners: phosphoprotein phosphatase 1 
(PPP1) and amyloid precursor protein (APP). Both proteins were shown to be involved in 
processes such as spermatogenesis, sperm motility and sperm-egg adhesion. 
Moreover, we established biomarker "fingerprints" to assess spermatozoa quality based on 
molecular parameters (Chapters 4.1. and 4.2., Figure C.2). 
In Chapter 3.1. we constructed and analyzed a testis/sperm-enriched interaction network in order 
to unravel the phosphoprotein phosphatase 1 catalytic subunit gamma 2 (PPP1CC2) interactome 
and, therefore, identify potential complexes as targets for male contraception. We showed that 
PPP1CC2 had 106 direct interactors in the testis/sperm-enriched network. Among those, 10 were 
highly specific to or strongly expressed in the testis and 19 were previously associated with male 
infertility phenotypes in knockout mice. Sixteen PPP1CC2 interactors were involved in 
spermatogenesis-related categories. Also, we recognized that PPP1CC2 had 50 direct interactors 
highly interconnected and associated with motility-related annotations. Analyzing the PPP1CC2-
centric motility subnetwork, AKAP4 was the most appealing interactor since it was the only that 
fulfilled the following criteria: (1) testis/sperm-specific protein, (2) involved in all major motility-
related annotations and (3) associated to a motility-related infertility phenotype. In addition to the 
asthenozoospermia phenotype, the Akap4 gene knockout mice also presented a significant change 
in the activity and phosphorylation status of PPP1CC2. The interaction between PPP1CC2 and 
AKAP4 in human spermatozoa was further validated for the first time. Blocking motility-related 
PPP1CC2-PIP interactions during the epididymal transit, such as with AKAP4, will generate active 
PPP1. This, in turn, will originate dephosphorylation of a subset of substrates thereby preventing 
motility acquisition, representing an excellent contraceptive strategy. The mechanism of sperm 
motility is a perfect target for a new male contraceptive since it allows normal hormone and 
spermatozoa production and affects only the post-testicular sperm maturation. An attractive 
approach to modulate PPP1 activity is to target specific interfaces between PPP1 and tissue/event-
specific PIPs, disrupting their interaction. To further address this topic, in Chapter 3.2., we 
successfully modulated PPP1CC2-specific interactions and PPP1CC2/AKAP4 complex in 
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spermatozoa using cell-penetrating peptides (CPP) as a drug intracellular delivery system. PPI 
disruption peptides were designed, synthetized and coupled with CPP to selectively disrupt PPP1-
PIPs complexes. A CPP was used to deliver a peptide sequence that mimics the unique 22 amino 
acid C-terminus of PPP1CC2 into spermatozoa, compromising isoform-specific interactions and, 
consequently, affecting sperm motility. A peptide sequence that mimics the interaction interface 
between PPP1CC2 and the sperm-specific PIP AKAP4 was also successfully delivered to sperm 
cells with an impact in sperm motility. 
In Chapter 3.3. we characterized another PPP1 interacting protein – SARP2 – with the potential of 
being a target for male contraception. We demonstrated that SARP2 was highly expressed in testis 
and spermatozoa and interacted with PPP1CC2 in human spermatozoa. In testis, SARP2 protein 
was only present in the nucleus of elongating and mature spermatids. In spermatozoa, it was 
prominently expressed in the connecting piece and flagellum, as well as, to a lesser extent, in the 
acrosome. Blocking PPP1CC2-PIP interactions only expressed in post-meiotic germ cells will 
potentially prevent a correct sperm morphogenesis, which may also represent a good reversible 
contraceptive target by preserving spermatogonia and spermatocytes. Additionally, a novel SPAG9 
variant, a testis and spermatozoa-specific c-Jun N-terminal kinase-binding protein, was identified 
by YTH and validated as a SARP2 interactor. 
In Chapter 3.4. we provided the first report on APP interactome in human testis/spermatozoa. We 
constructed and analyzed the interaction network in human testis/spermatozoa of APP in order to 
identify sentinel proteins related to male fertility. We identified 36 novel APP interacting proteins 
by YTH screen using a human testis cDNA library. Those included testis/sperm-specific proteins, 
such as, the transmembrane serine protease TMPRSS12. The most abundant interaction detected 
was with SEC22C, a protein involved in vesicle transport between the ER and the Golgi complex. 
G-protein coupled receptor protein signaling pathway and cell adhesion were recognized as the 
most significantly represented biological processes among the APP interactors in human 
testis/sperm. Also, the majority of APP interactors in testis/spermatozoa were located at the plasma 
membrane. Our approach allowed the identification of novel interactions and recognition of key 
APP interacting proteins for male reproduction, particularly to sperm-oocyte interaction, which 
represent a potential mechanism for male contraception modulation.  
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Figure C.1 – Overview of the main hypothesis and approaches used to achieve aim 1. 
 
In Chapters 4.1. and 4.2. we have identified several proteins that showed a high degree of 
differential activity and have the potential to integrate a quantitative array, which may have several 
applications: explain idiopathic infertility, failure in assisted reproductive techniques (ART) or 
repeated abortion; choice of the appropriate ART; assess the efficacy of medical interventions to 
treat, for instance, varicocele and infectious diseases; and assess the efficacy of antioxidant 
therapies and lifestyle alterations. Moreover, “treatments” for poor semen quality usually focus on 
ART that bypass the need for a normal ejaculated sperm sample. However, the success rates and 
elevated costs of ART demonstrate the need to increase the knowledge on the molecular processes 
underlying sperm function. Eventually, conditions such as poor sperm motility may be treatable by, 
for example, stimulating relevant signaling pathways. Though, the players involved in regulating 
spermatozoa function are still far from being all identified. To further address this topic, in 
Chapter 4.1. we identified 34 protein kinases expressed in normozoospermic samples. From those, 
8 (CDK2, PAK3, KSR1, BMX, DAPK1, CSNK1D, MAP4K2 and ZIPK) were identified for the 
first time in human spermatozoa. Additionally, the activity patterns of 13 signaling proteins in 
human spermatozoa revealed significant correlations with specific semen parameters 
(concentration, motility, morphology or sperm DNA fragmentation). Besides the potential to 
integrate a biomarker "fingerprint" to assess sperm quality, those molecules have the potential to 
allow the recognition of the signaling pathways accountable for regulating specific spermatozoa 
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functions. 
Several studies have investigated age-based impact in basic semen parameters, but the molecular 
mechanisms responsible for age-dependent decline in spermatozoa quality are poorly understood. 
The identification of the molecular factors associated with the age-dependent decline in sperm 
quality and, consequently, in the reproductive outcomes, will improve fertility management. In 
Chapter 4.2. we established the association between age and proteins involved in specific 
signaling pathways that were previously correlated with spermatozoa quality. The activity of 9 
signaling proteins in human spermatozoa revealed significant positive correlations with male age: 
p53 (S15), PRAS40 (T246), Bad (S112), p38 (T180/Y182), mTOR (S2448), Hsp27 (S78), GSK-3β 
(S9) and Akt (S473) and Caspase-3 (D175). Additionally, we determined that consistent and 
significant alterations in molecular parameters were observed as early as 25 years of age. 
 
Figure C.2 – Overview of the main hypothesis and approaches used to achieve aim 2. 
 
Concluding, the work described in this thesis identified, characterized and modulated protein 
complexes in human testis and spermatozoa as potential targets for contraceptive intervention and 
identified spermatozoa signaling proteins which may incorporate a diagnostic platform. 
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Future Perspectives 
The testis/sperm-enriched/specific protein interaction networks constructed in this study offered us 
a platform to identify potential contraceptive targets. Furthermore, we demonstrated that rationally-
designed bioportides can modulate spermatozoa complexes and, consequently, motility. Future 
efforts will focus upon the identification of novel bioportides likely to possess highly efficient 
uptake and pharmacodynamic parameters. The interactions of bioportides on their target interfaces 
will be modelled in silico and the most promising candidates will be redesigned to achieve better 
affinity, activity and specificity. High throughput peptide synthesis will support the production of 
small number libraries of potential protein-protein interaction modulatory bioportides. The most 
promising bioportide candidates will be selected for validation in heterogeneous human sperm 
samples and detailed in vivo studies. In vivo studies will allow, for instance, to assess the ability of 
these compounds to cross the blood-epididymis barrier. Collaborations with international experts in 
molecular pharmacology (John Howl, Molecular Pharmacology Group, University of 
Wolverhampton, UK), biomolecular simulations/computational chemistry (Giorgio Colombo, 
Biomolecular Simulations and Computational Chemistry Group, Italy) and human reproduction 
(Steve Publicover, School of Biosciences, The University of Birmingham, UK), as well as with a 
local hospital (António Patrício, Urology Unit, Infante D. Pedro Hospital, Portugal) are already 
established and will be essential in the next steps proposed. 
Additionally, this study holds promising results for the development of novel, clinically useful 
male fertility biomarkers. Further studies will need to establish the thresholds (basal level versus 
pathological levels) for each molecular parameter identified and address the design and 
costeffectiveness of an array of biomarkers to assess male fertility, in which the collaboration 
established with a fertility clinic (Ferticentro – Centre for Fertility Studies, Portugal) will be 
crucial. 
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Supplementary Table D.1 – Proteins identified in at least 2 databases (DB) as testis-enriched/specific. 
Supplementary Table D.2 – Gene ontology categories of the testis-enriched proteins. Enriched categories are identified as 
those with p value <0.01. 
Supplementary Table D.3 – PPP1CC interactors obtained from the different sources. 
Supplementary Table D.4 – (A). Topological properties of proteins in testis/sperm specific network. (B) Topological 
clusters of proteins in testis/sperm specific network. The number in Module is the index of topologically clustered 
groups. (C) Topological clusters of proteins in sub-networks for spermatogenesis and motility. The number in Module is 
the index of topologically clustered groups. Blue colored proteins are overlapped in both sub-networks. 
Supplementary Table D.5 – PPP1CC interactors from the testis-enriched network associated with male infertility-related 
phenotypes in knockout mice. 
Supplementary Table D.6 – Gene ontology and KEGG categories of the different modules of the testis-enriched network. 
Enriched GO categories are identified as those with p value <0.01. Only the top 3 KEGG categories are presented. 
Supplementary Table D.7 – (A). Proteins from the testis-enriched network associated with spermatogenesis-related 
biological processes. Gene ontology data obtained from the "GO Term Enrichement" tool of the AmiGO database. GO, 
gene ontology. (B) Proteins from the testis-enriched network associated with motility-related biological processes (BP) 
and cellular components (CC). Gene ontology data obtained from the "GO Term Enrichement" tool of the AmiGO 
database. GO, gene ontology.  
 
Due to the extent of Supplementary Table D.1 to D.7 and until the paper is available online the 
information is available on 
https://www.dropbox.com/s/73f0nfcfbmj35tf/Supplementary%20Information.xlsx?dl=0 
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Supplementary Table D.8 – Quantitative analysis of peptide translocation into bovine and human spermatozoa. Bovine 
and human spermatozoa were incubated with TAMRA-labeled bioportides (10 µM) for 1 h at 37°C. Data are expressed 
as fluorescence (minus negative control). Three independent experiments were performed in quadriplicate. 
Human 
 Experiment 1 Experiment 2 Experiment 3 
TAMRA-
PPP1CC2-CT 37166 37225 36603 36992 30614 30534 30065 30168 43443 44051 42722 43266 
TAMRA-
AKAP4-BM 25581 25175 24616 25222 41315 40612 41028 40596 22868 22593 22201 22461 
TAMRA-
AKAP4-BM M 9228 9271 9506 9066 12619 12780 12634 12487 9055 8675 8565 8887 
Bovine 
 Experiment 1 Experiment 2 Experiment 3 
TAMRA-
PPP1CC2-CT 6616 6441 6714 6616 5571 5336 5350 5421 6108 6061 6318 6146 
TAMRA-
AKAP4-BM 21247 20923 20930 20852 14760 14390 14580 14588 19320 18946 19170 19362 
TAMRA-
AKAP4-BM M 2774 2616 2703 2789 2204 2201 2282 2284 3523 3400 3442 3539 
 
Supplementary Table D.9 – Descriptive analysis; Statistical measures: Mean and standard deviation (SD) associated with 
PPP1CC2 CT peptides treatments in bovine spermatozoa. NC, negative control; PM, progressive motility; NPM, non-
progressive motility; IM, immotile spermatozoa; V, viability. Data are expressed as mean of three independent 
experiments performed in triplicate. 
 
1h 2h 
PPP1CC2-CT TAMRA-PPP1CC2-CT NC PPP1CC2-CT 
TAMRA-
PPP1CC2-CT NC 
10 µM 20 µM 10 µM 20 µM 10 µM 20 µM 10 µM 20 µM 10 µM 20 µM 10 µM 20 µM 
PM fast 
(%) 
Mean 17,10 13,68 9,71 10,61 37,07 38,14 21,51 24,04 16,79 7,47 46,83 44,03 
SD 11,87 6,37 7,24 8,05 13,47 15,18 10,78 5,00 6,04 2,37 13,28 9,52 
PM slow 
(%) 
Mean 4,29 4,19 3,83 4,81 13,82 6,37 6,79 8,07 8,08 6,17 10,88 10,56 
SD 1,82 2,17 2,45 3,25 8,21 1,96 2,91 2,43 3,00 2,89 4,33 2,87 
NPM (%) Mean 14,39 16,13 11,57 13,21 15,99 16,30 13,56 12,48 13,03 10,03 13,69 12,38 SD 4,68 5,69 3,63 4,16 5,94 6,39 4,46 2,62 3,68 2,92 4,33 3,62 
IM (%) Mean 64,19 65,12 74,84 71,38 38,47 39,24 58,21 56,37 68,00 76,32 28,64 33,01 SD 11,66 6,54 6,46 13,78 10,23 12,77 15,13 5,95 9,79 4,76 10,42 8,62 
V (%) Mean 80,17 77,03 76,97 72,57 80,77 76,43 77,97 75,83 76,53 72,83 78,63 84,10 SD 3,78 8,28 6,14 5,56 9,12 9,46 5,49 4,92 5,22 6,12 4,97 2,50 
 
Supplementary Table D.10 – Descriptive analysis; Statistical measures: Mean and standard deviation (SD) associated 
with AKAP4-BM peptides treatments in bovine spermatozoa. NC, negative control; PM, progressive motility; NPM, 
non-progressive motility; IM, immotile spermatozoa; V, viability. Data are expressed as mean of three independent 
experiments performed in triplicate 
 
10 µM 20 µM 
1h 2h 1h 2h 
AKAP4- 
BM 
AKAP4- 
BM M NC 
AKAP4- 
BM 
AKAP4 BM 
M NC 
AKAP4-
BM 
AKAP4-
BM M NC 
AKAP4-
BM 
AKAP4-
BM M NC 
PM 
fast 
(%) 
Mean 23,02 39,13 46,93 22,88 40,97 45,92 1,54 30,60 42,76 0,42 27,18 34,44 
SD 9,48 10,47 9,05 7,57 7,44 10,57 1,96 6,17 9,58 0,74 5,13 12,30 
PM 
slow 
(%) 
Mean 5,52 8,28 7,66 4,17 6,29 7,53 0,33 8,28 7,36 0,42 6,30 6,83 
SD 2,81 4,10 1,92 1,85 1,78 2,29 0,38 2,33 2,23 0,41 2,80 2,39 
NPM 
(%) 
Mean 23,30 19,21 18,97 20,89 21,72 18,51 9,10 25,20 18,54 9,07 24,78 23,57 
SD 8,20 5,89 4,02 4,79 5,73 4,29 1,72 3,97 2,76 2,14 3,97 5,85 
IM 
(%) 
Mean 48,14 33,38 26,49 51,9 31,03 27,32 89,04 30,90 31,58 90,02 41,54 35,46 
SD 7,89 7,8 5,64 8,38 5,42 4,64 2,79 6,53 10,57 2,98 7,75 13,03 
V (%) Mean 76,83 82,07 80,90 79,03 82,67 87,13 83,77 67,67 79,67 80,10 77,80 43,33 SD 1,27 1,72 5,34 6,67 6,86 4,62 5,40 1,90 8,2 3,6 1,65 2,84 
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Supplementary Table D.11 – Inferential statistics; Test for difference between means of two independent groups 
associated with PPP1CC2-CT peptides treatments in bovine spermatozoa. NC, negative control; PM, progressive 
motility; NPM, non-progressive motility; IM, immotile spermatozoa; V, viability. 
Variable Groups 10 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
PPP1CC2-CT/ NC 
 
Mann-Whitney 0,007 NC 
PM fast (2h) T-student 0.000 NC 
PM slow (1h) Mann-Whitney 0,004 NC 
PM slow (2h) T-student 0.032 NC 
NPM (1h) T-student  - 
NPM (2h) T-student  - 
IM (1h) T-student 0.000 PPP1CC2-CT 
IM (2h) T-student 0.000 PPP1CC2-CT 
V (1h) T-student  - 
V (2h) T-student  - 
Variable Groups 20 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
PPP1CC2-CT/ NC 
T-student 0.000 NC 
PM fast (2h) T-student 0.000 NC 
PM slow (1h) T-student 0.040 NC 
PM slow (2h) T-student  - 
NPM (1h) T-student  - 
NPM (2h) T-student  - 
IM (1h) T-student 0.000 PPP1CC2-CT 
IM (2h) T-student 0.000 PPP1CC2-CT 
V (1h) T-student  - 
V (2h) T-student  - 
Variable Groups 10 µM Test  
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
TAMRA-PPP1CC2-CT 
/ NC 
Mann-Whitney 0,001 NC 
PM fast (2h) T-student 0.000 NC 
PM slow (1h) Mann-Whitney 0,003 NC 
PM slow (2h) T-student  - 
NPM (1h) T-student  - 
NPM (2h) T-student  - 
IM (1h) Mann-Whitney 0,000 TAMRA-PPP1CC2-CT 
IM (2h) T-student 0.000 TAMRA-PPP1CC2-CT 
V (1h) T-student  - 
V (2h) T-student  - 
Variable Groups 20 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
TAMRA-PPP1CC2-CT 
/ NC 
T-student 0.000 NC 
PM fast (2h) T-student 0.000 NC 
PM slow (1h) T-student  - 
PM slow (2h) Mann-Whitney 0,019 NC 
NPM (1h) T-student  - 
NPM (2h) T-student  - 
IM (1h) T-student 0.000 TAMRA-PPP1CC2-CT 
IM (2h) T-student 0.000 TAMRA-PPP1CC2-CT 
V (1h) T-student  - 
V (2h) T-student 0.000 NC 
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Supplementary Table D.12 – Inferential statistics; Test for difference between means of two independent groups 
associated with AKAP4 peptides treatments in bovine spermatozoa. NC, negative control; PM, progressive motility; 
NPM, non-progressive motility; IM, immotile spermatozoa; V, viability. 
Variable Conditions 10 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
AKAP4-BM/ NC 
T-student 0.000 NC 
PM fast (2h) T-student 0.000 NC 
PM slow (1h) T-student  - 
PM slow (2h) T-student 0.003 NC 
NPM (1h) Mann-Whitney  - 
NPM (2h) T-student  - 
IM (1h) T-student 0.000 AKAP4-BM 
IM (2h) Mann-Whitney 0,000 AKAP4-BM 
V (1h) T-student  - 
V (2h) T-student  - 
Variable Conditions 20 µM Test  
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
AKAP4-BM/ NC 
Mann-Whitney 0,000 NC 
PM fast (2h) Mann-Whitney 0,000 NC 
PM slow (1h) Mann-Whitney 0,000 NC 
PM slow (2h) T-student 0.000 NC 
NPM (1h) T-student 0.000 NC 
NPM (2h) T-student 0.000 NC 
IM (1h) T-student 0.000 AKAP4-BM 
IM (1h) T-student 0.000 AKAP4-BM 
V (1h) T-student  - 
V (2h) T-student 0.000 NC 
Variable Conditions 10 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
AKAP4-BM M /NC 
Mann-Whitney  - 
PM fast (2h) T-student  - 
PM slow (1h) T-student  - 
PM slow (2h) T-student  - 
NPM (1h) Mann-Whitney  - 
NPM (2h) T-student  - 
IM (1h) T-student 0,047 AKAP4-BM M 
IM (1h) Mann-Whitney  - 
V (1h) Mann-Whitney  - 
V (2h) Mann-Whitney  - 
Variable Conditions 20 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
AKAP4-BM M /NC 
T-student 0,000 NC 
PM fast (2h) T-student   
PM slow (1h) T-student   
PM slow (2h) T-student   
NPM (1h) T-student 0,001 AKAP-BM M 
NPM (2h) T-student   
IM (1h) T-student   
IM (1h) T-student   
V (1h) T-student   
V (2h) T-student   
Variable Conditions 10 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) AKAP4-BM/ AKAP4- Mann-Whitney 0,002 AKAP-BM M 
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Variable Conditions 10 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (2h) BM M T-student 0,000 AKAP-BM M 
PM slow (1h) T-student  - 
PM slow (2h) T-student 0,024 AKAP-BM M 
NPM (1h) T-student  - 
NPM (2h) T-student  - 
IM (1h) T-student 0,001 AKAP-BM 
IM (2h) T-student 0,000 AKAP-BM 
V (1h) Mann-Whitney 0,05 AKAP-BM M 
V (2h) Mann-Whitney  - 
Variable Conditions 20 µM Test 
Sig (2-
tailled) 
Interpretation Unilateral Test 
% of spermatozoa (variable) is significantly 
higher in 
PM fast (1h) 
AKAP4-BM/ AKAP4-
BM M 
 
Mann-Whitney 0,000 AKAP-BM M 
PM fast (2h) Mann-Whitney 0,000 AKAP-BM M 
PM slow (1h) Mann-Whitney 0,000 AKAP-BM M 
PM slow (2h) T-student 0,000 AKAP-BM M 
NPM (1h) T-student 0,000 AKAP-BM M 
NPM (2h) T-student 0,000 AKAP-BM M 
IM (1h) T-student 0,000 AKAP-BM 
IM (2h) T-student 0,000 AKAP-BM 
 
Supplementary Table D.13 – Descriptive analysis; Statistical measures: Mean and standard deviation (SD) associated 
with PPP1CC2 CT and AKAP4-BM peptides treatments in human spermatozoa. NC, negative control; PM, progressive 
motility; NPM, non-progressive motility; IM, immotile spermatozoa; Data are expressed as mean of two independent 
experiments performed in triplicate. 
20µM 1h 2h 
PM fast (%) PM slow (%) NPM (%) IM (%) PM fast (%) PM slow (%) NPM (%) IM (%) 
PPP1CC2-CT 
N Valid 6 6 6 6 6 6 6 6 
Mean 9,50 11,23 18,32 60,93 7,25 8,63 27,67 56,43 
SD 5,73 7,46 4,25 16,34 1,43 3,70 12,25 14,30 
AKAP4-BM 
N Valid 6 6 6 6 6 6 6 6 
Mean 1,27 1,82 9,60 87,30 1,28 1,73 9,10 87,97 
SD 0,71 1,09 3,36 3,91 1,76 1,18 2,50 1,92 
AKAP4-BM M 
N Valid 6 6 6 6 6 6 6 6 
Mean 9,72 11,90 18,18 60,23 6,82 10,03 19,90 62,55 
SD 3,43 2,84 4,85 8,64 1,42 1,39 4,00 6,17 
NC 
N Valid 6 6 6 6 6 6 6 6 
Mean 14,65 13,65 15,05 55,08 11,18 13,05 23,80 51,98 
SD 5,11 3,12 5,04 10,08 1,68 3,75 7,21 10,73 
 
Supplementary Table D.14 – Inferential statistics; Test for difference between means of two independent groups 
associated with PPP1CC2-CT peptide treatment in human spermatozoa. NC, negative control; PM, progressive motility; 
NPM, non-progressive motility; IM, immotile spermatozoa; 
Time Variable Test Sig (2-tailled) 
Interpretation Unilateral Test 
Statistically significant 
% of spermatozoa (variable) is significantly 
higher in 
1h 
PM fast Mann-Whitney U U=8; W=29; sig=0,109 - 
PM slow Mann-Whitney U U=15; W=36; sig=0,631 - 
NPM Mann-Whitney U U=12; W=33; sig=0,337 - 
IM Mann-Whitney U U=12; W=33; sig=0,337 - 
2h 
PM fast Mann-Whitney U U=0; W=21; sig=0,004 NC 
PM slow Mann-Whitney U U=8; W=29; sig=0,109 - 
NPM Mann-Whitney U U=15; W=36; sig=0,631 - 
IM Mann-Whitney U U=14; W=35; sig=0,520 - 
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Supplementary Table D.15 – Inferential statistics; Test for difference between means of two independent groups 
associated with AKAP4-BM peptides treatment in human spermatozoa. NC, negative control; PM, progressive motility; 
NPM, non-progressive motility; IM, immotile spermatozoa; 
Time Variable Condition Test Sig (2-tailled) 
Interpretation 
Unilateral Test 
Statistically significant 
% of spermatozoa 
(variable) is significantly 
higher in 
1h 
PM fast 
AKAP4-BM/ NC 
Mann-Whitney U U=0; W=21; sig=0,004 NC 
PM slow Mann-Whitney U U=0; W=1; sig=0,004 NC 
NPM Mann-Whitney U U=7; W=28; sig=0,078 NC 
IM Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM 
2h 
PM fast Mann-Whitney U U=0; W=21; sig=0,004 NC 
PM slow Mann-Whitney U U=0; W=21; sig=0,004 NC 
NPM Mann-Whitney U U=0; W=21; sig=0,004 NC 
IM Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM 
1h 
PM fast 
AKAP4-BM M/ NC 
Mann-Whitney U U=6; W=27; sig=0,054 NC 
PM slow Mann-Whitney U U=12; W=33; sig=0,337 - 
NPM Mann-Whitney U U=14; W=35; sig=0,522 - 
IM Mann-Whitney U U=11; W=32; sig=0,262 - 
2h 
PM fast Mann-Whitney U U=0; W=21; sig=0,004 NC 
PM slow Mann-Whitney U U=11; W=32; sig=0,262 - 
NPM Mann-Whitney U U=11; W=32; sig=0,262 - 
IM Mann-Whitney U U=8,5; W=29,5; sig=0,128 - 
1h 
PM fast 
AKAP4-BM/ AKAP4-
BM M 
Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM M 
PM slow Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM M 
NPM Mann-Whitney U U=1; W=22; sig=0,006 AKAP4 BM M 
IM Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM 
2h 
PM fast Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM M 
PM slow Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM M 
NPM Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM M 
IM Mann-Whitney U U=0; W=21; sig=0,004 AKAP4 BM 
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Supplementary Table D.16 – Primers used for cellular markers and housekeeping genes in qRT-PCR analysis (Mus 
musculus). 
Housekeeping genes Gene Sequence Position Acc. No 
Glyceraldehyde-3-phosphate 
dehydrogenase Gapdh 
TGTCCGTCGTGGATCTGAC 763-781 
NM_008084 CCTGCTTCACCACCTTCTTG 818-837 
Hypoxanthine guanine 
phosphoribosyl transferase 1  Hprt1 
TCCTCCTCAGACCGCTTTT 104-122 NM_013556 CCTGGTTCATCATCGCTAATC 173-193 
Marker for spermatogonia 
Tumor-associated calcium 
signal transducer 1   (= Ep-
CAM) 
Tacstd1 
CAGAATACTGTCATTTGCTCCA 615-637 
NM_008532 GTTCTGGATCGCCCCTTC 708-725 
Kit oncogene c-kit GGTTGTCCAACTTATTGAGAAGC 2813-2835 BC075716 GCAGTTTGCCAAGTTGGAGT 2863-2882 
Marker for spermatocytes 
Stathmin 1 (= Phosphoprotein 
p19) Stmn1 
CTGCAGAAGAAAGACGCAAGT 246-266 NM_019641 TGCTGAAGTTGTTGTTCTCCTC 341-362 
Synaptonemal complex protein 
3 Sycp3 
GGACAGCGACAGCTCACC 106-123 NM_011517 TTCCCAGATTTCCCAGAATG 170-189 
Marker for spermatids 
Transition protein 1 Tpn1 AGCCGCAAGCTAAAGACTCA 19-38 NM_009407 CGGTAATTGCGACTTGCAT 146-164 
Protamine 2 Prmn2 CAGAAGGCGGAGGAGACAC 309-327 NM_008933 CTCCTCCTTCGGGATCTTCT 364-383 
Marker for Leydig cells 
Hydroxysteroid (17-beta) 
dehydrogenase 3 Hsd17b3 
AATATGTCACGATCGGAGCTG 813-833 NM_008291 GAAGGGATCCGGTTCAGAAT 872-891 
Marker for Sertoli cells 
Androgen receptor Ar CCAGTCCCAATTGTGTCAAA 1513-1532 NM_013476 TCCCTGGTACTGTCCAAACG 1584-1603 
Marker for peritubular cells 
Actin alpha 2 Acta2 ACTCTCTTCCAGCCATCTTTCA 854-875 NM_007392 ATAGGTGGTTTCGTGGATGC 894-913 
 
Supplementary Table D.17 – Primers used for the target genes in qRT-PCR analysis (Mus musculus). 
Target genes Gene Sequence Position Acc. No 
Phosphoprotein phosphatase 1 
alpha isoform Ppp1ca 
TGTTCCTTCCAGATCCTCAAGCCC 914-937 
NM_031868 
TGGCTTTGGCAGAATTGCGGG 1008-1028 
Phosphoprotein phosphatase 1 
beta isoform Ppp1cb 
AGCTCATCAGGTGGTGGAAGACG 1121-1143 
NM_172707 
GGTGGATTAGCTGTTCGAGGCG 1336-1357 
Phosphoprotein phosphatase 1 
gamma 1 isoform Ppp1cc 
GAGCCCATCAGGTGGTTGAAGATG 1019-1042 
NM_013636 
AGTCCCAACCAGGCAGTGTCAAG 1261-1283 
Phosphoprotein phosphatase 1 
gamma 2 isoform Ppp1cc 
CCACGGGGTTGGATCAGGC 1219-1237 
NM_013636 
CCGGTGGACGGCAAGTTAGTTC 2287-2308 
Phosphoprotein phosphatase 1 
gamma isoform Ppp1cc 
GCCCATCAGGTGGTTGAAGATGGC 1021-1044 
NM_013636 
TGTGACAGGTCTCGTGGCGTTG 1194-1215 
Ankyrin repeat domain 42 
(=SARP) Ankrd42 
TCCCAGCGTGACTGACAAGAGAG 1408-1430 
NM_028665 
GGCTGCTAAATGAACCGGGAGG 1534-1555 
Ankyrin repeat domain 42 
isoform 2 (=SARP2) Ankrd42 
GCTGGATGAGTATCGAGTGGAAGTG 2341-2365 
NM_028665 
GTCATCTTCCATAGCCGCGACAC 2406-2428 
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Supplementary Table D.18 –  – Enriched GO categories of the APP interactors identified by YTH. Enriched categories 
are identified as those with p<0.05 
Supplementary Table D.19 – Distribution of APP interacting proteins in human testicular, epididymal and sperm 
proteomes, and their overlap. The human epididymis proteome includes both epididymal tissue and fluid proteomes. The 
secretory vesicular (epididymosome) part of the human epididymosome proteome was also considered. In bold are the 
APP interactors identified in the YTH screen. 
Supplementary Table D.20 – Statistics of collected protein-protein interaction data. 
Supplementary Table D.21 – Topological properties of 457 proteins in local APP/APLP2 network. (a) Rank of degree, 
clustering coefficient, betweenness centrality, and closeness centrality. (b) k-core and community that proteins are 
involved. Note that the number in community column is only index of the community. 
Supplementary Table D.22 – Topological properties of proteins in extended APP/APLP2 network. (a) Top 1000 rank of 
degree, clustering coefficient, betweenness centrality, and closeness centrality. Note that proteins with clustering 
coefficient 0 are neglected. (b) kcore and community that proteins are involved. The number in the community column is 
only index of the community. (c) Topological properties of APP partners identified by YTH in the extended APP/APLP2 
network. Proteins with prominent topological properties are indicated with purple color. 
 
Due to the extent of Supplementary Table D.18 to D.22 the information is available on 
http://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-014-0432-9. 
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Supplementary Table D.23 – Basic semen parameters, sperm DNA fragmentation (SDF) and expression patterns of 18 well-characterized signaling molecules when phosphorylated or 
cleaved (PathScan Intracellular Signaling Array) of 32 random men providing semen samples for routine analysis. MP, Midpiece. 
Volunteer Age (years) 
Volume 
(ml) 
Concentration 
(x106/ml) 
No. spermatozoa 
(x106) 
Motility (%) Morphology (%) SDF 
(%) Varicocele Total Progressive Non-progressive Immotile Normal Head MP Tail ERC TZI 
1 35 7,70 20,00 158,00 89,00 82,00 7,00 11,00 6,00 99,00 67,00 4,00 16,00 1,86 14,00 No 
2 36 2,50 91,00 228,00 89,00 73,00 16,00 11,00 9,00 100,00 56,00 16,00 8,00 1,80 23,00 No 
3 33 7,00 18,00 129,00 81,00 62,00 19,00 19,00 9,00 91,00 37,00 16,00 12,00 1,57 12,00 No 
4 33 4,00 24,00 97,00 39,00 32,00 7,00 61,00 4,00 99,00 60,00 22,00 17,00 1,99 41,00 No 
5 35 3,20 20,00 64,00 70,00 53,00 17,00 30,00 5,00 99,00 65,00 21,00 5,00 1,91 16,00 No 
6 35 7,00 2,00 14,00     3,00 89,00 49,00 37,00 0,00 1,80 30,00 Yes 7 36 5,10 49,00 250,00 56,00 30,00 26,00 44,00 6,00 90,00 52,00 23,00 0,00 1,80 49,00 No 
8 39 3,20 9,00 29,00 44,00 18,00 26,00 56,00 3,00 70,00 40,00 27,00 1,00 1,42 13,00 No 
9 32 3,30 95,00 314,00 41,00 23,00 18,00 59,00 6,00 58,00 39,00 19,00 3,00 1,27 10,00 No 
10 36 3,00 13,00 39,00 49,00 32,00 17,00 51,00 10,00 84,00 41,00 19,00 3,00 1,58 7,00 No 
11  5,40 140,00 756,00 76,00 66,00 10,00 24,00 13,00 60,00 25,00 6,00 3,00 1,18 23,00 No 12 31 4,70 9,00 42,00 37,00 27,00 10,00 63,00 16,00 43,00 34,00 23,00 0,00 1,17 13,00 No 
13 35 3,20 29,00 93,00 58,00 35,00 23,00 42,00 5,00 79,00 33,00 24,00 3,00 1,45 13,00 No 
14 29 1,50 2,00 3,00     6,00 70,00 45,00 39,00 1,00 1,64 9,00 No 15 25 3,00 59,00 177,00 82,00 69,00 13,00 18,00 7,00 79,00 32,00 30,00 0,00 1,52 10,00 Yes 
16 20 4,00 24,00 96,00 76,00 60,00 16,00 24,00 4,00 76,00 40,00 49,00 2,00 1,73 18,00 No 
17 36 0,90 2,00 1,80     2,00 80,00 45,00 40,00 0,00 1,68 34,00 No 18 34 4,00 8,00 32,00 44,00 30,00 14,00 56,00 7,00 78,00 40,00 20,00 3,00 1,51 17,00 No 
19 47 4,00 94,00 376,00 78,00 72,00 6,00 22,00 11,00 50,00 32,00 49,00 0,00 1,39 11,00 No 
20 32 3,00 197,00 591,00 81,00 76,00 5,00 19,00 18,00 44,00 31,00 24,00 1,00 1,00 9,00 No 
21 39 0,70 57,00 40,00 65,00 45,00 20,00 35,00 12,00 73,00 44,00 20,00 0,00 1,37 9,00 No 
22 32 4,20 4,00 17,00 54,00 39,00 15,00 46,00 5,00 79,00 39,00 27,00 5,00 1,60 36,00 No 
23 19 4,30 22,00 95,00 62,00 50,00 12,00 38,00 5,00 72,00 31,00 21,00 0,00 1,25 12,00 Yes 
24 29 2,30 30,00 69,00 57,00 48,00 9,00 43,00 6,00 77,00 47,00 39,00 7,00 1,57 7,00 Yes 
25 28 3,00 90,00 270,00 62,00 52,00 10,00 38,00 7,00 64,00 39,00 28,00 3,00 1,31 20,00 Yes 
26 26 2,20 13,00 29,00 44,00 33,00 11,00 66,00 4,00 84,00 43,00 40,00 0,00 1,67 24,00 Yes 
27 22 1,70 67,00 114,00 85,00 76,00 9,00 15,00 14,00 75,00 6,00 28,00 1,00 1,28 9,00 No 
28 21 3,00 140,00 420,00 83,00 68,00 15,00 17,00 5,00 81,00 44,00 29,00 3,00 1,65 17,00 No 
29 24 2,50 110,00 275,00 87,00 75,00 12,00 13,00 6,00 80,00 47,00 21,00 1,00 1,59 9,00 No 
30 20 1,00 60,00 60,00 64,00 43,00 21,00 36,00 5,00 78,00 32,00 37,00 2,00 1,57 16,00 No 
31 20 2,10 58,00 122,00 115,0 65,00 50,00 15,00 12,00 60,00 30,00 21,00 0,00 1,26 10,00 No 
32 28 2,50 86,00 215,00 79,00 72,00 7,00 21,00 12,00 54,00 31,00 30,00 0,00 1,31 8,00 No 
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Supplementary Table D.23 – (continuation) Basic semen parameters, sperm DNA fragmentation (SDF) and expression patterns of 18 well-characterized signaling molecules when 
phosphorylated or cleaved (PathScan Intracellular Signaling Array) of 32 random men providing semen samples for routine analysis. 
Volunteer 
PathScan® Intracellular Signaling Array 
Erk1/2 
(T202/ 
Y204) 
Stat1 
(Y701) 
Stat3 
(Y705) 
Akt 
(T308) 
Akt 
(S473) 
AMPKa 
(T172) 
S6 
Ribosomal 
Protein 
(S235/236) 
mTOR 
(S2448) 
HSP27 
(S78) 
Bad 
(S112) 
p70 S6 
Kinase 
(T389) 
PRAS40 
(T246) 
p53 
(S15) 
p38 
(T180/Y182) 
SAPK/JNK 
(T183/Y185) 
PARP 
Asp214 
Cleavage 
Caspase-3 
Asp175 
Cleavage 
GSK-
3b (S9) 
1 0,05 0,05 0,05 0,04 0,04 0,05 0,04 0,07 0,07 0,07 0,02 0,07 0,03 0,06 0,06 0,06 0,05 0,08 
2 0,13 0,19 0,09 0,11 0,15 0,27 0,15 0,35 0,25 0,17 0,06 0,20 0,08 0,27 0,23 0,16 0,16 0,30 
3 0,09 0,10 0,07 0,07 0,09 0,11 0,10 0,21 0,09 0,06 0,04 0,05 0,04 0,15 0,08 0,07 0,08 0,15 
4 0,13 0,14 0,11 0,09 0,17 0,29 0,18 0,34 0,34 0,25 0,06 0,23 0,09 0,29 0,31 0,22 0,19 0,35 
5 0,05 0,06 0,06 0,12 0,05 0,08 0,06 0,10 0,08 0,10 0,02 0,07 0,05 0,07 0,07 0,07 0,06 0,09 
6 0,16 0,09 0,07 0,07 0,09 0,21 0,10 0,20 0,17 0,15 0,03 0,14 0,05 0,16 0,18 0,10 0,10 0,16 
7 0,06 0,08 0,06 0,05 0,06 0,09 0,06 0,12 0,11 0,11 0,02 0,09 0,05 0,11 0,11 0,08 0,08 0,17 
8 0,09 0,11 0,09 0,08 0,09 0,18 0,09 0,21 0,20 0,17 0,03 0,12 0,05 0,15 0,29 0,12 0,12 0,17 
9 0,10 0,14 0,09 0,11 0,09 0,18 0,09 0,23 0,14 0,12 0,04 0,09 0,05 0,16 0,12 0,11 0,10 0,18 
10 0,25 0,32 0,18 0,18 0,25 0,39 0,27 0,61 0,49 0,38 0,09 0,42 0,13 0,44 0,49 0,26 0,31 0,58 
11 0,08 0,08 0,08 0,06 0,06 0,11 0,06 0,13 0,09 0,09 0,02 0,04 0,04 0,09 0,09 0,09 0,08 0,15 
12 0,29 0,35 0,29 0,19 0,28 0,45 0,29 0,70 0,66 0,37 0,10 0,44 0,16 0,50 0,63 0,35 0,32 0,70 
13 0,11 0,09 0,10 0,09 0,10 0,14 0,09 0,21 0,16 0,16 0,04 0,15 0,06 0,14 0,15 0,11 0,10 0,18 
14 0,26 0,23 0,14 0,13 0,18 0,40 0,17 0,38 0,30 0,17 0,06 0,22 0,09 0,32 0,26 0,18 0,21 0,34 
15 0,05 0,07 0,06 0,06 0,06 0,14 0,06 0,15 0,12 0,11 0,03 0,07 0,04 0,09 0,09 0,08 0,06 0,14 
16 0,41 0,18 0,13 0,09 0,12 0,27 0,12 0,29 0,25 0,19 0,05 0,20 0,07 0,16 0,24 0,13 0,15 0,27 
17 0,03 0,04 0,04 0,02 0,03 0,05 0,03 0,06 0,06 0,06 0,02 0,04 0,02 0,05 0,05 0,04 0,04 0,04 
18 0,14 0,16 0,11 0,12 0,14 0,23 0,15 0,29 0,26 0,23 0,07 0,19 0,08 0,23 0,22 0,15 0,15 0,25 
19 0,05 0,06 0,06 0,05 0,03 0,07 0,04 0,06 0,05 0,06 0,02 0,04 0,03 0,05 0,06 0,05 0,04 0,19 
20 0,12 0,09 0,11 0,09 0,06 0,10 0,07 0,09 0,07 0,07 0,06 0,07 0,06 0,09 0,07 0,07 0,07 0,24 
21 0,39 0,44 0,51 0,31 0,28 0,53 0,26 0,34 0,33 0,16 0,12 0,19 0,19 0,38 0,25 0,27 0,25 0,82 
22 0,13 0,14 0,09 0,10 0,12 0,18 0,12 0,23 0,21 0,21 0,04 0,16 0,07 0,19 0,19 0,14 0,15 0,38 
23 0,15 0,19 0,14 0,14 0,14 0,36 0,13 0,24 0,22 0,11 0,06 0,13 0,08 0,23 0,16 0,15 0,13 0,44 
24 0,11 0,12 0,08 0,09 0,10 0,20 0,10 0,18 0,16 0,11 0,04 0,13 0,06 0,17 0,16 0,12 0,11 0,27 
25 0,21 0,30 0,20 0,17 0,23 0,31 0,22 0,39 0,43 0,18 0,08 0,28 0,12 0,34 0,31 0,25 0,28 0,59 
26 0,07 0,07 0,07 0,06 0,05 0,11 0,05 0,10 0,06 0,08 0,05 0,06 0,06 0,07 0,05 0,07 0,07 0,14 
27 0,25 0,29 0,19 0,20 0,24 0,41 0,24 0,26 0,27 0,10 0,09 0,24 0,13 0,29 0,19 0,25 0,25 0,25 
28 0,07 0,07 0,05 0,05 0,06 0,11 0,05 0,11 0,08 0,08 0,03 0,06 0,04 0,09 0,09 0,07 0,06 0,08 
29 0,08 0,09 0,07 0,07 0,08 0,12 0,08 0,16 0,13 0,13 0,04 0,08 0,04 0,12 0,11 0,10 0,11 0,20 
30 0,08 0,11 0,09 0,07 0,08 0,15 0,08 0,17 0,14 0,11 0,03 0,10 0,05 0,14 0,15 0,11 0,10 0,15 
31 0,07 0,09 0,08 0,06 0,06 0,13 0,05 0,12 0,10 0,07 0,02 0,07 0,03 0,10 0,10 0,08 0,05 0,08 
32 0,16 0,21 0,15 0,14 0,18 0,22 0,16 0,34 0,30 0,16 0,07 0,22 0,09 0,23 0,25 0,19 0,19 0,36 
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Supplementary Table D.24 – Descriptive statistics of the human sperm samples used in the PathScan Intracellular 
Signaling Array and the intensity patterns of the 16 phosphorylated signaling proteins and cleavage of the 2 apoptosis 
proteins analyzed. The intensity from the negative control within each PathScan Intracellular Signaling array was 
subtracted from all signals, and all data from each array were normalized to the internal positive control within each 
array. 
Parameter N Minimum Maximum Mean Std. Dev. 
Age (years) 30 19 47 30.6 6.9 
Varicocele (presence/absence) 32 0 1 0.19 0.40 
Sexual Abstinence (days) 32 1 10 4 2.1 
Volume (ml) 32 0.7 7.7 3.4 1.7 
Concentration (x106/ml) 32 2 197 51 49 
Total Number of Spermatozoa (x106) 32 2 756 163 175 
Motility (%) 29 37 115 67 19 
Progressive Motility (%) 29 18 82 52 19 
Non-Progressive Motility (%) 29 5 50 15 8.8 
Immotile (%) 29 11 66 34 18 
Normal morphology (%) 29 3 18 8 4 
Head Defects (%) 29 43 100 75 16 
Midpiece Defects (%) 29 6 67 40 12 
Tail Defects (%) 29 4 49 25 10 
Teratozoospermia índex (TZI) 32 1 1.99 1.52 0.24 
Sperm DNA Fragmentation (SDF) (%) 32 7 49 17.16 10.54 
Erk1/2 (T202/Y204) 32 0.03 0.41 0.14 0.10 
Stat1 (Y701) 32 0.04 0.44 0.15 0.10 
Stat3 (Y705) 32 0.04 0.51 0.115 0.09 
Akt (T308) 32 0.02 0.31 0.10 0.06 
Akt (S473) 32 0.03 0.28 0.12 0.07 
AMPKa (T172) 32 0.05 0.53 0.21 0.13 
S6 Ribosomal Protein (S235/236) 32 0.03 0.29 0.12 0.07 
mTOR (S2448) 32 0.06 0.70 0.23 0.15 
HSP27 (S78) 32 0.05 0.66 0.20 0.14 
Bad (S112) 32 0.06 0.38 0.14 0.08 
p70 S6 Kinase (T389) 32 0.02 0.12 0.05 0.03 
PRAS40 (T246) 32 0.04 0.44 0.145 0.10 
p53 (S15) 32 0.02 0.19 0.07 0.04 
p38 (T180/Y182) 32 0.05 0.50 0.185 0.12 
SAPK/JNK (T183/Y185) 32 0.05 0.63 0.18 0.13 
PARP D214 Cleavage 32 0.04 0.35 0.135 0.08 
Caspase-3 D175 Cleavage 32 0.04 0.32 0.13 0.08 
GSK3b (S9) 32 0.04 0.82 0.27 0.19 
 
Supplementary Table D.25 – Characterization of the human sperm samples used in the Kinetworks™ Protein Kinase 
Screen 1.2 (KPKS-1.2). NZ, Normozoospermic. 
Sample Concentration (x106/mL) 
Motility 
Progressive 
Non-progressive (%) 
Immotile 
(%) (%) 
NZ 
125 45 16 39 
112 44 7 49 
258 43 17 40 
68 55 10 35 
127 43 9 48 
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Supplementary Table D26  – Proteins analyzed by the Kinetworks™ Protein Kinase Screen 1.2 (KPKS-1.2). 
ABBREVIATION FULL NAME  ANTIBODY SITE TYPE REACTIVITY MW REFERENCE LINKS 
Target Protein Name Full Target Protein Name Code Pan (Human Site) Ab (species) H M R Predicted UniProt 
Kinexus Target 
Size Refseq Swissprot  
Aurora A (AIK) 
Aurora Kinase A 
(serine/threonine protein 
kinase 6) 
NK008-2 Pan-specific RpAb T T F 39,28 45-50 NP_940835 O14965 
BMX (Etk) Bone marrow X protein-tyrosine kinase NK012 Pan-specific MmAb T T T 78,011 69-75 NP_001712 P51813 
Btk 
Bruton's 
agammaglobulinemia tyrosine 
kinase 
NK014 Pan-specific RpAb T T F 76,281 63-69 NP_000052 Q06187 
CaMK1d 
Calcium/calmodulin-
dependent protein-serine 
kinase 1 delta 
NK016-2 Pan-specific GpAb T T T 40,189 39-45 NP_003647 Q8IU85 
CaMK4 
Calcium/calmodulin-
dependent protein-serine 
kinase 4 
NK021 Pan-specific RpAb T T T 52   NP_001735 Q16566 
CaMKK (CaMKK2) 
Calcium/calmodulin-
dependent protein-serine 
kinase kinase 
NK022 Pan-specific RpAb T T T 55,736 50-55 NP_006540 Q8N5S9 
CDK1 (CDC2) Cyclin-dependent protein-serine kinase 1  NK025-2 Pan-specific MmAb T T T 34,095 24-28 NP_001777 P06493 
CDK2 Cyclin-dependent protein-serine kinase 2 NK026-3 Pan-specific MmAb T T T 33,93 24-29 NP_001789 P24941 
CDK4 Cyclin-dependent protein-serine kinase 4 NK027 Pan-specific MmAb T T T 33,73 23-29 NP_000066 P11802 
CDK5 Cyclin-dependent protein-serine kinase 5 NK028-1 Pan-specific RpAb T T T 33,305 22-28 NP_004926 Q00535 
CDK6 Cyclin-dependent protein-serine kinase 6 NK029 Pan-specific MmAb T T T 37 32-37 NP_001250 Q00534 
CDK7 Cyclin-dependent protein-serine kinase 7 NK030-2 Pan-specific MmAb T T T 39,038 34-38 NP_001790 P50613 
CDK9 Cyclin-dependent protein-serine kinase 9 NK032 Pan-specific RpAb T T T 42,792 33-37 NP_001252 P50750 
CK1d Casein protein-serine kinase 1 delta NK036 Pan-specific GpAb T T T 47,33 37-43 NP_001884 P48730 
CK1e Casein protein-serine kinase 1 epsilon NK037 Pan-specific MmAb T T T 47,315 32-37 NP_001885 P49674 
CK2a Casein protein-serine kinase 2 alpha/ alpha prime NK041 Pan-specific RpAb T T T 45 + 41 
32-36 + 34-38 + 
36-40 NP_001887 P68400 
COT Osaka thyroid oncogene protein-serine kinase (Tpl2) NK042 Pan-specific RpAb T T T 52,898 50-56 NP_005195 P41279 
Csk C-terminus of Src tyrosine NK044 Pan-specific MmAb T T T 50,704 41-47 NP_004374 P41240 
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ABBREVIATION FULL NAME  ANTIBODY SITE TYPE REACTIVITY MW REFERENCE LINKS 
Target Protein Name Full Target Protein Name Code Pan (Human Site) Ab (species) H M R Predicted UniProt 
Kinexus Target 
Size Refseq Swissprot  
kinase 
DNAPK DNA-activated protein-serine kinase NK048 Pan-specific RpAb T T T 469,14 215-300 NP_008835 P78527 
eEF2K Elongation factor-2 protein-serine kinase NK051 Pan-specific RpAb T T T 82,172 100-106 NP 037434 O00418 
Erk2 
Extracellular regulated 
protein-serine kinase 2 (p42 
MAP kinase) 
NK056 Pan-specific RpAb T T T 41,39 36-41 + 38-43 NP_002736 P28482 
Erk3 Extracellular regulated protein-serine kinase 3 NK057-2 Pan-specific RpAb T T T 82,681 51-55 + 53-58 NP_002739 Q16659 
FAK Focal adhesion protein-tyrosine kinase NK060 Pan-specific RpAb T T T 119,233 112-126 NP_005598 Q05397 
Fyn Fyn proto-oncogene-encoded protein-tyrosine kinase NK065 Pan-specific MmAb T T T 60,631 43-48 + 45-50 NP_002028 P06241 
GCK Germinal centre protein-serine kinase NK066 Pan-specific GpAb T T T 91,586 80-89 NP_004570 Q12851 
GRK2 (BARK1) G protein-coupled receptor-serine kinase 2  NK067 Pan-specific RpAb T T T 79,668 71-79 NP_001610 P25098 
GSK3a + GSK3b 
Glycogen synthase-serine 
kinase 3 alpha + Glycogen 
synthase-serine kinase 3 beta 
NK069-NK070 Pan-specific MmAb T T T 51 + 47 40-45 + 34-37  NP_063937 + NP_002084 
P49840 + 
P49841 
GSK3a + GSK3b 
Glycogen synthase-serine 
kinase 3 alpha + Glycogen 
synthase-serine kinase 3 beta 
NK069-NK070-2 Pan-specific MmAb T T T 51 + 47 40-45 + 34-37  NP_063937 + NP_002084 
P49840 + 
P49841 
Hpk1 Hematopoetic progenitor protein-serine kinase 1 NK072 Pan-specific GpAb T T T 91,296 83-95 NP_009112 Q92918 
IKKa 
Inhibitor of NF-kappa-B 
protein-serine kinase alpha 
(CHUK) 
NK075-3 Pan-specific RpAb T T T 84,654 80-90 NP_001269 O15111 
IKKb Inhibitor of NF-kappa-B protein-serine kinase beta NK076-1 Pan-specific RpAb T T T 86,564 83-90 NP_001547 O14920 
JAK1 Janus protein-tyrosine kinase 1 NK084-2 Pan-specific RpAb T T T 131,957 115-124 NP_002218 P23458 
JAK2 Janus protein-tyrosine kinase 2 NK085 Pan-specific RpAb T T T 130,674 105-124 NP_004963 O60674 
JNK1/2/3 
Jun N-terminus protein-serine 
kinases (stress-activated 
protein kinase (SAPK)) 1/2/3 
NK088-1 Pan-specific RpAb T T T 44+48+53 36-42 + 43-49 NP_002741 P45983 
Ksr1 Protein-serine kinase suppressor of Ras 1 NK090 Pan-specific RpAb T T T 71,671 90-97 AAC50354.1   Q8IVT5 
Lck Lymphocyte-specific protein- NK092-2 Pan-specific MmAb T T T 57,869 41-47 NP_005347 P06239 
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ABBREVIATION FULL NAME  ANTIBODY SITE TYPE REACTIVITY MW REFERENCE LINKS 
Target Protein Name Full Target Protein Name Code Pan (Human Site) Ab (species) H M R Predicted UniProt 
Kinexus Target 
Size Refseq Swissprot  
tyrosine kinase 
Lyn Yes-related protein-tyrosine kinase NK095 Pan-specific MmAb T T T 58,443 44-48 NP_002341 P07948 
MEK1 (MAP2K1) MAPK/ERK protein-serine kinase 1 (MKK1) NK099-1 Pan-specific MmAb T T T 43,308 37-43 NP_002746 Q02750 
MEK2 (MAP2K2) MAPK/ERK protein-serine kinase 2 (MKK2) NK100-1 Pan-specific MmAb T T T 44,424 37-43 AAH00471.1   P36507 
MEK4 (MAP2K4) MAPK/ERK protein-serine kinase 4 (MKK4) NK103 Pan-specific RpAb T T T 44,288 34-40 NP_003001 P45985 
MEK6 (MAP2K6) MAPK/ERK protein-serine kinase 6 (MKK6) NK105-1 Pan-specific RpAb T T T 37+ 31 31-36 NP_002749 P52564 
Mnk2 
MAP kinase-interacting 
protein-serine kinase 2 
(calmodulin-activated) 
NK111 Pan-specific GpAb T F F 46,615 51-56 NP_060042 Q9HBH9 
MST1 
Mammalian STE20-like 
protein-serine kinase 1 
(KRS2) 
NK113-2 Pan-specific MmAb T T T 55,63 57-59 NP_006273 Q13043 
p38a MAPK  Mitogen-activated protein-serine kinase p38 alpha NK120-3 Pan-specific RpAb T T T 41,293 36-41 NP_001306 Q16539 
p38g MAPK (Erk6) 
Mitogen-activated protein-
serine kinase p38 gamma 
(MAPK12) 
NK059-1 Pan-specific RpAb T T T 41,94 38-40 NP_002960 P53778 
PAK1 
p21-activated kinase 1 (alpha) 
(serine/threonine-protein 
kinase PAK 1) 
NK122 Pan-specific RpAb T T T 60,661 63-69 NP_002567 Q13153 
PAK3 
p21-activated kinase 3 (beta) 
(serine/threonine-protein 
kinase PAK 3) 
NK123 Pan-specific GpAb T T T 60,693 58-63 NP_002569 O75914 
PDK1 3-phosphoinositide-dependent protein-serine kinase 1 NK126-2 Pan-specific GpAb T T T 63,152 48-55 NP_002604 O15530 
PKA Ca/b 
cAMP-dependent protein-
serine kinase catalytic subunit 
alpha/beta 
NK127-1 Pan-specific MmAb T T T 40/ 40 35-40 NP_002721 P17612 
PKBa (Akt1) Protein-serine kinase B alpha NK129 Pan-specific MmAb T T T 55,716 56-60 + 58-63 NP_005154 P31749 
PKCa Protein-serine kinase C alpha NK132 Pan-specific MmAb T T T 76,764 73-82 NP_002728 P17252 
PKCb1 Protein-serine kinase C beta 1 NK133 Pan-specific RpAb T T T 76,869 74-82 NP_002729 P05771 
PKCd Protein-serine kinase C delta NK135 Pan-specific RpAb T T T 77,477 70-74 NP_006245 Q05655 
PKCe Protein-serine kinase C epsilon NK136 Pan-specific RpAb T T T 83,674 88-95 + 93-101 NP_005391 Q02156 
PKCg Protein-serine kinase C gamma NK137 Pan-specific RpAb T T T 78,448 72-80 NP_002730 P05129 
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ABBREVIATION FULL NAME  ANTIBODY SITE TYPE REACTIVITY MW REFERENCE LINKS 
Target Protein Name Full Target Protein Name Code Pan (Human Site) Ab (species) H M R Predicted UniProt 
Kinexus Target 
Size Refseq Swissprot  
PKCl/i Protein-serine kinase C lambda/iota NK138 Pan-specific RpAb T T T 67,258 74-80 NP_002731 P41743 
PKCm (PKD) Protein-serine kinase C mu (Protein kinase D) NK142 Pan-specific RpAb T T T 101,888 106-112 + 110-117 NP_002733 Q15139 
PKCq Protein-serine kinase C theta NK140 Pan-specific MmAb T T T 81,865 69-76 NP_006248 Q04759 
PKCz Protein-serine kinase C zeta NK141 Pan-specific RpAb T T T 67,718 74-84 + 79-86 NP_002735 Q05513 
PKG1 
Protein-serine kinase G1 
(cGMP-dependent protein 
kinase) 
NK143 Pan-specific RpAb T T T 76 + 79 69-74 NP_006249 Q13976 
PKR1 
Double stranded RNA 
dependent protein-serine 
kinase 
NK144-1 Pan-specific MmAb T T T 62,094 75-76 NP_002750 P19525 
Pyk2 Protein-tyrosine kinase 2 NK154 Pan-specific GpAb T T T 115,875 110-113 NP_004094 Q14289 
Raf1 Raf1 proto-oncogene-encoded protein-serine kinase NK155-3 Pan-specific RpAb T N/A T 73,052   NP_002871 P04049 
RafB (Braf) RafB proto-oncogene-encoded protein-serine kinase NK156 Pan-specific RpAb T T T 84,491 93-98 NP_004324 P15056 
ROKa (ROCK2) RhoA protein-serine kinase alpha NK159-1 Pan-specific MmAb T T T 160,913 149-163 NP_004841 O75116 
RSK1 Ribosomal S6 protein-serine kinase 1 NK164 Pan-specific RpAb T T T 82,723 72-84 + 79-88 NP_002944 Q15418 
RSK2 Ribosomal S6 protein-serine kinase 2 NK165 Pan-specific RpAb T T T 83,736 69-78 + 75-83 NP_004577 P51812 
S6Ka (p70 S6Ka)  + 
S6Ka (p85 S6Ka) 
p70 ribosomal protein-serine 
S6 kinase alpha + p85 
ribosomal protein-serine S6 
kinase alpha 
NK168-NK169-1 Pan-specific MmAb T T T 70 60-72 + 78-83 NP_003152 P23443 
Src Src proto-oncogene-encoded protein-tyrosine kinase NK172 Pan-specific MmAb T T T 59,704 45-50 NP_005408 P12931 
Syk Spleen protein-tyrosine kinase NK174 Pan-specific MmAb T T T 72,066 65-68 NP_003168 P43405 
Yes 
Yamaguchi sarcoma proto-
oncogene-encoded tyrosine 
kinase 
NK186 Pan-specific MmAb T T T 60,801 52-57 NP_005424 P07947 
ZAP70 
Zeta-chain (TCR) associated 
protein-tyrosine kinase, 70 
kDa 
NK187 Pan-specific MmAb T T T 69,872 61-65 NP_003168 P43403 
ZIPK 
ZIP kinase (death associated 
protein-serine kinase 3 
(DAPK3)) 
NK188-2 Pan-specific RpAb T T T 52,536 41-46 + 44-49 NP_001339 O43293 
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Supplementary Table D.27 – Age, basic semen parameters and expression patterns of 18 signaling molecules when phosphorylated or cleaved of 63 random men.  
Volunteer Age (years) 
Volume 
(ml) 
Concentration 
(x106/mL) 
No. Spermatozoa 
(x106) 
Motility (%) Morphology (%) 
Total Progressive Non-progressive Immotile Normal Head Middpiece Tail 
1 35 7,70 20,00 158,00 89,00 82,00 7,00 11,00 6,00 99,00 67,00 4,00 
2 36 2,50 91,00 228,00 89,00 73,00 16,00 11,00 9,00 100,00 56,00 16,00 
3 33 7,00 18,00 129,00 81,00 62,00 19,00 19,00 9,00 91,00 37,00 16,00 
4 33 4,00 24,00 97,00 39,00 32,00 7,00 61,00 4,00 99,00 60,00 22,00 
5 35 3,20 20,00 64,00 70,00 53,00 17,00 30,00 5,00 99,00 65,00 21,00 
6 35 7,00 2,00 14,00     3,00 89,00 49,00 37,00 7 36 5,10 49,00 250,00 56,00 30,00 26,00 44,00 6,00 90,00 52,00 23,00 
8 39 3,20 9,00 29,00 44,00 18,00 26,00 56,00 3,00 70,00 40,00 27,00 
9 32 3,30 95,00 314,00 41,00 23,00 18,00 59,00 6,00 58,00 39,00 19,00 
10 36 3,00 13,00 39,00 49,00 32,00 17,00 51,00 10,00 84,00 41,00 19,00 
11 31 4,70 9,00 42,00 37,00 27,00 10,00 63,00 16,00 43,00 34,00 23,00 
12 35 3,20 29,00 93,00 58,00 35,00 23,00 42,00 5,00 79,00 33,00 24,00 
13 29 1,50 2,00 3,00     6,00 70,00 45,00 39,00 14 25 3,00 59,00 177,00 82,00 69,00 13,00 18,00 7,00 79,00 32,00 30,00 
15 20 4,00 24,00 96,00 76,00 60,00 16,00 24,00 4,00 76,00 40,00 49,00 
16 36 0,90 2,00 1,80     2,00 80,00 45,00 40,00 17 34 4,00 8,00 32,00 44,00 30,00 14,00 56,00 7,00 78,00 40,00 20,00 
18 47 4,00 94,00 376,00 78,00 72,00 6,00 22,00 11,00 50,00 32,00 49,00 
19 32 3,00 197,00 591,00 81,00 76,00 5,00 19,00 18,00 44,00 31,00 24,00 
20 39 0,70 57,00 40,00 65,00 45,00 20,00 35,00 12,00 73,00 44,00 20,00 
21 32 4,20 4,00 17,00 54,00 39,00 15,00 46,00 5,00 79,00 39,00 27,00 
22 19 4,30 22,00 95,00 62,00 50,00 12,00 38,00 5,00 72,00 31,00 21,00 
23 29 2,30 30,00 69,00 57,00 48,00 9,00 43,00 6,00 77,00 47,00 39,00 
24 28 3,00 90,00 270,00 62,00 52,00 10,00 38,00 7,00 64,00 39,00 28,00 
25 26 2,20 13,00 29,00 44,00 33,00 11,00 66,00 4,00 84,00 43,00 40,00 
26 22 1,70 67,00 114,00 85,00 76,00 9,00 15,00 14,00 75,00 6,00 28,00 
27 21 3,00 140,00 420,00 83,00 68,00 15,00 17,00 5,00 81,00 44,00 29,00 
28 24 2,50 110,00 275,00 87,00 75,00 12,00 13,00 6,00 80,00 47,00 21,00 
29 20 1,00 60,00 60,00 64,00 43,00 21,00 36,00 5,00 78,00 32,00 37,00 
30 20 2,10 58,00 122,00 115,00 65,00 50,00 15,00 12,00 60,00 30,00 21,00 
31 28 2,50 86,00 215,00 79,00 72,00 7,00 21,00 12,00 54,00 31,00 30,00 
32 22 0,70 35,00 24,50 74,00 37,00 37,00 50,00 9,00 59,00 49,00 42,00 
33 22 1,00 90,00 90,00 61,00 49,00 12,00 39,00 17,00 50,00 49,00 37,00 
34 20 2,20 35,00 77,00 39,00 28,00 11,00 51,00 18,00 71,00 38,00 28,00 
35 20 3,00 35,00 105,00 63,00 49,00 14,00 37,00 17,00 63,00 39,00 18,00 
36 24 3,10 31,00 96,10 27,00 16,00 11,00 73,00 4,00 79,00 60,00 51,00 
37 24 5,00 61,00 305,00 41,00 18,00 23,00 59,00 4,00 83,00 69,00 60,00 
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Volunteer Age (years) 
Volume 
(ml) 
Concentration 
(x106/mL) 
No. Spermatozoa 
(x106) 
Motility (%) Morphology (%) 
Total Progressive Non-progressive Immotile Normal Head Middpiece Tail 
38 24 3,60 50,00 180,00 36,00 30,00 6,00 63,00 6,00 65,00 43,00 43,00 
39 25 1,20 19,00 22,80 19,00 4,00 15,00 81,00 5,00 77,00 34,00 39,00 
40 25 3,30 26,00 85,80 29,00 14,00 15,00 71,00 6,00 71,00 52,00 44,00 
41 25 3,80 20,00 76,00 40,00 24,00 16,00 60,00 7,00 60,00 49,00 32,00 
42 18 3,10 56,00 173,60 69,00 41,00 28,00 31,00 13,00 60,00 44,00 21,00 
43 18 7,00 74,00 518,00 40,00 15,00 25,00 60,00 4,00 90,00 40,00 33,00 
44 18 3,80 95,00 361,00 68,00 59,00 9,00 32,00 8,00 80,00 34,00 12,00 
45 20 2,80 113,00 316,40 89,00 51,00 38,00 11,00 18,00 70,00 47,00 38,00 
46 20 2,10 194,00 407,40 82,00 46,00 36,00 17,00 18,00 60,00 41,00 30,00 
47 20 3,50 120,00 420,00 69,00 56,00 13,00 31,00 19,00 71,00 36,00 15,00 
48 25 2,60 27,00 70,20 41,00 26,00 15,00 59,00 10,00 69,00 50,00 39,00 
49 23 5,50 23,00 115,00 42,00 12,00 30,00 58,00     50 23 4,00 55,00 220,00 26,00 6,00 20,00 74,00     51 23 1,60 46,00 73,60 44,00 33,00 11,00 56,00 10,00 65,00 39,00 45,00 
52 23 4,00 25,00 100,00 60,00 39,00 21,00 40,00 12,00 51,00 39,00 30,00 
53 23 2,10 42,00 88,20 42,00 31,00 11,00 58,00     54 20 5,00 40,00 200,00 78,00 71,00 7,00 22,00     55 20 2,00 74,00 148,00 51,00 31,00 20,00 49,00     56 22 0,70 35,00 24,50 74,00 37,00 37,00 50,00 9,00 59,00 49,00 42,00 
57 22 6,00 29,00 174,00 68,00 50,00 18,00 32,00 13,00 70,00 51,00 29,00 
58 22 5,50 67,00 368,50 78,00 59,00 19,00 22,00 22,00 60,00 42,00 20,00 
59 20 1,30 111,00 144,30 84,00 80,00 4,00 16,00 7,00 63,00 42,00 21,00 
60 22 2,50 28,00 70,00 38,00 24,00 14,00 62,00 10,00 74,00 36,00 20,00 
61 22 3,20 23,00 73,60 29,00 20,00 9,00 71,00 9,00 81,00 34,00 29,00 
62 23 5,60 24,00 134,40 85,00 56,00 29,00 15,00 3,00 88,00 30,00 19,00 
63 23 6,80 19,00 129,20 45,00 26,00 19,00 55,00 2,00 91,00 51,00 20,00 
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PathScan® Intracellular Signaling Array 
E
rk
1/
2 
(T
20
2/
Y
20
4)
 
St
at
1 
(Y
70
1)
 
St
at
3 
(Y
70
5)
 
A
kt
 (T
30
8)
 
A
kt
 (S
47
3)
 
A
M
PK
a 
(T
17
2)
 
S6
 
R
ib
os
om
al
 
Pr
ot
ei
n 
(S
23
5/
23
6)
 
m
T
O
R
 
(S
24
48
) 
H
SP
27
 (S
78
) 
B
ad
 (S
11
2)
 
p7
0 
S6
 
K
in
as
e 
(T
38
9)
 
PR
A
S4
0 
(T
24
6)
 
p5
3 
(S
15
) 
p3
8 
(T
18
0/
Y
18
2)
 
SA
PK
/J
N
K
 
(T
18
3/
Y
18
5)
 
PA
R
P 
(D
21
4)
 
C
as
pa
se
-3
 
(D
17
5)
 
G
SK
-3
b 
(S
9)
 
1 0,05 0,05 0,05 0,04 0,04 0,05 0,04 0,07 0,07 0,07 0,02 0,07 0,03 0,06 0,06 0,06 0,05 0,08 
2 0,13 0,19 0,09 0,11 0,15 0,27 0,15 0,35 0,25 0,17 0,06 0,20 0,08 0,27 0,23 0,16 0,16 0,30 
3 0,09 0,10 0,07 0,07 0,09 0,11 0,10 0,21 0,09 0,06 0,04 0,05 0,04 0,15 0,08 0,07 0,08 0,15 
4 0,13 0,14 0,11 0,09 0,17 0,29 0,18 0,34 0,34 0,25 0,06 0,23 0,09 0,29 0,31 0,22 0,19 0,35 
5 0,05 0,06 0,06 0,12 0,05 0,08 0,06 0,10 0,08 0,10 0,02 0,07 0,05 0,07 0,07 0,07 0,06 0,09 
6 0,16 0,09 0,07 0,07 0,09 0,21 0,10 0,20 0,17 0,15 0,03 0,14 0,05 0,16 0,18 0,10 0,10 0,16 
7 0,06 0,08 0,06 0,05 0,06 0,09 0,06 0,12 0,11 0,11 0,02 0,09 0,05 0,11 0,11 0,08 0,08 0,17 
8 0,09 0,11 0,09 0,08 0,09 0,18 0,09 0,21 0,20 0,17 0,03 0,12 0,05 0,15 0,29 0,12 0,12 0,17 
9 0,10 0,14 0,09 0,11 0,09 0,18 0,09 0,23 0,14 0,12 0,04 0,09 0,05 0,16 0,12 0,11 0,10 0,18 
10 0,25 0,32 0,18 0,18 0,25 0,39 0,27 0,61 0,49 0,38 0,09 0,42 0,13 0,44 0,49 0,26 0,31 0,58 
11 0,29 0,35 0,29 0,19 0,28 0,45 0,29 0,70 0,66 0,37 0,10 0,44 0,16 0,50 0,63 0,35 0,32 0,70 
12 0,11 0,09 0,10 0,09 0,10 0,14 0,09 0,21 0,16 0,16 0,04 0,15 0,06 0,14 0,15 0,11 0,10 0,18 
13 0,26 0,23 0,14 0,13 0,18 0,40 0,17 0,38 0,30 0,17 0,06 0,22 0,09 0,32 0,26 0,18 0,21 0,34 
14 0,05 0,07 0,06 0,06 0,06 0,14 0,06 0,15 0,12 0,11 0,03 0,07 0,04 0,09 0,09 0,08 0,06 0,14 
15 0,41 0,18 0,13 0,09 0,12 0,27 0,12 0,29 0,25 0,19 0,05 0,20 0,07 0,16 0,24 0,13 0,15 0,27 
16 0,03 0,04 0,04 0,02 0,03 0,05 0,03 0,06 0,06 0,06 0,02 0,04 0,02 0,05 0,05 0,04 0,04 0,04 
17 0,14 0,16 0,11 0,12 0,14 0,23 0,15 0,29 0,26 0,23 0,07 0,19 0,08 0,23 0,22 0,15 0,15 0,25 
18 0,05 0,06 0,06 0,05 0,03 0,07 0,04 0,06 0,05 0,06 0,02 0,04 0,03 0,05 0,06 0,05 0,04 0,19 
19 0,12 0,09 0,11 0,09 0,06 0,10 0,07 0,09 0,07 0,07 0,06 0,07 0,06 0,09 0,07 0,07 0,07 0,24 
20 0,39 0,44 0,51 0,31 0,28 0,53 0,26 0,34 0,33 0,16 0,12 0,19 0,19 0,38 0,25 0,27 0,25 0,82 
21 0,13 0,14 0,09 0,10 0,12 0,18 0,12 0,23 0,21 0,21 0,04 0,16 0,07 0,19 0,19 0,14 0,15 0,38 
22 0,15 0,19 0,14 0,14 0,14 0,36 0,13 0,24 0,22 0,11 0,06 0,13 0,08 0,23 0,16 0,15 0,13 0,44 
23 0,11 0,12 0,08 0,09 0,10 0,20 0,10 0,18 0,16 0,11 0,04 0,13 0,06 0,17 0,16 0,12 0,11 0,27 
24 0,21 0,30 0,20 0,17 0,23 0,31 0,22 0,39 0,43 0,18 0,08 0,28 0,12 0,34 0,31 0,25 0,28 0,59 
25 0,07 0,07 0,07 0,06 0,05 0,11 0,05 0,10 0,06 0,08 0,05 0,06 0,06 0,07 0,05 0,07 0,07 0,14 
26 0,25 0,29 0,19 0,20 0,24 0,41 0,24 0,26 0,27 0,10 0,09 0,24 0,13 0,29 0,19 0,25 0,25 0,25 
27 0,07 0,07 0,05 0,05 0,06 0,11 0,05 0,11 0,08 0,08 0,03 0,06 0,04 0,09 0,09 0,07 0,06 0,08 
28 0,08 0,09 0,07 0,07 0,08 0,12 0,08 0,16 0,13 0,13 0,04 0,08 0,04 0,12 0,11 0,10 0,11 0,20 
29 0,08 0,11 0,09 0,07 0,08 0,15 0,08 0,17 0,14 0,11 0,03 0,10 0,05 0,14 0,15 0,11 0,10 0,15 
30 0,07 0,09 0,08 0,06 0,06 0,13 0,05 0,12 0,10 0,07 0,02 0,07 0,03 0,10 0,10 0,08 0,05 0,08 
31 0,16 0,21 0,15 0,14 0,18 0,22 0,16 0,34 0,30 0,16 0,07 0,22 0,09 0,23 0,25 0,19 0,19 0,36 
32 0,09 0,13 0,09 0,09 0,05 0,11 0,07 0,07 0,10 0,07 0,02 0,04 0,02 0,05 0,07 0,06 0,04 0,23 
33 0,09 0,13 0,08 0,10 0,05 0,10 0,06 0,07 0,09 0,06 0,03 0,03 0,02 0,04 0,07 0,06 0,04 0,23 
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PathScan® Intracellular Signaling Array 
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34 0,12 0,07 0,09 0,08 0,05 0,07 0,06 0,06 0,05 0,05 0,03 0,04 0,01 0,04 0,12 0,06 0,04 0,07 
35 0,15 0,07 0,10 0,10 0,06 0,09 0,07 0,07 0,04 0,06 0,04 0,03 0,02 0,04 0,10 0,05 0,04 0,05 
36 0,09 0,07 0,12 0,09 0,05 0,12 0,06 0,08 0,04 0,06 0,03 0,03 0,02 0,04 0,10 0,09 0,08 0,10 
37 0,14 0,08 0,20 0,12 0,06 0,20 0,09 0,13 0,09 0,09 0,06 0,05 0,02 0,07 0,13 0,09 0,06 0,23 
38 0,09 0,07 0,08 0,06 0,04 0,05 0,06 0,05 0,04 0,05 0,03 0,04 0,01 0,04 0,09 0,06 0,04 0,08 
39 0,13 0,08 0,19 0,14 0,05 0,19 0,08 0,12 0,12 0,09 0,04 0,04 0,02 0,05 0,11 0,09 0,05 0,17 
40 0,14 0,06 0,08 0,07 0,05 0,09 0,05 0,06 0,05 0,06 0,01 0,05 0,02 0,05 0,12 0,08 0,05 0,09 
41 0,09 0,06 0,07 0,07 0,06 0,08 0,07 0,07 0,06 0,08 0,03 0,04 0,03 0,06 0,11 0,09 0,07 0,07 
42 0,10 0,08 0,13 0,11 0,05 0,12 0,07 0,10 0,07 0,07 0,03 0,04 0,02 0,05 0,11 0,08 0,04 0,17 
43 0,11 0,07 0,10 0,09 0,05 0,10 0,05 0,08 0,07 0,06 0,04 0,04 0,01 0,05 0,09 0,07 0,04 0,37 
44 0,14 0,14 0,10 0,12 0,07 0,10 0,10 0,09 0,13 0,13 0,03 0,08 0,03 0,06 0,17 0,11 0,06 0,21 
45 0,12 0,30 0,10 0,10 0,05 0,13 0,06 0,07 0,05 0,05 0,02 0,03 0,01 0,03 0,07 0,04 0,03 0,10 
46 0,07 0,23 0,09 0,09 0,03 0,13 0,06 0,08 0,06 0,03 0,02 0,03 0,01 0,03 0,11 0,05 0,03 0,12 
47 0,13 0,27 0,11 0,12 0,06 0,21 0,07 0,08 0,06 0,06 0,03 0,05 0,03 0,06 0,10 0,08 0,05 0,08 
48 0,09 0,05 0,07 0,08 0,03 0,10 0,05 0,08 0,05 0,06 0,01 0,03 0,02 0,05 0,07 0,08 0,05 0,08 
49 0,08 0,05 0,07 0,07 0,03 0,09 0,04 0,07 0,05 0,06 0,02 0,03 0,02 0,04 0,07 0,07 0,04 0,09 
50 0,16 0,09 0,13 0,13 0,05 0,16 0,09 0,13 0,11 0,11 0,04 0,08 0,04 0,10 0,11 0,13 0,09 0,23 
51 0,07 0,07 0,06 0,05 0,03 0,07 0,05 0,06 0,04 0,05 0,03 0,04 0,02 0,05 0,07 0,06 0,06 0,06 
52 0,13 0,07 0,11 0,11 0,05 0,15 0,08 0,11 0,07 0,09 0,04 0,05 0,03 0,08 0,09 0,13 0,09 0,09 
53 0,09 0,10 0,10 0,08 0,04 0,18 0,05 0,09 0,06 0,08 0,02 0,02 0,02 0,07 0,07 0,11 0,08 0,07 
54 0,15 0,13 0,10 0,10 0,07 0,13 0,09 0,10 0,09 0,12 0,03 0,08 0,03 0,09 0,11 0,14 0,09 0,13 
55 0,11 0,05 0,06 0,06 0,04 0,07 0,05 0,07 0,05 0,06 0,03 0,03 0,02 0,06 0,06 0,07 0,07 0,06 
56 0,10 0,05 0,06 0,06 0,04 0,06 0,04 0,06 0,04 0,05 0,01 0,03 0,02 0,05 0,07 0,08 0,05 0,05 
57 0,12 0,08 0,10 0,12 0,05 0,13 0,06 0,10 0,05 0,08 0,04 0,03 0,02 0,07 0,10 0,11 0,09 0,08 
58 0,10 0,05 0,10 0,10 0,05 0,14 0,06 0,10 0,06 0,09 0,02 0,05 0,03 0,06 0,08 0,10 0,06 0,08 
59 0,13 0,05 0,04 0,04 0,02 0,07 0,04 0,04 0,02 0,04 0,01 0,01 0,00 0,07 0,04 0,07 0,06 0,04 
60 0,10 0,06 0,14 0,14 0,04 0,16 0,08 0,13 0,12 0,11 0,03 0,06 0,03 0,08 0,12 0,13 0,08 0,10 
61 0,08 0,05 0,07 0,07 0,03 0,08 0,05 0,08 0,08 0,07 0,02 0,03 0,02 0,05 0,08 0,10 0,05 0,09 
62 0,06 0,04 0,04 0,04 0,03 0,03 0,04 0,04 0,04 0,06 0,02 0,04 0,02 0,05 0,07 0,08 0,06 0,05 
63 0,09 0,07 0,16 0,12 0,04 0,22 0,08 0,14 0,08 0,09 0,03 0,05 0,04 0,07 0,06 0,11 0,07 0,06 
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Supplementary Table D.28 – Descriptive statistics of the intensity patterns of the 16 phosphorylated signaling proteins and cleavage of the 2 apoptosis proteins analyzed. The intensity from 
the negative control within each PathScan Intracellular Signaling array was subtracted from all signals, and all data from each array were normalized to the internal positive control within 
each array. 
Parameter Minimum Maximum Mean SD 
Age 18 47 26 7 
Erk1/2 (T202/Y204) 0,05 0,41 0,12 0,07 
Stat1 (Y701) 0,04 0,44 0,12 0,09 
Stat3 (Y705) 0,04 0,51 0,11 0,07 
Akt (T308) 0,04 0,31 0,10 0,05 
Akt (S473) 0,02 0,28 0,08 0,06 
AMPKa (T172) 0,03 0,50 0,16 0,10 
S6 Ribosomal Protein (S235/236) 0,04 0,29 0,09 0,06 
mTOR (S2448) 0,04 0,70 0,16 0,13 
HSP27 (S78) 0,02 0,66 0,13 0,12 
Bad (S112) 0,03 0,38 0,11 0,07 
p70 S6 Kinase (T389) 0,01 0,12 0,04 0,02 
PRAS40 (T246) 0,01 0,44 0,09 0,09 
p53 (S15) 0,00 0,19 0,05 0,04 
p38 (T180/Y182) 0,03 0,50 0,12 0,10 
SAPK/JNK (T183/Y185) 0,04 0,63 0,14 0,10 
PARP (D214) 0,04 0,35 0,11 0,06 
Caspase-3 (D175) 0,03 0,32 0,09 0,07 
GSK-3b (S9) 0,04 0,82 0,19 0,16 
 
